AU7558501A - Calcium receptor active compounds - Google Patents

Description

AUSTRALIA

Patents Act COMPLETE SPECIFICATION

(ORIGINAL)

Class Int. Class Application Number: Lodged: Complete Specification Lodged: Accepted: Published: Priority Related Art: Name of Applicant: Kirin Beer Kabushiki Kaisha and NPS Pharmaceuticals, Inc.

Actual Inventor(s): Teruyuki Sakai, Atsuya Takami, Rika Suzuki Address for Service: PHILLIPS ORMONDE FITZPATRICK Patent and Trade Mark Attorneys 367 Collins Street Melbourne 3000 AUSTRALIA Invention Title: CALCIUM RECEPTOR ACTIVE COMPOUNDS Our Ref: 653133 POF Code: 456097/217479, 352960 The following statement is a full description of this invention, including the best method of performing it known to applicant(s): -1- 8ooq CALCIUM RECEPTOR ACTIVE COMPOUNDS The present application is a divisional application from Australian patent application number 734710 (33597/97), the entire disclosure of which is incorporated herein by reference.

Field of the Invention This invention relates to the design, development, composition and use of novel molecules able to modulate the activity of inorganic ion receptor.

Background of the Invention Certain cells in the body respond not only to chemical signals, but also to ions such as extracellular calcium ions Changes in the concentration of extracellular Ca 2 (referred to herein as "[Ca 2 alter the functional responses of these cells. One such specialized cell is the parathyroid cell which secretes parathyroid hormone (PTH). PTH is the principal endocrine factor regulating Ca2+ homeostasis in the blood and extracellular fluids.

PTH, by acting on bone and kidney cells, increases the level of Ca2+ in the blood. This increase in [Ca 2 then acts as a negative feedback signal, depressing PTH secretion. The reciprocal relationship between [Ca 2 and PTH secretion forms the essential mechanism maintaining bodily Ca 2 homeostasis.

Extracellular Ca 2 acts directly on parathyroid cells to regulate PTH secretion. The existence of a parathyroid cell surface protein which detects changes in [Ca 2 has been confirmed. Brown et al., 366 Nature 574, 1993. In parathyroid cells, this protein acts as a receptor for extracellular Ca 2 ("the calcium receptor"), and detects changes in [Ca 2 and to initiate a functional cellular response, PTH secretion.

S: Extracellular Ca 2 can exert effects on different cell functions, reviewed in Nemeth et al., 11 Cell Calcium 319, 1990. The role of extracellular Ca2+ in parafollicular (C cells) and parathyroid cells is discussed in Nemeth, 11 Cell Calcium 323, 1990. These cells have been shown to express similar Ca 2 receptor. Brown et al., 366 Nature 574, 1993; Mithal et al., 9 Suppl. 1 J. Bone and Mineral Res. s282, 1994; Rogers et al., 9 Suppl. 1 J. Bone and Mineral Res. s409, 1994; Garrett et al., 9 Suppl. 1 J. Bone and Mineral Res. s409, 1994. The role of extracellular Ca 2 on bone osteoclasts is discussed by Zaidi, -1Q Bioscience Reports 493, 1990. in addition keratinocytes, juxtaglomerular cells, trophoblasts, pancreatic beta cells and fat/adipose cells all respond to increases in extracellular calcium which likely reflects activation of calcium receptors of these cells.

The ability of various compounds to mimic extracellular Ca2+ in vitro is discussed by Nemeth et al., (spermine and spermidine) in "Calcium-Binding Proteins in Health and Disease", 1987, Academic Press, Inc., pp. 33-35; Brown et al., neomycin) 128 Endocrinology 3047, 1991; Chen et al., (diltiazem and its analog, TA-3090) 5 J. Bone and Mineral Res. 581, 1990; and Zaidi et al., (verapamil) 167 Biochem. Biophys. Res. Commun. 807, 1990. Nemeth et al., PCT/US93/01642, International Publication Number WO 94/18959, Nemeth et al., PCT/US92/07175, International Publication Number WO 93/04373, Nemeth et al., PCT/US94/12117, International Publication Number WO 95/11221 and Nemeth et al., PCT/US95/13704, International Publication .:Number WO 96/12697 describe various compounds which can modulate the o effect of an inorganic ion on a cell having an inorganic ion receptor, preferably modulate the effects of calcium on a calcium receptor.

The object of the present invention is to provide a novel inorganic ion receptor active compound having the structure different from the compounds described above.

Disclosure of the Invention The present invention features molecules which can modulate one or more activities of an inorganic ion receptor. Preferably, the molecule can mimic or block the effect of extracellular Ca 2 on a calcium receptor. The preferred use of such molecules is to treat diseases or disorders by altering inorganic ion receptor activity, preferably calcium receptor activity.

The present invention provides a novel calcium receptor active compound of the formula: Arl-[CR R 2 ]p-X-[CR 3

R

4 q-[CR 5 R6-NR 7

-[CR

8 R]-Ar 2 (1) wherein: -2- -3- Ar 1 is selected from the group consisting of aryl, heteroaryl, bis(arylmethyl)amino, bis(heteroarylmethyl)amino and arylmethyl(heteroarylmethyl)amino; X is selected from the group consisting of oxygen, sulfur, sulfinyl, sulfonyl, carbonyl and amino;

R

2

R

3

R

4

R

5

R

6

R

8 and R 9 are independently selected from the group consisting of hydrogen, alkyl, cycloalkyl, alkenyl, alkynyl, trihalomethyl, aryl, heteroaryl, heteroalicyclic, halogen, hydroxy, alkoxy, thioalkoxy, aryloxy, thioaryloxy, carbonyl, thiocarbonyl, C-carboxyl, O-carboxyl, C-amido, N-amido, O-carbamyl, N-carbamyl, O-thiocarbamyl, N-thiocarbamyl, cyano, nitro, amino and NRioR wherein,

R

10 and R 11 are independently selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, carbonyl, trihaloacetyl, sulfonyl, trihalomethanesulfonyl and, combined, a five- or six-member heteroalicyclic ring containing at least one nitrogen; 15 any two adjacent groups may be combined to form five- or six-member fused cycloalkyl groups; *7

R

7 is selected from the group consisting of hydrogen, alkyl, cycloalkyl, alkenyl, alkynyl, aryl, halogen, cyano, hydroxy, alkoxy, O-carboxyl, trihaloacetyl and trihalomethanesulfonyl; Ar 2 is selected from the group consisting of aryl and heteroaryl; p is an integer of from 0 to 6, inclusive; and, q is an integer of from 0 to 14, inclusive; or a pharmaceutically acceptable salt or hydrate of said compound.

Throughout the description and claims of the specification the word 25 "comprise" and variations of the word, such as "comprising" and "comprises", is not intended to exclude other additives, components, integers or steps.

As used herein, the term "aryl" refers to an all-carbon monocyclic or fused ring polycyclic rings which share adjacent pairs of carbon atoms) groups in which one or more of the rings has a completely conjugated pi-electron system.

Examples, without limitation, of aryl groups, are phenyl, naphthyl, anthracenyl, phenanthrenyl, fluorenyl, and indanyl. The aryl group may be substituted or unsubstituted. When substituted, the substituted group(s) is preferably one or more selected from halogen, trihalomethyl, alkyl, FT A:133597SPC.DOC alkenyl, alkynyl, hydroxy, alkoxy, aryloxy, thiohydroxy, thioalkoxy, thioaryloxy, cyano, nitro, carbonyl, thiocarbonyl, C-carboxy, O-carboxy, O-carbamyl, Ncarbamyl, O-thiocarbamyl, N-thiocarbamyl, C-amido, N-amido, sulfinyl, sulfonyl, S-sulfonamido, N-sulfonamido, trihalomethane- sulfonamido, amino and NR 1 oR 1 1 wherein:

R

1 0 o and R" are independently selected from the group consisting of hydrogen, alkyl, cycloalkyl, aryl, carbonyl, sulfonyl, trihalomethanesulfonyl, and, combined, a five- or six-member heteroalicyclic ring which heteroalicyclic ring may be unsubstituted or substituted with one or more halogens.

A "heteroaryl" group refers to a monocyclic or fused ring rings which share an adjacent pair of atoms) group having in the ring(s) one or more atoms selected from the group consisting of nitrogen, oxygen and sulfur and, in addition, at least one of the rings has a completely conjugated pi-electron system. Examples, without limitation, of heteroaryl groups are pyrrole, furan, dibenzofuran, carbazole, acridine, thiophene, imidazole, benzimidazole, oxazole, thiazole, phenothiazine, triazole, thiadiazole, pyrazole, benzoxazole, benzthiazole, indole, benzofuran, indazole, pyridine, pyrimidine, quinoline, isoquinoline, quinazoline, purine, phthalazine and flavone. The heteroaryl group may be substituted or unsubstituted. When substituted, the substituted group(s) is preferably one or more selected from alkyl, cycloalkyl, halogen, trihalomethyl, hydroxy, alkoxy, aryloxy, thiohydroxy, thioalkoxy, thioaryloxy, cyano, nitro, carbonyl, thiocarbonyl, sulfonamido, C-carboxy, O-carboxy, sulfinyl, sulfonyl, O-carbamyl, N-carbamyl, O-thiocarbamyl, N-thiocarbamyl, C-amido, N-amido, S-sulfonamido, N-sulfonamido, trihalomethanesulfonamido, amino and NR 1 oR" 1 where R'o and R" 1 are previously defined herein.

As used herein, the term "alkyl" refers to a saturated aliphatic hydrocarbon including straight chain and branched chain groups. Preferably, the alkyl group has 1 to 20 carbon atoms. More preferably, it is a medium size alkyl having 1 to 10 carbon atoms. Most preferably, it is a lower alkyl having 1 to 4 carbon atoms. The alkyl group may be substituted or unsubstituted. When -4substituted, the substituent group(s) is preferably one or more individually selected from cycloalkyl, aryl, heteroaryl, heteroalicyclic, hydroxy, alkoxy, aryloxy, thiohydroxy, thioalkoxy, thioaryloxy, cyano, halogen, carbonyl, thiocarbonyl, O-carbamyl, N-carbamyl, O-thiocarbamyl, N-thiocarbamyl, Camido, N-amido, C-carboxy, O-carboxy, nitro, sulfonamido, trihalomethanesulfonamido, amino and NR 10 R" where R 1 0 and R" are previously defined herein. More preferably, the alkyl group is a medium or lower alkyl which is optionally substituted with one or more groups independently selected from halogen, hydroxy, nitro, cyano and unsubstituted lower alkoxy, lower alkoxy substituted with one or more halogens; an unsubstituted lower alkyl; and a lower alkyl substituted with one or more halogens.

A "cycloalkyl" group refers to an all-carbon monocyclic or fused ring rings which share an adjacent pair of carbon atoms) group wherein none of the rings has a completely conjugated pi-electron system. Examples, without limitation, of cycloalkyl groups are cyclopropane, cyclobutane, cyclopentane, cyclopentene, cyclohexane, cyclohexadiene, cycloheptane and, cycloheptatriene. A cycloalkyl group may be substituted or unsubstituted.

When substituted, the substituent group(s) is preferably one or more individually selected from alkyl, aryl, heteroaryl, heteroalycyclic, hydroxy, alkoxy, aryloxy, thiohydroxy, thioalkoxy, thioaryloxy, cyano, halogen, carbonyl, thiocarbonyl, C-carboxy, O-carboxy, O-carbamyl, N-carbamyl, C-amido, Namido, S-sulfonamido, N-sulfonamido, nitro, amino and NR'R 11 where R 10 and R 1 are previously defined herein. Preferably the cycloalkyl group is selected from unsubstituted cyclopropane, unsubstituted cyclopentane, unsubstituted cyclohexane, and cyclopropane, cyclopentane and cyclohexane substituted with one or more groups independently selected from halogen, nitro, cyano, hydroxy, unsubstituted lower alkoxy, C-carboxyl wherein R" is unsubstituted lower alkyl and O-carboxyl wherein R" is unsubstituted lower alkyl.

An "alkenyl" group refers to an alkyl group, as defined herein, consisting of at least two carbon atoms and at least one carbon-carbon double bond. A "lower alkenyl" group refers to a lower alkyl group containing at least one double bond.

A "cycloalkenyl" group refers to a cycloalkyl group which contains one or more double bonds in the ring wherein the double bonds do not produce a completely conjugated pi-electron system within the ring.

An "alkynyl" group refers to an alkyl group, as defined herein, consisting of at least two carbon atoms and at least one carbon-carbon triple bond. A "lower alkynyl" group refers to a lower alkyl group containing at least one triple bond.

A "heteroalicyclic" group refers to a monocyclic or fused ring group having in the ring(s) one or more atoms selected from the group consisting of nitrogen, oxygen and sulfur. The rings may also have one or more double bonds. However, none of the rings has a completely conjugated pi-electron system. The heteroalicyclic ring may be substituted or unsubstituted. When substituted, the substituted group(s) is preferably one or more selected from alkyl, cycloalkyl, halogen, trihalomethyl, hydroxy, alkoxy, aryloxy, thiohydroxy, thioalkoxy, thioaryloxy, cyano, nitro, carbonyl, thiocarbonyl, C-carboxy, Ocarboxy, O-carbamyl, N-carbamyl, O-thiocarbamyl, N-thiocarbamyl, sulfinyl, sulfonyl, S-sulfonamido, N-sulfonamido, C-amido, N-amido, amino and NRIoR" where R' 1 and R 1 are previously defined herein.

A "phenyl" group refers to a six-member ring aryl group.

A "benzyl" group refers to a phenyl-CH 2 group.

A "hydroxy" group refers to an -OH group.

An "alkoxy" group refers to both an -O-alkyl and an -O-cycloalkyl group, as defined herein; preferably an alkoxy group refers to a methoxy or trihalomethoxy.

A "trihalomethoxy" group refers to a Y 3 CO- group with Y as defined herein; preferably Y is fluorine.

A "benzyloxy" refers to a benzyl-O- group.

-6- An "aryloxy" group refers to both an -O-aryl and an -O-heteroaryl group, as defined herein. A "phenoxy" group refers to an aryloxy group in which the aryl group is a phenyl group. A "thiohydroxy" group refers to an -SH group.

A "thioalkoxy" group refers to both an S-alkyl and an -S-cycloalkyl group, as defined herein.

A "thioaryloxy" group refers to both an -S-aryl and an -S-heteroaryl group, as defined herein.

A "carbonyl" or "acyl" group refers to a group, where R" is selected from the group consisting of hydrogen, alkyl, cycloalkyl, aryl, heteroaryl (bonded through a ring carbon) and heteroalicyclic (bonded through a ring carbon), as defined herein.

An "formyl" group refers to a carbonyl group wherein R" is hydrogen.

An "acetyl" group refers to a carbonyl group wherein R" is CHs.

A "thiocarbonyl" group refers to a group, with R" as defined herein.

I A "trihalomethyl" group refers to a -CY 3 group wherein Y is a halogen group; preferably Y is fluorine.

A "trihaloacetyl" group refers to a Y 3 group with Y as defined herein.

A "C-carboxyl" group refers to a groups, with R" as defined herein.

An "O-carboxyl" group refers to a group, with R" as defined herein.

An "acetoxy" group refers to an O-carboxyl group in which R" is CH 3 A "carboxylic acid" group refers to a C-carboxyl group in which R" is hydrogen.

A "halo" or "halogen" group refers to fluorine, chlorine, bromine or iodine.

A "trihalomethanesulfonyl" group refers to a Y 3 CS(=0) 2 groups with Y as defined above.

-7- A "trihalomethanesulfonamido" group refers to a Y 3

CS(=O)

2

NR

1 0 group with Y and R 10 as defined herein.

A "sulfinyl" group refers to a group, with R" as defined herein or R" may not exist if both S-bonds are already in use internally in a particular molecule.

A "sulfonyl" group refers to a 2 R" group, with R" as defined herein or R" may not exist is both S-bonds are already in use internally in an particular molecule.

An "S-sulfonamido" group refers to a 2

NRR

11 with Ro 1 and R 11 as defined herein.

An "N-sulfonamido" group refers to a R'OS(=0) 2 NR"- group, with R 10 and R 11 as defined herein.

An "O-carbamyl" group refers to a -OC(=O)NR'OR" group with R 1 0 and

R

1 as defined herein..

An "N-carbamyl" group refers to a R'OOC(=O)NR"- group, with R 10 and R" as defined herein.

An "O-thiocarbamyl" group refers to a -OC(=S)NRR" 11 group with R 1 0 and R" as defined herein.

An "N-thiocarbamyl" group refers to a R'OOC(=S)NR"- group, with R 10 and R 11 as defined herein.

An "amino" group refers to an -NR 1 oR 11 group, with R 1 0 and R 11 as defined herein.

A "C-amido" group refers to a -C(=O)NRi'R" group with R 10 and R 1 as defined herein.

An "N-amido" group refers to a R'OC(=O)NR"- group, with R 10 and R 11 as defined herein.

A "nitro" group refers to a -NO 2 group.

A "methylenedioxy" group refers to a -OCH 2 0- group in which the two oxygens are covalently bonded to adjacent carbon atoms of an aryl or heteroaryl group.

-8- An "ethylenedioxy" group refers to a -OCH 2

CH

2 0- groups in which the two oxygens are covalently bonded to adjacent carbon atoms of an aryl or heteroaryl group.

Preferably, in the formula R 5 is selected from the group consisting of hydrogen, unsubstituted lower alkyl and lower alkyl substituted with one or more halogens; R 1

R

2

R

3

,R

4

R

5

,R

6 and R 7 are hydrogen; and R 8 and R 9 are independently selected from the group consisting of hydrogen, unsubstituted alkyl, lower alkyl substituted with one or more halogens, unsubstituted alkenyl, lower alkenyl substituted with one or more halogens, unsubstituted alkynyl, alkynyl substituted with one or more halogens and, combined, unsubstituted cycloalkyl and cycloalkenyl. Also preferably, Arl is selected from the group consisting of phenyl, naphthyl, indolyl, fluorenyl, dibenzofuranyl, carbazolyl, benzoxazole-2-yl, benzthiazole-2-yl, pyridin-4-yl, quinolin-2-yl and dibenzylamino and Ar 2 is selected from the group consisting of phenyl, naphthyl, quinolin-4-yl, pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyrimidinyl, furan- 2-yl, furan-3-yl, thiophen-2-yl, thiophen-3-yl, pyrrol-2-yl and pyrrol-3-yl. More preferably, Arl is phenyl substituted with one or more groups selected from the group consisting of unsubstituted lower alkyl, halogen, trihalomethyl, unsubstituted lower alkoxy, trihalomethoxy, trihaloacetyl and nitro, and Ar 2 is selected from the group consisting of optionally substituted phenyl and optionally substituted naphthyl. Even more preferably, Ar 2 is 3-methoxyphenyl or unsubstituted naphthyl. Preferably, R 8 is hydrogen, R 9 is methyl and X is oxygen or sulfur.

In another aspect, the present invention provides a compound of the formula: Ar 3

-(CHR

12 )r-Q-(CH 2 )s-CHR 3

-NH-CR

1 4

R

15 -Ar 4 (2) wherein: Ar 3 is selected from the group consisting of aryl and heteroaryl optionally substituted with one or more groups independently selected from the group consisting of unsubstituted lower alkyl, lower alkyl substituted with one or more halogens, unsubstituted lower alkenyl, lower alkenyl substituted with one or -9more halogens, halogen, hydroxy, unsubstituted lower alkoxy, lower alkoxy substituted with one or more halogens, unsubstituted lower thioalkoxy, nitro, formyl, acetoxy, acetyl, -CH 2 0H, CH 3 CH(OH)-, -C(=O)NH 2 cyano, -N(lower alkyl) 2 phenyl, phenoxy, benzyl, benzyloxy, methylenedioxy, ethylenedioxy, a, a-dimethylbenzyl, and -OCH 2

COOH;

Ar 4 is selected from the group consisting of aryl and heteroaryl optionally substituted with one or more groups independently selected from the group consisting of unsubstituted lower alkyl, lower alkyl substituted with one or more halogens, unsubstituted lower alkenyl, lower alkenyl substituted with one or more halogens, unsubstituted lower alkoxy, lower alkoxy substituted with one or more halogens, hydroxy, lower thioalkoxy, halogen, methylenedioxy, ethylenedioxy, acetoxy, -OCH 2 COOH, -C(=O)NH 2 cyano, and .r is an integer of from 0 to 6, inclusive; s is an integer of from 0 to 14, inclusive; Q is selected from the group consisting of oxygen, sulfur, carbonyl and -NH-;

R'

3 is hydrogen or lower alkyl; and

R

14 and R 15 are independently selected from the group consisting of hydrogen, alkyl and, combined, cycloalkyl and cycloalkenyl; or a pharmaceutically acceptable salt or hydrate of said compound.

Preferably, in the formula Ar 3 is selected from the groups consisting 9 of unsubstituted phenyl, phenyl substituted with one or more groups selected from the group consisting of unsubstituted lower alkyl, lower alkyl substituted with one or more halogens, halogen, unsubstituted lower alkoxy, lower alkoxy substituted with one or more halogens, nitro, dimethylamino and unsubstituted phenyl, and optionally substituted naphthyl; and Ar 4 is selected from the groups consisting of unsubstituted phenyl, phenyl substituted with one or more groups selected from the group consisting of unsubstituted lower alkyl, lower alkyl substituted with one or more halogens, unsubstituted lower alkoxy, lower alkoxy substituted with one or more halogens, and halogen, and optionally substituted naphthyl.

In another aspect, the present invention provides a compound of the formula: Ars-(CHR 16 )t-W-(CH 2 )u-CHR 7

-NH-CH(R'

8 )-Ar 6 (3) wherein: Ar 5 is aryl, dicyclic or tricyclic heteroaryl, arylmethyl(arylmethyl)amino, heteroarylmethy(heteroarylmethyl)amino or arylmethyl(heteroarylmethyl)amino optionally substituted with one or more groups independently selected from the group consisting of unsubstituted lower alkyl, unsubstituted lower alkenyl, halogen, hydroxy, unsubstituted lower alkoxy, unsubstituted lower thioalkoxy, lower alkyl substituted with one or more halogens, lower alkenyl substituted with one or more halogens, lower alkoxy substituted with one or more halogens, nitro, formyl, acetoxy, acetyl, -CH 2

OH,

CH

3 CH(OH)-, -C(=O)NH 2 cyano, -N(unsubstituted lower alkyl) 2 phenyl, phenoxy, benzyl, benzyloxy, a, a -dimethylbenzyl, methylenedioxy, ethylenedioxy and -OCH 2

COOH;

Ar 6 is aryl or dicyclic or tricyclic heteroaryl optionally substituted with one or more groups independently selected from the group consisting of unsubstituted lower alkyl, lower alkyl substituted with one or more halogens, unsubstituted lower alkenyl, lower alkenyl substituted with one or more halogens, unsubstituted lower alkoxy, lower alkoxy substituted with one or more halogens, halogen, hydroxy, unsubstituted lower thioalkoxy, lower thioalkoxy substituted with one or more halogens, benzyloxy, methylenedioxy, ethylenedioxy, acetoxy, -OCH 2 COOH, -C(=O)NH 2 cyano, and t is 0 or 1; u is an integer of from 0 to 11, inclusive; W is selected from the group consisting of oxygen, sulfur, sulfinyl, sulfonyl, carbonyl and amino;

R

16 and R 17 are H or unsubstituted lower alkyl; and

R'

8 is unsubstituted lower alkyl; or a pharmaceutically acceptable salt or hydrate of said compound.

-11 Preferably, in the formula Ar 5 is phenyl, indole, benzothiazole, benzoxazole, dibenzofuran, carbazole, pyridine, fluorene, quinoline, naphthalene, chromenone, tetrahydrobenzothiazepine, dibenzylamino, benzyl(naphthylmethyl)amino, benzyl(pyridylmethyl)amino, thienylmethyl(benzyl)amino, furylmethyl(benzyl)amino or N-alkylpyrrolylmethyl(benzyl)amino optionally substituted with one or more groups independently selected from the group consisting of unsubstituted lower alkyl, halogen, unsubstituted lower alkoxy, lower alkyl substituted with one or more halogens, lower alkoxy substituted with one or more halogens, nitro, dimethylamino and unsubstituted phenyl; and Ar 6 is thiophene, furan, pyrrole, phenyl, naphthalene, pyridine, pyrazine or thiazole optionally substituted with one or more groups independently selected from the group consisting of unsubstituted lower alkyl, halogen, unsubstituted lower alkoxy, lower alkyl .:substituted with one or more halogens, lower alkoxy substituted with one or more halogens, hydroxy and benzyloxy optionally substituted with halogen or methyl. More preferably, Ar 5 is selected from the group consisting of phenyl optionally substituted with one or more groups independently selected from the group consisting of unsubstituted lower alkyl, halogen, unsubstituted lower alkoxy, lower alkyl substituted with one or more halogens and lower alkoxy substituted with one or more halogens; and Ar 6 is 3-methoxyphenyl or anaphthyl, more preferably, cc-naphthyl. Also preferably, Ar 5 is dibenzylamino, benzyl(naphthylmethyl)amino or benzyl(pyridylmethyl)amino optionally S. substituted with one or more groups independently selected from the group consisting of unsubstituted lower alkyl, halogen, unsubstituted lower alkoxy, lower alkyl substituted with one or more halogens and lower alkoxy substituted with one or more halogens, and Are is naphthyl or methoxyphenyl. More preferably, Ar 5 is dibenzylamino optionally substituted with unsubstituted alkyl, and Ar 6 is a-naphthyl.

Preferably, the compound of the present invention represented by the formulae or is the R enantiomer. The present invention also provides a prodrug of any of the compounds described above.

12- The present invention provides a method for modulating calcium receptor activity by using a compound described herein. The featured compounds preferably modulate an interaction of Ca 2 with Ca 2 receptors by mimicking (including potentiating) the effect of Ca 2 on a Ca2' receptor (calcimimetic modulation) or blocking the effect of Ca 2 on a Ca2+ receptor (calcilytic modulation); preferably calcimimetic modulation.

Also provided is a method for the treatment in a patient of disorders characterized by an abnormal concentrations of one or more inorganic ions or other physiological biochemical substances, the concentration of which is regulated by an activity of one or more calcium receptors. In particular, treatment using the compounds disclosed hereof is contemplated for disorders characterized by abnormal extracellular Ca 2 concentration ([Ca 2 or abnormal intracellular Ca 2 concentration ([Ca2+1) in one or more cells including for example, but without limitation, parathyroid cells, bone osteoclasts, juxtaglomerular kidney cells, proximal tubule kidney cells, keratinocytes, parafollicular thyroid cells and placental trophoblasts.

An "abnormal" state is characterized by a level of a property that is statistically different from the level of that property observed in patients not suffering from a particular disorder. Thus, for example, the term "abnormal" as it relates to inorganic ion concentrations refers to a concentration of the ion in question which would be recognized by members of the medical community as being outside the normal range of such ion concentration in healthy patients.

As used herein, the terms "treat", "treating" and "treatment" refer to a method of alleviating, abrogating, and/or having a prophylactic effect with regard to, a disease or disorder and/or one or more, preferably all, its attendant symptoms.

In another aspect, the present invention provides a method for the treatment or prevention of primary and secondary hyperparathyroidism, renalosteodystrophy, hypercalcemia malignancy, osteoporosis, Paget's disease and hypertension comprising administering a therapeutically effective amount of a compound of this invention to a patient.

13 The term "administering" as used herein refers to a method for introducing a compound of this invention in vitro or in vivo. Thus, for example, the importance of inorganic ion receptor activity can be studied and associated diseases and disorders prevented or treated by the compounds and methods set forth herein. Cells existing outside the organism can be maintained or grown in cell culture dishes. In this context, the ability of a particular compound to affect an inorganic ion receptor activity can be determined; the IC50 or preferably the EC50, of a compound, defined below, before the use of the compounds in complex multicellular living organisms such as a human is attempted. For cells outside the organism, multiple methods exist, and are well-known to those skilled in the arts, to administer compounds including, but enot limited to, cell micro-injection, transformation and numerous carrier techniques.

For cells harbored within a multicellular living organism, myriad methods also exist, and are likewise well-known to those skilled in the art, to administer 5.5* compounds including, but not limited to, oral, parenteral, dermal, injection and aerosol applications.

•The present invention features a method for the modulation of one or So..

more activities of an inorganic ion receptor using the compounds disclosed herein. Preferably, the inorganic ion receptor is a Ca 2 receptor. The compounds of this invention can either mimic (including potentiation) or block the effect of extracellular Ca 2 on a calcium receptor. The preferred use of such compounds is to treat selected disorders by modulating the inorganic ion receptor activity. In particular the compounds of this invention can be used to treat the indicated disorders by modulating Ca 2 receptor activity.

Extracellular Ca 2 is under tight homeostatic control and controls various processes such as blood clotting, nerve and muscle excitability, and proper bone formation. Calcium receptor proteins enable certain specialized cells to respond to changes in extracellular Ca2+ concentration. For example, extracellular Ca 2 inhibits the secretion of parathyroid hormone from -14parathyroid cells, inhibits bone resorption by osteoclasts, and stimulates secretion of calcitonin from C-cells.

Compounds modulating inorganic ion receptor activity can be used to treat diseases or disorders by affecting one or more activities of an inorganic ion receptor resulting in a beneficial effect to the patient. For example, osteoporosis is an age related disorder characterized by loss of bone mass and increased risk of bone fracture. Compounds blocking osteoclastic bone resorption either directly a osteoclast ionmimetic compound) or indirectly by increasing endogenous calcitonin levels a C-cell ionmimetic), and/or by decreasing parathyroid hormone levels a parathyroid cell ionmimetic) can retard bone loss and, thus, result in beneficial effects to patients suffering from osteoporosis.

In addition, it is known that intermittent low dosing with PTH results in an anabolic effect on bone mass and appropriate bone remodeling. Thus, compounds and dosing regiments evoking transient increases in parathyroid *ooo hormone intermittent dosing with a parathyroid cell ionlytic) can increase bone mass in patients suffering from osteoporosis.

Additionally, diseases or disorders characterized by a defect in one or more inorganic ion receptor activities may be treated by the present invention.

0. be For example, certain forms of primary hyperparathyroidism are characterized by abnormally high levels of parathyroid hormone and decreased parathyroid gland responsiveness to circulating calcium. Calcium receptor modulating agents can be used to modulate parathyroid cell responsiveness to calcium.

Preferably, the compound modulates calcium receptor activity and is used in the treatment of diseases or disorders which can be affected by modulating one or more activities of a calcium receptor. Preferably, the disease or disorder is characterized by abnormal bone and mineral homeostasis, more preferably calcium homeostasis.

Abnormal calcium homeostasis is characterized by one or more of the following activities: an abnormal increase or decrease in serum calcium; (2) an abnormal increase or decrease in urinary excretion of calcium; an abnormal increase or decrease in bone calcium levels, for example, as assessed by bone mineral density measurements; an abnormal absorption of dietary calcium; and an abnormal increase or decrease in the production and/or release of circulating messengers or hormones which affect calcium homeostasis such as parathyroid hormone and calcitonin. The abnormal increase or decrease in these different aspects of calcium homeostasis is relative to that occurring in the general population and is generally associated with a disease or disorder.

More generally, a molecule which modulates the activity of an inorganic ion receptor is useful in the treatment of diseases characterized by abnormal inorganic ion homeostasis. Preferably, the molecule modulates one or more effects of an inorganic ion receptor. Inorganic ion receptor modulating agents include ionmimetics, ionlytics, calcimimetics, and calcilytics.

lonmimetics are molecules which mimic the effects of increasing ion concentration at an inorganic ion receptor. Preferably, the molecule affects one or more calcium receptor activities. Calcimimetics are ionmimetics which affect one or more calcium receptor activities and preferably binds to a calcium receptor.

lonlytics are molecules which reduce or block one or more activities caused by an inorganic ion on an inorganic ion receptor. Preferably, the molecule inhibits one or more calcium receptor activities. Calcilytics are ionlytics which inhibit one or more calcium receptor activities evoked by extracellular calcium and preferably bind to a calcium receptor.

Inorganic ion receptor modulating agents can be formulated as pharmacological agents or compositions to facilitate administration in a patient.

Pharmacological agents or compositions are agents or compositions in a form suitable for administration into a mammal, preferably a human, considerations concerning forms suitable for administration are known in the art and include toxic effects, solubility, route of administration, and maintaining activity.

Other aspects of the present invention feature methods for using the agents described herein for treating diseases or disorders by modulating -16inorganic ion receptor activity. Patients in need of such treatments can be identified by standard medical techniques, such as routine blood analysis. For example, by detecting a deficiency of protein whose production or secretion is affected by changes in inorganic ion concentrations, or by detecting abnormal levels of inorganic ions or hormones which effect inorganic ion homeostasis.

Therapeutic methods involve administering to the patient a therapeutically effective amount of an inorganic ion receptor modulating agent.

In preferred embodiments these methods are used to treat a disease or disorder characterized by abnormal inorganic ion homeostasis, more preferably a disease or disorder characterized by abnormal calcium homeostasis. Diseases and disorders characterized by abnormal calcium homeostasis include hyperparathyroidism, osteoporosis, renalosteodystrophy and other bone and mineral-related disorders, and the like (as described, e.g., in standard medical text books, such as "Harrison's Principles of Internal Medicine"). Such diseases and disorders are treated using calcium receptor modulating agents which mimic or block one or more of the effects of Ca 2 and, thereby, directly or indirectly affect the levels of proteins or other molecules in

S

the body of the patient.

By "therapeutically effective amount" is meant an amount of an agent 'which relieves to some extent one or more symptoms of the disease or disorder in the patient; or returns to normal either partially or completely one or more physiological or biochemical parameters associated with or causative of the disease or disorder.

In a preferred embodiment, the patient has a disease or disorder characterized by an abnormal level of one or more calcium receptor regulated components and the molecule is active on a calcium receptor of a cell selected from the group consisting of parathyroid cell, bone osteoclast, juxtaglomerular kidney cell, proximal tubule kidney cell, distal tubule kidney cell, central nervous system cell, peripheral nervous system cell, cell of the thick ascending limb of Henle's loop and/or collecting duct, keratinocyte in the epidermis, parafollicular cell in the thyroid (C-cell), intestinal cell, trophoblast in the placenta, platelet, -17vascular smooth muscle cell, cardiac atrial cell, gastrin-secreting cell, glucagon-secreting cell, kidney mesangial cell, mammary cell, beta cell, fat/adipose cell, immune cell and GI tract cell.

More preferably, the cell is a parathyroid cell and the molecule reduces the level of parathyroid hormone in the serum of the patient, even more preferably the level is reduced-to a degree sufficient to cause a decrease in 2+ plasma Ca 2 most preferably the parathyroid hormone level is reduced to that present in a normal individual.

Thus, the present invention features agents and methods useful in the treatment of diseases and disorders by modulating inorganic ion receptor activity. For example, the molecules of the present invention can be used to target calcium receptors on different cell types that detect and respond to changes to external calcium. For example, molecules mimicking external i. ~:calcium may be used to selectively depress secretion of parathyroid hormone from parathyroid cells, or depress bone resorption by osteoclasts, or stimulate secretion of calcitonin from C-cells. Such molecules can be used to treat diseases or disorders characterized by abnormal calcium homeostasis such as

.IO

hyperparathyroidism, renalosteodystrophy and osteoporosis.

Other features and advantages of the invention will be apparent from the following description of the preferred embodiments thereof and from the claims.

Brief Description of Drawings i Fig. 1 shows the structures of the compounds of the present invention S synthesized in Examples 1 to 23.

Fig. 2 shows the scheme of the synthesis of the compound of the present invention of the formula wherein X is O.

Fig. 3 shows the scheme of the synthesis of the compound of the present invention of the formula wherein X is S.

Fig. 4 shows the scheme of the synthesis of the compound of the present invention of the formula wherein Arl is benzothiazole or benzoxazole.

-18- Fig. 5 shows the structures of the compounds of the present invention synthesized in Examples 24 to 26 and the scheme of the synthesis thereof.

Fig. 6 shows the structures of the compounds of the present invention synthesized in Examples 27 to 32 and the scheme of the synthesis thereof.

Fig. 7 shows the structures of the compounds of the present invention synthesized in Examples 33 to 36 and the scheme of the synthesis thereof.

Fig. 8 shows the structures of the compounds of the present invention synthesized in Examples 37 to 40 and the scheme of the synthesis thereof.

Fig. 9 shows the structures of the compounds of the present invention synthesized in Examples 41 and 42 and the scheme of the synthesis thereof.

Fig. 10 shows the structures of the compounds of the present invention synthesized in Examples 43 to 56.

*Fig. 11 shows the structures of the compounds of the present invention synthesized in Examples 57 to Fig. 12 shows the structures of the compounds of the present invention synthesized in Examples 71 to 84.

Fig. 13 shows the structures of the compounds of the present invention synthesized in Examples 85 and 86.

Fig. 14 shows the structure of the compound of the present invention synthesized in Example 88 and the scheme of the synthesis thereof.

Fig. 15 shows the structures of the compounds of the present invention synthesized in Examples 89 and Fig. 16 shows the structure of the compound of the present invention synthesized in Examples 91 to 93 and the scheme of the synthesis thereof.

Fig. 17 shows the structures of the compounds of the present invention synthesized in Examples 94 to 96 and the scheme of the synthesis thereof.

Fig. 18 shows the structures of the compounds of the present invention synthesized in Examples 97 to 100 and the scheme of the synthesis thereof.

Fig. 19 shows the structures of the compounds of the present invention synthesized in Examples 101 to 103 and the scheme of the synthesis thereof.

19- Fig. 20 shows the structures of the compounds of the present invention synthesized in Examples 104 to 106 and the scheme of the synthesis thereof.

Fig. 21 shows the structures of the compounds of the present invention synthesized in Examples 107 to 109 and the scheme of the synthesis thereof.

Fig. 22 shows the structures of the compounds of the present invention synthesized in Examples 110 to 112 and the scheme of the synthesis thereof.

Fig. 23 shows the structures of the compounds of the present invention synthesized in Examples 113 to 115 and the scheme of the synthesis thereof.

Fig. 24 shows the structures of the compounds of the present invention synthesized in Examples 116 to 118 and the scheme of the synthesis thereof.

Fig. 25 shows the structures of the compounds of the present invention synthesized in Examples 119 to 121 and the scheme of the synthesis thereof.

*Fig. 26 shows the structures of the compounds of the present invention S.synthesized in Examples 122 to 134.

Fig. 27 shows the structures of the compounds of the present invention synthesized in Examples 135 to 147.

Fig. 28 shows the structures of the compounds of the present invention synthesized in Examples 148 to 189.

Fig. 29 shows the structures of the compounds of the present invention *synthesized in Examples 190 to 231.

Fig. 30 shows the structures of the compounds of the present invention synthesized in Examples 232 to 271.

S"Fig. 31 shows the structures of the compounds of the present invention synthesized in Examples 272 to 313.

Fig. 32 shows the structures of the compounds of the present invention synthesized in Examples 314 to 355.

Fig. 33 shows the structures of the compounds of the present invention synthesized in Examples 356 to 387.

Fig. 34 shows the structures of the compounds of the present invention synthesized in Examples 388 to 407.

20 Fig. 35 shows the structures of the compounds of the present invention synthesized in Examples 408 to 413.

Fig. 36 shows the structures of the compounds of the present invention synthesized in Examples 416 to 428.

Fig. 37 shows the structures of the compounds of the present invention synthesized in Examples 429 to 441.

Fig. 38 shows the structures of the compounds of the present invention synthesized in Examples 442 to 455.

Fig. 39 shows the structures of the compounds of the present invention synthesized in Examples 456 to 469.

Fig. 40 shows the structures of the compounds of the present invention ,*,synthesized in Examples 470 to 480.

Fig. 41 shows the structures of the compounds of the present invention i,;°:synthesized in Examples 481 to 490.

Fig. 42 shows the structures of the compounds of the present invention synthesized in Examples 491 to 495.

Fig. 43 shows the structures of the compounds of the present invention synthesized in Examples 496 to 504.

Fig. 44 shows the structures of the compounds of the present invention synthesized in Examples 505 to 517.

Fig. 45 shows the structures of the compounds of the present invention synthesized in Examples 518 to 529.

Fig. 46 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2027 was administered.

Fig. 47 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2052 was administered.

Fig. 48 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2076 was administered.

Fig. 49 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2087 was administered.

-21 Fig. 50 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2117 was administered.

Fig. 51 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2240 was administered.

Fig. 52 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2243 was administered.

Fig. 53 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2246 was administered.

Fig. 54 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2247 was administered.

Fig. 55 shows changes in the plasma Ca 2 level of the rats to which the *i **compound of the present invention K-2250 was administered.

Fig. 56 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2257 was administered.

Fig. 57 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2259 was administered.

Fig. 58 shows changes in the plasma Ca2+ level of the rats to which the compound of the present invention K-2262 was administered.

Fig. 59 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2263 was administered.

Fig. 60 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2264 was administered.

S"Fig. 61 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2265 was administered.

Fig. 62 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2266 was administered.

Fig. 63 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2267 was administered.

Fig. 64 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2269 was administered.

22- Fig. 65 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2270 was administered.

Fig. 66 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2271 was administered.

Fig. 67 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2272 was administered.

Fig. 68 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2279 was administered.

Fig. 69 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2280 was administered.

Fig. 70 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2281 was administered.

2+ Fig. 71 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2282 was administered.

2+ ~Fig. 72 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2283 was administered.

Fig. 73 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2284 was administered.

Fig. 74 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2286 was administered.

Fig. 75 shows changes in the plasma Ca2+ level of the rats to which the •compound of the present invention K-2287 was administered.

2+

:II

Fig. 76 shows changes in the plasma Ca. level of the rats to which the compound of the present invention K-2288 was administered.

Fig. 77 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2289 was administered.

Fig. 78 shows changes in the plasma Ca2+ level of the rats to which the compound of the present invention K-2290 was administered.

Fig. 79 shows changes in the plasma Ca level of the rats to which the compound of the present invention K-2291 was administered.

23- Fig. 80 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2292 was administered.

Fig. 81 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2293 was administered.

Fig. 82 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2294 was administered.

Fig. 83 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2296 was administered.

Fig. 84 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2297 was administered.

Fig. 85 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2298 was administered.

Fig. 86 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2299 was administered.

oFig. 87 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2300 was administered.

Fig. 88 shows changes in the plasma Ca 2 level of the rats to which the

.O

compound of the present invention K-2301 was administered.

oo•. Fig. 89 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2302 was administered.

Fig. 90 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2303 was administered.

.i Fig. 91 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2304 was administered.

Fig. 92 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2305 was administered.

Fig. 93 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2309 was administered.

Fig. 94 shows changes in the plasma Ca 2 level of the rats to which the compound of the present invention K-2310 was administered.

-24- Fig. 95 shows changes in the serum PTH level of the rats to which the compound of the present invention K-2076, K-2117 or K-2259 was administered.

Fig. 96 shows relative changes in the serum PTH level of the rats to which the compound of the present invention K-2076, K-2117 or K-2259 was administered to the pre-administration level.

Preferred Embodiments of the Invention The present invention describes inorganic ion receptor modulating agents able to mimic or block an effect of an inorganic ion at an inorganic ion receptor. The preferred use of inorganic ion receptor modulating agents is to treat a disease or disorder by modulating inorganic ion receptor activity.

Preferably, the molecules are used to treat diseases or disorders characterized by abnormal ion homeostasis, more preferably abnormal calcium homeostasis.

Other uses of inorganic ion receptor modulating agents, such as diagnostics uses, are known in the art. Nemeth et al., PCT/US93/01642, International Publication Number WO 94/18959.

1 I. CALCIUM RECEPTORS Calcium receptors and nucleic acid encoding calcium receptors are described by Nemeth et al., PCT/US93/01642, International Publication Number WO 94/18959. Calcium receptors are present on different cell types such as parathyroid cell, bone osteoclast, juxtaglomerular kidney cell, proximal tubule kidney cell, distal tubule kidney cell, central nervous system cell, peripheral nervous system cell, cell of the thick ascending limb of Henle's loop and/or collecting duct, keratinocyte in the epidermis, parafollicular cell in the thyroid (C-cell), intestinal cell, trophoblast in the placenta, platelet, vascular smooth muscle cell, cardiac atrial cell, gastrin-secreting cell, glucagonsecreting cell, kidney mesangial cell, mammary cell, beta cell, fat/adipose cell, immune cell, and GI tract cell. The calcium receptor on these cell types may be different. It is also possible that a cell can have more than one type of calcium receptor.

25 Comparison of calcium receptor activities and amino acid sequences from different cells indicate that distinct calcium receptor types exist. For example, calcium receptors can respond to a variety of di- and trivalent cations.

The parathyroid calcium receptor responds to calcium and Gd 3 while osteoclasts respond to divalent cations such as calcium but does not respond to Gd3+. Thus, the parathyroid calcium receptor is pharmacologically distinct from calcium receptor on the osteoclast.

On the other hand, the nucleic acid sequences encoding calcium receptors present in parathyroid cells and C-cells indicate that these receptors have a very similar amino acid structure. Nevertheless, calcimimetic compounds exhibit differential pharmacology and regulate different activities at parathyroid cells and C-cells. Thus, pharmacological properties of calcium receptors may vary significantly depending upon the cell type or organ in which .**they are expressed even though the calcium receptors may have similar structures.

Calcium receptors, in general, have a low affinity for extracellular Ca 2 (apparent Kd generally greater than about 0.5 mM). Calcium receptors may include a free or bound effector mechanism as defined by Cooper, Bloom and Roth, "The Biochemical Basis of Neuropharmacology", Ch. 4, and are thus distinct from intracellular calcium receptors, calmodulin and the troponins.

Calcium receptors respond to changes in extracellular calcium levels.

i The exact changes depend on the particular receptor and cell line containing the receptor. For example, the in vitro effect of calcium on the calcium receptor in a parathyroid cell include the following: 1. An increase in internal calcium. The increase is due to the influx of external calcium and/or mobilization of internal calcium. Characteristics of the increase in internal calcium include the following: A rapid (time to peak 5 seconds) and transient increase in that is refractory to inhibition by 1 mM La 3 or 1 mM Gd 3 and is abolished by pretreatment with ionomycin (in the absence of extracellular Ca 2 26 The increase is not inhibited by dihydropyridines; The transient increase is abolished by pretreatment for 10 minutes with mM sodium fluoride; The transient increase is diminished by pretreatment with an activator of protein kinase C (PKC), such as phorbol myristate acetate (PMA), mezerein or (-)-indolactam V. The overall effect of the protein kinase C activator is to shift the concentration-response curve to calcium to the right without affecting the maximal response; and Treatment with pertussis toxin (100 ng/ml for 4 hours) does not affect the increase.

2. A rapid 30 seconds) increase in the formation of inositol-1,4,5o*o. triphosphate or diacylglycerol. Treatment with pertussis toxin (100 ng/ml for 4 hours) does not affect this increase; 3. The inhibition of dopamine- and isoproterenol-stimulated cyclic AMP formation. This effect is blocked by pretreatment with pertussis toxin (100 ng/ml for 4 hours); and 4. The inhibition of PTH secretion. Treatment with pertussis toxin (100 ng/ml for 4 hours) does not affect the inhibition in PTH secretion.

Using techniques known in the art, the effect of calcium on other calcium receptors in different cells can be readily determined. Such effects may be similar in regard to the increase in internal calcium observed in parathyroid cells. However, the effect is expected to differ in other aspects, such as causing or inhibiting the release of a hormone other than parathyroid hormone.

II. INORGANIC ION RECEPTOR MODULATING AGENTS Inorganic ion receptor modulating agents either evokes one or more inorganic ion receptor activities, or blocks one or more inorganic ion receptor activities caused by an extracellular inorganic ion. Calcium receptor modulating agents can mimic or block an effect of extracellular Ca 2 on a calcium receptor. Preferred calcium receptor modulating agents are calcimimetics and calcilytics.

27 Inorganic ion receptor modulating agents can be identified by screening molecules which are modeled after a molecule shown to have a particular activity a lead molecule). Nemeth et al., PCT/US93/01642, International Publication Number WO 94/18959.

Preferred inorganic ion receptor modulation agents described by the present invention have considerably low ECs 0 values.

The EC 50 is the concentration of the molecule which evokes a halfmaximal effect. The ICso is the concentration of molecule which causes a half-maximal blocking effect. The EC 50 or IC50 can be determined by assaying one or more of the activities of an inorganic ion at an inorganic ion receptor.

Preferably, such assays are specific to a particular calcium receptor. For example, assays which measure hormones whose production or secretion is modulated by a particular inorganic ion receptor are preferred.

Increases in [Ca2 2 1, can be detected using standard techniques such as by using fluorimetric indicators or by measuring an increase in CI current in a Xenopus oocyte injected with nucleic acid coding for a calcium receptor.

Nemeth et al., PCT/US93/01642, International Publication Number WO 94/18959. For example, poly(A) mRNA can be obtained from cells expressing a calcium receptor, such as a parathyroid cell, bone osteoclast, juxtaglomerular .kidney cell, proximal tubule kidney cell, distal tubule kidney cell, cell of the thick ascending limb of Henle's loop and/or collecting duct, keratinocyte in the epidermis, parafollicular cell in the thyroid (C-cell), intestinal cell, central nervous system cell, peripheral nervous system cell, trophoblast in the placenta, platelet, vascular smooth muscle cell, cardiac atrial cell, gastrinsecreting cell, glucagon-secreting cell, kidney mesangial cell, mammary cell, beta cell, fat/adipose cell, immune cell, and GI tract cell. Preferably, the nucleic acid is from a parathyroid cell, C-cell, or osteoclast. More preferably, the nucleic acid encodes a calcium receptor and is present on a plasmid or vector.

Preferably, the molecule is either a calcimimetic or calcilytic having an

EC

5 0 or IC5o at a calcium receptor of less than or equal to 5 mM, and even more preferably less than or equal to 1 mM, 100 nmolar, 10 nmolar, or 1 nmolar.

28 Such lower EC 50 's or ICso's are advantageous since they allow lower concentrations of molecules to be used in vivo or in vitro for therapy or diagnosis. The discovery of molecules with such low ECso's and IC50's enables the design and synthesis of additional molecules having similar potency and effectiveness.

In preferred embodiments the calcium receptor modulating agent is a calcimimetic which inhibits parathyroid hormone secretion from a parathyroid cell in vitro and decreases PTH secretion in vivo; stimulates calcitonin secretion from a C-cell in vitro and elevates calcitonin levels in vivo; or blocks osteoclastic bone resorption in vitro and inhibits bone resorption in vivo.

In another preferred embodiment the calcium receptor modulating agent is a calcilytic which evokes the secretion of parathyroid hormone from parathyroid cells in vitro and elevates the level of parathyroid hormone in vivo.

Preferably, the agent selectively targets inorganic ion receptor activity, more preferably calcium receptor activity, in a particular cell. By "selectively" is meant that the molecule exerts a greater effect on inorganic ion receptor activity in one cell type than at another cell type for a given concentration of agent. Preferably, the differential effect is 10-fold or greater. Preferably, the concentration refers to blood plasma concentration and the measured effect is the production of extracellular messengers such as plasma calcitonin, parathyroid hormone or plasma calcium. For example, in a preferred embodiment, the agent selectively targets PTH secretion over calcitonin secretion.

In another preferred embodiment, the molecule has an EC 5 0 or IC50 less than or equal to 1 mM at one or more, but not all cells chosen from the group consisting of parathyroid cell, bone osteoclast, juxtaglomerular kidney cell, proximal tubule kidney cell, distal tubule kidney cell, cell of the thick ascending limb of Henle's loop and/or collecting duct, central nervous system cell, peripheral nervous system cell, keratinocyte in the epidermis, parafollicular cell in the thyroid (C-cell), intestinal cell, trophoblast in the placenta, platelet, vascular smooth muscle cell, cardiac atrial cell, gastrin-secreting cell, 29 glucagon-secreting cell, kidney mesangial cell, mammary cell, beta cell, fat/adipose cell, immune cell and GI tract cell.

Preferably, inorganic ion receptor modulating agents mimic or block all of the effects of extracellular ion in a cell having an inorganic ion receptor. For example, calcium receptor modulating agents preferably mimic or block all of the effects of extracellular ion in a cell having a calcium receptor.

Calcimimetics need not possess all the biological activities of extracellular Ca 2 but, rather, at least one such activity is mimicked. Similarly, calcilytics need not reduce or prevent all of the activities caused by extracellular calcium.

Additionally, different calcimimetics and different calcilytics do not need to bind to the same site on the calcium receptor as does extracellular Ca 2 to exert their effects.

A. Calcimimetics The ability of molecules to mimic or block the activity of Ca 2 at calcium receptors can be determined using procedures known in the art and described by Nemeth et al., PCT/US93/01642, International Publication Number WO 94/18959. For example, calcimimetics possess one or more and preferably all of the following activities when tested on parathyroid cells in vitro: 1. The molecule causes a rapid (time to peak 5 seconds) and transient increase in [Ca2+]1 that is refractory to inhibition by 1 mM La 3 or 1 mM Gd 3 The increase in [Ca2+1 persists in the absence of extracellular Ca 2 but is abolished by pretreatment with ionomycin (in the absence of extracellular Ca 2 2. The molecule potentiates increases in [Ca 2 1 elicited by submaximal concentrations of extracellular Ca2+; 3. The increase in [Ca 2 1i elicited by extracellular Ca 2 is not inhibited by dihydropyridines; 4. The transient increase in [Ca 2 li caused by the molecule is abolished by pretreatment for 10 minutes with 10 mM sodium fluoride; The transient increase in [Ca 2 1, caused by the molecule is diminished by pretreatment with an activator of protein kinase C (PKC), such as phorbol myristate acetate (PMA), mezerein or (-)-indolactam V. The overall effect of the protein kinase C activator is to shift the concentration-response curve of the molecule to the right without affecting the maximal response; 6. The molecule causes a rapid 30 seconds) increase in the formationof inositol-1,4,5-triphosphate and/or diacylglycerol; 7. The molecule inhibits dopamine- or isoproterenol-stimulated cyclic AMP formation; 8. The molecule inhibits PTH secretion; 9. Pretreatment with pertussis toxin (100 ng/ml for 4 hours) blocks the inhibitory effect of the molecule on cyclic AMP formation but does not effect increases in [Ca2 2 1i, inositol-1,4,5-triphosphate, or diacylglycerol, nor decreases in PTH secretion; S10. The molecule elicits increases in Clr current in Xenopus oocytes injected *g with poly enriched mRNA from bovine or human parathyroid cells, but is without effect in Xenopus oocytes injected with water, or rat brain or liver mRNA; and •11. Similarly, using a cloned calcium receptor from a parathyroid cell, the molecule will elicit a response in Xenopus oocytes injected with the specific cDNA or mRNA encoding the receptor.

Different calcium activities can be measured using available techniques.

Nemeth et al., PCT/US93/01642, International Publication Number WO 94/18959. Parallel definitions of molecules mimicking Ca 2 activity on other calcium responsive cell, preferably at a calcium receptor, are evident from the examples provided herein and Nemeth et al., PCT/US93/01642, International Publication Number WO 94/18959.

Preferably, the agent as measured by the bioassays described herein, or by Nemeth et al., PCT/US93/01642, International Publication Number WO 94/18959, has one or more, more preferably all of the following activities: evokes a transient increase in internal calcium, having a duration of less that seconds (preferably by mobilizing internal calcium); evokes a rapid increase in [Ca 2 1i, occurring within thirty seconds; evokes a sustained increase (greater 31 than thirty seconds) in [Ca 2 1i (preferably by causing an influx of external calcium); evokes an increase in inositol-1,4,5-triphosphate or diacylglycerol levels, preferably within less than 60 seconds; and inhibits dopamine- or isoproterenol-stimulated cyclic AMP formation.

The transient increase in [Ca2 2 1, is preferably abolished by pretreatment of the cell for ten minutes with 10 mM sodium fluoride, or the transient increase is diminished by brief pretreatment (not more than ten minutes) of the cell with an activator of protein kinase C, preferably, phorbol myristate acetate (PMA), mezerein or (-)-indolactam V.

B. Calcilytics The ability of a molecule to block the activity of external calcium can be determined using standard techniques. Nemeth et al., PCT/US93/01642, International Publication Number WO 94/18959. For example, molecules which block the effect of external calcium, when used in reference to a parathyroid cell, possess one or more, and preferably all of the following characteristics when tested on parathyroid cells in vitro: 1. The molecule blocks, either partially or completely, the ability of increased concentrations of extracellular Ca 2 to: increase [Ca 2 1" mobilize intracellular Ca 2 increase the formation of inositol-1,4,5-triphosphate, decrease dopamine- or isoproterenol-stimulated cyclic AMP formation, and inhibit PTH secretion; 2. The molecule blocks increases in CIl current in Xenopus oocytes injected with poly (A) mRNA from bovine or human parathyroid cells elicited by extracellular Ca 2 or calcimimetic compounds, but not in Xenopus oocytes injected with water or liver mRNA; 3. Similarly, using a cloned calcium receptor from a parathyroid cell, the molecule will block a response in Xenopus oocytes injected with the specific 32cDNA, mRNA or cRNA encoding the calcium receptor, elicited by extracellular Ca 2 or a calcimimetic compound.

Parallel definitions of molecules blocking Ca 2 activity on a calcium responsive cell, preferably at a calcium receptor, are evident from the examples provided herein and Nemeth et al., PCT/US93/01642, International Publication Number WO 94/18959.

II. TREATMENT OF DISEASES OR DISORDERS A preferred use of the compounds described by the present invention is in the treatment or prevention of different diseases or disorders by modulating inorganic ion receptor activity. The inorganic ion receptor modulating agents of the present invention can exert an affect on a inorganic ion receptor causing one or more cellular effects ultimately producing a therapeutic effect.

.Different diseases and disorders can be treated by the present invention by targeting cells having an inorganic ion receptor, such as a calcium receptor.

For example, primary hyperparathyroidism (HPT) is characterized by hypercalcemia and elevated levels of circulating PTH. A defect associated with the major type of HPT is a diminished sensitivity of parathyroid cells to negative feedback regulation by extracellular Ca 2 Thus, in tissue from patients with primary HPT, the "set-point" for extracellular Ca 2 is shifted to the right so that higher than normal concentrations of extracellular Ca 2 are required to depress PTH secretion. Moreover, in primary HPT, even high concentrations of extracellular Ca 2 often depress PTH secretion only partially. In secondary S" (uremic) HPT, a similar increase in the set-point for extracellular Ca 2 is observed even though the degree to which Ca 2 suppresses PTH secretion is normal. The changes in PTH secretion are paralleled by changes in [Ca 2 the set-point for extracellular Ca2'-induced increases in [Ca2+] is shifted to the right and the magnitude of such increases is reduced.

Molecules that mimic the action of extracellular Ca 2 are beneficial in the long-term management of both primary and secondary HPT. Such molecules provide the added impetus required to suppress PTH secretion which the hypercalcemic condition alone cannot achieve and, thereby, help to relieve the -33 hypercalcemic condition. Molecules with greater efficacy than extracellular Ca 2 may overcome the apparent nonsuppressible component of PTH secretion which is particularly troublesome in adenomatous tissue.

Alternatively or additionally, such molecules can depress synthesis of PTH, as prolonged hypercalcemia has been shown to depress the levels of preproPTH mRNA in bovine and human adenomatous parathyroid tissue. Prolonged hypercalcemia also depresses parathyroid cell proliferation in vitro, so calcimimetics can also be effective in limiting the parathyroid cell hyperplasia characteristic of secondary HPT.

Cells other than parathyroid cells can respond directly to physiological changes in the concentration of extracellular Ca 2 For example, calcitonin secretion from parafollicular cells in the thyroid (C-cells) is regulated by changes in the concentration of extracellular Ca 2 0 S. Isolated osteoclasts respond to increases in the concentration of extracellular Ca 2 with corresponding increases in [Ca 2 1i that arise partly from the mobilization of intracellular Ca 2 Increases in [Ca 2 1i in osteoclasts are •associated with the inhibition of bone resorption. Release of alkaline phosphatase from bone-forming osteoblasts is directly stimulated by calcium.

Renin secretion from juxtaglomerular cells in the kidney, like PTH secretion, is depressed by increased concentrations of extracellular Ca.

Extracellular Ca 2 causes the mobilization of intracellular Ca 2 in these cells.

Other kidney cells respond to calcium as follows: elevated Ca 2 inhibits formation of 1,25(OH) 2 -vitamin D by proximal tubular cells, stimulates production of calcium-binding protein in distal tubular cells, and inhibits tubular reabsorption of Ca 2 and Mg 2 and the action of vasopressin on the medullary thick ascending limb of Henle's loop (MTAL), reduces vasopressin action in the cortical collecting duct cells, and affects vascular smooth muscle cells in blood vessels of the renal glomerulus.

Calcium also promotes the differentiation of intestinal goblet cells, mammary cells, and skin cells; inhibits atrial natriuretic peptide secretion from cardiac atria; reduces cAMP accumulation in platelets; alters gastrin and 34 glucagon secretion; acts on vascular smooth muscle cells to modify cell secretion of vasoactive factors; and affects cells of the central nervous system and peripheral nervous system.

Thus, there are sufficient indications to suggest that Ca 2 in addition to its ubiquitous role as an intracellular signal, also functions as an extracellular signal to regulate the responses of certain specialized cells. Molecules of this invention can be used in the treatment of diseases or disorders associated with disrupted Ca 2 responses in these cells.

Specific diseases and disorders which might be treated or prevented, based upon the affected cells, also include those of the central nervous system such as seizures, stroke, head trauma, spinal cord injury, hypoxia-induced nerve cell damage such as in cardiac arrest or neonatal distress, epilepsy, neurodegenerative diseases such as Alzheimer's disease, Huntington's disease and Parkinson's disease, dementia, muscle tension, depression, anxiety, panic disorder, obsessive-compulsive disorder, post-traumatic stress disorder, schizophrenia, neuroleptic malignant syndrome, and Tourette's syndrome; diseases involving excess water reabsorption by the kidney such as syndrome of inappropriate ADH secretion (SIAH), cirrhosis, heart failure, and nephrosis; hypertension; preventing and/or decreasing renal toxicity from cationic antibiotics aminoglycoside antibiotics); gut motility disorders such as diarrhea, and spastic colon; GI ulcer diseases; GI absorption diseases such as sarcoidosis; and autoimmune diseases and organ transplant rejection.

While inorganic ion receptor modulating agents of the present invention will typically be used in therapy for human patients, they may be used to treat similar or identical diseases or disorders in other warm-blooded animal species such as other primates, farm animals such as swine, cattle, and poultry; and sports animals and pets such as horses, dogs and cats.

IV. ADMINISTRATION A compound of the present invention, or its pharmaceutically acceptable salt, hydrate or prodrug, can be administered to a human patient per se, or in pharmaceutical compositions where it is mixed with suitable carriers or 35 excipient(s). Techniques for formulation and administration of drugs may be found in "Remington's Pharmaceutical Sciences," Mack Publishing Co., Easton, PA, latest edition. Administration of ionmimetics and ionlytics is discussed by Nemeth, et al., PCT/US93/01642, International Publication No.

WO 94/18959.

A "pharmaceutical composition" refers to a mixture of one or more of the compounds described herein, or pharmaceutically acceptable salts, hydrates or prodrugs thereof, with other chemical components, such as physiologically acceptable carriers and excipients. The purpose of a pharmacological composition is to facilitate administration of a compound to an organism.

A "prodrug" refers to an agent which is converted into the parent drug in vivo. Prodrugs are often useful because, in some situations, they may be easier to administer than the parent drug. They may, for instance, be bioavailable by oral administration whereas the parent drug is not. The prodrug i'"49 may also have improved solubility in pharmacological compositions over the parent drug. An example, without limitation, of a prodrug would be a compound of the present invention wherein it is administered as an ester (the "prodrug") to facilitate transmittal across a cell membrane where water solubility is not o-4V- beneficial, but then it is metabolically hydrolyzed to the carboxylic acid Once S"inside the cell where water solubility is beneficial.

As used herein, an "ester" is a carboxyl group, as defined herein, wherein R" is any of the listed groups other than hydrogen.

.9 As used herein, a "physiologically acceptable carrier" refers to a carrier or diluent that does not cause significant irritation to an organism and does not abrogate the biological activity and properties of the administered compound.

An "excipient" refers to an inert substance added to a pharmacological composition to further facilitate administration of a compound. Examples, without limitation, of excipients include calcium carbonate, calcium phosphate, various sugars and types of starch, cellulose derivatives, gelatin, vegetable oils and polyethylene glycols.

36 Suitable forms, in part, depend upon the use or the route of entry, for example oral, transdermal, or by injection. Such forms should allow the agent to reach a target cell whether the target cell is present in a multicellular host or in culture. For example, pharmacological agents or compositions injected into the blood stream should be soluble in the concentrations used. Other factors are known in the art, and include considerations such as toxicity and forms which prevent the agent or composition from exerting its effect.

Agents can also be formulated as pharmaceutically acceptable salts acid addition salts) and complexes thereof. The preparation of such salts can facilitate the pharmacological use by altering the physical characteristics of the agent without preventing it from exerting its physiological effect. Examples :of useful alterations in physical properties include lowering the melting point to facilitate transmucosal administration and increasing the solubility to facilitate *=administering higher concentrations of the drug.

•For systemic administration, oral administration is preferred.

Alternatively, injection may be used, intramuscular, intravenous, intraperitoneal, and subcutaneous. For injection, the molecules of the 000• invention are formulated in liquid solutions, preferably in physiologically compatible buffers such as Hank's solution or Ringer's solution. In addition, the *•-.•*molecules may be formulated in solid form and redissolved or suspended 000• immediately prior to use. Lyophilized forms can also be produced.

Systemic administration can also be by transmucosal or transdermal i means, or the molecules can be administered orally. For transmucosal or transdermal administration, penetrants appropriate to the barrier to be permeated are used in the formulation. Such penetrants are generally known in the art, and include, for example, for transmucosal administration, bile salts and fusidic acid derivatives. In addition, detergents may be used to facilitate permeation. Transmucosal administration may be through nasal sprays, for example, or using suppositories. For oral administration, the molecules are formulated into conventional oral administration dosage forms such as capsules, tablets, and tonics.

37 For topical administration, the molecules of the invention are formulated into ointments, salves, gels, or creams, as is generally known in the art.

Generally, a therapeutically effective amount is between about 1 nmole and 3 mmole of the molecule, preferably 0.1 nmole and 1 mmole depending on its EC5 0 or IC 5 0 and on the age and size of the patient, and the disease or disorder associated with the patient. Generally it is an amount between about 0.1 and 50 mg/kg, preferably 0.01 and 20 mg/kg, animal to be treated.

Examples Examples of the synthesis of the compounds of the present invention are described below. However, it is to be understood that the present invention *.is not restricted by the exemplified compounds.

In Examples 1 to 23, compounds represented by Fig. 1 were synthesized. The compounds of the present invention represented by the formula wherein X is 0 were synthesized in accordance with the scheme of Fig. 2 with the use of 3- or 4-chlorophenol as the starting material. The •compounds of the present invention represented by the formula wherein X is S were synthesized in accordance with the scheme of Fig. 3 with the use of 2or 4-chlorothiophenol as the starting material. However, methylene chloride was used as the solvent in some cases. The compounds of the present invention represented by the formula wherein Ar is benzthiazole or benzoxazole were synthesized in accordance with the scheme of Fig. 4.

In Examples 24 to 36, the compounds of the present invention were synthesized in accordance with the schemes shown in Figs. 5 to 7.

Example 1: Synthesis of compound 2 500 mg (3.88 mmol) of 2-chlorophenol was dissolved in 10 ml of acetonitrile. After adding thereto 582 mg (4.28 mmol) of potassium carbonate and 1,4-dibromobutane at room temperature, the mixture was reacted while heating to 80 0C under reflux for 3 hours. After the completion of the reaction, the reaction mixture was allowed to stand at room temperature and water was added thereto followed by separating extraction with ethyl acetate. The organic layer thus obtained was washed with a saturated aqueous solution of sodium -38chloride and dried over sodium sulfate. Then the organic layer was concentrated under reduced pressure and the residue thus obtained was purified by silica gel column chromatography (50 g; hexane/acetone 12: 1) to thereby give 994 mg (3.88 mmol) of the compound 1 as a colorless and transparent syrup at a yield of 100 Next, 994 mg (3.88 mmol) of the compound 1 obtained above was dissolved in 18 ml of acetonitrile. After adding thereto 652 mg (4.7 mmol) of potassium carbonate and 1.1 g (7.28 mmol) of (R)-3-methoxy-amethylbenzylamine at room temperature, the mixture was stirred while heating to 90 oC under reflux for 12 hours. After the completion of the reaction, the reaction mixture was allowed to stand at room temperature and water was added thereto. Then it was subjected to separating extraction with ethyl acetate and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over sodium sulfate and concentrated under reduced pressure. The residue thus obtained was purified by silica gel t :column chromatography (100 g; chloroform/methanol 50 1) to thereby give 643 mg (1.93 mmol) of the compound 2 as a pale yellow and transparent syrup at a yield of 50.2 MS m/z: 333. 1H-NMR d: 1.34 (3H, d, J=6.7Hz), 1.60-1.73 (1H, 1.78-1.90 (1H, 2.48-2.62 (2H, 3.75 (3H, q, J=6.7Hz), 3.81 (3H, 3.98 (2H, t, J=6.7Hz), 6.77 (1H, dd, J=7.4Hz, J=2.0Hz), 6.89-6.90 (4H, 7.16-7.26 (2H, 7.34 (1H, dd, J=9.0Hz, J=2.6Hz).

Example 2: Synthesis of compound 4 The two steps described above were repeated but substituting the 1,4dibromobutane with 1,5-dibromopentane to thereby give the desired compound 4.

MS m/z: 347. 1H-NMR d: 1.35 (3H, d, J=6.5Hz), 1.48-1.57 (4H, 1.79-1.84 (2H, 2.44-2.55 (2H, 3.74 (1H, q, J=6.5Hz), 3.81 (3H, 4.00 (2H, t, 6.77-6.79 (1H, 6.85-6.89 (4H, 7.16-7.26 (2H, m) Example 3: Synthesis of compound 6 39 The two steps described above were repeated but substituting the 1,4dibromobutane with 1,6-dibromohexane to thereby give the desired compound 6.

MS m/z: 361. 1H-NMR d: 1.35 (3H, d, J=7.0Hz), 1.34-1.39 (2H, 1.45-1.54 (4H, 1.78-1.84 (2H, 2.41-2.54 (2H, 3.73 (1H, q, J=7.0Hz), 3.81 (3H, 4.00 (2H, t, J= 6.5Hz), 6.77-6.78 (1H, 6.85-6.90 (4H, 7.17-7.26 (2H, 7.34 (1H, dd, J=8.0Hz, J= Example 4: Synthesis of compound 8 548 mg (4.25 mmol) of 3-chlorophenol was dissolved in 10 ml of acetonitrile. After adding thereto 652 mg (4.72 mmol) of potassium carbonate and 0.56 ml (4.69 mmol) of 1,4-dibromobutane at room temperature, the mixture was reacted while heating to 80 oC under reflux for 3 hours. After the completion of the reaction, the reaction mixture was allowed to stand at room temperature and water was added thereto followed by separating extraction with ethyl acetate. The organic layer thus obtained was washed with a saturated aqueous solution of sodium chloride and dried over sodium sulfate.

Then the organic layer was concentrated under reduced pressure and the residue thus obtained was purified by silica gel column chromatography (50 g; hexane/acetone 12: 1) to thereby give 846 mg (3.31 mmol) of the compound :7 Z as a colorless and transparent syrup at a yield of 88.3 Next, 846 mg (3.31 mmol) of the compound 7 obtained above was dissolved in 18 ml of acetonitrile. After adding thereto 523 mg (3.78 mmol) of potassium carbonate and 550 mg (3.64 mmol) of (R)-3-methoxy-amethylbenzylamine at room temperature, the mixture was stirred while heating to 90 oC under reflux for 12 hours. After the completion of the reaction, the reaction mixture was allowed to stand at room temperature and water was added thereto. Then it was subjected to separating extraction with ethyl acetate and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over sodium sulfate and concentrated under reduced pressure. The residue thus obtained was purified by silica gel column chromatography (100 g; chloroform/methanol 50 1) to thereby give 40 481 mg (1.46 mmol) of the compound 8 as a pale yellow and transparent syrup at a yield of 45.0 MS m/z :333. 1H-NMR d: 1.35 (3H, d, J=6.5Hz), 1.57-1.67 (2H, 1.73-1.83 (2H, 2.46-2.60 (2H, 3.74 (1H, 3.81 (3H, 3.90 (2H, t, 6.74 (1 H, dd, J=8.0Hz, J=2.5Hz),6.85-6.86 (1 H, 7.5-7.18 (1 H, dd, J=2.7Hz), 7.22-7.26 (1H, m).

Example 5: Synthesis of compound The two steps described above were repeated but substituting the 1,4dibromobutane with 1,5-dibromopentane to thereby give the desired compound MS m/z: 347. 1 H-NMR d: 1.35 (3H, d, J=6.0Hz), 1.43-1.56 (4H, 1.72-1.77 (2H, 2.43-2.56 (2H, 3.73 (1H, q, J=6.5Hz), 3.81 (3H, 3.90 (2H, t, J=7.0Hz), 6.76 (1H, dd, J=2.0Hz, J=8.5Hz), 6.70-6.79 (1H, 6.86-6.91 (4H, 7.17 (1H, dd, J=3.0Hz), 7.22-7.26 (1H, m).

Example 6: Synthesis of compound 12 The two steps described above were repeated but substituting the 1,4dibromobutane with 1,6-dibromohexane to thereby give the desired compound 12.

MS m/z: 361. 1 H-NMR d: 1.35 (3H, d, J=6.5Hz), 1.33-1.53 (6H, 1.72-1.77 (2H, 3.73 (1 H, 3.81 (3H, 3.90 (2H, t, J=6.5Hz), 6.74-6.79 (2H, m), 6.86-6.91 (4H, 7.17 (1H, dd, J=8.3Hz), 7.22-7.26 (1H, m).

Example 7: Synthesis of compound 14 362 mg (2.82 mmol) of 4-chlorophenol was dissolved in 5 ml of acetonitrile. After adding thereto 429 mg (3.10 mmol) of potassium carbonate and 0.36 ml (3.01 mmol) of dibromobutane at room temperature, the mixture was reacted while heating to 80 °C under reflux for 3 hours. After the completion of the reaction, the reaction mixture was allowed to stand at room temperature and water was added thereto followed by separating extraction with ethyl acetate. The organic layer thus obtained was washed with a saturated aqueous solution of sodium chloride and dried over sodium sulfate.

Then the organic layer was concentrated under reduced pressure and the -41 residue thus obtained was purified by silica gel column chromatography (50 g; hexane/acetone 12: 1) to thereby give 414 mg (1.62 mmol) of the compound 13 as a colorless and transparent syrup at a yield of 69.4 Next, 846 mg (3.31 mmol) of the compound 13 obtained above was dissolved in 18 ml of acetonitrile. After adding thereto 523 mg (3.78 mmol) of potassium carbonate and 550 mg (3.64 mmol) of (R)-3-methoxy-amethylbenzylamine at room temperature, the mixture was stirred while heating to 90 OC under reflux for 12 hours. After the completion of the reaction, the reaction mixture was allowed to stand at room temperature and water was added thereto. Then it was subjected to separating extraction with ethyl acetate and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over sodium sulfate and concentrated under reduced pressure. The residue thus obtained was purified by silica gel column chromatography (100 g; chloroform/methanol 50 1) to thereby give 481 mg (1.46 mmol) of the compound 14 as a pale yellow and transparent syrup at a yield of 45.0 MS m/z: 333. 1 H-NMR d: 1.35 (3H, d, J=6.5Hz), 1.56-1.67 (2H, 1.73-1.83 (2H, 2.46-2.60 (2H, 3.72-3.76 (1H, q, J=6.5Hz), 3.81 (3H, 3.89 (2H, t, J=7.0Hz), 6.77-6.79 (3H, 6.88-6.90 (2H, 7.19-7.26 (3H, m).

Example 8: Synthesis of compound 16 The two steps described above were repeated but substituting the 1,4dibromobutane with 1,5-dibromopentane to thereby give the desired compound 16.

MS m/z: 347. 1 H-NMR d 1.34 (3H, d, J=6.5Hz), 1.43-1.56 (4H, 1.71-1.77 (2H, 2.42-2.55 (2H, 3.72 (2H, q, J=6.5Hz), 3.80 (3H, 3.89 (2H, t, 6.76-6.80 (3H, 6.87-6.89 (2H, 7.19-7.26 (3H, m).

Example 9: Synthesis of compound 18 The two steps described above were repeated but substituting the 1,4dibromobutane with 1,6-dibromohexane to thereby give the desired compound 18.

42 MS m/z 361. 1 H-NMR d: 1.35 (3H, d, J=7.0Hz), 1.32-1.53 (6H, 1.71- 1.77 (2H, 2.41-2.53 (2H,m) 3.73 (1H, 3.81 (3H, 3.89 (2H, t, 6.77-6.81 (3H, 6.88-6.89 (3H, 7.19-7.26 (3H, m).

Example 10: Synthesis of compound 330 mg (2.28 mmol) of 2-chlorothiophenol was dissolved in 6.5 ml of methylene chloride. After adding thereto 0.35 ml (2.51 mmol) of triethylamine and 0.23 ml (2.26 mmol) of 1,3-dibromopropane at room temperature, the mixture was reacted while heating to 45 °C under reflux for 6 hours. After the completion of the reaction, 0.30 ml (2.15 mmol) of triethylamine was dropped again into the reaction at room temperature. Then 350 mg (2.31 mmol) of (R)-3-methoxy-a-methylbenzylamine was added thereto and the resulting :mixture was stirred while heating to 90 °C under reflux for 12 hours. After the completion of the reaction, the reaction mixture was allowed to stand at room temperature and water was added thereto. Then it was subjected to separating extraction with ethyl acetate and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over sodium -sulfate and concentrated under reduced pressure. The residue thus obtained was purified by silica gel column chromatography (50 g; chloroform/methanol 65 1) to thereby give 102 mg (0.304 mmol) of the compound 20 as a pale Syellow and transparent syrup at an overall yield of the two steps of 13.2 MS m/z: 335. 1H-NMR d: 1.35 (3H, d, J=6.7Hz), 1.79-1.86 (2H, 2.55-2.69 (2H, 2.91-3.03 (2H, 3.74 (1H, q, J=6.7Hz), 3.81 (3H, 6.78 (1H, dd, J=8.0Hz), 6.88-6.90 (2H, 7.07-7.11 (1H, 7.18-7.26 (3H, m), 7.34 (1H, dd, J=8.0Hz, J=1.2Hz).

Example 11: Synthesis of compound 22 The two steps described above were repeated but substituting the 1,3dibromopropane with 1,4-dibromopentane to thereby give the desired compound 22.

MS m/z: 349. 1H-NMR d: 1.33 (3H, d, J=6.5Hz), 1.58-1.72 (4H, 2.43-2.56 (2H, 2.90 (2H, t, J=7.5Hz), 3.72 (1H, q, J=6.5Hz), 3.80 (3H, 6.76-6.78 43 (1H, 6.87-6.88 (2H, 7.07-7.10 (1H, 7.18-7.26 (3H, 7.35 (1H, dd, Example 12: Synthesis of compound 24 The two steps described above were repeated but substituting the 1,3dibromopropane with 1,5-dibromopentane to thereby give the desired compound 24.

MS m/z: 363. 1H-NMR d: 1.34 (3H, d, J=7.0Hz), 1.42-1.55 (4H, 1.64-1.72 (2H, 2.40-2.53 (2H, 2.90 (2H, t, J=7.5Hz), 3.72 (1H, q, J=7.0Hz), 3.81 (3H, 6.77-6.79 (1H, 6.87-6.91 (2H, 7.07-7.10 (1H, 7.18-7.26 (3H, 7.35 (1H, d, Example 13: Synthesis of compound 26 The two steps described above were repeated but substituting the 1,3dibromopropane with 1,6-dibromohexane to thereby give the desired .444 compound 26.

MS m/z: 377. 1H-NMR d: 1.34 (3H, d, J=6.5Hz), 1.41-1.50 (4H, 1.64-1.70 (2H, 2.90 (2H, t, J=7.5Hz), 3.72 (1H, q, J=6.5Hz), 3.81 (3H, 6.77-6.79 (1H, 6.88-6.89 (2H, 7.06-7.11 (1H, 7.19-7.26 (3H, 7.35 (1H, d, 4 Example 14: Synthesis of compound 28 540 mg (3.77 mmol) of 4-chlorothiophenol was dissolved in 10 ml of methylene chloride. After adding thereto 1.60 ml (11.5 mmol) of triethylamine and 0.63 ml (4.10 mmol) of 1,3-dibromopropane at room temperature, the mixture was reacted while heating to 45 °C under reflux for 3 hours. After the completion of the reaction, the methylene chloride was once removed under reduced pressure and the residue was dissolved in 9 ml of acetonitrile. Next, 500 mg (3.62 mmol) of potassium carbonate was added thereto at room temperature and 350 mg (2.31 mmol) of (R)-3-methoxy-a-methylbenzylamine was dropped thereinto. Then the resulting mixture was stirred while heating to °C under reflux for 12 hours. After the completion of the reaction, the reaction mixture was allowed to stand at room temperature and water was added thereto. Then it was subjected to separating extraction with ethyl 44 acetate and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over sodium sulfate and concentrated under reduced pressure. The residue thus obtained was purified by silica gel column chromatography (75 g; chloroform/methanol 65 1) to thereby give 397 mg (1.13 mmol) of the compound 28 as a pale yellow and transparent syrup at an overall yield of the two steps of 33.1 MS m/z: 335. 1H-NMR d: 1.33 (3H, d, J=7.0Hz), 1.72-1.78 (2H, 2.50-2.55 (1H, 2.56-2.64 (1H, 2.86-2.97 (2H, 3.71 (1H, q, J=7.0Hz), 3.81 (3H, 6.77-6.79 (1H, 6.85-6.89 (2H, 7.22-7.25 (4H, m).

Example 15: Synthesis of compound The two steps described above were repeated but substituting the 1,3dibromopropane with 1,4-dibromobutane to thereby give the desired compound MS m/z: 363. 1H-NMR d: 1.35 (3H, d, J=6.7Hz), 1.39-1.49 (2H, 1.60 (2H, tt, J=7.5Hz), 2.39-2.44 (1H, 2.86 (2H, t, J=7.3Hz), 3.72 (1 H, q, J=6.7Hz), 3.81 (3H, 6.77-6.79 (1H, 6.87-6.88 (2H, 7.20-7.26 (5H, m).

Example 16: Synthesis of compound 32 The two steps described above were repeated but substituting the 1,3dibromopropane with 1,5-dibromopentane to thereby give the desired compound 32.

MS m/z: 377. 1H-NMR d: 1.35 (3H, d, J=6.7Hz), 1.27-1.48 (4H, 1.60 (2H, tt, J=7.5Hz), 2.39-2.44 (1H, 2.46-2.51 (1 H, 2.85 (2H, t, J=7.3Hz), 3.72 (1H, q, J=6.7Hz), 3.81 (3H, 6.76-6.79 (1H, 6.87-6.89 (2H, 7.21-7.26 m).

Example 17: Synthesis of compound 34 The two steps described above were repeated but substituting the 1,3dibromopropane with 1,6-dibromohexane to thereby give the desired compound 34.

MS m/z: 349. 1H-NMR d: 1.34 (3H, d, J=6.5Hz), 1.52-1.67 (6H, 2.40-2.45 (1H, 2.48-2.53 (1H, 2.86 (2H, t, J=7.0Hz), 3.71 (1H, q, J=6.5Hz), 3.80 (3H, 6.76-6.79 (1H, 6.86-6.88 (2H, m) 45 Example 18: Synthesis of compound 36 440 mg (2.63 mmol) of 2-mercaptobenzothiazole was dissolved in 9 ml of methylene chloride. After adding thereto 1.1 ml (7.89 mmol) of triethylamine and 0.35 ml (2.93 mmol) of 1,4-dibromobutane at room temperature, the mixture was reacted at the same temperature for 12 hours. After the completion of the reaction, the methylene chloride was once removed under reduced pressure and the residue was dissolved in 8 ml of acetonitrile. Next, 800 mg (5.79 mmol) of potassium carbonate was added thereto at room temperature and 320 mg (2.12 mmol) of (R)-3-methoxy-a-methylbenzylamine i: was dropped thereinto. Then the resulting mixture was stirred while heating to °C under reflux for 12 hours. After the completion of the reaction, the reaction mixture was allowed to stand at room temperature and water was added thereto. Then it was subjected to separating extraction with ethyl acetate and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over sodium sulfate and concentrated under reduced pressure. The residue thus obtained was purified by silica gel column chromatography (70 g; chloroform/methanol 50 1) to thereby give 267 mg (0.72 mmol) of the compound 36 as a pale yellow and transparent syrup at an overall yield of the two steps of 27.1 MS m/z: 372. 1H-NMR d: 1.34 (3H, d, J=6.5Hz), 1.61-1.68 (2H, 1.82-1.88 S. (2H, 2.46-2.60 (2H, 3.32( 2H, t, J=7.5Hz), 3.73 (1H, q, J=6.5Hz), 3.80 (3H, 6.76-6.78 (1 H, 6.87-6.89 (2H, 7.21-7.30 (2H, 7.38-7.42 (1 H, 7.74 (1H, d, J=8.0Hz), 7.84 (1H, d, Example 19: Synthesis of compound 38 409 mg (2.45 mmol) of 2-mercaptobenzothiazole was dissolved in 4 ml of acetonitrile. After adding thereto 690 mg (4.99 mmol) of potassium carbonate and 0.32 ml (2.68 mmol) of 1,5-dibromopentane at room temperature, the mixture was stirred at the same temperature for 1 hour. After the completion of the reaction, 420 mg (3.04 mmol) of potassium carbonate was added thereto again and 260 mg (1.72 mmol) of (R)-3-methoxy-amethylbenzylamine was dropped thereinto. Then the resulting mixture was -46stirred while heating to 90 OC under reflux for 12 hours. After the completion of the reaction, the reaction mixture was allowed to stand at room temperature and water was added thereto. Then it was subjected to separating extraction with ethyl acetate and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over sodium sulfate and concentrated under reduced pressure. The residue thus obtained was purified by silica gel column chromatography (50 g; chloroform/methanol 50 1) to thereby give 215 mg (0.57 mmol) of the compound 38 as a pale yellow and transparent syrup at an overall yield of the two steps of 45.0 MS m/z 386. 1 H-NMR d: 1.33 (3H, d, J=6.5Hz), 1.44-1.56 (4H, 1.78-1.84 (2H, 2.42-2.51 (2H, 3.32 (2H, t, J=7.3Hz), 3.71 (1H, q, J=6.5Hz), 3.81 (3H, 6.76-6.78 (1H, 6.86-6.88 (2H, 7.22 (1H, dd, 7.26-7.30 (1H, 7,39-7.42 (1H, 7.74 (1H, d, J=7.5Hz), 7.85 (1H, d, Example 20: Synthesis of compound The two steps described above were repeated but substituting the dibromopentane with 1,6-dibromohexane to thereby give the desired compound MS m/z 400. 1H-NMR d: 1.34 (3H, d, J=6.5Hz), 1.43-1.50 (6H, 1.80 (2H, tt, J=7.5Hz), 2.40-2.52 (2H, 3.32 (2H, t, J=7.8Hz), 3.72 (1H, q, 3.81 (3H, 6.76-6.78 (1 H, 6.87-6.89 (2H, 7.22-7.30 (2H, 7.40 (1 H, dd, J=7.5Hz), 7.74 (1 H, d, J=7.5Hz), 7.85 (1 H, d, Example 21: Synthesis of compound 42 467 mg (3.09 mmol) of 2-mercaptobenzothiazole was dissolved in 7 ml of acetonitrile. After adding thereto 527 mg (3.81 mmol) of potassium carbonate and 0.41 ml (3.43 mmol) of 1,4-dibromobutane at room temperature, the mixture was stirred at the same temperature for 12 hours. After the completion of the reaction, 4.4 ml of acetonitrile and 420 mg (3.04 mmol) of potassium carbonate were added thereto again and 320 mg (2.12 mmol) of (R)-3-methoxy-a-methylbenzylamine was dropped thereinto. Then the resulting mixture was stirred while heating to 90 °C under reflux for 12 hours.

47 After the completion of the reaction, the reaction mixture was allowed to stand at room temperature and water was added thereto. Then it was subjected to separating extraction with ethyl acetate and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over sodium sulfate. Then the organic layer was concentrated under reduced pressure and the residue thus obtained was purified by silica gel column chromatography (50 g; chloroform/methanol 60: 1) to thereby give 147 mg (0.41 mmol) of the compound 42 as a pale yellow and transparent syrup at an overall yield of the two steps of 13.4 MS m/z: 356. 1H-NMR d: 1.35 (3H, d, 1.61-1.68 (2H, 1.81-1.89 (2H, 2.46-2.59 (2H, 3.28 (2H, t, J=7.5Hz), 3.73 (1H, q, J=6.7Hz), 3.80 (3H, 6.76-6.78 (1 H, 6.88-6.89 (2H, 7.21-7.28 (3H, 7.42 (1 H, d, 7.58 (1H, d, Example 22: Synthesis of compound 44 The two steps described above were repeated but substituting the 1,4dibromobutane with 1,5-dibromopentane to thereby give the desired compound 44.

MS m/z: 370. 1H-NMR d: 1.33 (3H, d, J=6.8Hz), 1.46-1.56 (4H, 1.81 (2H, 2.41-2.53 (2H, 3.29 (2H, t, J=7.3Hz), 3.72 (1H, q, J=6.8Hz), 3.81 (3H, 6.76-6.78 (1H, 6.86-6.89 (2H, 7.20-7.29 (1H, d, J=8.0Hz), 7.42 (1H, d, J=8.0Hz), 7.59 (1H, d, Example 23: Synthesis of compound 46 The two steps described above were repeated but substituting the 1,4dibromobutane with 1,6-dibromohexane to thereby give the desired compound 46.

MS m/z: 384. 1H-NMR d: 1.34 (3H, d, J=6.5Hz), 1.32-1.62 (6H, 1.81 (2H, qq, J=7.5Hz), 2.40-2.52 (2H, 3.29 (2H, t, J=7.5Hz), 3.72 (1H, q, 3.81 (3H, 6.76-6.79 (1H, 6.87-6.89 (2H, 7.21-7.29 (3H, 7.43 (1H, d, J=8.0Hz), 7.59 (1H, d, Example 24: Synthesis of compounds 52 and 53 48 To a solution of 25 g (122.4 mmol) of 5-methoxygramine 47 in 500 ml of ethanol was added 21.5 g (568.3 mmol, 4.6 moleq.) of sodium tetrahydroborate and the mixture was stirred under heating for 5.5 hours. After the completion of the reaction, ammonium chloride was added to the reaction mixture. Then the mixture was stirred at room temperature, poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained crystals were purified by column chromatography (silica gel, chloroform-ethyl acetate) to thereby give 17.31 g (87.8 of colorless prism crystals 48.

To a solution of 17.3 g of the compound 48 (107.5 mmol) in 500 ml of absolute tetrahydrofuran was added 20 g (500 mmol, 4.6 moleq.) of 52.9 sodium hydride and the mixture was stirred at room temperature for 1.5 hours.

Then 30 g (d 1.333, 157.4 mmol, 1.5 moleq.) of tosyl chloride was added thereto and the resulting mixture was stirred at room temperature for 6 hours.

After the completion of the reaction, the reaction mixture was poured into water under ice-cooling and extracted with ethyl acetate. The ethyl acetate layer was ::washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained crystals were purified by column chromatography (silica gel, chloroform-ethyl acetate) to thereby give 36.8 g (82.8 of colorless prism crystals 49.

17 ml (d 2.698, 183.1 mmol) of boron tribromide was dropped into a solution of 28.43 g (90.25 mmol) of the compound 49 in 800 ml of methylene chloride at an internal temperature of 0 to 5 OC. The mixture was stirred at room temperature for 4 hours. After the completion of the reaction, the reaction mixture was poured into water under ice-cooling and extracted with methylene chloride. The methylene chloride layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained crystals were 49 purified by column chromatography (silica gel: 400 g, chloroform-methanol 1000 1) to thereby give 16.46 g (60.6 of colorless prism crystals To a solution of 16.46 g (54.7 mmol) of the compound 50 in 300 ml of acetonitrile were added 11.2 ml (d 1.333, 109.5 mmol, 2.0 moleq.) of 1,3dibromopropane and 22 g (159.2 mmol, 2.9 moleq.) of potassium carbonate and the resulting mixture was stirred under heating at an external temperature of 60 °C for 2.5 hours. After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained crystals were purified by column chromatography (silica gel, n-hexane-acetone) to thereby give 18.34 g (79.7 of colorless prism Scrystals 51.

To a solution of 200 mg (0.48 mmol) of the compound 51 in 3 ml of acetonitrile were added 142.52 mg (0.95 mmol, 2.0 moleq.) of (R)-3-methoxya-methylbenzylamine and 131.3 mg (0.95 mmol, 2.0 moleq.) of potassium carbonate and the resulting mixture was stirred under heating at an external temperature of 60 °C for 4 hours. After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The Sethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained yellowish brown residue was dissolved in 3 ml of ethanol and 1 ml of a 35 aqueous solution of potassium hydroxide was added thereto. Then the mixture was stirred under heating at an external temperature of 80 °C for 2 hours. After the completion of the reaction, the reaction mixture was concentrated, poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained residue was purified by column chromatography (silica gel, ethyl acetate-n-hexane) to thereby give 122.6 mg (93.8 of a colorless oil 52.

50 MS m/z: 338(M'). 1 H-NMR d: 1.36 (3H, d, J =6.7Hz, CH 3 1.97 (2H, dt, J =6.7, 12.8Hz, CH2), 2.30 (3H, s, CH3), 2.67 (1H, dt, J 11.6Hz, CH2), 2.74 (1H, dt, J 13.4Hz, CH 2 3.77 (1H, q, J =6.7Hz, CH), 3.78 (3H, s, OCH3), 4.07 (2H, m, CH2), 6.78 (1H, dd, J 7.9Hz, C6-H 6.82 (1H, dd, J 7.9Hz,

C

6 6.90 (2H, d, J =1.8Hz, C 2 6.91 (1H, d, J =7.9Hz, C 4 6.94 (1H, s, 6.99 (1H, d, J =1.8Hz, C 4 7.21 (1H, d, J =7.9Hz, 7.23 (1H, t, J =7.9Hz, Cs-H), 7.81 (1H, s, NH).

To a solution of 200 mg (0.48 mmol) of the compound 51 in 3 ml of acetonitrile were added 162.7 mg (0.95 mmol, 2.0 moleq.) of naphthyl)ethylamine and 131.3 mg (0.95 mmol, 2.0 moleq.) of potassium carbonate and the resulting mixture was stirred under heating at an external temperature of 60 °C for 4 hours. After the completion of the reaction, the :reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent vunder reduced pressure, the obtained yellowish brown residue was dissolved in 1 ml of ethanol and 1 ml of a 35 aqueous solution of potassium hydroxide was added thereto. Then the mixture was stirred under heating at an external temperature of 80 oC for 2 hours. After the completion of the reaction, the reaction mixture was concentrated, poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained residue was purified by column chromatography (silica gel, ethyl acetate-n-hexane) to thereby give 122.6 mg (93.8 of a colorless oil 53.

MS m/z: 358(M'). 'H-NMR d: 1.53 (3H, d, J =6.7Hz, CH3), 2.03 (2H, dt, J =6.7, 12.8Hz, CH2), 2.30 (3H, s, CH3), 2.83 (2H, dt, J 12.8Hz, 4.12 (2H, dt, J 9.2Hz, CH2), 4.68 (1 H, q, J =6.7Hz, CH), 6.83 (1 H, dd, J 9.2Hz,

C

2 6.94 (1H, s, 7.01 (1H, d, J =1.8Hz, 7.21 (1H, d, J =7.9Hz,

C

4 7.48 (1H, t, J =7.9Hz, C3-H), 7.49 (1H, t, J =7.9Hz, C6-H), 7.50 (1H, t, J 51 =7.9Hz, Cy-H), 7.68 (1 H, d, J =7.9Hz, Cs-H), 7.75 (1 H, d, J =7.9Hz, Cs-H), 7.82 (1H, s, NH), 7.88 (1H, dd, J 7.9Hz, 8.21 (1H, d, J =7.9Hz, C7'-H).

Example 25: Synthesis of compound 56 To a solution of 500 mg (2.74 mmol) of 9-hydroxyfluorene 54 in 5 ml of toluene were added 0.273 ml (d 1.537, 3.02 mmol, 1.1 moleq.) of 3-bromo- 1-propanol and 5.1 mg (0.027 mmol, 0.01 moleq.) of p-toluenesulfonic acid and the resulting mixture was stirred at room temperature for 1 hour. After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water .and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained residue was purified by column chromatography (silica gel, n-hexane-ethyl acetate) to thereby give 723.4 mg (87.0 of a colorless oil To a solution of 200 mg (0.66 mmol) of the compound 55 in 3 ml of acetonitrile were added 148.5 mg (0.99 mmol, 1.5 moleq.) of (R)-3-methoxya-methylbenzylamine and 136.8 mg (0.99 mmol, 1.5 moleq.) of potassium carbonate and the resulting mixture was stirred under heating at an external temperature of 60 °C for 4 hours. After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained residue was purified by column chromatography (silica gel, ethyl acetate-n-hexane) to thereby give 216.6 mg (88.0 of a colorless oil 56.

MS m/z: 373(M'). 1 H-NMR d: 1.30 (3H, d, J =6.7Hz, CH3), 1.67 (2H, dt, J =6.7, 13.4Hz, CH2), 2.49 (1H, dt, J 14.0Hz, CH2), 2.56 (1H, dt, J 11.6Hz, CH2), 3.21 (2H, t, J =6.7Hz, CH2), 3.69 (1H, q, J =6.7Hz, CH), 3.78 (3H, s, OCH3), 5.59 (1H, s, CH), 6.76 (1H, dd, J 7.9Hz, C 6 6.85 (1H, d, J =1.8Hz, C 2 -H 6.87 (1 H, d, J =7.9Hz, C 4 -H 7.21 (1 H, t, J =7.9Hz C 5 7.28 (2H, t, J =7.9Hz, C3', 7.37 (2H, t, J =7.9Hz, C2', 7.53 (1H, d, J 52 =7.9Hz, 7.55 (1 H, d, J =7.9Hz, 7.65 (2H, d, J =7.9Hz, Ci', C8'-H), 7.81 (1H, s, NH).

Example 26: Synthesis of compound 59 To a solution of 200 mg (1.1 mmol) of 2-hydroxyfluorene 57 in 3 ml of acetonitrile were added 0.22 ml (d 1.333, 2.2 mmol, 2.0 moleq.) of 1,3dibromopropane and 182.0 mg (1.32 mmol, 1.2 moleq.) of potassium carbonate and the resulting mixture was stirred under heating at an external temperature of 60 °C for 4 hours. After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of *sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained crystals were purified by column chromatography (silica gel, n-hexane-ethyl acetate) to thereby give 202.4 mg (73.3 of a colorless prism crystals 58.

'H-NMR d: 2.35 (2H, dt, J =6.1,12.2Hz, CH2), 3.64 (2H, t, J =6.1Hz, CH2), 3.86 (2H, s, C9-H2), 4.17 (2H, t, J =6.1Hz, CHs), 6.93 (1H, dd, J 7.3Hz, C 2 7.11 (1 H, d, J =1.8Hz, C 4 7.23 (1 H, t, J =7.3Hz, C6-H), 7.34 (1 H, t, J =7.3Hz,

C

7 7.50 (1 H, d, J =7.3Hz, C 1 7.67 (1 H, d, J =6.7Hz, C 8 7.69 (1 H, t, J =6.7Hz, Cs-H).

To a solution of 100 mg (0.33 mmol) of the compound 58 in 3 ml of acetonitrile were added 49.5 mg (0.33 mmol, 1.0 moleq.) of (R)-3-methoxy-amethylbenzylamine and 54.7 mg (0.40 mmol, 1.2 moleq.) of potassium carbonate and the resulting mixture was stirred under heating at an external temperature of 60 °C for 4 hours. After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained residue was purified by column chromatography (silica gel, ethyl acetate-n-hexane) to thereby give 216.6 mg (88.0 of a colorless oil 59.

53 MS m/z: 373(M'). 1 H-NMR d: 1.36 (3H, d, J =6.7Hz, CH3), 1.96 (2H, m, CH), 2.65 (1 H, dt, J 11.6Hz, Ct2), 2.73 (1 H, dt, J 12.2Hz, CH2), 3.77 (1 H, q, J =6.7Hz, CH), 3.78 (3H, s, OCH3), 3.85 (2H, s, CH2), 4.07 (2H, q, J C9-H1), 6.77 (1H, dd, J 7.3Hz, Cs-H), 6.89 (1H, d, J =1.2Hz, C 2 6.90 (1H, d, J =7.3Hz, C 4 6.90 (1H, d, J =7.3Hz, 7.06 (1H, s, 7.22 (1H, t, J =7.3Hz, Cs-H), 7.22 (1H, t, J =7.3Hz, 7.33 (1H, t, J =7.3Hz, 7.49 (1 H, d, J =7.3Hz, 7.65 (1 H, d, J =7.3Hz, 7.68 (1 H, d, J =7.3Hz, Cs'-H).

Example 27: Synthesis of compound 62 To a solution of 500 mg (3.89 mmol) of o-chlorophenol 60 in 3 ml of acetonitrile were added 0.39 ml (d 1.989, 3.89 mmol, 1.0 moleq.) of 1,3dibromopropane and 591.2 mg (4.28 mmol, 1.1 moleq.) of potassium carbonate and the resulting mixture was stirred under heating at an external temperature of 60 °C for 4 hours. After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained residue was purified by column chromatography (silica gel, ethyl acetate-n-hexane) to thereby give 824.0 mg (84.9 of a colorless oil 61.

To a solution of 200 mg (0.66 mmol) of the compound 61 in 3 ml of acetonitrile were added 148.5 mg (0.99 mmol, 1.5 moleq.) of (R)-3-methoxya-methylbenzylamine and 136.8 mg (0.99 mmol, 1.5 moleq.) of potassium carbonate and the resulting mixture was stirred under heating at an external temperature of 60 °C for 4 hours. After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained residue was purified by column chromatography (silica gel, ethyl acetate-n-hexane) to thereby give 222.6 mg (87.1 of a colorless oil 62.

54 MS m/z: 319(M 'H-NMR d: 1.37 (3H, d, J =6.7Hz, CH3), 1.99 (2H, dt, J 12.2Hz, CH2), 2.67 (1H, dt, J 13.4Hz, CH2), 2.75 (1H, dt, J =6.7, 11.6Hz, CH2), 3.75-3.79 (1H, m, CH), 3.78 (3H, s, OCH3), 4.09 (2H, dt, J=1.8, 6.1Hz, CH2), 6.77 (1H, dd, J 7.3Hz, C6-H), 6.89 (1H, t, J =7.9Hz, C 4 6.90 (1H, d, J =1.8Hz, C2-H 6.90 (1H, d, J =7.9Hz, C 4 6.90 (1H, d, J =7.9Hz, 7.20 (1H, dt, J 7.3Hz, 7.22 (1H, t, J =7.9Hz, Cs-H), 7.4 (1H, dd, J 7.9Hz, C6'-H).

Example 28: Synthesis of compound To a solution of 500 mg (3.89 mmol) of m-chlorophenol 63 in 3 ml of S. acetonitrile were added 0.39 ml (d 1.989, 3.89 mmol, 1.0 moleq.) of 1,3dibromopropane and 591.2 mg (4.28 mmol, 1.1 moleq.) of potassium carbonate and the resulting mixture was stirred under heating at an external temperature of 60 °C for 4 hours. After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained residue was purified by column chromatography (silica gel, ethyl acetate-n-hexane) to thereby give 884.2 mg (91.1 of a colorless oil 64.

To a solution of 200 mg (0.66 mmol) of the compound 64 in 3 ml of i acetonitrile were added 148.5 mg (0.99 mmol, 1.5 moleq.) of (R)-3-methoxya-methylbenzylamine and 136.8 mg (0.99 mmol, 1.5 moleq.) of potassium carbonate and the resulting mixture was stirred under heating at an external temperature of 60 °C for 4 hours. After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained residue was purified by column chromatography (silica gel, ethyl acetate-n-hexane) to thereby give 229.3 mg (89.7 of a colorless oil 55 MS m/z: 319(M'). 'H-NMR d: 1.35 (3H, d, J =6.7Hz, CH3), 1.88-1.96 (2H, m, CH2), 2.61 (1 H, dt, J 11.6Hz, CH2), 2.70 (1 H, dt, J 11.6Hz, CH), 3.75 (1H, q, J =6.7Hz, CH), 3.80 (3H, s, OCH3), 3.96-4.04 (2H, m, CH1), 6.75 (1H, d, J =7.9Hz, C 6 6.78 (1H, d, J =7.9Hz, C 6 6.88 (1H, 6.88-6.92 (3H, 7.17 (1H, t, J =7.9Hz, 7.23 (1H, t, J =7.9Hz, Cs-H).

Example 29: Synthesis of compound 68 To a solution of 500 mg (3.89 mmol) of p-chlorophenol 66 in 3 ml of acetonitrile were added 0.39 ml (d 1.989, 3.89 mmol, 1.0 moleq.) of 1,3dibromopropane and 591.2 mg (4.28 mmol, 1.1 moleq.) of potassium carbonate and the resulting mixture was stirred under heating at an external temperature of 60 OC for 4 hours. After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained residue was purified by column chromatography (silica gel, ethyl acetate-n-hexane) to thereby give 876.5 mg (90.3 of a colorless oil 67.

To a solution of 200 mg (0.66 mmol) of the compound 67 in 3 ml of acetonitrile were added 148.5 mg (0.99 mmol, 1.5 moleq.) of (R)-3-methoxya-methylbenzylamine and 136.8 mg (0.99 mmol, 1.5 moleq.) of potassium carbonate and the resulting mixture was stirred under heating at an external temperature of 60 °C for 4 hours. After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained residue was purified by column chromatography (silica gel, ethyl acetate-n-hexane) to thereby give 293.1 mg (87.2 of a colorless oil 68.

MS m/z: 319 1 H-NMR (90MHz) d: 1.35 (3H, d, J =6.4Hz, CH3), 1.91 (2H, dt, J 12.7Hz, CH2), 2.67 (2H, dt, J 6.4Hz, CH2), 3.75 (1H, q, J 56- =6.4Hz, CH), 3.79 (3H, s, OCH3), 3.98 (2H, t, J =6.4Hz, CH2), 6.70-6.91 m 7.14 (3H, m).

Example 30: Synthesis of compound 71 To a solution of 500 mg (2.71 mmol) of 3-hydroxybenzofuran 69 in 5 ml of acetonitrile were added 0.55 ml (d 1.989, 5.43 mmol, 2.0 moleq.) of 1,3dibromopropane and 750.1 mg (5.43 mmol, 2.0 moleq.) of potassium carbonate and the resulting mixture was stirred under heating at an external temperature of 60 OC for 4 hours. After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained residue was purified by column chromatography (silica gel, ethyl acetate-n-hexane) to thereby give 804.3 mg (77.0 of colorless prism crystals To a solution of 800 mg (2.62 mmol) of the compound 70 in 5 ml of acetonitrile were added 590.2 mg (3.93 mmol, 1.5 moleq.) of (R)-3-methoxya-methylbenzylamine and 543.7 mg (3.93 mmol, 1.5 moleq.) of potassium carbonate and the resulting mixture was stirred under heating at an external temperature of 60 °C for 4 hours. After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained residue was purified by column chromatography (silica gel, ethyl acetate-n-hexane) to thereby give 880.8 mg (89.5 of a colorless oil 71.

MS m/z: 375(M'). 1 H-NMR d: 1.38 (3H, d, J =6.7Hz, CH), 2.01 (2H, m, CH2), 2.70 (1H, dt, J =6.7,14.0Hz, CH2), 2.77 (1H, dt, J =6.7,13.4Hz, CH2), 3.80 (1H, q, J =6.7Hz, CH), 3.80 (3H, s, OCH), 4.10-4.17 (2H, m, CH2), 6.79 (1H, dd, J 7.3Hz, C6-H), 6.91 (1H, d, J =1.8Hz, C2-H), 6.92 (1H, d, J =7.3Hz, C 4 7.02 (1H, dd, J 8.6Hz, 7.24 (1H, t, J =7.3Hz, Cs-H), 7.33 (1H, t, J =7.3Hz, 7.41 (1H, d, J =2.5Hz, 7.45 (1H, dt, J 7.3Hz, -57 7.46 (1H, d, J =7.3Hz, 7.55 (1H, d, J =8.6Hz, 7.91 (1H, d, J =7.3Hz, C8'-H).

Example 31: Synthesis of compound 74 To a solution of 300.0 mg (2.16 mmol) of 2-naphthol 72 in 3 ml of absolute tetrahydrofuran were added 300 ml (d 1.537, 2.16 mmol, moleq.) of 3-bromo-l-propanol and 622.7 mg (2.37 mmol, 1.1 moleq.) of triphenylphosphine. Then a solution of 0.41 ml (d 1.106, 2.37 mmol, 1.1 moleq.) of DEAD in 3 ml of absolute tetrahydrofuran was added thereto and the resulting mixture was stirred at room temperature for 4 hours. After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained residue was purified by column chromatography (silica gel, ethyl acetate-nhexane) to thereby give 551.8 mg (100 of a colorless oil 73.

S. To a solution of 200 mg (0.75 mmol) of the compound 73 in 5 ml of acetonitrile were added 169.8 mg (1.13 mmol, 1.5 moleq.) of (R)-3-methoxya-methylbenzylamine and 156.5 mg (1.13 mmol, 1.5 moleq.) of potassium carbonate and the resulting mixture was stirred under heating at an external temperature of 60 °C for 4 hours. After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained residue was purified by column chromatography (silica gel, ethyl acetate-n-hexane) to thereby give 230.8 mg (91.3 of a colorless oil 74.

MS m/z: 335 1 H-NMR d: 1.41 (3H, d, J =6.7Hz, CH 3 2.13 (2H, dt, J =6.7, 12.8Hz, CH), 2.73 (1H, dt, J 11.6Hz, CH1), 2.85 (1H, dt, J 11.6Hz, 3.79 (3H, s, OCHS), 3.83 (1H, q, J =6.7Hz, CH), 4.23 (2H, dt, J =1.2, 6.1Hz, CH2), 6.80 (1H,dd, J 7.9Hz, C 6 6.83 (1H, d, J =7.3Hz, C2'-H), 6.92 (1H, d, J =2.4Hz, C2-H), 6.93 (1H, d, J =7.9Hz, C 4 7.24 (1H, t, J 58 =7.9Hz, C5-H), 7.39 (1 H, t, J =7.9Hz, 7.45 (1 H, d, J =7.9Hz, 7.48 (1 H, dd, J 7.9Hz, 7.52 (1 H, dt, J 7.9Hz, Cy 7 7.83 (1 H, d, J =7.9Hz, 8.22 (1H, d, J =7.9Hz, Cs'-H).

Example 32: Synthesis of compound 77 To a solution of 300 mg (1.87 mmol) of 2-naphthalenethiol 75 in 5 ml of methylene chloride were added 0.23 ml (d 1.989, 2.25 mmol, 1.2 moleq.) of 1,3-dibromopropane and 0.31 mg (d 0.726, 2.25 mmol, 1.2 moleq.) of triethylamine and the resulting mixture was stirred under heating at an external temperature of 40 °C for 4 hours. After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with a 5 aqueous solution of hydrochloric acid, water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained residue was purified by column chromatography (silica gel, ethyl acetate-n-hexane) to thereby give 241.3 mg (45.9 of a colorless oil 76.

To a solution of 241 mg (0.86 mmol) of the compound 76 in 5 ml of acetonitrile were added 193.0 mg (1.29 mmol, 1.5 moleq.) of (R)-3-methoxya-methylbenzylamine and 177.8 mg (1.29 mmol, 1.5 moleq.) of potassium carbonate and the resulting mixture was stirred under heating at an external temperature of 60 OC for 4 hours. After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained residue was purified by column chromatography (silica gel, ethyl acetate-n-hexane) to thereby give 209.8 mg (69.7 of a colorless oil 77.

MS m/z: 351(M 1 H-NMR d: 1.38 (3H, d, J =6.7Hz, CH3), 2.01 (2H, dt, J =6.7Hz, CH2), 2.73 (2H, dt, J 25.0Hz, CH2), 3.80 (1H, q, J =6.7Hz, CH), 3.80 (3H, s, OCH3), 4.13 (2H, m, CH2), 6.79 (1H, dd, J 7.3Hz, C 6 6.91 (1H, d, J =1.2Hz, C 2 6.92 (1H, d, J =7.3Hz, C 4 7.02 (1H, dd, J 7.3Hz, 7.24 (1H, t, J =7.3Hz, C 5 7.33 (1H, t, J =7.3Hz, 7.41 59 (1H, d, J =2.5Hz, 7.45 (1H, dt, J 7.3Hz, 7.46 (1H, d, J =7.3Hz, 7.55 (1H, d, J =7.3Hz, 7.91 (1H, d, J =7.3Hz, C8'-H).

Example 33: Synthesis of compound To a solution of 500 mg (3.76 mmol) of 5-hydroxyindole 78 in 5 ml of acetonitrile were added 833.9 mg (d 1.989, 4.13 mmol, 1.1 moleq.) of 1,3dibromopropane and 570.9 mg (4.13 mmol, 1.1 moleq.) of potassium carbonate and the resulting mixture was stirred under heating at an external temperature of 60 °C for 4 hours. After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained residue was purified by column chromatography (silica gel, ethyl acetate-n-hexane) to thereby give 586 mg (61.4 of a colorless oil 79.

1 1H-NMR d: 2.33 (2H, dt, J 12.2Hz, CHH), 3.63 (2H, t, J =6.1Hz, CH), 4.13 (2H, t, J =6.1Hz, CH12), 6.47 (1 H, t, J =2.4Hz, C3-H), 6.85 (1 H, dd, J C6-H), 7.12 (1H, d, J =2.4Hz, C 4 7.17 (1H, t, J =2.4Hz, C2-H), 7.26 (1H,d, J Cy-H), 8.03 (1H, s, NE).

To a solution of 200 mg (0.79 mmol) of the compound 79 in 3 ml of acetonitrile were added 118.1 g (0.79 mmol, 1.5 moleq.) of (R)-3-methoxy-amethylbenzylamine and 130.6 mg (0.94 mmol, 1.2 moleq.) of potassium carbonate and the resulting mixture was stirred under heating at an external temperature of 40 °C for 4 hours. After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained residue was purified by column chromatography (silica gel, ethyl acetate-n-hexane) to thereby give 265.1 mg (82.8 of a colorless oil MS m/z: 324(M 'H-NMR d: 1.38 (3H, d, J =6.7Hz, CHS), 2.01 (2H, dt, J =6.7, 12.8Hz, CH2), 2.67 (1H, dt, J 11.6Hz, CH2), 2.74 (1H, dt, J 13.4Hz, 60 CH2), 3.78 (1H, q, J =6.7Hz, CH), 3.81 (3H, s, OCH3), 4.02-4.09 (2H, m, CH2), 6.47 (1 H, t, J =3.1Hz, 6.78 (1 H, dd, J 7.9Hz, C 6 6.83 (1 H, dd, J 8.5Hz, C 6 6.90 (1H, d, J =3.1Hz, C 2 6.91 (1H, d, J =7.9Hz, C 4 7.09 (1H, d, J =2.4Hz, 7.18 (1H, t, J =3.1Hz, C 2 7.23 (1H, t, J =7.9Hz, Cs-H), 7.27 (1H, d, J =8.5Hz, 8.07 (1H, s, NH).

Example 34: Synthesis of compound 83 To a solution of 400 mg (2.35 mmol) of 4-phenylphenol 81 in 5 ml of acetonitrile were added 0.48 ml (d 1.989, 4.7 mmol, 2.0 moleq.) of 1,3dibromopropane and 389.7 mg (2.82 mmol, 1.2 moleq.) of p'otassium carbonate and the resulting mixture was stirred under heating at an external temperature of 60 °C for 4 hours. After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained residue was purified by column chromatography (silica gel, ethyl acetate-n-hexane) to thereby give 564.9 mg (82.5 of colorless prism crystals 82.

To a solution of 300 mg (1.03 mmol) of the compound 82 in 4 ml of acetonitrile were added 309.3 mg (2.06 mmol, 2.0 moleq.) of (R)-3-methoxya-methylbenzylamine and 284.9 mg (2.06 mmol, 2.0 moleq.) of potassium carbonate and the resulting mixture was stirred under heating at an external temperature of 60 °C for 4 hours. After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained residue was purified by column chromatography (silica gel, ethyl acetate-n-hexane) to thereby give 311.9 mg (83.8 of colorless prism crystals 83.

MS m/z 361(M'). 1 H-NMR d: 1.36 (3H, d, J =6.7Hz, CH 3 1.93-2.01 (2H, m, CH2), 2.65 (1H, dt, J 11.6Hz, CH2), 2.73 (1H, dt, J 11.6Hz, CH2), 3.77 (1H, q, J =6.7Hz, CH), 3.80 (3H, s, OCH 3 4.02-4.10 (2H, m, CH2), 6.79 61 (1H,dd, J 7.3Hz, C6-H), 6.90 (1H, d, J =1.8Hz, C 2 6.91 (1H, d, J =7.3Hz, C 4 6.95 (2H, dt, J 9.2Hz, C 3 7.24 (1H, t, J =7.3Hz, Cs-H), 7.30 (1 H, t, J =7.3Hz, C 4 7.42 (2H, t, J =7.3Hz, C3", 5 7.51 (2H, dt, J 9.2Hz, C2", 7.55 (2H, dd, J 7.3Hz, Example 35: Synthesis of compound 88 To a solution of 600 mg (4.0 mmol) of (R)-3-methoxy-amethylbenzylamine 84 in 5 ml of methylene chloride were added 662.4 mg (d 1.176, 4.4 mmol, 1.1 moleq.) of ethylmalonyl chloride and 0.66 ml (d 0.726, 4.8 mmol, 1.2 moleq.) of triethylamine and the resulting mixture was stirred at room temperature for 2 hours. After the completion of the reaction, the reaction mixture was poured into water and extracted with methylene chloride. The methylene chloride layer was washed with a 5 aqueous solution of hydrochloric acid, water and a saturated aqueous solution of sodium chloride :.and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained crystals were purified by column chromatography (silica gel, n-hexane-ethyl acetate) to thereby give 790.0 mg (98.4 of colorless prism crystals 'H-NMR d: 1.21 (3H, t, J =6.7Hz, CH 2 CH3), 1.42 (3H, d, J =6.7Hz, CH3), 3.23 (2H, d, J =4.3Hz, CH2), 3.73 (3H, s, OCH3), 4.12 (2H, q, J =6.7Hz, CH2CH 3 5.04 (1H, dt, J 14.0Hz, CH), 6.72 (1H, dd, J 7.9Hz, C 6 6.79 (1H, d, J =1.8Hz, C 2 6.83 (1H, d, J =7.9Hz, C 4 7.18 (1H, t, J =7.9Hz, Cs-H), 7.36 (1H, s, NH).

To a solution of 897.6 mg (3.39 mmol) of the compound 85 in 5 ml of ethanol was added 2 ml of a 10 aqueous solution of sodium hydroxide and the resulting mixture was stirred under heating at an external temperature of °C for 1 hour. After the completion of the reaction, the reaction mixture was concentrated and acidified with a 5 aqueous solution of hydrochloric acid.

Then the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with a 5 aqueous solution of hydrochloric acid, water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced 62 pressure, the obtained crystals were was purified by column chromatography (silica gel, n-hexane-ethyl acetate) to thereby give 790.0 mg (98.4 of colorless prism crystals 86.

'H-NMR d: 1.47 (3H, d, J =6.7Hz, CH3), 3.27 (2H, d, J =9.2Hz, CH2), 3.77 (3H, s, OCH3), 5.05 (1H, dt, J 14.0Hz, CH), 6.78 (1H, dd, J 7.9Hz, C6-H), 6.83 (1H, d, J =2.4Hz, C 2 6.86 (1H, d, J =7.9Hz, C 4 7.23 (1H, t, J =7.9Hz, Cs-H 7.47 (1 H, d, J =7.9Hz, NH).

To a solution of 400 mg (1.68 mmol) of the compound 86 in 5 ml of dimethylformamide were added 278.5 mg (1.86 mmol, 1.1 moleq.) of methoxy-a-methylbenzylamine and 389.5 mg (2.02 mmol, 1.2 moleq.) of WSCxHCI and the resulting mixture was stirred at room temperature for 1 hour.

After the completion of the reaction, the reaction mixture was poured into water .:and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained crystals were purified by column chromatography (silica gel, n- Shexane-ethyl acetate) to thereby give 615.4 mg (98.5 of colorless prism crystals 87.

MS m/z: 370(M'). 'H-NMR d: 1.42 (6H, d, J =6.7Hz, CH3), 3.15 (2H, s, CH2), 3.75 (6H, s, OCH3), 5.04 (2H, dt, J 14.7Hz, CH), 6.77 (2H, dd, J =2.4, 7.9Hz, C6, 6 6.80 (2H, d, J =2.4Hz, C2, 2 6.83 (2H, d, J =7.9Hz, C 4 4 7.20 (2H, t, J =7.9Hz, C 5 s-H 7.47 (2H, s, NH).

To a solution of 100 mg (0.270 mmol) of the compound 87 in 5 ml of absolute tetrahydrofuran was added 0.59 ml (0.59 mmol, 1.2 moleq.) of a 1 mol solution of boron trihydride in tetrahydrofuran. The resulting mixture was heated to room temperature and then stirred for 3 hours. After the completion of the reaction, the reaction mixture was poured into water, acidified with a 5 aqueous solution of hydrochloric acid and then extracted with ethyl acetate.

The hydrochloric acid layer was made alkaline by adding a 5 aqueous solution of sodium hydroxide and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of 63 sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained residue was purified by column chromatography (silica gel, n-hexane-ethyl acetate) to thereby give 76.3 mg (82.6 of a colorless oil 88.

MS m/z: 342(M+). 1 H-NMR d: 1.43 (6H, d, J =6.7Hz, CHs), 1.62 (2H, dt, J =6.7, 13.4Hz, CH2), 2.46 (2H, dt, J 13.4Hz, CH2), 2.54 (2H, dt, J 11.6Hz, CH2), 3.70 (2H, q, J =6.7Hz, CH), 3.80 (6H, s, OCH3), 6.77 (2H, dd, J =2.4, 7.3Hz, C6, 6 6.86 (2H, d, J =2.4Hz, C2,2-H), 6.87 (2H, d, J =7.3Hz, C4, 4 7.23 (2H, t, J =7.3Hz, C5, 5 -H Example 36: Synthesis of compound 93 To a solution of 600 mg (3.5 mmol) of -naphthyl)ethylamine 89 in 5 ml of methylene chloride were added 580.3 mg (d 1.176, 3.85 mmol, 1.1 moleq.) of ethylmalonyl chloride and 0.59 ml (d 0.726, 4.2 mmol, 1.2 moleq.) of triethylamine and the resulting mixture was stirred at room temperature for 2 .hours. After the completion of the reaction, the reaction mixture was poured into water and extracted with methylene chloride. The methylene chloride layer was washed with a 5 aqueous solution of hydrochloric acid, water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate.

After distilling off the solvent, the obtained crystals were purified by column chromatography (silica gel, n-hexane-ethyl acetate) to thereby give 662.9 mg (66.5 of colorless prism crystals 'H-NMR d: 1.16 (3H, t, J =7.3Hz, CH 2 CH3), 1.60 (3H, d, J =7.3Hz, CH3), 3.24 (2H, dd, J =17.7, 26.3Hz, CHS), 4.07 (2H, q, J =7.3Hz, CH2CH 3 5.89 (1H, dt, J 14.6Hz, CH), 7.35 (1H, d, J =7.9Hz, NH), 7.38 (1H, t, J =7.9Hz, C3-H), 7.44 (1H, t, J =12.2Hz, C6-H), 7.45 (1H, d, J =7.9Hz, C 2 7.46 (1H, t, J =12.2Hz, C 7 7.72 (1H, d, J =7.9Hz, C 4 7.79 (1H, d, J =7.9Hz, Cs-H), 8.03 (1H, d, J =7.9Hz, C 8 To a solution of 662.5 mg (2.32 mmol) of the compound 90 in 5 ml of ethanol was added 2 ml of a 10 aqueous solution of sodium hydroxide. The resulting mixture was stirred under heating at an external temperature of 80 °C for 1 hour. After the completion of the reaction, the reaction mixture was 64concentrated, acidified with a 5 aqueous solution of hydrochloric acid. The reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with a 5 aqueous solution of hydrochloric acid, water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained crystals were purified by column chromatography (silica gel, nhexane-ethyl acetate) to thereby give 596.0 mg (99.8 of colorless prism crystals 91.

1 H-NMR d: 1.66 (3H, d, J =6.7Hz, CH3), 3.20 (2H, dd, J =18.3, 29.9Hz, CH2), 5.91 (1H, dt, J 14.7Hz, CH), 6.99 (1H, d, J =7.3Hz, NH), 7.43 (1H, t, J =7.9Hz, C3-H), 7.48 (1 H, t, J =7.9Hz, C 6 7.49 (1H, d, J =7.9Hz, C 2 7.53 (1 H, dt, J 7.9Hz, Cy-H), 7.77 (1 H, d, J =7.9Hz, C 4 7.83 (1H, d, J =7.9Hz, C 5 8.00 (1 H, d, J =7.9Hz, C 8 To a solution of 400 mg (1.56 mmol) of the compound 91 in 5 ml of dimethylformamide were added 293.2 mg (1.71 mmol, 1.1 moleq.) of naphthyl)ethylamine and 359.2 mg (1.87 mmol, 1.2 moleq.) of WSCxHCI and the resulting mixture was stirred at room temperature for 1 hour. After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained crystals were purified by column chromatography (silica gel, n-hexane-ethyl acetate) to thereby give 615.1 mg (96.4 of colorless prism crystals 92.

To a solution of 100 mg (0.24 mmol) of the compound 92 in 5 ml of absolute tetrahydrofuran was added 0.54 ml (0.54 mmol, 2.2 moleq.) of a 1 mol solution of boron trihydride in tetrahydrofuran. The resulting mixture was heated to room temperature and then stirred for 3 hours. After the completion of the reaction, the reaction mixture was poured into water, acidified with a 5 aqueous solution of hydrochloric acid and then extracted with ethyl acetate.

The hydrochloric acid layer was made alkaline by adding a 5 aqueous solution of sodium hydroxide and extracted with ethyl acetate. The ethyl 65 acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained residue was purified by column chromatography (silica gel, n-hexane-ethyl acetate) to thereby give 82.0 mg (88.0 of a colorless oil 93.

MS m/z: 382(M'). 'H-NMR d: 1.47 (6H, d, J =6.7Hz, CH3), 1.72 (2H, dt, J =6.7, 13.4Hz, CH2), 2.62 (2H, dt, J 13.4Hz, CH2), 2.68 (2H, dt, J 11.6Hz, CH), 4.60 (2H, q, J CH), 7.45 (2H, t, J =7.9Hz, C3, 3 7.48 (2H, dt, J 7.9Hz, C6, 6 7.50 (2H, t, J =7.9Hz, C7, 7 7.60 (2H, d, J =7.9Hz, C2, 2 7.74 (2H, d, J =7.9Hz, C4, 4 7.87 (2H, dd, J 7.9Hz, C 5 5 8.16 (2H, d, J =7.9Hz, C8, e 8 uExample 37: Synthesis of compound 103 Compound 102: To a solution of 6-hydroxyflavone 101 (300 mg, 1.26 mmol) in acetonitrile (5 ml) were added 1,3-dibromopropane (0.26 ml, d 1.989, 2.52 mmol, 2.0 mol eq.) and potassium carbonate (208.8 mg, 1.51 mmol, 1.2 mol eq.) and the resulting mixture was stirred under heating at an outer temperature of 60 °C for 4 hours.

After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride. After drying over sodium sulfate, the solvent was distilled off under reduced pressure. The residue thus obtained was purified by column chromatography [silica gel, ethyl acetate/n-hexane] to thereby give 361.8 mg (80.0 of the compound 102 as colorless prisms.

MS m/z: 375(M').'H-NMR 6: 2.34-2.39(2H, m, CH), 3.62(2H, t, J=6.7Hz, CH2), 4.22(2H, t, J=6.7Hz, CH), 6.82(1 H, s, Ar-H), 7.29(1 H, dd, J=3.1, 9.2Hz, Ar-H), 7.51 (4H, m, Ar-H), 7.61 (1H, d, J=3.1Hz, Ar-H), 7.92(1H, dd, J=1.8, 7.9Hz, Ar- 7.19(1H, dd, J=3.1, 9.2Hz, Ar-H), 7.44-7.53(7H, m, Ar-H), 7.57(1H, d, J=3.1Hz, Ar-H), 7.68(1 H, d, J=7.3Hz, Ar-H), 7.74(1 H, d, J=7.9Hz, Ar-H), 66 7.86(1H, d, J=7.9Hz, Ar-H), 7.91-7.93(2H, m, Ar-H), 8.19(1H, d, J=8.5Hz, Ar-

H).

Compound 103: To a solution of the above compound 102 (125.8 mg, 0.38 mmol, 1.2 mol eq.) in acetonitrile (3 ml) were added (R)-(+)-(1-naphthyl)ethylamine mg, 0.29 mmol) and potassium carbonate (60.5 mg, 0.44 mmol, 1.5 mol eq.) and the resulting mixture was stirred under heating at an outer temperature of °C for 6 hours.

After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride. After drying over sodium sulfate, the solvent was distilled off under reduced pressure. The residue thus obtained was purified by column chromatography [silica gel, ethyl acetate/n-hexane] to thereby give 67.1 mg (89.5 of the compound 103 as a colorless oil.

MS m/z: 449(M ).'H-NMR 6: 1.55(3H, d, J=6.7Hz, CH3), 2.04(2H, t, J=6.1Hz, CH), 2.07(1 H, s, NH), 2.82(2H, m, CH2), 4.15(1 H, t, J=6.1Hz, Ci2), 4.71(1H, q, J=6.7Hz, CH), 6.82(1H, s, Ar-H), 7.19(1H, dd, J=3.1, 9.2Hz, Ar-H), 7.44- 7.53(7H, m, Ar-H), 7.57(1 H, d, J=3.1Hz, Ar-H), 7.68(1H, d, J=7.3Hz, Ar-H), .7.74(1 H, d, J=7.9Hz, Ar-H), 7.86(1 H, d, J=7.9Hz, Ar-H), 7.91-7.93(2H, m, Ari 8.19(1 H, d, J=8.5Hz, Ar-H).

Example 38: Synthesis of compound 106 Compound 105: To a solution of 9-hydroxyfluorene 104 (500 mg, 2.74 mmol) in toluene ml) were added 3-bromo-l-propanol (0.273 ml, d 1.537, 3.02 mmol, 1.1 mol eq.) and p-toluenesulfonic acid hydrate (5.1 mg, 0.027 mmol, 0.01 mol eq.) and the resulting mixture was stirred at room temperature for 1 hour.

After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride. After drying over sodium sulfate, the solvent was distilled off under reduced 67 pressure. The residue thus obtained was purified by column chromatography [silica gel, n-hexane/ethyl acetate] to thereby give the compound 105 (723.4 mg, 87.0 as a colorless oil.

Compound 106: To a solution of the above compound 105 (106.2 mg, 0.35 mmol, 1.2 mol eq.) in acetonitrile (3 ml) were added (R)-(+)-(1-naphthyl)ethylamine mg, 0.29 mmol) and potassium carbonate (48.4 mg, 0.35 mmol, 1.2 mol eq.) and the resulting mixture was stirred under heating at an outer temperature of °C for 6 hours.

After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride. After drying over sodium sulfate, the solvent was distilled off under reduced pressure. The residue thus obtained was purified by column chromatography .[silica gel, ethyl acetate/n-hexane] to thereby give 33.7 mg (76.1 of the compound 106 as a colorless oil.

MS m/z: 393(M+).'H-NMR 6: 1.47(3H, d, J=6.1Hz, CH3), 1.70-1.76(2H, m, CH2), 2.60-2.71(2H, m, CHg), 3.26(2H, t, J=6.1Hz, CH), 4.61 (1 H, q, J=6.7Hz, CH), 5.59(1 H, s, CH), 7.26(1H, t, J=7.3Hz, Ar-H), 7.28(1H, t, J=7.3Hz, Ar-H), 7.37(1 H, d, J=7.3Hz, Ar-H), 7.38(1 H, t, J=7.3Hz, Ar-H), 7.46(1 H, t, J=7.3Hz, Ar-H), 7.48(1 H, t, J=7.3Hz, Ar-H), 7.49(1 H, t, J=7.9Hz, Ar-H), 7.53(1 H, d, J=7.3Hz, Ar-H), 7.54(1 H, d, J=7.3Hz, Ar-H), 7.63(1H, d, J=6.7Hz, Ar-H), 7.66(2H, d, J=7.9Hz, Ar-H), 7.75(1 H, d, J=8.5Hz, Ar-H), 7.88(1H, d, J=7.9Hz, Ar-H), 8.20(1H, d, J=8.5Hz, Ar-H).

Example 39: Synthesis of compound 109 Compound 108: To a solution of 2-hydroxybenzofuran 107 (500 mg, 2.71 mmol) in acetonitrile (5 ml) were added 1,3-dibromopropane (0.55 ml, d 1.989, 5.43 mmol, 2.0 mol eq.) and potassium carbonate (750.1 mg, 5.43 mmol, 2.0 mol eq.) and the resulting mixture was stirred at an outer temperature of 60 °C for 4 hours.

68 After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride. After drying over sodium sulfate, the solvent was distilled off under reduced pressure. The residue thus obtained was purified by column chromatography [silica gel, ethyl acetate/n-hexane] to thereby give 804.3 mg (77.0 of the compound 108 as colorless prisms.

Compound 109: To a solution of the above compound 108 (106.9 mg, 0.35 mmol, 1.2 mol eq.) in acetonitrile (3 ml) were added (R)-(+)-1-(1-naphthyl)ethylamine mg, 0.29 mmol) and potassium carbonate (60.5 mg, 0.44 mmol, 1.5 mol eq.) and the resulting mixture was stirred under heating at an outer temperature of 60 OC for 6 hours.

After the completion of the reaction, the reaction mixture was poured

S

into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride. After drying over sodium sulfate, the solvent was distilled off under reduced pressure. The residue thus obtained was purified by column chromatography [silica gel, ethyl acetate/n-hexane] to thereby give 67.2 mg (58.3 of the compound 109 as a colorless oil.

MS m/z: 395(M ).'H-NMR 8: 1.53(3H, d, J=6.7Hz, CH), 2.02-2.07(2H, m, CH2), 2.78-2.89(2H, m, CHg), 4.13-4.16(2H, m, CH2), 4.69(1H, q, J=6.7Hz, CH), 7.00(1 H, dd, J=2.4, 8.6Hz, Ar-H), 7.33(1H, t, J=7.3Hz, Ar-H), 7.38(1 H, d, J=2.4Hz, Ar-H), 7.44-7.51 (6H, m, Ar-H), 7.67(1H, d, J=7.3Hz, Ar-H), 7.75(1 H, d, J=7.9Hz, Ar-H), 7.87(1 H, dd, J=2.4, 9.7H, Ar-H), 7.89(1 H, d, J=7.9Hz, Ar-H), 8.22(1H, d, J=8.6Hz, Ar-H).

Example 40: Synthesis of compound 112 Compound 111: To a solution of 5-hydroxyindole 110 (500 mg, 3.76 mmol) in acetonitrile ml) were added 1,3-dibromopropane (833.9 mg, d 1.989, 4.13 mmol, 1.1 mol eq.) and potassium carbonate (570.9 mg, 4.13 mmol, 1.1 mol eq.) and the 69 resulting mixture was stirred under heating at an outer temperature of 60 °C for 4 hours.

After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride. After drying over sodium sulfate, the solvent was distilled off under reduced pressure. The residue thus obtained was purified by column chromatography [silica gel, ethyl acetate/n-hexane] to thereby give 586 mg (61.4 of the compound 111 as a colorless oil.

'H-NMR 6: 1.70(3H, d, J=6.7Hz, CHg), 3.63(2H, t, J=6.7Hz, CH), 4.13(2H, t, J=6.7Hz, CH2), 6.47(1 H, t, J=2.4Hz, Ar-H), 6.85(1 H, dd, J=2.4, 9.2Hz, Ar-H), 7.12(1H, d, J=2.4Hz, Ar-H), 7.17(1H, t, J=2.4Hz, Ar-H), 7.26(1H, d, Ar-H), 8.03(1 H, s, NH).

Compound 112: To a solution of the above compound 111 (65.3 mg, 0.26 mmol, 1.5 mol eq.) in acetonitrile (3 ml) were added (R)-(+)-1-(1-naphthyl)ethylamine (29.3 mg, 0.17 mmol) and potassium carbonate (35.5 mg, 0.26 mmol, 1.5 mol eq.) and the resulting mixture was stirred under heating at an outer temperature of 60 OC for 6 hours.

After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride. After drying over sodium sulfate, the solvent was distilled off under reduced pressure. The residue thus obtained was purified by column chromatography [silica gel, ethyl acetate/n-hexane] to thereby give 36.5 mg (62.0 of the compound 112 as a colorless oil.

MS m/z: 344(M').'H-NMR 6: 1.52(3H, d, J=6.1Hz, CH3), 1.99-2.04(2H, m, CH2), 2.76-2.86(2H, m, CHg), 4.05-4.12(2H, m, CH2), 4.67(1H, q, J=6.1Hz, CH), 6.47(1 H, s, Ar-H), 6.83(1 H, dd, J=2.4, 8.6Hz, Ar-H), 7.09(1H, d, J=2.4Hz, Ar-H), 7.17(1 H, t, J=2.4Hz, Ar-H), 7.26(1 H, d, J=9.2Hz, Ar-H), 7.44-7.50(3H, m, 70 Ar-H), 7.67(1 H, d, J=7.3Hz, Ar-H), 7.74(1 H, d, J=8.5Hz, Ar-H), 7.87(1H, dd, J=2.4, 6.7Hz, Ar-H), 8.10(1 H, s, NH), 8.20(1 H, d, J=7.9Hz, Ar-H).

Example 41: Synthesis of compound 117 Compound 114: To a solution of (R)-(+)-1-(1-naphthyl)ethylamine (600 mg, 3.5 mmol) in dichloromethane (5 ml) were added ethylmalonyl chloride 113 (580.3 mg, 3.85 mmol, 1.1 mol eq.) and triethylamine (0.59 ml, d 0.726, 3.85 mmol, 1.1 mol eq.) and the resulting mixture was stirred at room temperature for 2 hours.

After the completion of the reaction, the reaction mixture was poured into water and extracted with dichloromethane. The dichloromethane layer Swas washed successively with a 5 aqueous solution of hydrochloric acid, ~water and a saturated aqueous solution of sodium chloride. After drying over sodium sulfate, the solvent was distilled off under reduced pressure. The crystals thus obtained were purified by column chromatography [silica gel, ethyl S"acetate/n-hexane] to thereby give 662.9 mg (66.5 of the compound 114 as colorless prisms.

'H-NMR 8: 1.16(3H, t, J=7.3Hz, CH 2 CH), 1.60(3H, d, J=7.3Hz, CH), 3.24(2H, dd, J=17.7, 26.3Hz, CH2), 4.07(2H, q, J=7.3Hz, CH 2

CH

3 5.89(1H, dt, J=7.3, 14.6Hz, CH), 7.35(1H, d, J=7.9Hz, NH), 7.38(1H, t, J=7.9Hz), Ar-H, 7.44(1H, t, J=12.2Hz, Ar-H), 7.46(1 H, t, J=12.2Hz, Ar-H), 7.72(1 H, d, J=7.9Hz, Ar-H), 7.79(1H, d, J=7.9Hz, Ar-H), 8.03(1 H, d, J=7.9Hz, Ar-H).

Compound 115: To a solution of the above compound 114 (662.5 mg, 2.32 mmol) in ethanol (5 ml) was added a 10 aqueous solution of sodium hydroxide (1 ml) and the resulting mixture was stirred under heating at an outer temperature of OC for 1 hour.

After the completion of the reaction, the reaction mixture was concentrated, acidified with a 5 aqueous solution of hydrochloric acid, poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed successively with a 5 aqueous solution of hydrochloric acid, water 71 and a saturated aqueous solution of sodium chloride. After drying over sodium sulfate, the solvent was distilled off under reduced pressure. The crystals thus obtained were purified by column chromatography [silica gel, ethyl acetate/nhexane] to thereby give 659.5 mg of the compound 115 as colorless prisms.

1 H-NMR 6: 1.66(3H, d, J=6.7Hz, CH 3 3.20(2H, dd, J=18.3, 29.9Hz, CHg), 5.91 (1H, dt, J=6.7, 14.7Hz, CH), 6.99(1 H, d, J=7.3Hz, NH), 7.43(1 H, t, J=7.9Hz, Ar-H), 7.48(1 H, d, J=7.9Hz, Ar-H), 7.53(1H, dt, J=1.2, 6.7Hz, Ar-H), 7.77(1 H, d, J=8.5Hz, Ar-H), 7.83(1 H, d, J=7.9Hz, Ar-H), 8.00(1 H, d, Ar-H).

Compound 116: To a solution of the above compound 115 (50 mg, 0.19 mmol) in N,Ndimethylformamide (3 ml) were added (R)-(+)-1-(1-naphthyl)ethylamine (45.0 mg, 0.21 mmol, 1.1 mol eq.) and WSC'HCI (44.9 mg, 0.23 mmol, 1.2 mol eq.) and the resulting mixture was stirred at room temperature for 1 hour.

After the completion of the reaction, the reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride. After drying over sodium sulfate, the solvent was distilled off under reduced pressure. The crystals thus obtained were purified by column chromatography [silica gel, ethyl acetate/n-hexane] to thereby give 61.6 mg (70.5 of the compound 116 as colorless prisms.

S1'H-NMR 6: 1.43(3H, d, J=6.7Hz, CH 2 CHb), 1.72(3H, d, J=6.7Hz, CH3), 3.38(2H, d, J=2.5Hz, CH2), 4.36(2H, q, J=6.7Hz, CH2CH 3 5.32-6.01(1 H, m, CH), 6.88(1 H, d, J=9.2Hz, Ar-H), 7.21(1H, t, J=6.7Hz, Ar-H), 7.33(1 H, d, J=8.6Hz, Ar-H), 7.40(1 H, d, J=7.9Hz, Ar-H), 7.44-7.56(5H, m, Ar-H), 7.80(1H, d, J=7.9Hz, Ar-H), 7.88(1 H, d, J=9.2Hz, Ar-H), 8.06(1H, d, J=7.9Hz, Ar-H), 8.11(1 H, d, J=8.5Hz, Ar-H), 8.29(1 H, d, J=1.8Hz, Ar-H).

Compound 117: To a solution of the above compound 116 (50 mg, 0.11 mol) in tetrahydrofuran (3 ml) was added a 1 M solution of borane-tetrahydrofuran 72 (0.24 ml, 0.24 mmol, 2.2 mol eq.) under ice-cooling. Then the temperature was elevated to room temperature and the mixture was stirred for 6 hours.

After the completion of the reaction, water was poured into the reaction mixture. Then the mixture was acidified with a 5 aqueous solution of hydrochloric acid and extracted with ethyl acetate. The layer of the 5 aqueous solution of hydrochloric acid was made alkaline by adding a 5 aqueous solution of sodium hydroxide and then extracted with ethyl acetate.

After washing with water and a saturated aqueous solution of sodium chloride and drying over sodium sulfate, the solvent was distilled off under reduced pressure. The crystals thus obtained were purified by column chromatography [silica gel, ethyl acetate/n-hexane] to thereby give 18.0 mg (88.0 of the compound 117 as a colorless oil.

MS m/z: 421(M ).'H-NMR 6: 1.38(3H, d, J=7.3Hz, CH 2 CH), 1.56(3H, d, J=6.7Hz, CH), 1.90(2H, m, CH), 2.75(1H, m, CHg), 2.81(2H, m, CHS), 3.29(2H, t, J=6.7Hz, CH2), 4.29(2H, q, J=7.3Hz, CH2CH 3 4.79(1 H, q, J=6.1 Hz, CH), 6.81(1H, dd, J=1.8, 8.6Hz, Ar-H), 7.13(1H, t, J=7.3Hz, Ar-H), 7.20(1H, d, J=8.6Hz, Ar-H), 7.27(1 H, d, J=1.8Hz, Ar-H), 7.32(1H, d, J=7.9Hz, Ar-H), 7.39(1 H, t, J=7.3Hz, Ar-H), 7.46(3H, m, Ar-H), 7.65(1 H, d, J=10.4Hz, Ar-H), 7.75(1 H, d, J=8.6Hz, Ar-H), 7.86(1H, dd, J=2.4, 6.7Hz, Ar-H), 7.98(1 H, d, J=7.3Hz, Ar-H), 8.16(1 H, d, J=8.6Hz, Ar-H).

Example 42: Synthesis of compound 123 Compound 119: 2-Methoxycarbonylthiophenol 118 (9.7 g) was dissolved in N,Ndimethylformamide (200 ml) and sodium hydride (60 (2.7 g) was added thereto at 0 OC. When foaming was ceased, (±)-2-tert-butoxycarbonylamino- 1 -methanesulfonyloxy-2-phenylethane (20.0 g) was added thereto and the resulting mixture was stirred at room temperature for 12 hours.

After the completion of the reaction, ammonium chloride was added thereto in excess and the reaction mixture was extracted with ethyl acetate.

The extract was washed with a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced 73 pressure, the crystals thus obtained were purified by column chromatography [silica gel, ethyl acetate/n-hexane] to thereby give 16.0 g of the compound 119.

Compound 120: The above compound 119 (1.9 g) was dissolved in diphenyl ether and p-toluenesulfonic acid hydrate (100 mg) was added thereto. The resulting mixture was heated at 250 to 260 °C for 40 minutes.

After cooling by allowing to stand, it was purified by column chromatography and eluted with ethyl acetate/n-hexane to thereby give 700 mg of the compound 120.

Compound 121: The above compound 120 (150 g) was dissolved in tetrahydrofuran and lithium aluminum hydride (310 mg) was added thereto. The resulting mixture was then heated under reflux for 5 hours.

After the completion of the reaction, sodium sulfate decahydrate was .added in excess thereto and the mixture was filtered through celite. The filtrate was concentrated and thus 330 mg of the compound 121 was obtained.

Compound 122: The above compound 121 (3.0 g) and triethylamine (1.5 g) were dissolved in tetrahydrofuran and acryloyl chloride (1.2 g) was added thereto under ice-cooling. After stirring the mixture at room temperature for minutes, a saturated aqueous solution of sodium hydrogen carbonate was added thereto followed by extraction with chloroform. The extract was washed with a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained residue was purified by column chromatography [silica gel, ethyl acetate/nhexane] to thereby give 1.5 g of the compound 122.

Compound 123: The above compound 122 (150 mg, 0.51 mmol) and naphthyl)ethylamine (104.5 mg, 0.61 mmol, 1.2 mol eq.) were dissolved in chloroform/methanol (3 ml) and then allowed to stand at room temperature for 1 week.

74 After the completion of the reaction, the solvent was distilled off under reduced pressure. The oil thus obtained was purified by column chromatography [silica gel, chloroform/ methanol] to thereby give 167.4 mg (70.7 of the compound 123 as a colorless oil.

MS m/z: 466(M ).'H-NMR 6: 1.46(3H, q, J=6.7Hz, CH3), 2.33-2.36(1H, m, CH2), 2.79-2.93(3H, m, CH 3.25-3.38(1 H, m, C 3.57-3.65(1 H, m, CH2), 4.41-4.45(1 H, m, CH2), 4.56-4.65(2H, m, CH2), 6.30-6.34(1 H, m, CH), 7.07- 7.17(3H, m, Ar-H), 7.27-7.51(9H, m, Ar-H), 7.63(1 H, t, J=4.9Hz, Ar-H), 7.73(1H, t, J=8.5Hz, Ar-H), 7.84-7.87(1H, m, Ar-H), 8.11-8.19(1H, m, Ar-H).

Example 43: Synthesis of K-2003 4-Bromophenol (520 mg, 3.01 mmol) was dissolved in acetonitrile (11 and then potassium carbonate (1.243 g, 8.99 mmol) and 1,3dibromopropane (0.37 ml, 3.64 mmol) were successively added thereto at room temperature. The resulting mixture was stirred under heat-reflux at 95 °C for 4 hours. After confirming the completion of the reaction by TLC, potassium carbonate (800 mg, 5.79 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (450 mg, 2.98 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 95 °C for additional 18 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 100 1) to thereby give 364 mg (1.00 mmol) of the compound K-2003 as a pale yellow syrup at a yield of 33 500MHz NMR 7.22(1H, dd, J=8.3Hz, J=8.3Hz), 7.34(2H, dd, J=8.3Hz, J=8.3Hz), 6.87-6.88(1H, 6.87(1 H, 6.76-6.78(1 H, 6.74(2H, dd, J=8.3Hz, J=2.0Hz), 3.93-4.00(2H, 3.79(3H, 3.74(1H, q, J=6.5Hz), 2.58- 2.71 (2H, 1.88-1.95(2H, 1.53(1H, 1.34(3H, d, J=6.5Hz), m/z=363, 365.

75 Example 44: Synthesis of K-2004 4-Bromophenol (570 mg, 3.29 mmol) was dissolved in acetonitrile (11 ml) and then potassium carbonate (1.08 g, 7.81 mmol) and 1,4-dibromobutane (0.44 ml, 3.68 mmol) were successively added thereto at room temperature.

The resulting mixture was stirred under heat-reflux at 95 OC for 4 hours. After confirming the completion of the reaction by TLC, potassium carbonate (455 mg, 3.29 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (400 mg, 2.64 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 95 °C for additional 18 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 100: 1) to thereby give 422 mg (1.11 mmol) of the compound K-2004 as a pale yellow syrup at a yield of 43 500MHz NMR 7.34(2H, d, J=9.0Hz), 7.23(1H, dd, J=8.3Hz, J=8.3Hz), 6.77- 6.88(3H, 6.73(2H, d, J=6.5Hz), 3.86(2H, t, J=6.5Hz), 3.80(3H, 3.72(1 H, q, J=7.0Hz), 2.46-2.59(2H, 1.73-1.83(2H, 1.56-1.67(2H, 1.51(1H, 1.34(3H, d, J=7.0Hz), m/z=377, 379.

Example 45: Synthesis of K-2005 4-Bromophenol (710 mg, 4.10 mmol) was dissolved in acetonitrile (11 ml) and then potassium carbonate (710 mg, 5.14 mmol) and dibromopentane (0.44 ml, 4.55 mmol) were successively added thereto at room temperature. The resulting mixture was stirred under heat-reflux at 95 °C for 4 hours. After confirming the completion of the reaction by TLC, potassium carbonate (455 mg, 3.29 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (370 mg, 2.45 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 95 °C for additional 24 hours.

76 After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 100: 1) to thereby give 295 mg (0.75 mmol) of the compound K-2005 as a pale yellow syrup at a yield of 31 500MHz NMR 7.34(2H, d, J=7.0Hz), 7.23(1H, dd, J=8.5Hz, J=8.5Hz), 6.87- 6.89(2H, 6.77(1 H, dd, J=8.5Hz, J=1.5Hz), 6.74(2H, d, J=8.5Hz), 3.88(2H, t, J=6.3Hz), 3.80(3H, 3.72(1 H, q, J=6.5Hz), 2.36-2.55(4H, 1.55-1.77(2H, 1.43-1.57(2H, 1.34(3H, d, J=6.5Hz), m/z=391, 393.

Example 46: Synthesis of K-2006 4-Bromophenol (500 mg, 2.89 mmol) was dissolved in acetonitrile ml) and then potassium carbonate (540 mg, 3.90 mmol) and 1,6dibromohexane (0.49 ml, 3.18 mmol) were successively added thereto at room temperature. The resulting mixture was stirred under heat-reflux at 95 °C for 4 hours. After confirming the completion of the reaction by TLC, potassium carbonate (400 mg, 2.89 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (270 mg, 1.79 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 95 °C for additional 24 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 100 1) to thereby give 364 mg (0.896 mmol) of the compound K-2006 as a pale yellow syrup at a yield of 77 500MHz NMR 7.34(2H, d, J=8.0Hz), 7.23(1H, dd, J=8.0Hz, J=8.0Hz), 6.88- 6.89(1 H, 6.88(1H, 6.78(1H, dd, J=8.0Hz, J=3.0Hz), 6.75(2H, d, 3.88(2H, t, J=6.3Hz), 3.81 (3H, 3.73(1 H, q, J=7.0Hz), 2.41- 2.53(2H, 1.71-1.77(2H, 1.35-1.52(7H, 1.34(3H, d, m/z=405, 407.

Example 47: Synthesis of K-2007 4-Bromophenol (490 mg, 2.83 mmol) was dissolved in acetonitrile ml) and then potassium carbonate (495 mg, 3.58 mmol) and 1,7dibromoheptane (0.53 ml, 3.10 mmol) were successively added thereto at room temperature. The resulting mixture was stirred under heat-reflux at 95 °C for 4 hours. After confirming the completion of the reaction by TLC, potassium 0" carbonate (400 mg, 2.89 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine S 0 (300 mg, 1.98 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 95 °C for additional 24 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 100 1) to thereby give 150 mg (0.36 *mmol) of the compound K-2007 as a pale yellow syrup at a yield of 18 500MHz NMR 7.34(2H, d, J=8.5Hz), 7.24(1H, dd, J=7.8Hz, J=7.8Hz), 6.90- 6.93(2H, 6.79(1 H, dd, J=7.8Hz, J=1.8Hz), 6.75(2H, d, J=8.5Hz), 3.88(2H, t, J=6.3Hz), 3.82(3H, 3.79-3.80(1H, 2.43-2.54(2H, 1.70-1.84(2H, m), 1.20-1.56(9H, 1.41(3H, d, J=6.5Hz), m/z=419, 421.

Example 48: Synthesis of K-2010 3-Trifluoromethylthiophenol (615 mg, 3.45 mmol) was dissolved in acetonitrile (12 ml) and then potassium carbonate (467 mg, 3.38 mmol) and 1,4-dibromobutane (0.46 ml, 3.85 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature 78 for 5 hours. After confirming the completion of the reaction by TLC, potassium carbonate (210 mg, 1.52 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (360 mg, 2.38 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 95 °C for additional 18 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 150 1) to thereby give 180 mg (0.47 mmol) of the compound K-2010 as a pale yellow syrup at a yield of 20 500MHz NMR 7.51(1 H, 7.35-7.44(3H, 7.23(1 H, dd, J=8.0Hz, 6.86-6.88(2H, 6.76-6.78(1 H, 3.80(3H, 3.71 (1H, q, 2.93(2H, t, J=7.5Hz), 2.50-2.55(1 H, 2.42-2.47(1 H, 1.55-1.71 (4H, m), 1.45(1 H, 1.33(3H, d, J=6.5Hz), m/z=383.

0 Example 49: Synthesis of K-2011 3-Trifluoromethylthiophenol (600 mg, 3.37 mmol) was dissolved in acetonitrile (12 ml) and then potassium carbonate (540 mg, 3.96 mmol) and 1,5-dibromopentane (0.50 ml, 3.67 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 5 hours. After confirming the completion of the reaction by TLC, potassium carbonate (240 mg, 1.74 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (300 mg, 1.98 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 95 °C for additional 18 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column 79 chromatography (chloroform methanol 150: 1) to thereby give 220 mg (0.55 mmol) of the compound K-2011 as a pale yellow syrup at a yield of 28 500MHz NMR 7.51(1H, 7.45-7.44(1 H, 7.35-7.40(2H, 7.23(1 H, dd, J=8.0Hz), 6.86-6.88(2H, 6.76-6.79(1 H, 3.81(3H, 3.71 (1H, q, J=6.5Hz), 2.93(2H, t, J=7.3Hz), 2.47-2.52(1 H, 2.40-2.45(1H, 1.61- 1.67(2H, 1.41-1.52(5H, 1.34(3H, d, J=6.5Hz), m/z=397.

Example 50: Synthesis of K-2012 3-Trifluoromethylthiophenol (515 mg, 2.89 mmol) was dissolved in acetonitrile (10 ml) and then potassium carbonate (440 mg, 3.18 mmol) and 1,6-dibromohexane (0.45 ml, 2.93 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 5 hours. After confirming the completion of the reaction by TLC, potassium carbonate (270 mg, 1.95 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (260 mg, 1.72 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 95 °C for additional 24 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 150: 1) to thereby give 272 mg (0.66 mmol) of the compound K-2012 as a pale yellow syrup at a yield of 38 500MHz NMR 7.51(1H, 7.43-7.45(1 H, 7.35-7.40(2H, 7.23(1 H, dd, J=7.5Hz), 6.87-6.89(2H, 6.76-6.79(1 H, 3.81(3H, 3.71(1H, q, J=6.5Hz), 2.93(2H, t, J=7.5Hz), 2.46-2.51 (1H, 2.40-2.44(1 H, 1.61- 1.67(2H, 1.38-1.50(7H, 1.34(3H, d, J=6.5Hz), m/z=411.

Example 51: Synthesis of K-2015 2-Bromobenzenethiol (445 mg, 2.35 mmol) was dissolved in acetonitrile ml) and then potassium carbonate (420 mg, 3.04 mmol) and 1-bromo-2chloroethane (0.22 ml, 2.64 mmol) were successively added thereto at room 80 temperature. The resulting mixture was stirred at the same temperature for 4 hours. After confirming the completion of the reaction by TLC, potassium carbonate (315 mg, 2.28 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (250 mg, 1.65 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 95 °C for additional 120 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform: methanol 150 1) to thereby give 207 mg (0.57 mmol) of the compound K-2015 as a pale yellow syrup at a yield of 34 500MHz NMR 7.53(1 H, d, J=8.0Hz), 7.18-7.26(4H, 6.87-6.88(2H, m), 6.78-6.81(1 H, 3.81(3H, 3.04(2H, t, J=7.0Hz), 3.76(1 H, q, 2.67-2.81 (2H, 1.73(1 H, 1.35(3H, d, J=6.5Hz), m/z=365, 367.

Example 52: Synthesis of K-2016 2-Bromobenzenethiol (517 mg, 2.73 mmol) was dissolved in acetonitrile ml) and then potassium carbonate (475 mg, 3.44 mmol) and 1,3dibromopropane (0.31 ml, 3.05 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 4 hours. After confirming the completion of the reaction by TLC, potassium carbonate (352 mg, 2.76 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (250 mg, 1.65 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 °C for additional 12 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column 81 chromatography (chloroform methanol 150: 1) to thereby give 249 mg (0.66 mmol) of the compound K-2016 as a pale yellow syrup at a yield of 40 500MHz NMR 7.52(1 H, d, J=7.5Hz), 7.22-7.26(3H, 7.00(1 H, ddd, J=2.0Hz), 6.88(1 H, d, J=7.5Hz), 6.87(1 H, 6.77(1 H, dd, 3.81(3H, 3.73(1H, q, J=7.0Hz), 2.90-3.02(2H, 2.55-2.69(2H, 1.80-1.86(2H, 1.46(1 H, 1.34(3H, d, J=7.0Hz), m/z=379, 3.81.

Example 53: Synthesis of K-2017 2-Bromobenzenethiol (505 mg, 2.67 mmol) was dissolved in acetonitrile ml) and then potassium carbonate (445 mg, 3.22 mmol) and 1,4dibromobutane (0.35 ml, 2.93 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 4 hours. After confirming the completion of the reaction by TLC, potassium carbonate (330 mg, 2.39 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (250 mg, 1.65 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 95 °C for additional 12 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform: methanol 150: 1) to thereby give 311 mg (0.79 mmol) of the compound K-2017 as a pale yellow syrup at a yield of 48 500MHz NMR 7.52(1 H, d, J=8.0Hz), 7.19-7.25(3H, 7.00(1 H, ddd, J=2.0Hz), 6.87-6.88(2H, 6.78(1 H, dd, J=2.0Hz, J=8.0Hz), 3.80(3H, 3.72(1 H, q, J=6.5Hz), 2.90(2H, t, J=7.5Hz), 2.43-2.56(2H, 1.68-1.73(2H, 1.68-1.73(2H, 1.58-1.67(2H, 1.47(1H, 1.34(3H, d, m/z=393, 395.

Example 54: Synthesis of K-2018 2-Bromobenzenethiol (445 mg, 2.35 mmol) was dissolved in acetonitrile ml) and then potassium carbonate (407 mg, 2.95 mmol) and 82 dibromopentane (0.31 ml, 2.60 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 4 hours. After confirming the completion of the reaction by TLC, potassium carbonate (330 mg, 2.39 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (220 mg, 1.46 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 95 °C for additional 12 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 150: 1) to thereby give 307 mg (0.75 mmol) of the compound K-2018 as a pale yellow syrup at a yield of 52 500MHz NMR 7.52(1 H, d, J=6.5Hz), 7.18-7.25(3H, 6.99(1H, dd, J=7.5Hz), 6.87-6.89(2H, 6.78(1 H, dd, J=7.5Hz, J=2.0Hz), 3.81(3H, s), 3.72(1H, q, J=6.5Hz), 2.90(2H, q, J=7.5Hz), 2.41-2.51(2H, 1.65-1.69(2H, 1.44-1.53(5H, 1.34(3H, d, J=6.5Hz), m/z=409.

Example 55: Synthesis of K-2027 (N-{5-[(4-chlorophenyl)thio]pentyl}-N-[(1 R)- 1-(1-naphthyl)ethyl]amine) 4-Chlorobenzenethiol (550 mg, 3.80 mmol) was dissolved in acetonitrile ml) and then potassium carbonate (520 mg, 3.76 mmol) and dibromopentane (0.52 ml, 3.82 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 1 hour. After confirming the completion of the reaction by TLC, potassium carbonate (241 mg, 1.74 mmol) and (R)-(+)-1-(1-naphthyl)ethylamine (0.31 ml, 1.92 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 95 °C for additional 12 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed -83 with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 150 1) to thereby give 288 mg (0.75 mmol) of the compound K-2027 as a pale yellow syrup at a yield of 40 500MHz NMR 8.17(1H, d, J=8.0Hz), 7.87(1H, d, J=7.5Hz), 7.74(1H, d, 7.63(1H, d, J=9.0Hz), 7.63(1H, d, J=7.5Hz), 7.45-7.52(3H, m), 7.19-7.23(4H, 4.61(1H, q, J=6.5Hz), 2.85(2H, t, J=7.2Hz), 2.50-2.61 (2H, 1.41-1.63(7H, 1.48(3H, d, J=6.5Hz), m/z=383.

Example 56: Synthesis of K-2030 3-Chlorophenol (420 mg, 3.27 mmol) was dissolved in acetonitrile ml) and then potassium carbonate (1.19 g, 8.61 mmol) and 1-bromo-2- S: chloroethane (0.41 ml, 4.93 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at 70 °C for 24 hours. After confirming the completion of the reaction by TLC, potassium carbonate (1.70 g, 12.3 mmol) and (R)-(+)-1-(1-naphthyl)ethylamine (0.45 ml, 2.79 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 °C for additional 120 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 150 1) to thereby give 321 mg (0.99 mmol) of the compound K-2030 as a pale yellow syrup at a yield of 35 500MHz NMR 8.21(1 H, d, J=8.5Hz), 7.87(1 H, d, J=7.5Hz), 7.75(1 H, d, 7.69(1H, d, J=8.0Hz), 7.46-7.53(3H, 7.18(1H, dd, 6.89-3.93(2H, 6.76-6.78(1H, dd, J=1.5Hz, J=8.0Hz), 4.71 (1H, q, 4.04(2H, t, J=5.3Hz), 2.90-3.00(2H, 1.78(1H, 1.53(3H, d, m/z=325.

84 Example 57: Synthesis of K-2033 4-Nitrobenzenethiol (470 mg, 3.03 mmol) was dissolved in acetonitrile ml) and then potassium carbonate (450 mg, 3.26 mmol) and 1,4dibrorhobutane (0.36 ml, 3.01 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 3 hours. After confirming the completion of the reaction by TLC, potassium carbonate (250 mg, 1.81 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (250 mg, 1.65 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 °C for additional 12 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform: methanol 150 to thereby give 206 mg (0.57 mmol) of the compound K-2033 as a yellow syrup at a yield of 35 500MHz NMR 8.11(2H, d, J=9.0Hz), 7.29(2H, d, J=9.0Hz), 7.24(1H, dd, J=8.0Hz), 6.88(1 H, d, J=8.0Hz), 6.87(1 H, 6.79(1H, dd, J=2.5Hz), 3.81 (3H, 3.72(1H, q, J=6.5Hz), 2.99(2H, t, J=7.5Hz), 2.44- 2.60(2H, 1.71-1.76(2H, 1.60-1.66(3H, 1.35(3H, d, m/z=360.

Example 58: Synthesis of K-2034 4-Nitrobenzenethiol (520 mg, 3.35 mmol) was dissolved in acetonitrile ml) and then potassium carbonate (492 mg, 3.56 mmol) and dibromopentane (0.46 ml, 3.38 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 3 hours. After confirming the completion of the reaction by TLC, potassium carbonate (300 mg, 2.17 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (300 mg, 1.98 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 °C for additional 12 hours.

85 After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 150 1) to thereby give 102 mg (0.27 mmol) of the compound K-2034 as a yellow syrup at a yield of 14 500MHz NMR 8.11(2H, d, J=9.5Hz), 7.28(2H, d, J=9.5Hz), 7.24(1 H, dd, J=7.8Hz, J=7.8Hz), 6.87-6.89(2H, 6.77-6.79(1 H, 3.81(3H, 3.72(1 H, q, J=6.5Hz), 2.99(2H, q, J=7.5Hz), 2.49-2.52(1 H, 2.41-2.45(1H, 1.67- 1.72(2H, 1.45-1.53(5H, 1.35(3H, d, J=6.5Hz), m/z=374.

Example 59: Synthesis of K-2035 4-Nitrobenzenethiol (460 mg, 2.96 mmol) was dissolved in acetonitrile (7.0 ml) and then potassium carbonate (432 mg, 3.13 mmol) and 1,6dibromohexane (0.46 ml, 2.99 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 3 hours. After confirming the completion of the reaction by TLC, potassium carbonate (120 mg, 0.86 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (230 mg, 1.52 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 °C for additional 12 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 150 1) to thereby give 133 mg (0.342 mmol) of the compound K-2035 as a yellow syrup at a yield of 23 500MHz NMR 8.12(2H, d, J=9.0Hz), 7.29(2H, d, J=9.0Hz), 7.24(1H, dd, 6.88(1 H, d, J=8.0Hz), 6.88(1 H, 6.77-6.79(1H, 3.81 (3H, s), 86- 3.73(1 H, q, J=6.5Hz), 2.99(2H, t, J=7.5Hz), 2.40-2.53(2H, 1.67-1.73(2H, 1.41-1.50(5H, 1.25-1.36(2H, 1.35(3H, d, J=6.5Hz), m/z=388.

Example 60: Synthesis of K-2040 4-Fluorobenzenethiol (520 mg, 4.06 mmol) was dissolved in acetonitrile (10.0 ml) and then potassium carbonate (864 mg, 6.26 mmol) and 1,4dibromobutane (0.49 ml, 4.12 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for hours. After confirming the completion of the reaction by TLC, potassium carbonate (320 mg, 2.32 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (310 mg, 2.05 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 °C for additional 12 hours.

.:After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the .0* mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 150: 1) to thereby give 170 mg (0.51 mmol) of the compound K-2040 as a pale yellow syrup at a yield of 25 500MHz NMR 7.28-7.32(2H, 7.23(1H, dd, J=8.3Hz, J=8.3Hz), 6.95- 6.70(2H, 6.86-6.87(2H, 6.76-6.79(1 H, 3.80(3H, 3.71 (1 H, q, 2.83(2H, dd, J=7.0Hz, J=7.0Hz), 2.47-2.52(1H, 2.39-2.44(1 H, 1.52-1.64(5H, 1.33(3H, d, J=6.5Hz), m/z=333.

Example 61: Synthesis of K-2041 4-Fluorobenzenethiol (590 mg, 4.61 mmol) was dissolved in acetonitrile (10.0 ml) and then potassium carbonate (340 mg, 2.46 mmol) and dibromopentane (0.63 ml, 4.62 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 3 hours. After confirming the completion of the reaction by TLC, potassium carbonate (340 mg, 2.46 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine 87 (350 mg, 2.31 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 °C for additional 12 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 150: 1) to thereby give 245 mg (0.71 mmol) of the compound K-2041 as a pale yellow syrup at a yield of 31 500MHz NMR 7.29-7.32(2H, 7.23(1H, dd, J=8.0Hz, J=8.0Hz), 6.96-6.99(2 H, 6.86-6.88(2H, 6.77-6.79(1 H, 3.81 (3H, 3.71(1 H, q, S: 2.83(2H, t, J=7.2Hz), 2.45-2.50(1H, 2.38-2.43(1 H, 1.54-1.60(2H, m), 1.38-1.48(3H, 1.34(3H, d, J=7.0Hz), m/z=347.

Example 62: Synthesis of K-2045 3-Bromobenzenethiol (650 mg, 3.44 mmol) was dissolved in acetonitrile (10.0 ml) and then potassium carbonate (524 mg, 3.79 mmol) and 1-bromo-2chloroethane (0.29 ml, 3.48 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 3 hours. After confirming the completion of the reaction by TLC, potassium carbonate (280 mg, 2.02 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (420 mg, 2.78 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 °C for additional 120 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 185 1) to thereby give 395 mg (1.23 mmol) of the compound K-2045 as a pale yellow syrup at a yield of 44 88 500MHz NMR 7.43(1 H, 7.28(1 H, d, J=8.0Hz), 7.22(1H, dd, 7.18(1H, d, J=8.0Hz), 7.19(1H, dd, J=7.5Hz, J=7.5Hz), 6.87(1H, d, 6.86(1 H, 6.77(1 H, dd, J=7.5Hz, J=1.5Hz), 3.80(3H, 3.74(1 H, q, J=6.5Hz), 3.02(2H, t, J=6.5Hz), 2.66-2.77(2H, 1.68(1H, 1.34(3H, d, m/z=365, 367.

Example 63: Synthesis of K-2046 3-Bromobenzenethiol (580 mg, 3.06 mmol) was dissolved in acetonitrile ml) and then potassium carbonate (432 mg, 3.13 mmol) and 1,3dibromopropane (0.31 ml, 3.05 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 5 hours. After confirming the completion of the reaction by TLC, potassium carbonate (280 mg, 2.02 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (230 mg, 1.52 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 °C for additional 24 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed **with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 150 to thereby give 213 mg (0.56 mmol) of the compound K-2046 as a pale yellow syrup at a yield of 37 500MHz NMR 7.40-7.41(1H, 7.18-7.28(3H, 7.11(1H, dd, 6.86-6.88(2H, 6.76-6.79(1H, 3.80(3H, 3.72(1H, q, 2.88(2H, 2.49-2.54(1 H, 2.41-2.46(1H, 1.54-1.69(2H, m), 1.34(3H, d, J=7.0Hz), m/z=379, 381.

Example 64: Synthesis of K-2047 3-Bromobenzenethiol (470 mg, 2.49 mmol) was dissolved in acetonitrile (10.0 ml) and then potassium carbonate (347 mg, 2.51 mmol) and 1,4dibromobutane (0.30 ml, 2.51 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 89 hours. After confirming the completion of the reaction by TLC, potassium carbonate (320 mg, 2.32 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (200 mg, 1.32 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 °C for additional 24 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 150 to thereby give 185 mg (0.47 mmol) of the compound K-2047 as a pale yellow syrup at a yield of 36 500MHz NMR 7.19-7.28(3H, 7.02-7.13(2H, 6.86-6.88(2H, 6.76- 6.79(1H, 3.81(3H, 3.77(1H, q, J=6.5Hz), 1.76-1.79(2H, 2.89- 3.01 (2H, 2.60-2.65(1 H, 2.51-2.56(1 H, 2.31-2.42(2H, 1.52(1 H, 1.33(3H, d, J=6.5Hz), m/z=393, 395.

Example 65: Synthesis of K-2048 3-Bromobenzenethiol (530 mg, 2.80 mmol) was dissolved in acetonitrile (10.0 ml) and then potassium carbonate (395 mg, 2.86 mmol) and dibromopentane (0.38 ml, 2.78 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 2 hours. After confirming the completion of the reaction by TLC, potassium carbonate (213 mg, 1.54 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (200 mg, 1.32 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 °C for additional 24 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column 90 chromatography (chloroform methanol 150: 1) to thereby give 226 mg (0.55 mmol) of the compound K-2048 as a pale yellow syrup at a yield of 42 500MHz NMR 7.41(1 H, 7.18-7.28(3H, 7.11(1 H, dd, J=7.5Hz, 6.88(1 H, d, J=7.5Hz), 6.87(1 H, 6.78(1 H, dd, J=7.5Hz, J=2.5Hz), 3.81 (3H, 3.72(1 H, q, J=6.5Hz), 2.89(2H, q, J=7.2Hz), 2.47-2.51 (1H, 2.40- 2.43(1 H, 1.62(2H, 1.40-1.50(5H, 1.234(3H, d, Example 66: Synthesis of K-2049 3-Bromobenzenethiol (600 mg, 3.17 mmol) was dissolved in acetonitrile (10.0 ml) and then potassium carbonate (500 mg, 3.62 mmol) and 1,6dibromohexane (0.50 ml, 3.25 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 2 hours. After confirming the completion of the reaction by TLC, potassium carbonate (205 mg, 1.48 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (250 mg, 1.66 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 °C for additional 24 hours.

9 After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus :.....obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 150: 1) to thereby give 267 mg (0.63 mmol) of the compound K-2049 as a pale yellow syrup at a yield of 38 500MHz NMR 7.41(1 H, dd, J=1.8Hz, J=1.8Hz), 7.19-7.27(3H, 7.11(1 H, dd, J=8.0Hz), 6.87-6.89(2H, 6.77(1H, dd, J=8.0Hz, 3.81 (3H, 3.72(1H, t, J=6.5Hz), 2.88(2H, t, J=7.8Hz), 2.39-2.51 (2H, m), 1.50-1.65(2H, 1.25-1.49(7H, 1.34(3H, d, Example 67: Synthesis of K-2050 3-Bromobenzenethiol (525 mg, 2.78 mmol) was dissolved in acetonitrile (10.0 ml) and then potassium carbonate (325 mg, 2.36 mmol) and 1,7dibromoheptane (0.47 ml, 2.75 mmol) were successively added thereto at 91 room temperature. The resulting mixture was stirred at the same temperature for 1 hour. After confirming the completion of the reaction by TLC, potassium carbonate (182 mg, 1.32 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (210 mg, 1.39 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 °C for additional 24 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 150 to thereby give 260 mg (0.60 mmol) of the compound K-2050 as a pale yellow syrup at a yield of 43 500MHz NMR 7.41 (1H, dd, J=2.0Hz, J=2.0Hz), 7.23-7.27(2H, 7.18- 7.21 (1 H, 7.11(1 H, dd, J=8.0Hz, J=8.0Hz), 6.90-6.93(2H, 6.80(1 H, dd, J=8.0Hz, J=2.5Hz), 3.82(3H, 3.77-3.80(1H, 2.88(2H, t, J=7.5Hz), 2.42- 2.54(2H, 1.58-1.64(2H, 1.50-1.55(1 H, 1.35-1.45(4H, 1.42(3H, d, J=7.5Hz), 1.21-1.29(4H, m/z=4.35, 437.

Example 68: Synthesis of K-2051 3-Bromobenzenethiol (610 mg, 3.22 mmol) was dissolved in acetonitrile 4 :(10.0 ml) and then potassium carbonate (490 mg, 3.55 mmol) and 1,8dibromooctane (0.59 ml, 3.20 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 1 hour. After confirming the completion of the reaction by TLC, potassium carbonate (218 mg, 1.58 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (250 mg, 1.66 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 °C for additional 24 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus 92 obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform: methanol 150: 1) to thereby give 170 mg (0.38 mmol) of the compound K-2051 as a pale yellow syrup at a yield of 24 500MHz NMR 7.41-7.42(1 H, 7.19-7.27(3H, 7.11(1H, dd, J=7.8Hz, J=7.8Hz), 6.90-6.92(2H, 6.79(1H, dd, J=7.8Hz, J=2.0Hz), 3.82(3H, s), 3.76-3.82(1 H, 2.89(2H, t, J=7.8Hz), 2.42-2.53(2H, 1.59-1.65(2H, m), 1.49(1 H, 1.41(3H, d, J=6.5Hz), 1.36-1.43(4H, 1.22-1.28(6H, m), m/z=449, 451.

Example 69: Synthesis of K-2052 (N-{5-[(4-fuluorophenyl)thio]pentyl}-N-[(1 R)- 1 -naphthyl)ethyl]amine) 4-Fluorobenzenethiol (460 mg, 3.60 mmol) was dissolved in acetbnitrile (10.0 ml) and then potassium carbonate (500 mg, 3.62 mmol) and dibromopentane (0.50 ml, 3.67 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature 0 for 1 hour. After confirming the completion of the reaction by TLC, potassium carbonate (210 mg, 1.52 mmol) and (R)-(+)-1-(1-naphthyl)ethylamine (300 mg, 1.86 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 °C for additional 24 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 150 1) to thereby give 210 mg (0.57 mmol) of the compound K-2052 as a pale yellow syrup at a yield of 31 500MHz NMR 8.17(1H, d, J=8.0Hz), 7.87(1H, d, J=8.5Hz), 7.74(1H, d, 7.62(1H, d, J=8.0Hz), 7.41-7.50(5H, 7.29(2H, d, 4.61 (1H, q, J=6.5Hz), 2.82(2H, t, J=7.5Hz), 2.56-2.57(2H, 2.37-2.43(2H, 1.40-1.59(5H, 1.46(3H, d, J=6.5Hz), m/z=367.

93 Example 70: Synthesis of K-2055 4-Trifluoromethylbenzenethiol (408 mg, 2.29 mmol) was dissolved in acetonitrile (10.0 ml) and then potassium carbonate (330 mg, 2.39 mmol) and 1,3-dibromopropane (0.23 ml, 2.28 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 1 hour. After confirming the completion of the reaction by TLC, potassium carbonate (172 mg, 1.25 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (210 mg, 1.39 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 °C for additional 24 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the Smixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 150 1) to thereby give 122 mg (0.33 mmol) of the compound K-2055 as a pale yellow syrup at a yield of 24 •500MHz NMR 7.44-7.50(2H, 7.32(1H, d, J=8.5Hz), 7.23(1H, dd, 7.17-7.20(1H, 6.85-6.88(2H, 6.77-6.79(1H, 3.80(3H, s), 3.70-3.74(1H, 1.77-1.83(2H, 1.34(3H, d, J=6.5Hz), 1.25-1.26(1H, m), m/z=369.

Example 71: Synthesis of K-2056 4-Trifluoromethylbenzenethiol (487 mg, 2.74 mmol) was dissolved in acetonitrile (10.0 ml) and then potassium carbonate (374 mg, 2.71 mmol) and 1,4-dibromobutane (0.33 ml, 2.77 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 1 hour. After confirming the completion of the reaction by TLC, potassium carbonate (172 mg, 1.25 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (250 mg, 1.65 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 °C for additional 24 hours.

-94 After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 150: 1) to thereby give 152 mg (0.40 mmol) of the compound K-2056 as a pale yellow syrup at a yield of 24 500MHz NMR 7.49(2H, d, J=8.5Hz), 7.32(2H, d, J=8.0Hz), 7.23(1H, dd, J=8.0Hz, J=8.0Hz), 6.86-6.88(2H, 6.76-6.79(1H, 3.80(1 H, 3.71 (1 H, q, J=6.5Hz), 2.92-2.95(2H, t, J=7.5Hz), 1.55-1.73(4H, 1.47(1H, 1.33(3H, d, J=6.5Hz), 2.50-2.55(1 H, 2.42-2.47(1 H, m/z=383.

Example 72: Synthesis of K-2057 4-Trifluoromethylbenzenethiol (560 mg, 3.15 mmol) was dissolved in acetonitrile (10.0 ml) and then potassium carbonate (440 mg, 3.19 mmol) and 1,5-dibromopentane (0.43 ml, 3.16 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 1 hour. After confirming the completion of the reaction by TLC, potassium carbonate (240 mg, 1.74 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (290 mg, 1.92 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 °C for additional 24 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 150 1) to thereby give 129 mg (0.32 mmol) of the compound K-2057 as a pale yellow syrup at a yield of 17 500MHz NMR 7.49(2H, d, J=8.5Hz), 7.31(2H, d, J=8.0Hz), 7.23(1 H, dd, J=8.0Hz), 6.86-6.89(2H, 6.76-6.79(1H, 3.81(3H, 3.71 (1H, 95 q, J=6.8Hz), 2.94(2H, t, J=7.3Hz), 2.40-2.51(2H, 1.63-1.68(2H, 1.42- 1.51(5H, 14.34(3H, d, J=6.8Hz), m/z=397.

Example 73: Synthesis of K-2058 4-Trifluoromethylbenzenethiol (500 mg, 2.81 mmol) was dissolved in acetonitrile (10.0 ml) and then potassium carbonate (420 mg, 3.64 mmol) and 1,6-dibromohexane (0.43 ml, 2.79 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 1 hour. After confirming the completion of the reaction by TLC, potassium carbonate (150 mg, 1.09 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (260 mg, 1.72 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 °C for additional 24 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column •chromatography (chloroform methanol 150 1) to thereby give 155 mg (0.38 mmol) of the compound K-2058 as a pale yellow syrup at a yield of 22 500MHz NMR 7.49(2H, d, J=8.5Hz), 7.32(2H, d, J=7.0Hz), 7.23(1H, dd, J=8.0Hz, J=8.0Hz), 6.87-6.89(2H, 6.76-6.79(1H, 3.81(3H, 3.72(1 H, q, J=6.5Hz), 2.94(2H, t, J=7.5Hz), 2.39-2.52(2H, 1.63-1.69(2H, 1.39- 1.50(5H, 1.29-1.34(2H, 1.34(3H, d, J=6.5Hz), m/z=411.

Example 74: Synthesis of K-2059 4-Trifluoromethylbenzenethiol (500 mg, 2.81 mmol) was dissolved in acetonitrile (10.0 ml) and then potassium carbonate (420 mg, 3.64 mmol) and 1,7-dibromoheptane (0.48 ml, 2.81 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 1 hour. After confirming the completion of the reaction by TLC, potassium carbonate (150 mg, 1.09 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine 96 (260 mg, 1.72 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 °C for additional 24 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 150: 1) to thereby give 204 mg (0.48 .mmol) of the compound K-2059 as a pale yellow syrup at a yield of 28 500MHz NMR 7.49(2H, d, J=8.5Hz), 7.32(2H, d, J=6.5Hz), 7.23(1H, dd, J=6.0Hz), 6.87-6.89(2H, 6.76-6.79(1 H, 3.81(3H, 3.73(1H, q, J=6.0Hz), 2.94(2H, t, J=6.5Hz), 2.39-2.51(2H, 1.62-1.68(2H, 1.34- 1.48(9H, 1.35(3H, d, J=6.0Hz), m/z=425.

Example 75: Synthesis of K-2061 3-Chlorobenzenethiol (460 mg, 3.18 mmol) was dissolved in acetonitrile (10.0 ml) and then potassium carbonate (440 mg, 3.19 mmol) and 1,3dibromopropane (0.32 ml, 3.15 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 2 hours. After confirming the completion of the reaction by TLC, potassium carbonate (210 mg, 1.52 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (300 mg, 1.99 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 OC for additional 24 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 150 1) to thereby give 272 mg (0.81 mmol) of the compound K-2061 as a pale yellow syrup at a yield of 41 97 500MHz NMR 7.11-7.27(5H, 6.86-6.88(2H, 6.77-6.79(1 H, 3.81 (3H, 3.70(1 H, q, J=6.5Hz), 2.89-3.01(2H, 2.60-2.65(1 H, 2.51-2.56(1 H, 1.75-1.81(2H, 1.47(1 H, 1.33(3H, d, J=6.5Hz), m/z=335.

Example 76: Synthesis of K-2066 (575 mg, 3.21 mmol) was dissolved in acetonitrile (11.0 ml) and then potassium carbonate (440 mg, 3.19 mmol) and 1-bromo-2-chloroethane (0.26 ml, 3.12 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 1 hour. After confirming the completion of the reaction by TLC, potassium carbonate (225 mg, 1.63 mmol) and (R)-(+)-3-methoxy-amethylbenzylamine (340 mg, 2.25 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 °C for additional 100 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under 0 reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 150 1) to thereby give 182 mg (0.51 mmol) of the compound K-2066 as a pale yellow syrup at a yield of 23 500MHz NMR 7.21-7.30(3H, 7.19(1 H, d, J=2.5Hz), 6.88-6.89(2H, m), 6.77(1 H, dd, J=8.5Hz, J=2.5Hz), 3.81(3H, 3.76(1 H, q, J=6.5hZ), 3.04(2H, t, 2.72-2.83(2H, 1.66(1H, 1.36(3H, d, J=6.5Hz), m/z=355, 357.

Example 77: Synthesis of K-2075 2-Bromobenzenethiol (702 mg, 3.71 mmol) was dissolved in acetonitrile (14.0 ml) and then potassium carbonate (525 mg, 3.80 mmol) and dibromopentane (0.50 ml, 3.67 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 1 hour. After confirming the completion of the reaction by TLC, potassium carbonate (247 mg, 1.79 mmol) and (R)-(+)-1-(1-naphthyl)ethylamine (0.30 ml, 98 1.86 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 °C for additional 24 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 200 1) to thereby give 144 mg (0.34 mmol) of the compound K-2075 as a pale yellow syrup at a yield of 18 500MHz NMR 8.18(1H, d, J=8.5Hz), 7.87(1H, d, J=8.5Hz), 7.64(1H, d, 7.74(1H, d, J=8.5Hz), 7.45-7.53(4H, 7.13-7.25(2H, 6.99(1H, ddd, J=1.5Hz, J=6.0Hz, J=6.0Hz), 4.62(1 H, q, J=7.0Hz), 2.89(2H, t, 2.52-2.63(2H, 1.66-1.71(2H, 1.45-1.59(5H, 1.49(3H, d, m/z=427.

Example 78: Synthesis of K-2076 -naphthyl)ethyl]-N-(5-{[4- (trifluoromethyl)phenyl]thio}pentyl)amine) 4-Trifluoromethylbenzenethiol (510 mg, 2.861 mmol) was dissolved in acetonitrile (12.0 ml) and then potassium carbonate (400 mg, 2.89 mmol) and 1,5-dibromopentane (0.39 ml, 2.86 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 1 hour. After confirming the completion of the reaction by TLC, potassium carbonate (200 mg, 1.45 mmol) and (R)-(+)-1-(1-naphthyl)ethylamine (0.28 ml, 1.73 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 °C for additional 24 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column 99 chromatography (chloroform methanol 180 1) to thereby give 53 mg (0.13 mmol) of the compound K-2076 as a pale yellow syrup at a yield of 7 500MHz NMR 8.18(1H, d, J=8.5Hz), 7.87(1H, d, J=7.0Hz), 7.74(1H, d, 7.63(1H, d, J=6.5Hz), 7.45-7.52(5H, 7.30(2H, d, 4.62(1 H, q, J=6.5Hz), 2.93(2H, t, J=6.5Hz), 2.93(2H, t, J=7.0Hz), 2.51-2.63(2H, 1.63-1.69(2H, 1.44-1.56(5H, 1.49(3H, d, J=6.5Hz), m/z=417.

Example 79: Synthesis of K-2078 3,4-Dichlorobenzenethiol (469 mg, 2.62 mmol) was dissolved in acetonitrile (10.0 ml) and then potassium carbonate (400 mg, 2.89 mmol) and 1,3-dibromopropane (0.27 ml, 2.67 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 1 hour. After confirming the completion of the reaction by TLC, potassium carbonate (180 mg, 1.30 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (240 mg, 1.59 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 oC for additional 24 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column °chromatography (chloroform: methanol 150 1) to thereby give 143 mg (0.39 mmol) of the compound K-2078 as a pale yellow syrup at a yield of 25 500MHz NMR 7.36(1H, d, J=1.5Hz), 7.31 (1H, d, J=8.5Hz), 7.24(1H, dd, J=6.5Hz), 7.10(1H, dd, J=8.5Hz, J=1.5Hz), 6.85-6.88(2H, 6.77- 6.79(1 H, 3.81 (3H, 3.71 (1H, q, J=6.5Hz), 2.88-3.00(2H, 2.50- 2.64(2H, 1.71-1.81(2H, 1.52(1H, 1.33(3H, d, J=6.5Hz), m/z=369, 371.

Example 80: Synthesis of K-2079 3,4-Dichlorobenzenethiol (556 mg, 3.11 mmol) was dissolved in acetonitrile (12.0 ml) and then potassium carbonate (412 mg, 2.99 mmol) and 100 1,4-dibromobutane (0.37 ml, 3.10 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 1 hour. After confirming the completion of the reaction by TLC, potassium carbonate (242 mg, 1.75 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (280 mg, 1.85 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 °C for additional 24 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 150 1) to thereby give 156 mg (0.41 mmol) of the compound K-2079 as a pale yellow syrup at a yield of 22%.

500MHz NMR 7.34(1H, d, J=2.5Hz), 7.31(1H, d, J=8.5Hz), 7.23(1H, dd, J=7.5Hz, J=7.5Hz), 7.10(1 H, dd, J=8.5Hz, J=2.5Hz), 6.87(1 H, d, 6.86(1H, 6.76-6.79(1H, 3.80(3H, 3.71(1H, q, J=7.0Hz), 2.87(2H, t, 2.41-2.54(2H, 1.53-1.68(4H, 1.46(1 H, 1.33(3H, d, J=7.0Hz), m/z=383, 385.

Example 81: Synthesis of K-2080 3,4-Dichlorobenzenethiol (515 mg, 2.88 mmol) was dissolved in acetonitrile (11.0 ml) and then potassium carbonate (410 mg, 2.97 mmol) and (0.39 ml, 2.86 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 1 hour. After confirming the completion of the reaction by TLC, potassium carbonate (230 mg, 1.66 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (260 mg, 1.72 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 °C for additional 24 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed -101 with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 150: 1) to thereby give 250 mg (0.63 mmol) of the compound K-2080 as a pale yellow syrup at a yield of 37 500MHz NMR 7.34(1 H, d, J=2.5Hz), 7.31 (1H, d, J=8.5Hz), 7.22-7.25(1H, m), 7.09(1 H, dd, J=2.5Hz, J=8.5Hz), 6.88(1 H, d, J=8.5Hz), 6.87(1H, 6.78(1 H, dd, J=8.5Hz, J=2.5Hz), 3.81(3H, 3.72(1 H, q, J=6.5Hz), 2.87(2H, t, 2.39-2.52(2H, 1.59-1.64(2H, 1.38-1.51(5H, 1.34(3H, d, m/z=395, 397.

Example 82: Synthesis of K-2082 3,4-Dichlorobenzenethiol (720 mg, 4.02 mmol) was dissolved in acetonitrile (15.0 ml) and then potassium carbonate (550 mg, 3.98 mmol) and 1,7-dibromoheptane (0.64 ml, 3.75 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 1 hour. After confirming the completion of the reaction by TLC, potassium carbonate (230 mg, 1.66 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (360 mg, 2.38 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 °C for additional 24 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 150 1) to thereby give 253 mg (0.59 mmol) of the compound K-2082 as a pale yellow syrup at a yield of 25 500MHz NMR 7.35(1 H, d, J=2.5Hz), 7.31(1H, d, J=8.0Hz), 7.22-7.25(1 H, m), 7.10(1H, dd, J=8.5Hz, J=2.5Hz), 6.88-6.90(1H, 6.90(1H, 6.78(1H, dd, J=8.5Hz), 3.81 (3H, 3.75(1 H, q, J=6.5Hz), 2.87(2H, t, J=7.3Hz), 102 2.40-2.52(2H, 1.58-1.64(2H, 1.48(1 H, 1.34-1.64(2H, 1.37(3H, d, 1.24-1.33(4H, m/z=425, 427.

Example 83: Synthesis of K-2084 2,6-Dichlorobenzenethiol (540 mg, 3.02 mmol) was dissolved in acetonitrile (11.0 ml) and then potassium carbonate (420 mg, 3.04 mmol) and 1,3-dibromopropane (0.31 ml, 3.05 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 1 hour. After confirming the completion of the reaction by TLC, potassium carbonate (234 mg, 1.69 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine (230 mg, 1.52 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 OC for additional 24 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 150: 1) to thereby give 182 mg (0.49 •mmol) of the compound K-2084 as a pale yellow syrup at a yield of 32 500MHz NMR 7.6(2H, d, J=8.0Hz), 7.22(1 H, dd, J=8.0Hz, J=8.0Hz), 7.16(1 H, dd, J=8.0Hz, J=8.0Hz), 6.86(1 H, d, J=8.0Hz), 6.85(1 H, 6.76-6.78(1 H, m), 3.81(3H, 3.70(1 H, q, J=6.0Hz), 2.89-2.98(2H, 2.52-2.64(2H, 1.65- 1.71(2H, 1.46(1H, 1.32(3H, d, J=6.0Hz), m/z=369, 371.

Example 84: Synthesis of K-2085 2,6-Dichlorobenzenethiol (500 mg, 2.79 mmol) was dissolved in acetonitrile (10.0 ml) and then potassium carbonate (400 mg, 2.90 mmol) and 1,4-dibromobutane (0.33 ml, 2.76 mmol) were successively added thereto at room temperature. The resulting mixture was stirred at the same temperature for 1 hour. After confirming the completion of the reaction by TLC, potassium carbonate (230 mg, 1.65 mmol) and (R)-(+)-3-methoxy-a-methylbenzylamine 103 (250 mg, 1.65 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 °C for additional 24 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 150: 1) to thereby give 293 mg (0.76 mmol) of the compound K-2085 as a pale yellow syrup at a yield of 46 500MHz NMR 7.36(2H, d, J=7.5Hz), 7.23(1 H, dd, J=7.5Hz, J=7.5Hz), 7.16(1 H, dd, J=8.0Hz, J=8.0Hz), 6.85-6.87(1 H, 6.86(1 H, 6.76-6.78(1 H, m), 3.81(3H, 3.70(1 H, q, J=6.5Hz), 2.89(2H, t, J=7.0Hz), 2.38-2.51(2H, m), o 1.51-1.63(4H, in), 1.49(1H, 1.32(3H, d, Example 85: Synthesis of K-2087 -naphthyl)ethyl]-N-(4-{[3- (trifluoromethyl) phenyl]thio}butyl)amine) 3-Trifluoromethylbenzenethiol (670 mg, 3.76 mmol) was dissolved in acetonitrile (14.0 ml) and then potassium carbonate (516 mg, 3.73 mmol) and 1,4-dibromobutane (0.45 ml, 3.77 mmol) were successively added thereto at room temperature. The resulting mixture was stirred under ice-cooling for 2 hours. After confirming the completion of the reaction by TLC, potassium carbonate (300 mg, 2.17 mmol) and (R)-(+)-1-(1-naphthyl)ethylamine (0.30 ml, 1.86 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 °C for additional 12 hours.

.o After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column 104 chromatography (chloroform methanol 150: 1) to thereby give 298 mg (0.74 mmol) of the compound K-2087 as a pale yellow syrup at a yield of 40 500MHz NMR 8.18(1 H, d, J=8.0Hz), 7.86-7.88(1 H, 7.74(1 H, d, 7.63(1 H, d, J=7.5Hz), 7.45-7.52(4H, 7.41-7.43(1 H, 7.33-7.39(2H, m), 4.62(1 H, q, J=6.5Hz), 2.92(2H, d, J=7.0Hz), 2.60-2.65(1 H, 2.52-2.57(1 H, 1.63-1.72(4H, 4.54(1H, 1.48(3H, d, J=6.5Hz), m/z=403.

Example 86: Synthesis of K-2117 ((R)-N-[1-(1'-naphthyl)ethyl]-2-(2',5'dichlorophenylthio)ethylamine) (5.10 g, 28.5 mmol) was dissolved in acetonitrile (30 ml) and then potassium carbonate (4.20 g, 30.4 mmol) and 1bromo-2-chloroethane (2.45 ml, 29.4 mmol) were successively added thereto at room temperature. The resulting mixture was stirred under ice-cooling for 2 hours. After confirming the completion of the reaction by TLC, potassium carbonate (4.0 g, 28.9 mmol) and (R)-(+)-1-(1-naphthyl)ethylamine (3.70 ml, 22.9 mmol) were added at room temperature to the reaction system and the resulting mixture was stirred at 100 °C for additional 120 hours.

After the completion of the reaction, the reaction mixture was cooled by allowing to stand at room temperature. After pouring water thereinto, the mixture was subjected to separatory extraction with chloroform and washed with a saturated aqueous solution of sodium chloride. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 200 1) to thereby give 5.70 g (15.2 mmol) of the compound K-2117 as a pale yellow syrup at a yield of 66%.

S" 500MHz NMR 8.17(1H, d, J=8.5Hz), 7.85-7.87(1H, 7.73(1H, d, 7.65(1 H, d, J=7.5Hz), 7.44-7.52(4H, 7.26(1 H, d, J=8.5Hz), 7.20(1H, d, 7.05(1 H, dd, J=2.5Hz, J=8.5Hz), 4.65(1 H, q, J=6.5Hz), 3.09(2H, m), 2.82-2.91(2H, 1.68(1H, 1.51(3H, d, J=6.5Hz), m/z=375, 377.

Example 87: Synthesis of K-2117 hydrochloride 105 The compound K-2117 (7.01 g, 18.6 mmol) was dissolved in a 30 hydrochloric acid-methanol solution (HCI-MeOH) (40 ml) and stirred at room temperature for 5 minutes.

After the completion of the reaction, the reaction system was concentrated in situ under reduced pressure to thereby completely remove the hydrochloric acid-methanol solution. The residue was filtered through a Kiriyama funnel and the resulting crystals were washed with hexane. Thus 5.87 g (14.2 mmol) of K-2117 hydrochloride was obtained in the form of white crystals at a yield of 76 m/z=375, 377. 1 H-NMR (400MHz) 10.97 (1H, bs), 10.30 (1H, bs), 8.18 (1H, d, J=7.32Hz), 7.88-7.97 (3H, 7.53-7.66 (3H, 7.31 (1H, d, J=2.4Hz), 7.14 (1H, d, J=8.56Hz), 7.01 (1H, dd, J=1.36Hz, J=8.56Hz), 5.23-5.27 (1H, m), 3.55-3.61 (2H, 2.95-3.10 (2H, 2.04 (3H, d, J=6.60Hz).

Example 88: Synthesis of K-2177 Dibenzylamine (1.0 g, 0.51 mmol) and triethylamine (0.85 ml, 0.61 mmol, 1.2 mol eq.) were dissolved in chloroform and acryloyl chloride (0.505 g, 0.56 mmol, 1.1 mol eq.) was added under-ice cooling thereto. The resulting mixture was stirred at room temperature for 30 minutes.

After the completion of the reaction, the reaction mixture was poured into water and extracted with chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium chloride. After drying over sodium sulfate, the solvent was distilled off under reduced pressure. The crystals thus obtained were purified by column chromatography (silica gel, chloroform-methanol) to thereby give colorless prisms (1.085 g, 85.0 The compound thus obtained (50 mg, 0.20 mmol) and naphthyl)ethylamine (41.0 mg, 0.24 mmol, 1.2 mol eq.) were dissolved in chloroform-methanol (2 ml) and allowed to stand at room temperature for 1 week.

After the completion of the reaction, the solvent was distilled off under reduced pressure. The oil thus obtained was purified by column 106 chromatography (silica gel, chloroform-methanol) to thereby give 50.9 mg of K-2177 as a colorless oil at a yield of 60.5 MS m/z: 422(M ).'H-NMR 6: 1.53(3H, d, J=6.7Hz, CH3), 2.60-2.70(2H, m, CH2), 2.86-2.96(2H, m, CHg), 4.42(2H, s, CHg), 4.62(2H, s, CHg), 4.69(1 H, q, J=6.7Hz, CH), 7.13(2H, d, J=7.3Hz, Ar-H), 7.21(2H, d, J=6.7Hz, Ar-H), 7.27- 7.36(6H, m, Ar-H), 7.45-7.50(3H, m, Ar-H), 7.70(1 H, d, J=6.7Hz, Ar-H), 7.74(1 H, d, J=7.9Hz, Ar-H), 7.86(1 H, dd, J=1.8, 6.7Hz, Ar-H), 8.16(1 H, d, J=7.9Hz, Ar-H).

Example 89: Synthesis of K-2246 -naphthyl)ethyl]-N-(4-{[4- (trifluoromethyl)phenyl]thio}butyl)amine) 960 mg (5.39 mmol) of 4-trifluoromethylthiophenol was dissolved in 8 ml of acetonitrile. Subsequently, 802 mg (5.80 mmol) of potassium carbonate and 0.65 ml (5.44 mmol) of 1,4-dibromobutane were added thereto at room temperature and the obtained mixture was stirred at the same temperature for minutes. After confirming the completion of the reaction by TLC, 5 ml of acetonitrile, 693 mg (5.01 mmol) of potassium carbonate and 0.49 ml (2.96 mmol) of -naphthyl)ethylamine were added thereto at room temperature and the obtained mixture was stirred at 85 OC for 12 hours.

After the completion of the reaction, the mixture was cooled by allowing to stand at room temperature and water was poured thereinto. Next, it was subjected to separating extraction with chloroform and a saturated aqueous solution of sodium chloride and the organic layer thus obtained was dried over sodium sulfate. Further, the organic layer was concentrated under reduced pressure and the obtained residue was purified by silica gel column chromatography (80 g, chloroform/methanol 200/1) to thereby give 210 mg (0.52 mmol, 17.6 of K-2246 as a pale yellow transparent syrup.

Subsequently, the K-2246 thus obtained was dissolved in a 10 solution of hydrochloric acid in methanol, stirred for 5 minutes and then concentrated as such under reduced pressure. The crystals thus formed were washed with diethyl ether to thereby give 104 mg (0.24 mmol, 8.1 of K-2246 hydrochloride as white crystals.

107 1 H-NMR (400MHz) 10.6 (1H, bs), 10.1 (1H, bs), 8.24 (1H, d, J=7.08Hz), 7.99 (1H, d, J=8.52Hz), 7.90-7.96 (2H, 7.55-7.67 (3H, 7.39-7.41 (2H, m), 7.17-7.19 (2H, 5.17-5.24 (1H, 2.73-2.84 (4H, 2.11-2.18 (2H, m), 2.06 (3H, d, J=6.60Hz), 1.57-1.62 (4H, m/z=403.

Example 90: Synthesis of K-2076: 1.040 g (5.83 mmol) of 4-trifluoromethylthiophenol was dissolved in ml of acetonitrile. Subsequently, 1.024 g (7.40 mmol) of potassium carbonate and 0.80 ml (5.87 mmol) of 1,5-dibromopentane were added thereto at room temperature and the obtained mixture was stirred at the same temperature for 1 hour. After confirming the completion of the reaction by TLC, 8 ml of acetonitrile, 853 mg (6.17 mmol) of potassium carbonate and 0.60 ml (3.63 mmol) of (R)-(+)-1-(1-naphthyl)ethylamine were added thereto at room temperature and the obtained mixture was stirred at 85 °C for 12 hours.

.00 After the completion of the reaction, the mixture was cooled by allowing to stand at room temperature and water was poured thereinto. Next, it was subjected to separating extraction with chloroform and a saturated aqueous solution of sodium chloride and the organic layer thus obtained was dried over sodium sulfate. Further, the organic layer was concentrated under reduced pressure and the obtained residue was purified by silica gel column chromatography (100 g, chloroform/methanol 200/1) to thereby give 240 mg (0.57 mmol, 17.7 of K-2076 as a pale yellow transparent syrup.

Subsequently, the K-2076 thus obtained was dissolved in a 10 solution of hydrochloric acid in methanol, stirred for 5 minutes and then concentrated as such under reduced pressure. The crystals thus formed were 'washed with diethyl ether to thereby give 115 mg (0.25 mmol, 6.9 of K-2076 hydrochloride as white crystals.

1 H-NMR (400MHz) 10.55 (1H, bs), 10.01 (1H, bs), 8.24 (1H, d, J=7.08Hz), 7.89-7.99 (3H, 7.52-7.66 (3H, 7.44 (2H, d, J=8.32Hz), 7.23 (2H, d, J=8.32Hz), 5.19 (1H, bs), 2.82 (2H, t, J=7.08Hz), 2.74 (2H, bs), 2.04 (3H, d, J=6.36Hz), 1.96-2.04 (2H, 1.50-1.57 (2H, 1.30-1.38 (2H, m/z=417.

108 Example 91: Synthesis of K-2243 (N1,N1-di(4-chlorobenzyl)-3-{[(1 naphthyl) ethyl]amino}propanamide) To 500 mg (3.56 mmol) of p-chlorobenzaldehyde and 503.6 mg (3.56 mmol, 1.0 mol eq.) of p-chlorobenzylamine was added 1.26 ml (4.27 mmol, 1.2 mol eq.) of titanium tetraisopropoxide and the obtained mixture was stirred at room temperature for 4 hours. After the completion of the reaction, the reaction mixture was dissolved in methanol and 538.7 mg (14.24 mmol, 4.0 mol eq.) of sodium boron hydride was added thereto. The obtained mixture was stirred at room temperature for 12 hours.

After the completion of the reaction, the solvent was distilled off under reduced pressure. Ethyl acetate and water were poured into the residue, and filtered through celite. The residue was washed with ethyl acetate and then the washing liquor was combined with the filtrate and extracted with ethyl acetate.

'i The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained oil was purified by column chromatography (silica gel, chloroform) to thereby give 819 mg (86.6 of the compound 124 as a colorless oil.

MS m/z:266. 1H-NMR 6:3.74 (4H, d, J=2.7, CHgx2), 7.24-7.30 (8H, m, Ar-H).

500 mg (1.88 mmol) of the above-mentioned compound 124 and 0.31 ml (2.26 mmol, 1.2 mol eq.) of triethylamine were dissolved in chloroform and 187.1 mg (2.07 mmol, 1.1 mol eq.) of acryloyl chloride was added thereto under ice-cooling. The obtained mixture was then stirred at room temperature for minutes. After the completion of the reaction, the reaction mixture was poured into water and extracted with chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained oil was purified by column chromatography (silica gel, chloroform) to thereby give 570.3 mg (94.4 of the compound 125 as a colorless oil.

MS m/z:320. 1 H-NMR 6:4.47 (2H, s, CH), 4.59 (2H, s, CH2), 5.77 (1H, dd, J=2.7, 9.8Hz, CH=CHg), 6.52 (1H, d, J=2.7Hz, CH=CH 2 6.54 (1H, d, J=9.8Hz, 109 CH=CH2), 7.08 (2H, d, J=8.1Hz, Ar-H), 7.18 (2H, d, J=8.1Hz, Ar-H), 7.29 (2H, d, J=8.1Hz, Ar-H), 7.33 (2H, d, J=8.1Hz, Ar-H).

100 mg (0.31 mmol) of the above-mentioned compound 125 and 64.2 mg (0.38 mmol, 1.2 mol eq.) of (R)-(+)-(1-naphthyl)ethylamine were dissolved in chloroform/methanol 1) and allowed to stand at room temperature for 1 week. After the completion of the reaction, the solvent was distilled off under reduced pressure and the oil thus obtained was purified by column chromatography (silica gel, chloroform) to thereby give 106.6 mg (69.5 of K-2243 as a colorless oil.

MS m/z:491. 1 H-NMR 8:1.51 (3H, d, J=6.6Hz, CH3), 2.60 (2H, t, J=6.1Hz, CHg), 2.84-2.96 (2H, m, CHg), 4.35 (2H, s, CHS), 4.53 (2H, s, CH), 4.66 (1H, q, J=6.6Hz, CH), 7.03 (2H, d, J=8.3Hz, Ar-H), 7.12 (2H, d, J=8.3Hz, Ar-H), 7.27 (2H, d, J=8.3Hz, Ar-H), 7.30 (2H, d, J=8.3Hz, Ar-H), 7.47 (1H, t, J=5.1Hz, Ar- 7.48 (1 H, t, J=5.1Hz, Ar-H), 7.49 (1 H, t, J=5.1Hz, Ar-H), 7.67 (1H, d, J=5.1Hz, Ar-H), 7.74 (1H, d, J=5.1Hz, Ar-H), 7.87 (1H, d, J=7.5Hz, Ar-H), 7.16 (1H, d, J=7.5Hz, Ar-H).

Example 92: Synthesis of K-2257 (N1,N1-di[4-(trifluoromethoxy)benzyl]-3- R)-1 -naphthyl)ethyl]amino}propanamide) S:i To 500 mg (2.62 mmol) of p-(trifluoromethoxy)benzylamine and 497.3 mg (2.62 mmol, 1.0 mol eq.) of p-(trifluoromethoxy)-benzaldehyde was added 0.926 ml (3.14 mmol, 1.2 mol eq.) of titanium tetraisopropoxide and the obtained mixture was stirred at room temperature for 4 hours. After the completion of the reaction, the reaction mixture was dissolved in methanol and 396.5 mg (10.48 mmol, 4.0 mol eq.) of sodium boron hydride was added thereto. The obtained mixture was stirred at room temperature for 12 hours.

After the completion of the reaction, the solvent was distilled off under reduced pressure. Ethyl acetate and water were poured into the residue and filtered through celite. The residue was washed with ethyl acetate and then the washing liquor was combined with the filtrate and extracted with ethyl acetate.

The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the 110solvent under reduced pressure, the obtained oil was purified by column chromatography (silica gel, chloroform) to thereby give 835.2 mg (87.5 of the compound 126 as a colorless oil.

MS m/z:365. H-NMR 8:3.80 (4H, s, CHx2), 7.17 (4H, d, J=8.1Hz, Ar-H), 7.36 (4H, d, J=8.1Hz, Ar-H).

500 mg (1.37 mmol) of the above-mentioned compound 126 and 0.23 ml (1.64 mmol, 1.2 mol eq.) of triethylamine were dissolved in chloroform and 136.3 mg (1.51 mmol, 1.1 mol eq.) of acryloyl chloride was added thereto under ice-cooling. The obtained mixture was then stirred at room temperature for minutes. After the completion of the reaction, the reaction mixture was poured into water and extracted with chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained oil was purified by column chromatography (silica gel, chloroform) to thereby give 519.3 mg (90.5 of the compound 127 as a colorless oil.

MS m/z:419. H-NMR 6:4.53 (2H, s, CH), 4.64 (2H, s, CHi), 5.79 (1H, dd, J=2.7, 9.5Hz, CH=CH 2 6.53 (1H, d, J=2.7Hz, CH=CH 2 6.56 (1H, d, CH=CH2), 7.15-7.31 (8H, m, Ar-H).

450 mg (1.07 mmol) of the above-mentioned compound 127 and 220.7 mg (1.29 mmol, 1.2 mol eq.) of (R)-(+)-(1-naphthyl)ethylamine were dissolved in chloroform/methanol (4 1) and allowed to stand at room temperature for 1 week. After the completion of the reaction, the solvent was distilled off under reduced pressure and the oil thus obtained was purified by column chromatography (silica gel, chloroform) to thereby give 363 mg (57.3 of K- 2257 as a colorless oil.

MS m/z:590. 1 H-NMR 6:1.50 (3H, d, J=6.6Hz, CH 3 2.60 (2H, t, J=5.9Hz, CH), 2.84-2.97 (2H, m, CH), 4.41 (2H, s, CH), 4.57 (2H, s, CH), 6.65 (1H, q, J=6.6Hz, CH), 7.12-7.29 (8H, m, Ar-H), 7.44-7.51 (3H, m, Ar-H), 7.66 (1H, d, J=6.8Hz, Ar-H), 7.73 (1H, d, J=8.3Hz, Ar-H), 7.86 (1H, dd, J=2.4, 7.1Hz, Ar-H), 8.17 (1H, d, J=7.1Hz, Ar-H).

111 Example 93: Synthesis of K-2259 (N1,N1-di[4-(trifluoromethyl)benzyl]-3- -naphthyl)ethyl]amino}propanamide) To 500 mg (2.85 mmol) of p-(trifluoromethyl)benzylamine and 497.1 mg (2.85 mmol, 1.0 mol eq.) of p-(trifluoromethyl)- benzaldehyde was added 1.01 ml (3.43 mmol, 1.2 mol eq.) of titanium tetraisopropoxide and the obtained mixture was stirred at room temperature for 4 hours. After the completion of the reaction, the reaction mixture was dissolved in methanol and 431.3 mg (11.4 mmol, 4.0 mol eq.) of sodium boron hydride was added thereto. The obtained mixture was stirred at room temperature for 12 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure.

Ethyl acetate and water were poured into the residue and filtered through celite.

The residue was washed with ethyl acetate and then the washing liquor was combined with the filtrate and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained oil was purified by column chromatography (silica gel, chloroform) to thereby give 458.7 mg (48.3 of the compound 128 as a colorless oil.

MS m/z:333. 1 H-NMR 6:3.86 (4H, s, CH 2 x2), 7.47 (4H, d, J=8.1Hz, Ar-H), 7.59 (4H, d, J=8.1Hz, Ar-H).

450 mg (1.35 mmol) of the above-mentioned compound 128 and 0.23 ml (1.62 mmol, 1.2 mol eq.) of triethylamine were dissolved in chloroform and 134.4 mg (1.48 mmol, 1.1 mol eq.) of acryloyl chloride was added thereto under ice-cooling. The obtained mixture was then stirred at room temperature for minutes. After the completion of the reaction, the reaction mixture was poured into water and extracted with chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent under reduced pressure, the obtained oil was purified by column chromatography (silica gel, chloroform) to thereby give 519.3 mg (99.3 of the compound 129 as a colorless oil.

-112 MS m/z:387. H-NMR 6:4.59 (2H, s, CH), 4.70 (2H, s, CHg), 5.80 (1H, dd, J=3.7, 8.8Hz, CH=CH2), 6.54 (1H, d, J=3.7Hz, CH=CH 2 6.56 (1H, d, J=8.8Hz, CH=CH), 7.23-7.64 (8H, m, Ar-H).

800 mg (2.06 mmol) of the above-mentioned compound 129 and 424.0 mg (2.48 mmol, 1.2 mol eq.) of (R)-(+)-(1-naphthyl)ethylamine were dissolved in chloroform/methanol (4 1) and allowed to stand at room temperature for 1 week. After the completion of the reaction, the solvent was distilled off under reduced pressure and the oil thus obtained was purified by column chromatography (silica gel, chloroform) to thereby give 580.7 mg (50.3 of K-2259 as a colorless oil.

MS m/z:558. 1 H-NMR 6:1.51 (3H, d, J=6.6Hz, CH3), 2.60 (2H, t, J=6.1Hz, CHg), 2.85-2.98 (2H, m, CH 2 4.47 (2H, s, CHg), 4.64 (2H, s, CHg), 4.65 (1H, q, J=6.6Hz, CH), 7.23 (2H, d, J=8.3Hz, Ar-H), 7.31 (2H, d, J=8.3Hz, Ar-H), 7.44- 7.51 (3H, m, Ar-H), 7.55 (2H, d, J=8.3Hz, Ar-H), 7.59 (2H, d, J=8.3Hz, Ar-H), 7.66 (1H, d, J=8.1Hz, Ar-H), 7.74 (1H, d, J=8.1Hz, Ar-H), 7.87 (1H, dd, J=2.4, 8.1Hz, Ar-H), 8.18 (1H, dd, J=2.4, 8.1Hz, Ar-H).

Example 94: Synthesis of K-2247 (N1-benzyl-N1-(4-chlorobenzyl)-3-{[(1R)-1- (1-naphthyl)ethyl]amino}propanamide) To 4-chlorobenzaldehyde (500 mg, 3.56 mmol) and benzylamine (381.2 mg, 3.56 mmol, 1.0 mol eq.) was added titanium tetraisopropoxide (1.26 ml, 4.27 mmol, 1.2 mol eq.) and the mixture was stirred at room temperature for 4 hours. After the completion of the reaction, the reaction mixture was dissolved in ethanol and sodium boron hydride (538.7 mg, 14.24 mmol, 4.0 mol eq.) was added thereto. Then the obtained mixture was stirred at room temperature for S12 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure. To the obtained residue were added ethyl acetate and water and the mixture was filtered through celite. The residue was washed with ethyl acetate and the washing liquor was combined with the filtrate and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate and the solvent was distilled off under reduced pressure. The oil thus -113 obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 201 (572.6 mg, 69.5 MS m/z:231.

The dibenzylamine compound 201 (300 mg, 1.29 mmol) and triethylamine (0.22 ml, 1.55 mmol, 1.2 mol eq.) were dissolved in chloroform and acryloyl chloride (128.9 mg, 1.42 mmol, 1.1 mol eq.) dissolved in chloroform was added thereto under ice-cooling. The reaction mixture was stirred at room temperature for 30 minutes. After the completion of the reaction, the reaction mixture was poured into water and extracted with chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent, the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 202 (372.1 mg, 100.0 MS m/z: 285.

II The conjugated ketone compound 202 (100.3 mg, 0.35 mmol, 1.2 mol eq.) and (R)-(+)-1-(1-naphthyl)ethylamine (50 mg, 0.29 mmol) were dissolved in chloroform/methanol (4 1) and allowed to stand at room temperature for 1 week. After the completion of the reaction, the solvent was distilled off under reduced pressure and the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil K-2247 (64.5 mg, 40.2 MS m/z: 456, 'H-NMR 6: 1.53 (3H, d, J=6.7Hz, CH3), 2.60-2.67 (2H, m, CiHg), 2.86-2.95 (2H, m, CHg), 4.39 (2H, d, J=18.3Hz, CH), 4.58 (2H, d, J=13.4Hz, CH2), 4.69 (1H, q, J=6.7Hz, CH), 7.04 (1H, d, J=8.5Hz, Ar-H), 7.12 (1H, d, J=6.7Hz, Ar-H), 7.15 (1H, d, J=8.5Hz, Ar-H), 7.20 (1H, d, J=6.7Hz, Ar-H), 7.28-7.36 (5H, m, Ar-H), 7.46-7.51 (3H, m, Ar-H), 7.69 (1H, d, J=7.3Hz, Ar-H), 7.75 (1H, d, J=7.9Hz, Ar-H), 7.87 (1H, dd, J=1.8, 7.9Hz, Ar-H), 8.17 (1H, d, J=7.9Hz, Ar-H).

Example 95: Synthesis of K-2248 To 2-naphthaldehyde (500 mg, 3.20 mmol) and benzylamine (343.1 mg, 3.20 mmol, 1.0 mol eq.) was added titanium tetraisopropoxide (1.13 ml, 3.84 mmol, 1.2 mol eq.) and the mixture was stirred at room temperature for 4 hours.

-114- After the completion of the reaction, the reaction mixture was dissolved in ethanol and sodium boron hydride (484.2 mg, 12.8 mmol, 4.0 mol eq.) was added thereto. Then the obtained mixture was stirred at room temperature for 12 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure. To the obtained residue were added ethyl acetate and water and the mixture was filtered through celite. The residue was washed with ethyl acetate and the washing liquor was combined with the filtrate and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate and the solvent was distilled off under reduced pressure. The oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 203 (769.1 mg, 97.1 MS m/z: 247.

The dibenzylamine compound 203 (500 mg, 2.02 mmol) and :triethylamine (0.34 ml, 2.43 mmol, 1.2 mol eq.) were dissolved in chloroform and acryloyl chloride (201.3 mg, 2.22 mmol, 1.1 mol eq.) dissolved in chloroform was added thereto under ice-cooling. The reaction mixture was stirred at room temperature for 30 minutes. After the completion of the reaction, the reaction mixture was poured into water and extracted with S:ao** chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent, the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 204 (579.7 mg, 95.0 MS m/z: 301.

"The conjugated ketone compound 204 (105.8 mg, 0.35 mmol, 1.2 mol .i eq.) and -naphthyl)ethylamine (50 mg, 0.29 mmol) were dissolved in chloroform/methanol (4 1) and allowed to stand at room temperature for 1 week. After the completion of the reaction, the solvent was distilled off under reduced pressure and the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil K-2248 (69.8 mg, 42.0 -115- MS m/z: 472, 1 H-NMR 8: 1.52 (3H, dd, J=6.7, 8.5Hz, CH3), 2.66-2.69 (2H, m, 2.89-3.00 (2H, m, 4.51 (2H, d, J=65.3Hz, CHi), 4.67 (1H, q, J=36.7Hz, CH), 4.75 (2H, d, J=48.2Hz, 7.16 (1H, d, J=7.3Hz, Ar-H), 7.22-7.39 (5H, m, Ar-H), 7.43-7.52 (5H, m, Ar-H), 7.58 (1H, d, J=25.6Hz, Ar-H), 7.68-7.88 (6H, m, Ar-H), 8.17 (1H, dd, J=7.9, 21.4Hz, Ar-H).

Example 96: Synthesis of K-2249 To 2-chlorobenzaldehyde (500 mg, 3.56 mmol) and benzylamine (381.2 mg, 3.56 mmol, 1.0 mol eq.) was added titanium tetraisopropoxide (1.26 ml, 4.17 mmol, 1.2 mol eq.) and the mixture was stirred at room temperature for 4 hours. After the completion of the reaction, the reaction mixture was dissolved in ethanol and sodium boron hydride (538.7 mg, 14.24 mmol, 4.0 mol eq.) was added thereto. Then the obtained mixture was stirred at room temperature for 12 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure. To the obtained residue were added ethyl acetate S and water and the mixture was filtered through celite. The residue was washed with ethyl acetate and the washing liquor was combined with the filtrate and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate and the solvent was distilled off under reduced pressure. The oil thus 0 obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 205 (427.7 mg, 51.9 MS m/z: 231.

The dibenzylamine compound 205 (300 mg, 1.29 mmol) and triethylamine (0.22 ml, 1.55 mmol, 1.2 mol eq.) were dissolved in chloroform and acryloyl chloride (128.9 mg, 1.42 mmol, 1.1 mol eq.) dissolved in chloroform was added thereto under ice-cooling. The reaction mixture was stirred at room temperature for 30 minutes. After the completion of the reaction, the reaction mixture was poured into water and extracted with chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent, the oil thus obtained was purified by column 116chromatography [silica gel, chloroform] to thereby give a colorless oil 206 (358.8 mg, 96.8 MS m/z: 285.

The conjugated ketone compound 206 (100.3 mg, 0.35 mmol, 1.2 mol eq.) and (R)-(+)-1-(1-naphthyl)ethylamine (50 mg, 0.29 mmol) were dissolved in chloroform/methanol 1) and allowed to stand at room temperature for 1 week. After the completion of the reaction, the solvent was distilled off under reduced pressure and the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil K-2249 (67.8 mg, 50.8 MS m/z: 456, 'H-NMR 6: 1.53 (3H, dd, J=6.7, 4.3Hz, CH3), 2.51-2.74 (2H, m, Cj_2), 2.85-2.98 (2H, m, CH2), 4.50 (2H, d, J=9.8Hz, CHg), 4.64 (1H, s, CH), 4.66-4.70 (1H, m, CH), 4.78 (1H, s, CH2), 7.15 (1H, d, J=7.9Hz, Ar-H), 7.19- S7.39 (8H, m, Ar-H), 7.45-7.51 (3H, m, Ar-H), 7.70 (1 H, t, J=7.9Hz, Ar-H), 7.74 (1H, dd, J=3.7, 7.9Hz, Ar-H), 7.87 (1H, d, J=7.3Hz, Ar-H), 8.17 (1H, t, J=7.3Hz, Ar-H).

Example 97: Synthesis of K-2250 (N1-benzyl-N1-(3,4-dichlorobenzyl)-3-{[(1 R)-1 -naphthyl)ethyl]amino}propanamide) To benzaldehyde (300 mg, 2.83 mmol) and 3,4-dichlorobenzylamine (497.7 mg, 2.83 mmol, 1.0 mol eq.) was added titanium tetraisopropoxide (1.00 ml, 3.39 mmol, 1.2 mol eq.) and the mixture was stirred at room temperature for 4 hours. After the completion of the reaction, the reaction mixture was dissolved in ethanol and sodium boron hydride (428.2 mg, 11.32 mmol, 4.0 mol eq.) was added thereto. Then the obtained mixture was stirred at room temperature for 12 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure. To the obtained residue were added ethyl acetate and water and the mixture was filtered through celite. The residue was washed with ethyl acetate and the washing liquor was combined with the filtrate and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate and the solvent was distilled off under reduced pressure. The -117 oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 207 (568 mg, 75.5 MS m/z: 266.

The dibenzylamine compound 207 (300 mg, 1.13 mmol) and triethylamine (0.189 ml, 1.35 mmol, 1.2 mol eq.) were dissolved in chloroform and acryloyl chloride (112.3 mg, 1.24 mmol, 1.1 mol eq.) dissolved in chloroform was added thereto under ice-cooling. The reaction mixture was stirred at room temperature for 30 minutes. After the completion of the reaction, the reaction mixture was poured into water and extracted with chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent, the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 208 (358.3 mg, 99.3 MS m/z: 320.

The conjugated ketone compound 208 (100 mg, 0.31 mmol) and (+)-1-(1-naphthyl)ethylamine (64.2 mg, 0.38 mmol, 1.2 mol eq.) were dissolved in chloroform/methanol 1) and allowed to stand at room temperature for 1 week. After the completion of the reaction, the solvent was distilled off under reduced pressure and the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil K-2250 (96.5 mg, 62.9 MS m/z: 491, 'H-NMR 6: 1.51 (3H, d, J=6.6Hz, CH3), 2.49-2.68 (2H, m, CH2), 2.82-2.96 (2H, m, CH2), 4.38 (2H, d, J=32.4Hz, CH2), 4.54 (1H, s, CH2), 4.67 (1H, d, J=42.5Hz, CH), 4.66 (1H, q, J=6.6Hz, CH), 7.11 (1H, d, J=6.6Hz, Ar- S* 7.19 (1H, d, J=6.8Hz, Ar-H), 7.21-7.41 (6H, m, Ar-H), 7.43-7.51 (3H, m, Ar-H), 7.67 (1H, dd, J=2.0, 7.1Hz, Ar-H), 7.74 (1H, d, J=8.3Hz, Ar-H), 7.86 (1H, dd, J=2.2, 8.1Hz, Ar-H), 8.16 (1H, d, J=7.3Hz, Ar-H).

Example 98: Synthesis of K-2251 To benzaldehyde (300 mg, 2.83 mmol) and 2,4-dichlorobenzylamine (497.7 mg, 2.83 mmol, 1.0 mol eq.) was added titanium tetraisopropoxide (1.00 ml, 3.39 mmol, 1.2 mol eq.) and the mixture was stirred at room temperature for 4 hours. After the completion of the reaction, the reaction mixture was -118 dissolved in ethanol and sodium boron hydride (428.2 mg, 11.32 mmol, 4.0 mol eq.) was added thereto. Then the obtained mixture was stirred at room temperature for 12 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure. To the obtained residue were added ethyl acetate and water and the mixture was filtered through celite. The residue was washed with ethyl acetate and the washing liquor was combined with the filtrate and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate and the solvent was distilled off under reduced pressure. The oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 209 (469 mg, 62.4 MS m/z: 266.

The dibenzylamine compound 209 (300 mg, 1.13 mmol) and triethylamine (0.189 ml, 1.35 mmol, 1.2 mol eq.) were dissolved in chloroform and acryloyl chloride (112.3 mg, 1.24 mmol, 1.1 mol eq.) dissolved in chloroform was added thereto under ice-cooling. The reaction mixture was stirred at room temperature for 30 minutes. After the completion of the reaction, the reaction mixture was poured into water and extracted with chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent, the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 210 (311.6 mg, 86.3 MS m/z: 320.

The conjugated ketone compound 210 (100 mg, 0.31 mmol) and (+)-1-(1-naphthyl)ethylamine (64.2 mg, 0.38 mmol, 1.2 mol eq.) were dissolved in chloroform/methanol (4 1) and allowed to stand at room temperature for 1 week. After the completion of the reaction, the solvent was distilled off under reduced pressure and the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil K-2251 (126.7 mg, 82.6 MS m/z: 491, 1 H-NMR 8:1.51 (3H, dd, J=2.5, 6.6Hz, CH3), 2.51-2.53 (1H, m, CHg), 2.64-2.68 (1H, m, CH2), 2.84-2.96 (2H, m, CH2i), 4.46 (2H, d, J=13.4Hz, 119- CH2), 4.60 (1H, s, CH2), 4.65-4.68 (1H, m, CH), 4.69 (1H, s, CH2), 7.13 (1H, d, J=7.3Hz, Ar-H), 7.17-7.39 (7H, m, Ar-H), 7.44-7.50 (3H, m, Ar-H), 7.67 (1H, t, J=7.3Hz, Ar-H), 7.73 (1H, dd, J=3.7, 7.9Hz, Ar-H), 7.86 (1H, d, J=7.3Hz, Ar-H), 8.16 (1H, d, J=7.9Hz, Ar-H).

Example 99: Synthesis of K-2252 To benzaldehyde (500 mg, 4.71 mmol) and 3-chlorobenzylamine (667.2 mg, 4.71 mmol, 1.0 mol eq.) was added titanium tetraisopropoxide (1.67 ml, 5.65 mmol, 1.2 mol eq.) and the mixture was stirred at room temperature for 4 hours. After the completion of the reaction, the reaction mixture was dissolved in ethanol and sodium boron hydride (712.7 mg, 18.84 mmol, 4.0 mol eq.) was added thereto. Then the obtained mixture was stirred at room temperature for 12 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure. To the obtained residue were added ethyl acetate and water and the mixture was filtered through celite. The residue was washed S. with ethyl acetate and the washing liquor was combined with the filtrate and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium 0 sulfate and the solvent was distilled off under reduced pressure. The oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 211 (930.5 mg, 85.2 MS m/z: 231.

The dibenzylamine compound 211 (500 mg, 2.16 mmol) and triethylamine (0.36 ml, 2.59 mmol, 1.2 mol eq.) were dissolved in chloroform "i and acryloyl chloride (214.8 mg, 2.37 mmol, 1.1 mol eq.) dissolved in 0* chloroform was added thereto under ice-cooling. The reaction mixture was stirred at room temperature for 30 minutes. After the completion of the reaction, the reaction mixture was poured into water and extracted with chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent, the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 212 (308.5 mg, 50.0 MS m/z: 285.

120 The conjugated ketone compound 212 (100 mg, 0.35 mmol) and (+)-1-(1-naphthyl)ethylamine (71.8 mg, 0.42 mmol, 1.2 mol eq.) were dissolved in chloroform/methanol (4 1) and allowed to stand at room temperature for 1 week. After the completion of the reaction, the solvent was distilled off under reduced pressure and the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil K-2252 (85.0 mg, 53.2 MS m/z: 456, 1 H-NMR 8: 1.50 (3H, d, J=6.6Hz, CH3), 2.61 (2H, dt, J=6.1, 21.0Hz, CHg), 2.82-2.96 (2H, m, CH1), 4.40 (2H, d, J=19.3Hz, CHg), 4.60 (2H, d, J=13.7Hz, CH2), 4.66 (1H, q, J=6.6Hz, CH), 7.13 (2H, d, J=7.1Hz, Ar-H), 7.20-7.37 (7H, m, Ar-H), 7.43-7.51 (3H, m, Ar-H), 7.68 (1H, d, J=8.1Hz, Ar-H), 7.73 (1H, d, J=8.1Hz, Ar-H), 7.86 (1H, dd, J=2.2, 7.3Hz, Ar-H), 8.17 (1H, d, J=7.6Hz, Ar-H).

Example 100: Synthesis of K-2253 To 3-chlorobenzaldehyde (500 mg, 3.56 mmol) and 3chlorobenzylamine (503.7 mg, 3.56 mmol, 1.0 mol eq.) was added titanium tetraisopropoxide (1.26 ml, 4.27 mmol, 1.2 mol eq.) and the mixture was stirred at room temperature for 4 hours. After the completion of the reaction, the reaction mixture was dissolved in ethanol and sodium boron hydride (538.7 mg, 14.24 mmol, 4.0 mol eq.) was added thereto. Then the obtained mixture was stirred at room temperature for 12 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure. To the obtained residue were added ethyl acetate and water and the mixture was filtered through celite.

The residue was washed with ethyl acetate and the washing liquor was combined with the filtrate and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate and the solvent was distilled off under reduced pressure. The oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 213 (756.5 mg, 80.3 MS m/z: 266.

121 The dibenzylamine compound 213 (500 mg, 1.88 mmol) and triethylamine (0.31 ml, 2.26 mmol, 1.2 mol eq.) were dissolved in chloroform and acryloyl chloride (187.1 g, 2.07 mmol, 1.1 mol eq.) dissolved in chloroform was added thereto under ice-cooling. The reaction mixture was stirred at room temperature for 30 minutes. After the completion of the reaction, the reaction mixture was poured into water and extracted with chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent, the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 214 (595.3 mg, 98.8 MS m/z: 320.

The conjugated ketone compound 214 (100 mg, 0.31 mmol) and -naphthyl)ethylamine (64.2 mg, 0.38 mmol, 1.2 mol eq.) were dissolved in chloroform/methanol (4 1) and allowed to stand at room temperature for 1 week. After the completion of the reaction, the solvent was distilled off under reduced pressure and the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil K-2253 (96.5 mg, 62.9 MS m/z: 491, H-NMR 6: 1.51 (3H, d, J=6.1Hz, CH3), 2.58 (2H, t, J=6.1Hz, CH2), 2.85-2.97 (2H, m, CHg), 4.38 (2H, s, CHg), 4.57 (2H, d, J=3.1Hz, CH_), 4.65 (1H, q, J=6.1Hz, CH), 6.99 (1H, d, J=5.5Hz, Ar-H), 7.08 (1H, d, J=6.1Hz, Ar-H), 7.11 (1 H, s, Ar-H), 7.20 (1H, s, Ar-H), 7.23-7.27 (4H, m, Ar-H), 7.44-7.49 (3H, m, Ar-H), 7.67 (1H, d, J=7.3Hz, Ar-H), 7.72 (1H, d, J=7.9Hz, Ar-H), 7.85 (1H, d, J=7.9Hz, Ar-H), 8.18 (1H, d, J=7.9Hz, Ar-H).

Example 101: Synthesis of K-2254 To 2-chlorobenzaldehyde (500 mg, 3.56 mmol) and 2chlorobenzylamine (503.6 mg, 3.56 mmol, 1.0 mol eq.) was added titanium tetraisopropoxide (1.25 ml, 4.27 mmol, 1.2 mol eq.) and the mixture was stirred at room temperature for 4 hours. After the completion of the reaction, the reaction mixture was dissolved in ethanol and sodium boron hydride (538.7 mg, 14.2 mmol, 4.0 mol eq.) was added thereto. Then the obtained mixture was stirred at room temperature for 12 hours. After the completion of the reaction, 122 the solvent was distilled off under reduced pressure. To the obtained residue were added ethyl acetate and water and the mixture was filtered through celite.

The residue was washed with ethyl acetate and the washing liquor was combined with the filtrate and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate and the solvent was distilled off under reduced pressure. The oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 215 (632.6 mg, 66.9 MS m/z: 266.

The dibenzylamine compound 215 (400 mg, 1.50 mmol) and triethylamine (0.25 ml, 1.80 mmol, 1.2 mol eq.) were dissolved in chloroform and acryloyl chloride (149.7 g, 1.65 mmol, 1.1 mol eq.) dissolved in chloroform was added thereto under ice-cooling. The reaction mixture was stirred at room temperature for 30 minutes. After the completion of the reaction, the reaction mixture was poured into water and extracted with chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent, the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 216 (391.7 mg, 81.2 MS m/z: 320.

The conjugated ketone compound 216 (100 mg, 0.31 mmol) and (+)-1-(1-naphthyl)ethylamine (64.2 mg, 0.38 mmol, 1.2 mol eq.) were dissolved in chloroform/methanol (4 1) and allowed to stand at room temperature for 1 00. week. After the completion of the reaction, the solvent was distilled off under reduced pressure and the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil K-2254 (72.7 mg, 47.4 MS m/z: 491, 'H-NMR 6: 1.49 (3H, d, J=6.6Hz, CHS), 2.53-2.60 (2H, m, CH), 2.83-2.93 (2H, m, CH1), 4.57 (2H, s, CH12), 4.64 (1H, q, J=6.6Hz, CH), 4.77 (2H, s, CH1), 7.13-7.38 (8H, m, Ar-H), 7.44-7.51 (3H, m, Ar-H), 7.66 (1H, d, J=6.6Hz, Ar-H), 7.72 (1 H, d, J=8.1Hz, Ar-H), 7.85 (1 H, dd, J=2.4, 7.1 Hz, Ar-H), 8.14 (1H, dd, J=2.2, 7.1Hz, Ar-H).

123 Example 102: Synthesis of K-2256 To 4-fluorobenzaldehyde (484.2 mg, 3.90 mmol) and 4fluorobenzylamine (500 mg, 3.90 mmol, 1.0 mol eq.) was added titanium tetraisopropoxide (1.38 ml, 4.68 mmol, 1.2 mol eq.) and the mixture was stirred at room temperature for 4 hours. After the completion of the reaction, the reaction mixture was dissolved in ethanol and sodium boron hydride (590.1 mg, 15.6 mmol, 4.0 mol eq.) was added thereto. Then the obtained mixture was stirred at room temperature for 12 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure. To the obtained residue were added ethyl acetate and water and the mixture was filtered through celite.

The residue was washed with ethyl acetate and the washing liquor was combined with the filtrate and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate and the solvent was distilled off under reduced pressure. The oil thus obtained was purified by column i chromatography [silica gel, chloroform] to thereby give a colorless oil 217 (783.2 mg, 84.0 MS m/z: 233.

The dibenzylamine compound 217 (500 mg, 2.15 mmol) and triethylamine (0.36 ml, 2.58 mmol, 1.2 mol eq.) were dissolved in chloroform and acryloyl chloride (213.6 g, 2.36 mmol, 1.1 mol eq.) dissolved in chloroform was added thereto under ice-cooling. The reaction mixture was stirred at room temperature for 30 minutes. After the completion of the reaction, the reaction :mixture was poured into water and extracted with chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent, the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 218 (572.6 mg, 86.8 MS m/z: 287.

The conjugated ketone compound 218 (800 mg, 1.63 mmol) and (+)-1-(1-naphthyl)ethylamine (33.7 mg, 1.95 mmol, 1.2 mol eq.) were dissolved in chloroform/methanol (4 1) and allowed to stand at room temperature for 1 week. After the completion of the reaction, the solvent was distilled off under 124 reduced pressure and the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil K-2256 (375.1 mg, 48.2 MS m/z: 458, 1 H-NMR 6: 1.50 (3H, d, J=6.6Hz, CH3), 2.60 (2H, t, J=6.1Hz, CH), 2.84-2.96 (2H, m, CH2), 4.36 (2H, s, CH2), 4.54 (2H, s, CH2), 4.66 (1 H, q, J=6.6Hz, CH), 6.95-7.09 (6H, m, Ar-H), 7.16 (1H, d, J=8.8Hz, Ar-H), 7.17 (1H, d, J=8.8Hz, Ar-H), 7.43-7.51 (3H, m, Ar-H), 7.67 (1H, d, J=6.6Hz, Ar-H), 7.73 (1H, d, J=8.3Hz, Ar-H), 7.87 (1H, dd, J=2.4, 7.0Hz, Ar-H), 8.17 (1H, dd, 7.3Hz, Ar-H).

Example 103: Synthesis of K-2261 To 3-chlorobenzaldehyde (992.7 mg, 7.06 mmol) and 4- ,,chlorobenzylamine (1 g, 7.06 mmol, 1.0 mol eq.) was added titanium tetraisopropoxide (2.5 ml, 8.47 mmol, 1.2 mol eq.) and the mixture was stirred at room temperature for 4 hours. After the completion of the reaction, the reaction mixture was dissolved in ethanol and sodium boron hydride (1.0683 g, 28.4 mmol, 4.0 mol eq.) was added thereto. Then the obtained mixture was stirred at room temperature for 12 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure. To the obtained residue were added ethyl acetate and water and the mixture was filtered through celite.

The residue was washed with ethyl acetate and the washing liquor was combined with the filtrate and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate and the solvent was distilled off under reduced pressure. The oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 219 (1.5847 g, 84.4 MS m/z: 266.

The dibenzylamine compound 219 (1.3 g, 4.89 mmol) and triethylamine (0.82 ml, 5.86 mmol, 1.2 mol eq.) were dissolved in chloroform and acryloyl chloride (486.6 mg, 5.38 mmol, 1.1 mol eq.) dissolved in chloroform was added thereto under ice-cooling. The reaction mixture was stirred at room temperature for 30 minutes. After the completion of the reaction, the reaction 125 mixture was poured into water and extracted with chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent, the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 220 (1.2967 g, 82.7 MS m/z: 320.

The conjugated ketone compound 220 (1 g, 3.13 mmol) and (1-naphthyl)ethylamine (642.2 mg, 3.75 mmol, 1.2 mol eq.) were dissolved in chloroform/methanol (4 1) and allowed to stand at room temperature for 1 week. After the completion of the reaction, the solvent was distilled off under reduced pressure and the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil K-2261 S. (624.8 mg, 40.7 MS m/z: 491, 1 H-NMR 6: 1.50 (3H, d, J=6.6Hz, CH3), 2.54-2.63 (2H, m, CH2), 2.82-2.96 (2H, m, CH2), 4.36 (2H, d, J=4.4Hz, CH2), 4.55 (2H, d, J=2.9Hz, CHS), 4.65 (1H, q, J=6.6Hz, CH), 7.04 (2H, d, J=8.6Hz, Ar-H), 7.13 (2H, d, J=8.6Hz, Ar-H), 7.18-7.31 (4H, m, Ar-H), 7.44-7.51 (3H, m, Ar-H), 7.67 (1H, d, J=7.3Hz, Ar-H), 7.73 (1H, d, J=8.1Hz, Ar-H), 7.85 (1H, dd, J=2.2Hz, J=7.3Hz, Ar-H), 8.16 (1H, d, J=7.6Hz, Ar-H).

Example 104: Synthesis of K-2262 (N1 -(2-chlorobenzyl)-N1 -(4-chlorobenzyl)- R)-1 -naphthyl)ethyl]amino}propanamide) To 2-chlorobenzaldehyde (992.7 mg, 7.06 mmol) and 4chlorobenzylamine (1 g, 7.06 mmol, 1.0 mol eq.) was added titanium tetraisopropoxide (2.5 ml, 8.47 mmol, 1.2 mol eq.) and the mixture was stirred at room temperature for 4 hours. After the completion of the reaction, the reaction mixture was dissolved in ethanol and sodium boron hydride (1.0683 g, 28.4 mmol, 4.0 mol eq.) was added thereto. Then the obtained mixture was stirred at room temperature for 12 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure. To the obtained residue were added ethyl acetate and water and the mixture was filtered through celite.

The residue was washed with ethyl acetate and the washing liquor was combined with the filtrate and extracted with ethyl acetate. The ethyl acetate 126 layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate and the solvent was distilled off under reduced pressure. The oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 221 (673.6 mg, 40 MS m/z: 266.

The dibenzylamine compound 221 (600 mg, 2.26 mmol) and triethylamine (0.38 ml, 2.71 mmol, 1.2 mol eq.) were dissolved in chloroform and acryloyl chloride (224.6 mg, 2.48 mmol, 1.1 mol eq.) dissolved in chloroform was added thereto under ice-cooling. The reaction mixture was stirred at room temperature for 30 minutes. After the completion of the reaction, the reaction mixture was poured into water and extracted with chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent, the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 222 (684.2 mg, 94.8 MS m/z: 320.

The conjugated ketone compound 222 (500 mg, 1.56 mmol) and (+)-1-(1-naphthyl)ethylamine (321.1 mg, 1.88 mmol, 1.2 mol eq.) were dissolved in chloroform/methanol 1) and allowed to stand at room temperature for 1 week. After the completion of the reaction, the solvent was distilled off under reduced pressure and the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil K-2262 (552.4 mg, 72.0 MS m/z: 491, 'H-NMR 6: 1.56 (3H, d, J=6.6Hz, CH 3 2.51-2.72 (2H, m, CH), 2.83-2.98 (2H, m, 4.43 (1H, s, CHg), 4.48 (1H, s, CH2), 4.56 (1H, d, CHg), 4.68-4.72 (1H, m, CH), 4.73 (1H, d, J=5.6Hz, CH), 7.05 (1H, d, J=8.3Hz, Ar-H), 7.15 (1 H, d, J=8.3Hz, Ar-H), 7.20-7.39 (6H, m, Ar-H), 7.45-7.52 (3H, m, Ar-H), 7.68 (1H, d, J=6.3Hz, Ar-H), 7.75 (1H, d, J=8.3Hz, Ar-H), 7.87 (1H, d, J=7.1Hz, Ar-H), 8.14 (1H, d, J=6.6Hz, Ar-H).

Example 105: Synthesis of K-2264 (N1-(3,4-dichlorobenzyl)-N1-[(4trifluoromethyl)benzyl]-3-{[(1 R)-1 -naphthyl)ethyl]-amino}propanamide) 127 To 3,4-dichlorobenzaldehyde (1 g, 5.71 mmol) and 4trifluoromethylbenzylamine (1 g, 5.71 mmol, 1.0 mol eq.) was added titanium tetraisopropoxide (2.02 ml, 6.86 mmol, 1.2 mol eq.) and the mixture was stirred at room temperature for 4 hours. After the completion of the reaction, the reaction mixture was dissolved in ethanol and sodium boron hydride (864.6 mg, 22.86 mmol, 4.0 mol eq.) was added thereto. Then the obtained mixture was stirred at room temperature for 12 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure. To the obtained residue were added ethyl acetate and water and the mixture was filtered through celite.

The residue was washed with ethyl acetate and the washing liquor was combined with the filtrate and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate and the solvent was distilled off under reduced pressure. The oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 223 (1.668 g, 87.4%).

MS m/z: 334, 1 H-NMR d: 3.75 (2H, s, Ch2), 3.84 (2H, s, CH), 7.17 (1H, dd, J=2.2, 8.3Hz, Ar-H), 7.39 (2H, d, 8.3Hz, Ar-H), 7.45 (1H, d, J=8.3Hz, Ar-H), 7.46 (1H, d, J=2.2Hz, Ar-H), 7.59 (2H, d, J=8.3Hz, Ar-H).

The dibenzylamine compound 223 (800 mg, 2.39 mmol) and triethylamine (0.4 ml, 2.87 mmol, 1.2 mol eq.) were dissolved in chloroform and acryloyl chloride (238.4 mg, 2.63 mmol, 1.1 mol eq.) dissolved in chloroform was added thereto under ice-cooling. The reaction mixture was stirred at room temperature for 30 minutes. After the completion of the reaction, the reaction mixture was poured into water and extracted with chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent, the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 224 (930 mg, 100.0 128- MS m/z: 388, 1 H-NMR d: 4.54 (2H, d, J=42.0Hz, CHg), 4.64 (2H, d, J=39.0Hz, CH), 5.79-5.82 (1H, m, CH=CH2), 6.53-6.60 (2H, m, CH=CH_), 7.23-7.45 m, Ar-H), 7.58 (1H, d, J=7.8Hz, Ar-H), 7.63 (1H, d, J=7.8Hz, Ar-H).

The conjugated ketone compound 224 (800 mg, 2.06 mmol) and (+)-1-(1-naphthyl)ethylamine (387.7 mg, 2.26 mmol, 1.1 mol eq.) were dissolved in chloroform/methanol 1) and allowed to stand at room temperature for 1 week. After the completion of the reaction, the solvent was distilled off under reduced pressure and the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil K-2264 (807.4 mg, 70.1 MS m/z: 559, 'H-NMR d: 1.51 (3H, d, J=6.6Hz, CH3), 2.59 (2H, t, J=6.1 Hz, CHi2), 2.85-2.98 (2H, m, Ch2), 4.41 (2H, d, J=42.0Hz, CH), 4.58 (2H, d, 0J=38.1Hz, 4.66 (1H, q, J=6.6Hz, CH), 7.19 (1H, d, J=2.0Hz, Ar-H), 7.22 (1H, d, J=8.3Hz, Ar-H), 7.30 (2H, d, J=8.3Hz, Ar-H), 7.44-7.52 (3H, m, Ar-H), 7.55 (1H, d, J=8.3Hz, Ar-H), 7.59 (1H, d; J=8.3Hz, Ar-H), 7.66 (1H, d, J=7.1Hz, Ar-H), 7.74 (1H, d, J=8.3Hz, Ar-H), 7.86 (1H, dd, J=2.9, 6.6Hz, Ar-H), 8.17 (1H, d, J=8.3Hz, Ar-H).

Example 106: Synthesis of K-2265 (N1,N1-di(3,4-dichlorobenzyl)-3-{[(1 R)-1 (1 -naphthyl)ethyl]amino}propanamide) To 3,4-dichlorobenzaldehyde (500 mg, 2.86 mmol) and 3,4dichlorobenzylamine (0.382 ml, 2.86 mmol) was added titanium tetraisopropoxide (1.51 ml, 5.14 mmol, 1.8 mol eq.) and the mixture was stirred :at room temperature for 28 hours. After the completion of the reaction, the reaction mixture was dissolved in ethanol and sodium boron hydride (443 mg, 11.44 mmol, 4.0 mol eq.) was added thereto. Then the obtained mixture was stirred at room temperature for 20 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure. To the obtained residue were added chloroform and water and the mixture was filtered through celite.

The residue was washed with chloroform and the washing liquor was combined with the filtrate and extracted with chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium chloride and -129 dried over sodium sulfate and the solvent was distilled off under reduced pressure. The oil thus obtained was purified by column chromatography [silica gel, hexane ethyl acetate (9 1 4 to thereby give a colorless oil 225 (712.2 mg, 74.3 MS m/z: 335, 1 H-NMR d: 3.74 (4H, d, J=2.7, CH 2 X 7.17 (2H, dd, 8.3Hz, Ar-H), 7.39 (2H, d, J=8.3Hz, Ar-H), 7.44 (2H, d, J=2.0Hz, Ar-H).

The dibenzylamine compound 225 (315 mg, 0.94 mmol) and triethylamine (0.16 ml, 1.13 mmol, 1.2 mol eq.) were dissolved in chloroform and acryloyl chloride (94 mg, 1.04 mmol, 1.1 mol eq.) dissolved in chloroform was added thereto under ice-cooling. The reaction mixture was stirred at room temperature for 1 hour. After the completion of the reaction, the reaction mixture was poured into water and extracted with chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent, the oil :thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 226 (347.1 mg, 94.9 MS m/z: 389, 1 H-NMR d: 4.47 (2H, s, CH2), 4.58 (2H, s, CH2), 5.58 (1H, dd, J=5.9, 6.6Hz, CH=CH 2 6.52 (1H, d, J=5.9Hz, CH=CH 2 6.52 (1H, d, J=6.6Hz, CH=CH2), 6.99 (1 H, d, J=7.6Hz, Ar-H), 7.08 (1 H, d, J=7.6Hz, Ar-H), 7.23 (1 H, s, Ar-H), 7.32 (1H, s, Ar-H), 7.39 (1H, d, J=7.8Hz, Ar-H), 7.44 (1H, d, J=7.3Hz, Ar-H).

The conjugated ketone compound 226 (280 mg, 0.72 mmol) and (+)-1-(1-naphthyl)ethylamine (148 mg, 0.864 mmol, 1.2 mol eq.) were dissolved in chloroform/methanol (4 1) and allowed to stand at room temperature for 8 days. After the completion of the reaction, the solvent was distilled off under reduced pressure and the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil K-2265 (314.1 mg, 77.9 Subsequently, the obtained K-2265 (201.7 mg, 0.36 mmol) was dissolved in a 10 solution of hydrochloric acid/methanol and stirred for 10 minutes. Then it was concentrated as such under reduced 130 pressure. The crystals thus formed were recrystallized from ethanol/water to thereby give K-2265 hydrochloride (188.2 mg, 87.6 as colorless crystals.

MS m/z: 560, 'H-NMR d: 1.56 (3H, d, J=6.6Hz, CH3), 2.55-2.63 (2H, m, CH), 2.86-2.99 (2H, m, CH2), 4.35 (2H, s, 4.51 (2H, s, CH2), 4.71 (1H, q, J=6.6Hz, CH), 6.94 (1H, dd, J=2.2, 8.3Hz, Ar-H), 7.04 (1H, dd, J=2.2, 8.1Hz, Ar-H), 7.18 (1H, d, J=2.0Hz, Ar-H), 7.27 (1H, d, J=2.0Hz, Ar-H), 7.37 (1H, d, J=8.1 Hz, Ar-H), 7.40 (1 H, d, J=8.3Hz, Ar-H), 7.45-7.52 (3H, m, Ar-H), 7.68 (1 H, d, J=6.6Hz, Ar-H), 7.75 (1H, d, J=8.1Hz, Ar-H), 7.87 (1H, dd, J=2.2, 7.3Hz, Ar-H), 8.15 (1H, d, J=7.3Hz, Ar-H).

Example 107: Synthesis of K-2266 (N1-(4-chlorobenzyl)-N1-[(4trifluoromethyl)benzyl]-3-{[(1 R)-1 -naphthyl) ethyl]amino}propanamide) To 4-(trifluoromethyl)benzaldehyde (1 g, 5.74 mmol) and 4chlorobenzylamine (813.2 mg, 5.74 mmol, 1.0 mol eq.) was added titanium tetraisopropoxide (2.03 ml, 6.89 mmol, 1.2 mol eq.) and the mixture was stirred at room temperature for 4 hours. After the completion of the reaction, the reaction mixture was dissolved in ethanol and sodium boron hydride (868.6 mg, 22.96 mmol, 4.0 mol eq.) was added thereto. Then the obtained mixture was stirred at room temperature for 12 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure. To the obtained residue were added ethyl acetate and water and the mixture was filtered through celite.

C' The residue was washed with ethyl acetate and the washing liquor was combined with the filtrate and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate and the solvent was distilled off under reduced pressure. The oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 227 (1.6267 g, 94.5 MS m/z: 299, 'H-NMR d: 3.77 (2H, s, CH2), 3.84 (2H, s, 7.27 (2H, d, Ar-H), 7.30 (2H, d, J=9.0Hz, Ar-H), 7.46 (2H, d, J=8.1Hz, Ar-H), 7.58 (2H, d, J=8.1Hz, Ar-H).

131 The dibenzylamine compound 227 (800 mg, 2.67 mmol) and triethylamine (0.45 ml, 3.20 mmol, 1.2 mol eq.) were dissolved in chloroform and acryloyl chloride (265.7 mg, 2.94 mmol, 1.1 mol eq.) dissolved in chloroform was added thereto under ice-cooling. The reaction mixture was stirred at room temperature for 30 minutes. After the completion of the reaction, the reaction mixture was poured into water and extracted with chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent, the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 228 (938.5 mg, 99.3 MS m/z: 353, 'H-NMR d: 4.53 (2H, d, J=26.8Hz, CH2), 4.65 (2H, d, J=24.4Hz, 5.79 (1H, dd, J=2.4, 9.8Hz, CH=CH2), 6.50 (1H, dd, J=2.4, 16.6Hz,

CH=CH

2 6.59 (1H, dd, J=9.8, 16.6Hz, CH=CHg), 7.10 (1H, d, J=8.3Hz, Ar-H), 7.19 (1H, d, J=8.3Hz, Ar-H), 7.27 (1H, d, J=8.3Hz, Ar-H), 7.29 (1H, d, J=8.3Hz, Ar-H), 7.34 (1H, d, J=7.8Hz, Ar-H), 7.36 (1H, d, J=6.8Hz, Ar-H), 7.57 (1H, d, J=7.8Hz, Ar-H), 7.62 (1H, d, J=7.8Hz, Ar-H).

The conjugated ketone compound 228 (800 mg, 2.26 mmol) and (+)-1-(1-naphthyl)ethylamine (425.4 mg, 2.48 mmol, 1.1 mol eq.) were dissolved in chloroform/methanol 1) and allowed to stand at room temperature for 1 week. After the completion of the reaction, the solvent was distilled off under reduced pressure and the oil thus obtained was purified by oo...

.O :column chromatography [silica gel, chloroform] to thereby give a colorless oil K-2266 (981.5 mg, 82.8 MS m/z: 524, 1 H-NMR d: 1.52 (3H, d, J=6.6Hz, CH3), 2.57-2.64 (2H, m, CHg), 2.84-2.97 (2H, m, CHg), 4.41 (2H, d, J=23.9Hz, CHg), 4.59 (2H, d, J=24.9Hz, CHg), 4.67 (1H, q, J=6.6Hz, CH), 7.04 (1H, d, J=8.3Hz, Ar-H), 7.13 (1H, d, J=8.3Hz, Ar-H), 7.21 (1 H, d, J=8.3Hz, Ar-H), 7.26-7.31 (3H, m, Ar-H), 7.44-7.51 (3H, m, Ar-H), 7.55 (1H, d, J=8.1Hz, Ar-H), 7.59 (1H, d, J=8.1Hz, Ar-H), 7.67 (1H, dd, J=3.0, 6.6Hz, Ar-H), 7.74 (1H, d, J=8.1Hz, Ar-H), 7.87 (1H, dd, 8.1Hz, Ar-H), 8.17 (1H, d, J=8.1Hz, Ar-H).

132- Example 108: Synthesis of K-2267 (N1-(4-chlorobenzyl)-N1-(3,4dichlorobenzyl)-3-{[(1 -naphthyl)ethyl]amino}propanamide) 4-Chlorobenzylamine (1 g, 7.06 mmol) and 3,4-dichloro-benzaldehyde (1.36 g, 7.77 mmol, 1.1 mol eq.) were dissolved in methanol and MgSO 4 (1.02 g, 8.47 mmol, 1.2 mol eq.) and AcOH (10 drops) were added thereto. Then the obtained mixture was stirred at room temperature for 2 hours. After the completion of the reaction, sodium boron hydride (334.0 mg, 8.83 mmol, 1.25 mol eq.) was added under ice-cooling to the reaction mixture. Then the obtained mixture was stirred at room temperature for 12 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure.

The obtained residue was extracted with ethyl acetate. The ethyl acetate layer was washed with a saturated aqueous solution of sodium hydrogencarbonate, water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate and the solvent was distilled off under reduced pressure. The oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 229 (1.6777 g, 79.2 MS m/z: 279, 'H-NMR d: 3.72 (2H, s, CHg), 3.73 (2H, s, CH 2 7.15 (1H, dd, J=2.0, 8.1Hz, Ar-H), 7.24 (2H, d, J=8.8Hz, Ar-H), 7.29 (2H, d, J=8.8Hz, Ar-H), 7.38 (1H, d, J=8.1Hz, Ar-H), 7.43 (1H, d, J=2.0Hz, Ar-H).

The dibenzylamine compound 229 (800 mg, 2.66 mmol) and triethylamine (0.45 ml, 3.19 mmol, 1.2 mol eq.) were dissolved in chloroform and acryloyl chloride (265 mg, 2.93 mmol, 1.1 mol eq.) dissolved in chloroform was added thereto under ice-cooling. The reaction mixture was stirred at room temperature for 30 minutes. After the completion of the reaction, the reaction mixture was poured into water and extracted with chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent, the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 230 (768.9 mg, 81.4 133 MS m/z: 333, 1 H-NMR d: 4.47 (2H, d, J=13.4Hz, CH), 4.57 (2H, d, J=13.9Hz, CH2), 5.79 (1H, dd, J=3.2, 9.0Hz, CH=CH2), 6.50 (1H, dd, J=3.2, 16.6Hz,

CH=CH

2 6.57 (1H, dd, J=9.0, 16.6Hz, CH=CH_), 7.08-7.46 (7H, m, Ar-H).

The conjugated ketone compound 230 (600 mg, 1.69 mmol) and (+)-1-(1-naphthyl)ethylamine (347.2 mg, 2.03 mmol, 1.2 mol eq.) were dissolved in chloroform/methanol 1) and allowed to stand at room temperature for 1 week. After the completion of the reaction, the solvent was distilled off under reduced pressure and the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil K-2267 (721.3 mg, 81.1 MS m/z: 504, 1 H-NMR d: 1.51 (3H, d, J=6.6Hz, CH3), 2.55-2.62 (2H, m, CH), 2.84-2.97 (2H, m, CH2), 4.35 (2H, d, J=18.3Hz, CH2), 4.52 (2H, d, J=12.9Hz, CH2), 4.66 (1H, q, J=6.6Hz, CH), 7.04 (2H, d, J=8.3Hz, Ar-H), 7.13 (1H, d, J=8.3Hz, Ar-H), 7.27-7.29 (1H, m, Ar-H), 7.31 (1H, d, J=8.3Hz, Ar-H), 7.36 (1H, d, J=8.1Hz, Ar-H), 7.39 (1H, d, J=8.1Hz, Ar-H), 7.45-7.50 (3H, m, Ar-H), 7.66 (1 H, d, J=7.1 Hz, Ar-H), 7.74 (1 H, d, J=8.3Hz, Ar-H), 7.87 (1 H, dd, J=2.2, 8.3Hz, Ar-H), 8.17 (1H, d, J=7.1Hz, Ar-H).

:i Example 109: Synthesis of K-2270 (N1,N1-di(4-methoxybenzyl)-3-{[(1 naphthyl)ethyl]amino}propanamide) To 4-anisaldehyde (0.447 ml, 3.67 mmol) and 4-methoxybenzylamine (0.479 ml, 3.67 mmol, 1.0 mol eq.) was added titanium tetraisopropoxide (1.30 ml, 4.40 mmol, 1.2 mol eq.) and the mixture was stirred at room temperature for 10 hours. After the completion of the reaction, the reaction mixture was dissolved in ethanol and sodium boron hydride (555 mg, 14.68 mmol, 4.0 mol eq.) was added thereto. Then the obtained mixture was stirred at room temperature for 12 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure. To the obtained residue were added ethyl acetate and water and the mixture was filtered through celite. The residue was washed with ethyl acetate and the washing liquor was combined with the filtrate and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over 134 sodium sulfate and the solvent was distilled off under reduced pressure. The oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 231 (762.7 mg, 80.9 MS m/z: 257, H-NMR d: 3.73 (4H, s, 3.80 (6H, s, OCH3), 6.86 (4H, d, Ar-H), 7.25 (4H, d, J=8.5Hz, Ar-H).

The dibenzylamine compound 231 (500 mg, 1.95 mmol) and triethylamine (0.33 ml, 2.33 mmol, 1.2 mol eq.) were dissolved in chloroform and acryloyl chloride (195 mg, 2.15 mmol, 1.1 mol eq.) dissolved in chloroform was added thereto under ice-cooling. The reaction mixture was stirred at room temperature for 30 minutes. After the completion of the reaction, the reaction mixture was poured into water and extracted with chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent, the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 232 (602.8 mg, 99.4 MS m/z: 311, 1 H-NMR d: 3.80 (3H, s, OCH3), 3.81 (3H, s, OCHJ, 4.43 (2H, s, CHS), 4.56 (2H, s, 5.73 (1H, dd, J=2.2, 10.2Hz, CH=CH), 6.48 (1H, dd, J=2.2, 16.6Hz, CH=CH 2 6.62 (1H, dd, J=10.2, 16.6Hz, CH=CH 2 6.85 (2H, d, Ar-H), 6.88 (3H, d, J=8.5Hz, Ar-H), 7.08 (2H, d, J=8.5Hz, Ar-H), 7.19 (1H, d, J=8.5Hz, Ar-H).

The conjugated ketone compound 232 (450 mg, 1.45 mmol) and (+)-1-(1-naphthyl)ethylamine (297 mg, 1.74 mmol, 1.2 mol eq.) were dissolved in chloroform/methanol (4 1) and allowed to stand at room temperature for 2 S° weeks. After the completion of the reaction, the solvent was distilled off under reduced pressure and the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil K-2270 (366.9 mg, 52.5 Subsequently, the obtained K-2270 (244.5 mg, 0.51 mmol) was dissolved in a 10 solution of hydrochloric acid/methanol and stirred for 10 minutes. Then it was concentrated as such under reduced pressure. The crystals thus formed were recrystallized from ethanol/water to thereby give K-2270 hydrochloride (150.7 mg, 57.3 as colorless crystals.

135 MS m/z: 482, 1 H-NMR d: 1.58 (3H, d, J=6.6Hz, CH3), 2.63-2.75 (2H, m, CH), 2.86-2.98 (2H, m, CH), 3.79 (3H, s, OCH3), 3.80 (3H, s, OCH 3 4.32 (2H, s, CH2), 4.48 (1H, d, J=14.5Hz, CH2), 4.55 (1H, d, J=14.5Hz, CH2), 4.75 (1H, q, J=6.6Hz, CH), 6.83 (2H, d, J=8.8Hz, Ar-H), 6.86 (2H, d, J=8.6Hz, Ar-H), 7.03 (2H, d, J=8.5Hz, Ar-H), 7.14 (2H, d, J=8.5Hz, Ar-H), 7.46-7.53 (3H, m, Ar-H), 7.74 (1 H, d, J=7.8Hz, Ar-H), 7.76 (1 H, d, J=8.8Hz, Ar-H), 7.88 (1H, d, J=7.6Hz, Ar-H), 8.15 (1H, d, J=8.1Hz, Ar-H).

Example 110: Synthesis of K-2272 (N1-(3,4-dichlorobenzyl)-N1-[4- (trifluoromethoxy) benzyl)-3-{[(1 R)-1 -naphthyl) ethyl]-amino}propanamide) 3,4-Dichlorobenzylamine (0.379 ml, 2.84 mmol) and 4- (trifluoromethoxy)benzaldehyde (503.6 mg, 3.56 mmol, 1.0 mol eq.) were dissolved in methanol and MgSO 4 (410.2 mg, 3.41 mmol, 1.2 mol eq.) and S* AcOH (3 drops) were added thereto. Then the obtained mixture was stirred at room temperature for 30 minutes. After the completion of the reaction, sodium boron hydride (134 mg, 3.55 mmol, 1.25 mol eq.) was added to the reaction mixture. Then the obtained mixture was stirred at room temperature for minutes. After the completion of the reaction, the solvent was distilled off under reduced pressure. The obtained residue was extracted with chloroform. The chloroform layer was washed with a saturated aqueous solution of sodium hydrogencarbonate, water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate and the solvent was distilled off under reduced pressure. The oil thus obtained was purified by column chromatography [silica gel, hexane ethyl acetate (9 :1 4 to thereby give a colorless oil 233 (777.3 mg, 78.2 MS m/z: 350, 1H-NMR d: 3.76 (2H, s, CHg), 3.79 (2H, s, CH), 7.18 (1H, dd, 8.5Hz, Ar-H), 7.18 (2H, d, J=8.5Hz, Ar-H), 7.36 (2H, d, J=8.5Hz, Ar-H), 7.39 (1H, d, J=8.5Hz, Ar-H), 7.46 (1H, d, J=2.0Hz, Ar-H).

The dibenzylamine compound 233 (500 mg, 1.43 mmol) and triethylamine (0.238 ml, 1.71 mmol, 1.2 mol eq.) were dissolved in chloroform and acryloyl chloride (142 mg, 1.57 mmol, 1.1 mol eq.) dissolved in chloroform was added thereto under ice-cooling. The reaction mixture was stirred at room 136 temperature for 30 minutes. After the completion of the reaction, the reaction mixture was poured into water and extracted with chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent, the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 234 (454.6 mg, 78.7 MS m/z: 404, 'H-NMR d: 4.50 (2H, d, J=19.0Hz, CH2), 4.61 (2H, d, J=21.7Hz, CHg), 5.80 (1H, dd, J=1.7, 9.5Hz, CH=CH), 6.53 (1H, d, J=1.7, 16.6Hz,

CH=CH

2 6.58 (1H, d, J=9.5, 16.6Hz, CH=CH_), 7.16-7.22 (5H, m, Ar-H), 7.32 (1H, s, Ar-H), 7.41 (1H, d, J=8.3Hz, Ar-H).

The conjugated ketone compound 234 (350 mg, 0.87 mmol) and (+)-1-(1-naphthyl)ethylamine (178 mg, 1.04 mmol, 1.2 mol eq.) were dissolved in chloroform/methanol (4 and allowed to stand at room temperature for 1 week. After the completion of the reaction, the solvent was distilled off under reduced pressure and the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil K-2272 (360.7 mg, 72.4 Subsequently, the obtained K-2272 (250 mg, 0.435 mmol) was dissolved in a 10 solution of hydrochloric acid/methanol and stirred for minutes. Then it was concentrated as such under reduced pressure. The crystals thus formed were recrystallized from ethanol/water to thereby give K- *2270 hydrochloride (230.2 mg, 86.5 as colorless crystals.

MS m/z: 575, 'H-NMR d: 1.60 (3H, d, J=6.6Hz, CH3), 2.60-2.76 (2H, m, CH), 2.88-3.02 (2H, m, CH_2), 4.37 (2H, d, J=22.7Hz, CHg), 4.51 (1H, d, J=2.4Hz, I CH2), 4.57 (1H, d, J=6.1Hz, CH), 4.72-4.82 (1H, m, CH), 7.13 (1H, d, J=8.8Hz, Ar-H), 7.15 (1H, d, J=7.3Hz, Ar-H), 7.17 (1H, d, J=6.8Hz, Ar-H), 7.19 (1H, d, J=8.8Hz, Ar-H), 7.22 (1H, d, J=8.8Hz, Ar-H), 7.28 (1H, d, J=2.0Hz, Ar-H), 7.37 (1H, d, J=8.3Hz, Ar-H), 7.38 (1H, dd, J=8.3, 9.3Hz, Ar-H), 7.47-7.55 (3H, m, Ar-H), 7.72 (1 H, d, J=7.1Hz, Ar-H), 7.77 (1 H, d, J=8.1Hz, Ar-H), 7.88 (1 H, dd, 7.8Hz, Ar-H), 8.14 (1H, d, J=7.8Hz, Ar-H).

Example 111: Synthesis of K-2283 (N1 -(4-chlorobenzyl)-N1-[4- (trifluoromethoxy)benzyl)-3-{[(1 R)-1-(1-naphthyl)ethyl]-amino}propanamide) 137 4-(Trifluoromethoxy)benzaldehyde (0.555 ml, 3.88 mmol, 1.1 mol eq.) and 4-chlorobenzylamine (0.430 ml, 3.53 mmol) were dissolved in methanol and MgSO 4 (509.89 mg, 4.24 mmol, 1.2 mol eq.) and AcOH (3 drops) were added thereto. Then the obtained mixture was stirred at room temperature for minutes. After the completion of the reaction, sodium boron hydride (167 mg, 4.41 mmol, 1.25 mol eq.) was added to the reaction mixture. Then the obtained mixture was stirred at room temperature for 10 minutes. After the completion of the reaction, the solvent was distilled off under reduced pressure.

The obtained residue was extracted with chloroform. The chloroform layer was washed with a saturated aqueous solution of sodium hydrogencarbonate, water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate and the solvent was distilled off under reduced pressure. The ;oil thus obtained was purified by column chromatography [silica gel, hexane ethyl acetate (9 1 4 to thereby give a colorless oil 235 (1.092 g, 98.1 MS m/z: 315, H-NMR d: 3.77 (2H, s, CH2), 3.79 (2H, s, CH2), 7.18 (2H, d, J=7.8Hz, Ar-H), 7.29 (4H, d, J=2.2Hz, Ar-H), 7.37 (2H, d, J=8.9Hz, Ar-H).

The dibenzylamine compound 235 (500 mg, 1.58 mmol) and triethylamine (0.265 ml, 1.90 mmol, 1.2 mol eq.) were dissolved in chloroform and acryloyl chloride (158 mg, 1.74 mmol, 1.1 mol eq.) dissolved in chloroform was added thereto under ice-cooling. The reaction mixture was stirred at room temperature for 40 minutes. After the completion of the reaction, the reaction mixture was poured into water and extracted with chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent, the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 236 (521.3 mg, 89.3 MS m/z: 369, 1 H-NMR d: 4.50 (2H, d, J=4.9Hz, Ch1), 4.61 (2H, d, J=8.1Hz, CH2), 5.78 (1H, dd, J=2.7, 9.5Hz, CH=CH2), 6.50 (1H, dd, J=2.7, 16.6Hz,

CH=CH

2 6.57 (1H, dd, J=9.5, 16.6Hz, CH=CH2), 7.09 (1H, d, J=8.3Hz, Ar-H), 7.15-7.21 (4H, m, Ar-H), 7.27 (1H, d, J=8.1Hz, Ar-H), 7.28 (1H, d, J=8.1Hz, Ar-H), 7.33 (1H, d, J=8.1Hz, Ar-H).

138 The conjugated ketone compound 236 (400 mg, 1.08 mmol) and (+)-1-(1-naphthyl)ethylamine (222 mg, 1.30 mmol, 1.2 mol eq.) were dissolved in chloroform/methanol (4 1) and allowed to stand at room temperature for 8 days. After the completion of the reaction, the solvent was distilled off under reduced pressure and the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil K-2283 (452.0 mg, 77.4 Subsequently, the obtained K-2283 (248.9 mg, 0.46 mmol) was dissolved in a 10 solution of hydrochloric acid/methanol and stirred for 15 minutes. Then it was concentrated as such under reduced pressure. The crystals thus formed were washed with diethyl ether to thereby give K-2283 hydrochloride (235.0 mg, 88.5 as colorless crystals.

MS m/z: 540, 1 H-NMR d: 1.60 (3H, d, J=6.3Hz, CH3), 2.62-2.74 (2H, m, CH), 2.87-2.99 (2H, m, CHg), 4.38 (2H, d, J=4.9Hz, CHg), 4.55 (2H, t, J=8.3Hz, CH), 4.75-4.80 (1H, m, CH), 7.04 (1H, d, J=8.5Hz, Ar-H), 7.12 (2H, d, J=8.5Hz, Ar- 7.14 (1H, d, J=8.5Hz, Ar-H), 7.22 (1H, d, J=8.5Hz, Ar-H), 7.27 (2H, d, Ar-H), 7.30 (1H, d, J=8.5Hz, Ar-H), 7.45-7.53 (3H, m, Ar-H), 7.72 (1H, d, J=7.1Hz, Ar-H), 7.77 (1H, d, J=8.1Hz, Ar-H), 7.88 (1H, dd, J=2.0, 7.3Hz, Ar-H), 8.14 (1H, d, J=7.8Hz, Ar-H).

Example 112: Synthesis of K-2289 (N1-(4-chlorobenzyl)-N1-(4methoxybenzyl)-3-{[(1 -naphthyl)ethyl]amino}propanamide) 4-Chlorobenzaldehyde (564 mg, 4.01 mmol, 1.1 mol eq.) and 4methoxybenzylamine (476 mg, 3.64 mmol) were dissolved in methanol and i MgSO 4 (525.8 mg, 4.37 mmol, 1.2 mol eq.) and AcOH (5 drops) were added thereto. Then the obtained mixture was stirred at room temperature for minutes. After the completion of the reaction, sodium boron hydride (172 mg, 4.55 mmol, 1.25 mol eq.) was added to the reaction mixture. Then the obtained mixture was stirred at room temperature for 15 minutes. After the completion of the reaction, the solvent was distilled off under reduced pressure. The obtained residue was extracted with chloroform. The chloroform layer was washed with a saturated aqueous solution of sodium hydrogencarbonate, water and a saturated aqueous solution of sodium chloride and dried over 139 sodium sulfate and the solvent was distilled off under reduced pressure. The oil thus obtained was purified by column chromatography [silica gel, hexane ethyl acetate (9 1 4 to thereby give a colorless oil 237 (711.8 mg, 74.8 MS m/z: 261, 'H-NMR d: 3.72 (2H, s, CH2), 3.75 (2H, s, CH2), 3.80 (3H, s, OCH3), 6.86 (2H, d, J=8.5Hz, Ar-H), 7.24 (2H, d, J=8.5Hz, Ar-H), 7.28 (4H, d, J=2.2Hz, Ar-H).

The dibenzylamine compound 237 (501.4 mg, 1.92 mmol) and triethylamine (0.32 ml, 2.30 mmol, 1.2 mol eq.) were dissolved in chloroform and acryloyl chloride (191 mg, 2.11 mmol, 1.1 mol eq.) dissolved in chloroform was added thereto under ice-cooling. The reaction mixture was stirred at room temperature for 30 minutes. After the completion of the reaction, the reaction mixture was poured into water and extracted with chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent, the oil 9 9 thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 238 (557.2 mg, 91.9 MS m/z: 315, 'H-NMR d: 3.80 (3H, d, J=5.4Hz, OCH3), 4.44 (2H, d, CH2), 4.57 (2H, d, J=4.1Hz, CH2), 5.75 (1H, dd, J=1.7, 10.3Hz, CH=CH2), 6.48 (1H, dd, J=1.7, 16.6Hz, CH=CH 2 6.64 (1H, dd, J=10.3, 16.6Hz, CH=CH2), 6.85 (1 H, d, J=8.3Hz, Ar-H), 6.88 (1 H, d, J=8.5Hz, Ar-H), 7.07 (1H, d, J=8.3Hz, Ar-H), 7.08 (1H, d, J=6.3Hz, Ar-H), 7.17 (1H, d, J=8.8Hz, Ar-H), 7.19 (1H, d, J=8.3Hz, Ar-H), 7.28 (1H, d, J=8.5Hz, Ar-H), 7.32 (2H, d, J=7.8Hz, Ar-H).

The conjugated ketone compound 238 (414 mg, 1.31 mmol) and (+)-1-(1-naphthyl)ethylamine (270 mg, 1.57 mmol, 1.2 mol eq.) were dissolved in chloroform/methanol 1) and allowed to stand at room temperature for 12 days. After the completion of the reaction, the solvent was distilled off under reduced pressure and the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil K-2289 (441.8 mg, 69.3 Subsequently, the obtained K-2289 (269.4 mg, 0.55 mmol) was dissolved in a 10 solution of hydrochloric acid/methanol and 140 stirred for 10 minutes. Then it was concentrated as such under reduced pressure. The crystals thus formed were recrystallized from ethanol/water to thereby give K-2289 hydrochloride (270.1 mg, 93.2 as colorless crystals.

MS m/z: 486, 'H-NMR d: 1.56 (3H, d, J=6.6Hz, CH3), 2.57-2.70 (2H, m, CH2), 2.84-2.95 (2H, m, CH), 3.80 (3H, d, J=2.2Hz, OCH), 4.33 (2H, d, J=5.4Hz, CH2), 4.52 (2H, t, J=6.6Hz, CH), 4.70-4.74 (1H, m, CH), 6.83 (1H, d, Ar-H), 6.85 (1H, d, J=9.0Hz, Ar-H), 7.02 (1H, d, J=8.5Hz, Ar-H), 7.03 (1H, d, Ar-H), 7.12 (1H, d, J=8.5Hz, Ar-H), 7.13 (1H, d, J=8.3Hz, Ar-H), 7.27 (1H, d, J=8.5Hz, Ar-H), 7.29 (1H, d, J=8.5Hz, Ar-H), 7.46-7.52 (3H, m, Ar-H), 7.71 (1H, dd, J=3.4, 6.8Hz, Ar-H), 7.75 (1H, d, J=8.3Hz, Ar-H), 7.87 (1H, d, J=7.6Hz, Ar-H), 8.15 (1H, d, J=7.6Hz, Ar-H).

Example 113: Synthesis of K-2290 (N1-(4-methoxybenzyl)-N1-[4- (trifluoromethyl)benzyl)-3-{[(1 R)-1 -naphthyl)ethyl]amino}propanamide) 4-(Trifluoromethyl)benzaldehyde (1.269 g, 7.29 mmol) and 4methoxybenzylamine (1 g, 7.29 mmol, 1.0 mol eq.) were dissolved in methanol and MgSO 4 (1.0530 g, 8.75 mmol, 1.2 mol eq.) and AcOH (10 drops) were added thereto. Then the obtained mixture was stirred at room temperature for 2 hours. After the completion of the reaction, the reaction mixture was dissolved in methanol and sodium boron hydride (344.7 mg, 9.11 mmol, 1.25 mol eq.) was added thereto. Then the obtained mixture was stirred at room temperature for 12 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure. The obtained residue was extracted with ethyl acetate. The ethyl acetate layer was washed with a saturated aqueous solution of sodium hydrogencarbonate, water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate and the solvent was distilled off under reduced pressure. The oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 239 (1.40 g, 65.0 MS m/z: 295, 1 H-NMR d: 3.73 (2H, s, CH2), 3.80 (3H, s, OCH3), 3.83 (2H, s, CH), 6.87 (2H, d, J=8.5Hz, Ar-H), 7.24 (2H, d, J=8.5Hz, Ar-H), 7.45 (2H, d, Ar-H), 7.57 (1H, d, J=8.5Hz, Ar-H), 7.59 (1H, d, J=8.5Hz, Ar-H).

141 The dibenzylamine compound 239 (1.30 g, 4.40 mmol) and triethylamine (0.74 ml, 5.28 mmol, 1.2 mol eq.) were dissolved in chloroform and acryloyl chloride (438.3 mg, 4.84 mmol, 1.1 mol eq.) dissolved in chloroform was added thereto under ice-cooling. The reaction mixture was stirred at room temperature for 30 minutes. After the completion of the reaction, the reaction mixture was poured into water and extracted with chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent, the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 240 (974.7 mg, 63.5 MS m/z: 349, 'H-NMR d: 3.80 (3H, d, J=4.9Hz, OCH3), 4.53 (2H, d, J=52.0Hz, CH2), 4.61 (2H, d, J=45.1 Hz, CH2), 5.77 (1 H, dd, J=2.0, 10.5Hz, CH=CHg), 6.49 (1H, dd, J=2.0, 16.6Hz, CH=CH 2 6.65 (1H, dd, J=10.5, 16.6Hz, CH=CH2), 6.85 (1H, d, J=8.3Hz, Ar-H), 6.89 (1H, d, J=8.5Hz, Ar-H), 7.07 (1H, d, J=8.3Hz, Ar-H), 7.17 (1H, d, J=8.1Hz, Ar-H), 7.27 (1H, d, J=6.8Hz, Ar-H), 7.35 (1H, d, J=7.8Hz, Ar-H), 7.56 (1H, d, J=8.1Hz, Ar-H), 7.61 (1H, d, J=7.3Hz, Ar-H).

The conjugated ketone compound 240 (874.7 mg, 2.50 mmol) and (+)-1-(1-naphthyl)ethylamine (513.9 mg, 3.00 mmol, 1.2 mol eq.) were dissolved in chloroform/methanol 1) and allowed to stand at room temperature for 1 week. After the completion of the reaction, the solvent was distilled off under reduced pressure and the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil K-2290 (1.005 g, 77.2 MS m/z: 520, 'H-NMR d: 1.51 (3H, dd, J=3.0, 6.6Hz, CH), 2.55 (1H, t, J=6.1Hz, CH2), 2.67 (1H, t, J=6.1Hz, CH2), 2.82-2.98 (2H, m, CHg), 3.79 (3H, d, J=4.6Hz, OCHI), 4.39 (2H, d, J=28.3Hz, CH2), 4.57 (2H, d, J=30.0Hz, CH2), 4.64-4.70 (1H, m, CH), 6.83 (1H, d, J=8.8Hz, Ar-H), 6.86 (1H, d, J=8.8Hz, Ar- 7.03 (1H, d, J=8.8Hz, Ar-H), 7.12 (1H, d, J=8.6Hz, Ar-H), 7.21 (1H, d, J=8.1 Hz, Ar-H), 7.30 (1 H, d, J=8.3Hz, Ar-H), 7.43-7.51 (3H, m, Ar-H), 7.54 (1 H, d, J=8.3Hz, Ar-H), 7.57 (1H, d, J=8.1Hz, Ar-H), 7.68 (1H, t, J=7.6Hz, Ar-H), 142 7.73 (1H, dd, J=3.7, 8.1Hz, Ar-H), 7.86 (1H, dd, J=2.4, 7.3Hz, Ar-H), 8.17 (1H, d, J=7.6Hz, Ar-H).

Example 114: Synthesis of K-2291 (N1-(4-chlorobenzyl)-N1-(2naphthylmethyl)-3-{[(1 R)-1 -(1-naphthyl) ethyl]amino}propanamide) To 2-naphthaldehyde (500 mg, 3.20 mmol) and 4-chlorobenzylamine (0.389 ml, 3.20 mmol, 1.0 mol eq.) was added titanium isopropoxide (1.70 ml, 5.76 mmol, 1.8 mol eq.) and the obtained mixture was stirred at room temperature for 4 hours. After the completion of the reaction, the reaction mixture was dissolved in ethanol and sodium boron hydride (485 mg, 12.82 mmol, 4.0 mol eq.) was added thereto. Then the obtained mixture was stirred at room temperature for 29 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure. To the obtained residue were added ethyl acetate and water and the mixture was filtered through celite. The residue was washed with ethyl acetate and the washing liquor was combined with the filtrate and extracted with ethyl acetate. The ethyl acetate layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate and the solvent was distilled off under reduced pressure. The oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 241 (767.4 mg, 85.2 MS m/z: 281, 'H-NMR d: 3.80 (2H, s, CH), 3.95 (2H, s, CHg), 7.26 (2H, d, J=12.0Hz, Ar-H), 7.31 (2H, d, J=12.0Hz, Ar-H), 7.42-7.49 (3H, m, Ar-H), 7.75 (1 H, s, Ar-H), 7.81 (1 H, d, J=8.1 Hz, Ar-H), 7.82 (1 H, d, J=8.5Hz, Ar-H), 7.83 (1H, d, J=8.1Hz, Ar-H).

The dibenzylamine compound 241 (506.7 mg, 1.80 mmol) and triethylamine (0.301 ml, 2.16 mmol, 1.2 mol eq.) were dissolved in chloroform and acryloyl chloride (179 mg, 1.98 mmol, 1.1 mol eq.) dissolved in chloroform was added thereto under ice-cooling. The reaction mixture was stirred at room temperature for 30 minutes. After the completion of the reaction, the reaction mixture was poured into water and extracted with chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent, the oil 143 thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 242 (652.4 mg, 100 MS m/z: 335, 1 H-NMR d: 4.58 (2H, d, J=65.9Hz, CHg), 4.74 (2H, d, J=52.0Hz, CHg), 5.76 (1H, dd, J=2.0, 10.2Hz, CH=CH2), 6.53 (1H, dd, J=2.0, 16.6Hz,

CH=CH

2 6.54 (1H, dd, J=10.2, 16.6Hz, CH=CHg), 7.10 (1H, d, J=8.1Hz, Ar- 7.21-7.35 (4H, m, Ar-H), 7.47-7.62 (3H, m, Ar-H), 7.79-7.86 (3H, m, Ar-H).

The conjugated ketone compound 242 (500 mg, 1.49 mmol) and (+)-1-(1-naphthyl)ethylamine (307 mg, 1.79 mmol, 1.2 mol eq.) were dissolved in chloroform/methanol 1) and allowed to stand at room temperature for 13 days. After the completion of the reaction, the solvent was distilled off under reduced pressure and the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil K-2291 (521.1 g, 69.0 Subsequently, the obtained K-2291 (394.1 mg, 0.78 mmol) was dissolved in a 10 solution of hydrochloric acid/methanol and stirred for 15 minutes. Then it was concentrated as such under reduced pressure. The crystals thus formed were recrystallized from ethanol/water to thereby give K- 2291 hydrochloride (358.7 mg, 85.1 as colorless crystals.

MS m/z: 506, 'H-NMR d: 1.56 (3H, d, J=6.8Hz, CH3), 2.61-2.76 (2H, m, CH2), 2.88-3.01 (2H, m, CH), 4.38 (1H, s, C2), 4.55 (1H, s, CH2), 4.62 (1H, d, J=3.7Hz, CH2), 4.75 (1H, d, J=6.8Hz, CH), 4.70-4.76 (1H, m, CH), 7.05 (1H, d, J=8.5Hz, Ar-H), 7.16 (1H, d, J=8.3Hz, Ar-H), 7.28 (1H, d, J=8.5Hz, Ar-H), 7.30 (1H, d, J=8.5Hz, Ar-H), 7.44-7.58 (6H, m, Ar-H), 7.69-7.89 (7H, m, Ar-H), 8.10-8.17 (1H, m, Ar-H).

Example 115: Synthesis of K-2294 (N1-(3,4-dichlorobenzyl)-N1-(4methylbenzyl)-3-{[(1 R)-1 -naphthyl)ethyl]amino}propanamide) 3,4-Dichlorobenzaldehyde (1.555 g, 8.25 mmol) and 4methylbenzylamine (1 g, 8.25 mmol, 1.0 mol eq.) were dissolved in methanol and MgSO 4 (1.1920 g, 9.90 mmol, 1.2 mol eq.) and AcOH (10 drops) were added thereto. Then the obtained mixture was stirred at room temperature for 2 hours. After the completion of the reaction, the reaction mixture was dissolved in methanol and sodium boron hydride (390.2 mg, 10.30 mmol, 1.25 144 mol eq.) was added thereto. Then the obtained mixture was stirred at room temperature for 12 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure. The obtained residue was extracted with ethyl acetate. The ethyl acetate layer was washed with a saturated aqueous solution of sodium hydrogencarbonate, water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate and the solvent was distilled off under reduced pressure. The oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 243 (1.5942 g, 69.2 MS m/z: 280, 'H-NMR d: 2.34 (3H, s, CH3), 3.73 (4H, s, CHX 7.14 (2H, d, J=8.1Hz, Ar-H), 7.16 (1H, dd, J=2.0, 8.1Hz, Ar-H), 7.19 (2H, d, J=8.1Hz, Ar-H), 7.37 (1H, d, J=8.1Hz, Ar-H), 7.43 (1H, d, J=2.0Hz, Ar-H).

The dibenzylamine compound 243 (1.4942 g, 5.35 mmol) and triethylamine (0.89 ml, 6.42 mmol, 1.2 mol eq.) were dissolved in chloroform and acryloyl chloride (532.6 mg, 5.88 mmol, 1.1 mol eq.) dissolved in chloroform was added thereto under ice-cooling. The reaction mixture was stirred at room temperature for 30 minutes. After the completion of the reaction, the reaction mixture was poured into water and extracted with chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent, the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 244 (1.6587 g, 92.9 MS m/z: 334, 1 H-NMR d: 2.34 (3H, d, J=6.3Hz, CH3), 4.46 (2H, d, J=13.4Hz, CH2), 4.58 (2H, d, J=16.1Hz, CH2), 5.76 (1H, dd, J=2.0, 10.2Hz, CH=CH2), 6.48 (1H, dd, J=2.0, 16.8Hz, CH=CH2), 6.63 (1H, dd, J=10.2, 16.8Hz, CH=CH), 7.04 (2H, d, J=7.8Hz, Ar-H), 7.09 (1H, d, J=8.3Hz, Ar-H), 7.17 (2H, d, J=7.8Hz, Ar-H), 7.31 (1H, s, Ar-H), 7.37 (1H, d, J=8.3Hz, Ar-H).

The conjugated ketone compound 244 (1.5587 g, 4.67 mmol) and (+)-1-(1-naphthyl)ethylamine (959.6 mg, 5.60 mmol, 1.2 mol eq.) were dissolved in chloroform/methanol 1) and allowed to stand at room 145temperature for 1 week. After the completion of the reaction, the solvent was distilled off under reduced pressure and the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil K-2294 (2.1115 g, 89.3 MS m/z: 505, 1 H-NMR d: 1.50 (3H, d, J=6.6Hz, CH3), 2.34 (3H, d, J=6.6Hz, CH3), 2.52 (1H, dt, J=3.4, 9.3Hz, CH2), 2.63 (1H, t, J=6.3Hz, CH), 2.74-2.96 (2H, m, CH2), 4.35 (2H, d, J=22.0Hz, CH2), 4.53 (2H, d, J=13.7Hz, CH2), 4.62-4.68 (1 H, m, CH), 6.99 (1 H, d, J=7.8Hz, Ar-H), 7.04 (1 H, dd, J=2.0, 8.1Hz, Ar-H), 7.09 (1H, d, J=8.3Hz, Ar-H), 7.12 (1H, d, J=8.1Hz, Ar-H), 7.14 (1H, d, J=8.1Hz, Ar-H), 7.26 (1H, d, J=2.0Hz, Ar-H), 7.34 (1H, d, J=8.3Hz, Ar-H), 7.43-7.52 (3H, m, Ar-H), 7.68 (1H, d, J=7.1Hz, Ar-H), 7.72 (1H, d, J=8.1Hz, Ar-H), 7.85 (1H, d, J=7.1Hz, Ar-H), 8.17 (1H, d, J=7.1Hz, Ar-H).

Example 116: Synthesis of K-2299 (N1-(4-methylbenzyl)-N1-[4- (trifluoromethyl)benzyl]-3-{[(1 R)-1-(1-naphthyl)ethyl]amino}propanamide) 4-(Trifluoromethyl)benzaldehyde (1.4369 g, 8.25 mmol) and 4methylbenzylamine (1 g, 8.25 mmol, 1.0 mol eq.) were dissolved in methanol and MgSO 4 (1.1920 g, 9.90 mmol, 1.2 mol eq.) and AcOH (10 drops) were added thereto. Then the obtained mixture was stirred at room temperature for 2 hours. After the completion of the reaction, the reaction mixture was dissolved in methanol and sodium boron hydride (390.2 mg, 10.30 mmol, 1.25 mol eq.) was added thereto. Then the obtained mixture was stirred at room temperature for 12 hours. After the completion of the reaction, the solvent was distilled off under reduced pressure. The obtained residue was extracted with ethyl acetate. The ethyl acetate layer was washed with a saturated aqueous solution of sodium hydrogencarbonate, water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate and the solvent was distilled off under reduced pressure. The oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 245 (1.6877 g, 73.2 146 MS m/z: 279, 'H-NMR d: 2.34 (3H, s, CH), 3.76 (2H, s, CHg), 3.85 (2H, s, CH), 7.14 (2H, d, J=7.8Hz, Ar-H), 7.21 (2H, d, J=8.1Hz, Ar-H), 7.46 (2H, d, J=8.1Hz, Ar-H), 7.57 (2H, d, J=8.3Hz, Ar-H).

The dibenzylamine compound 245 (1.5877 g, 5.68 mmol) and triethylamine (0.95 ml, 6.82 mmol, 1.2 mol eq.) were dissolved in chloroform and acryloyl chloride (565.96 mg, 6.25 mmol, 1.1 mol eq.) dissolved in chloroform was added thereto under ice-cooling. The reaction mixture was stirred at room temperature for 30 minutes. After the completion of the reaction, the reaction mixture was poured into water and extracted with chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent, the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 246 (1.5568 g, 82.0 MS m/z: 333, 1 H-NMR d: 2.34 (3H, d, J=6.8Hz, CH3), 4.52 (2H, d, J=26.8Hz, CH2), 4.65 (2H, d, J=22.4Hz, CH2), 5.76 (1H, dd, J=1.7, 10.2Hz, CH=CH2), 6.49 (1H, dd, J=1.7, 16.8Hz, CH=CH 2 6.64 (1H, dd, J=10.2, 16.8Hz, CH=CH2), 7.05 (2H, d, J=7.8Hz, Ar-H), 7.17 (2H, d, J=7.8Hz, Ar-H), 7.35 (2H, d, J=8.1 Hz, Ar-H), 7.56 (2H, d, J=8.1Hz, Ar-H).

The conjugated ketone compound 246 (1.4568 g, 4.36 mmol) and -naphthyl)ethylamine (896.8 mg, 5.24 mmol, 1.2 mol eq.) were dissolved in chloroform/methanol (4 1) and allowed to stand at room temperature for 1 week. After the completion of the reaction, the solvent was distilled off under reduced pressure and the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil K-2299 (884.4 mg, 40.1 MS m/z: 504, 'H-NMR d: 1.51 (3H, d, J=6.6Hz, CH 3 2.33 (3H, d, J=6.3Hz, CHt), 2.53 (1H, dt, J=6.1, 19.3Hz, CHg), 2.66 (1H, t, J=6.1Hz, CHg), 2.77-2.97 (2H, m, CHg), 4.40 (2H, d, J=19.8Hz, CHg), 4.59 (2H, d, J=24.9Hz, CH2), 4.65-4.69 (1H, m, CH), 7.00 (1H, d, J=7.8Hz, Ar-H), 7.08 (1H, d, J=8.3Hz, Ar- 7.12 (1H, d, J=7.8Hz, Ar-H), 7.14 (1H, d, J=7.8Hz, Ar-H), 7.20 (1H, d, 147 J=8.1 Hz, Ar-H), 7.30 (1 H, d, J=8.1 Hz, Ar-H), 7.43-7.51 (3H, m, Ar-H), 7.53 (1 H, d, J=8.3Hz, Ar-H), 7.57 (1H, d, J=8.1Hz, Ar-H), 7.68 (1H, d, J=6.8Hz, Ar-H), 7.73 (1H, dd, J=3.2, 8.1Hz, Ar-H), 7.86 (1H, dd, J=2.2, 7.6Hz, Ar-H), 8.17 (1H, d, J=7.6Hz, Ar-H).

Example 117: Synthesis of K-2300 (N1,N1-di(4-methylbenzyl)-3-{[(1R)-1-(1naphthyl)ethyl]amino}propanamide) 4-Tolualdehyde (500 mg, 3.56 mmol) and 4-methylbenzylamine (503.6 mg, 3.56 mmol, 1.0 mol eq.) were dissolved in methanol and MgSO 4 (514.2 mg, 4.27 mmol, 1.2 mol eq.) and AcOH (3 drops) were added thereto. Then the obtained mixture was stirred at room temperature for 50 minutes. After the completion of the reaction, sodium boron hydride (168.3 mg, 4.45 mmol, 1.25 mol eq.) was added to the reaction mixture. Then the obtained mixture was stirred at room temperature for 15 minutes. After the completion of the reaction, the solvent was distilled off under reduced pressure. The obtained residue was extracted with chloroform. The chloroform layer was washed with a saturated aqueous solution of sodium hydrogencarbonate, water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate and the solvent was distilled off under reduced pressure. The oil thus obtained was purified by column chromatography [silica gel, hexane ethyl acetate (9 1 4 to thereby give a colorless oil 247 (819.4 mg, 88.2 MS m/z: 225, 1 H-NMR d: 2.33 (6H, s, CE3X2), 3.75 (4H, s, CHgX 7.13 (4H, d, J=7.8Hz, Ar-H), 7.22 (4H, d, J=7.8Hz, Ar-H).

The dibenzylamine compound 247 (500 mg, 2.22 mmol) and triethylamine (0.372 ml, 2.67 mmol, 1.2 mol eq.) were dissolved in chloroform and acryloyl chloride (221 mg, 2.44 mmol, 1.1 mol eq.) dissolved in chloroform was added thereto under ice-cooling. The reaction mixture was stirred at room temperature for 30 minutes. After the completion of the reaction, the reaction mixture was poured into water and extracted with chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent, the oil 148 thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 248 (534.5 mg, 86.3 MS m/z: 279, 'H-NMR d: 2.34 (3H, s, CH3), 2.35 (3H, s, CH3), 4.45 (2H, s, CH2), 4.60 (2H, s, CH2), 5.71 (1H, dd, J=2.2, 10.2Hz, CH=CHl), 6.47 (1H, dd, J=2.2, 16.6Hz, CH=CH 2 6.60 (1H, dd, J=10.2, 16.6Hz, CH=CHg), 7.05 (2H, d, J=7.8Hz, Ar-H), 7.13-7.17 (6H, m, Ar-H).

The conjugated ketone compound 248 (400 mg, 1.43 mmol) and (+)-1-(1-naphthyl)ethylamine (295 mg, 1.72 mmol, 1.2 mol eq.) were dissolved in chloroform/methanol (4 1) and allowed to stand at room temperature for 2 weeks. After the completion of the reaction, the solvent was distilled off under reduced pressure and the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil K-2300 (372.5 mg, 57.9 Subsequently, the obtained K-2300 (253.6 mg, 0.56 mmol) was dissolved in a 10 solution of hydrochloric acid/methanol and stirred for 15 minutes. Then it was concentrated as such under reduced pressure. The crystals thus formed were recrystallized from ethanol/water to thereby give K-2300 hydrochloride (113.7 mg, 41.4 as colorless crystals.

MS m/z: 450, 1 H-NMR d: 1.57 (3H, d, J=6.6Hz, CH3), 2.34 (3H, s, 2.34 (3H, s, CH3), 2.60-2.71 (2H, m, CHg), 2.85-2.97 (2H, m, CHg), 4.35 (2H, s, CH2), 4.52 (1H, d, J=14.6Hz, CH2), 4.59 (1H, d, J=14.6Hz, CHb), 4.74 (1H, q, J=6.6Hz, CH), 7.00 (2H, d, J=8.1Hz, Ar-H), 7.11 (4H, d, J=1.2Hz, Ar-H), 7.14 (2H, d, J=7.8Hz, Ar-H), 7.45-7.52 (3H, m, Ar-H), 7.74 (1H, d, J=7.8Hz, Ar-H), 7.75 (1H, d, J=8.8Hz, Ar-H), 7.87 (1H, dd, J=2.2, 7.8Hz, Ar-H), 8.14 (1H, d, J=7.8Hz, Ar-H).

Example 118: Synthesis of K-2309 (N1-(3,4-dichlorobenzyl)-N1-(4methoxybenzyl)-3-{[(1 R)-1 -naphthyl) ethyl]amino}propanamide) 3,4-Dichlorobenzaldehyde (702 mg, 4.01 mmol, 1.1 mol eq.) and 4methoxybenzylamine (0.476 ml, 3.64 mmol) were dissolved in methanol and MgSO4 (525.8 mg, 4.37 mmol, 1.2 mol eq.) and AcOH (5 drops) were added thereto. Then the obtained mixture was stirred at room temperature for minutes. After the completion of the reaction, sodium boron hydride (172 mg, 149 4.55 mmol, 1.25 mol eq.) was added to the reaction mixture. Then the obtained mixture was stirred at room temperature for 20 minutes. After the completion of the reaction, the solvent was distilled off under reduced pressure. The obtained residue was extracted with chloroform. The chloroform layer was washed with a saturated aqueous solution of sodium hydrogencarbonate, water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate and the solvent was distilled off under reduced pressure. The oil thus obtained was purified by column chromatography [silica gel, hexane ethyl acetate (9 1 4 to thereby give a colorless oil 249 (827.0 mg, 76.8 MS m/z: 296, 'H-NMR d: 3.72 (2H, s, CH1), 3.74 (2H, s, CH2), 3.80 (3H, s, OCH), 6.87 (2H, d, J=8.8Hz, Ar-H), 7.18 (1H, dd, J=2.0, 8.3Hz, Ar-H), 7.24 (2H, d, J=8.3Hz, Ar-H), 7.38 (1H, d, J=8.1Hz, Ar-H), 7.45 (1H, d, J=2.0Hz, Ar-

H).

The dibenzylamine compound 249 (711.2 mg, 2.41 mmol) and triethylamine (0.402 ml, 2.89 mmol, 1.2 mol eq.) were dissolved in chloroform "and acryloyl chloride (240 mg, 2.65 mmol, 1.1 mol eq.) dissolved in chloroform was added thereto under ice-cooling. The reaction mixture was stirred at room temperature for 45 minutes. After the completion of the reaction, the reaction mixture was poured into water and extracted with chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium l e chloride and dried over sodium sulfate. After distilling off the solvent, the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 250 (837.2 mg, 99.3 MS m/z: 350, 'H-NMR d: 3.81 (3H, s, OCHS), 4.50 (2H, d, J=44.2Hz, CH2), 4.54 (2H, d, J=49.3Hz, CH2), 5.78 (1H, dd, J=1.7, 10.2Hz, CH=CH2), 6.59 (1H, dd, J=1.7, 16.6Hz, CH=CH 2 6.65 (1H, dd, J=10.2, 16.6Hz, CH=CHg), 6.89 (2H, d, Ar-H), 7.07 (2H, d, J=8.5Hz, Ar-H), 7.09 (1H, d, J=8.3Hz, Ar-H), 7.30 (1H, s, Ar-H), 7.38 (1H, d, J=8.3Hz, Ar-H).

The conjugated ketone compound 250 (692.4 mg, 1.98 mmol) and (+)-1-(1-naphthyl)ethylamine (407 mg, 2.37 mmol, 1.2 mol eq.) were dissolved 150 in chloroform/methanol 1) and allowed to stand at room temperature for 2 weeks. After the completion of the reaction, the solvent was distilled off under reduced pressure and the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil K-2309 (835.9 mg, 81.0 Subsequently, the obtained K-2309 (630.1 mg, 1.21 mmol) was dissolved in a 10 solution of hydrochloric acid/methanol and stirred for 15 minutes. Then it was concentrated as such under reduced pressure. The crystals thus formed were recrystallized from ethanol/water to thereby give K-2309 hydrochloride (566.8 mg, 84.0 as colorless crystals.

MS m/z: 521, "H-NMR d: 1.55 (3H, d, J=6.3Hz, CHA), 2.55-2.70 (2H, m, CH2), 2.86-2.97 (2H, m, CHg), 3.80 (3H, d, J=3.4Hz, OCH), 4.33 (2H, d, J=12.7Hz, CH2), 4.51 (2H, d, J=8.8Hz, CHg), 4.68-4.73 (1 H, m, CH), 6.85 (2H, d, J=8.8Hz, Ar-H), 7.02 (2H, d, J=8.5Hz, Ar-H), 7.11 (1H, d, J=8.5Hz, Ar-H), 7.26 (1H, s, Ar-H), 7.35 (1 H, d, J=8.3Hz, Ar-H), 7.45-7.52 (3H, m, Ar-H), 7.70 (1H, t, J=6.8Hz, Ar-H), 7.75 (1H, d, J=8.3Hz, Ar-H), 7.87 (1H, dd, J=2.2, 7.8Hz, Ar-H), 8.16 (1H, d, J=7.8Hz, Ar-H).

"Example 119: Synthesis of K-2310 (N1 -(4-methylbenzyl)-N1 (trifluoromethoxy)benzyl]-3-{[(1 -naphthyl)ethyl]amino}propanamide) 4-(Trifluoromethoxy)benzaldehyde (0.648 ml, 4.54 mmol, 1.1 mol eq.) and 4-methylbenzylamine (0.525 ml, 4.13 mmol) were dissolved in methanol S and MgSO 4 (596.6 mg, 4.96 mmol, 1.2 mol eq.) and AcOH (5 drops) were added thereto. Then the obtained mixture was stirred at room temperature for 0. 40 minutes. After the completion of the reaction, sodium boron hydride (195 mg, 5.16 mmol, 1.25 mol eq.) was added to the reaction mixture. Then the obtained mixture was stirred at room temperature for 20 minutes. After the completion of the reaction, the solvent was distilled off under reduced pressure.

The obtained residue was extracted with chloroform. The chloroform layer was washed with a saturated aqueous solution of sodium hydrogencarbonate, water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate and the solvent was distilled off under reduced pressure. The oil thus obtained was purified by column chromatography [silica gel, hexane 151 ethyl acetate (9 1 4 to thereby give a colorless oil 251 (979.1 mg, 80.4 MS m/z: 295, 1 H-NMR d: 2.34 (3H, s, CH3), 3.76 (2H, s, CH), 3.79 (2H, s, CHg), 7.14 (2H, d, J=8.1Hz, Ar-H), 7.16 (2H, d, J=8.5Hz, Ar-H), 7.22 (2H, d, J=8.1Hz, Ar-H), 7.36 (2H, d, J=8.5Hz, Ar-H).

The dibenzylamine compound 251 (846.8 mg, 2.87 mmol) and triethylamine (0.480 ml, 3.44 mmol, 1.2 mol eq.) were dissolved in chloroform and acryloyl chloride (286 mg, 3.16 mmol, 1.1 mol eq.) dissolved in chloroform was added thereto under ice-cooling. The reaction mixture was stirred at room temperature for 45 minutes. After the completion of the reaction, the reaction mixture was poured into water and extracted with chloroform. The chloroform layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent, the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 252 (844.5 mg, 84.3 MS m/z: 349, 'H-NMR d: 2.34 (3H, d, J=6.8Hz, 4.55 (2H, d, J=49.0Hz, CH), 4.56 (2H, d, J=50.2Hz, CH2), 5.75 (1H, dd, J=2.2, 10.0Hz, CH=CHg), 6.49 (1H, dd, J=2.2, 16.8Hz, CH=CH 2 6.62 (1H, dd, J=10.0, 16.8Hz, CH=CH2), 7.04 (2H, d, J=7.8Hz, Ar-H), 7.13-7.21 (4H, m, Ar-H), 7.28 (2H, d, Ar-H).

The conjugated ketone compound 252 (685.1 mg, 1.96 mmol) and (+)-1-(1-naphthyl)ethylamine (403 mg, 2.36 mmol, 1.2 mol eq.) were dissolved in chloroform/methanol 1) and allowed to stand at room temperature for 12 days. After the completion of the reaction, the solvent was distilled off under reduced pressure and the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil K-2310 (777.8 mg, 76.3 Subsequently, the obtained K-2310 (539.0 mg, 1.04 mmol) was dissolved in a 10 solution of hydrochloric acid/methanol and stirred for 15 minutes. Then it was concentrated as such under reduced pressure. The crystals thus formed were recrystallized from ethanol/water to thereby give K-2310 hydrochloride (493.0 mg, 85.1 as colorless crystals.

152 MS m/z: 520, 'H-NMR d: 1.52 (3H, d, J=6.6Hz, CH3), 2.34 (3H, d, J=5.4Hz, CH3), 2.62 (2H, dt, J=5.9, 21.7Hz, CH), 2.84-2.96 (2H, m, CHg), 4.38 (2H, s, CH), 4.56 (2H, d, J=8.6Hz, CH), 4.67 (1H, q, J=6.6Hz, CH), 7.00 (2H, d, J=8.1 Hz, Ar-H), 7.07-7.18 (4H, m, Ar-H), 7.22 (2H, d, J=8.6Hz, Ar-H), 7.44-7.51 (3H, m, Ar-H), 7.68 (1H, d, J=6.6Hz, Ar-H), 7.73 (1H, d, J=8.1Hz, Ar-H), 7.86 (1H, dd, J=2.2, 8.1Hz, Ar-H), 8.16 (1H, d, J=8.5Hz, Ar-H).

Example 120: Synthesis of K-2311 4-(Trifluoromethoxy)benzaldehyde (0.573 ml, 4.01 mmol, 1.1 mol eq.) and 4-methoxybenzylamine (0.476 ml, 3.64 mmol) were dissolved in methanol and MgSO 4 (525.8 mg, 4.37 mmol, 1.2 mol eq.) and AcOH (5 drops) were added thereto. Then the obtained mixture was stirred at room temperature for minutes. After the completion of the reaction, sodium boron hydride (172 mg, 4.55 mmol, 1.25 mol eq.) was added to the reaction mixture. Then the obtained mixture was stirred at room temperature for 30 minutes. After the completion of the reaction, the solvent was distilled off under reduced pressure.

The obtained residue was extracted with chloroform. The chloroform layer was washed with a saturated aqueous solution of sodium hydrogencarbonate, water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate and the solvent was distilled off under reduced pressure. The oil thus obtained was purified by column chromatography [silica gel, hexane ethyl acetate (9 1 4 to thereby give a colorless oil 253 (944.0 mg, 83.4 MS m/z: 311, 'H-NMR d: 3.74 (2H, s, CH 3.79 (2H, s, CHg), 3.80 (3H, s, OCH), 6.87 (2H, d, J=8.5Hz, Ar-H), 7.17 (2H, d, J=8.3Hz, Ar-H), 7.25 (2H, d, J=8.3Hz, Ar-H), 7.37 (2H, d, J=8.5Hz, Ar-H).

The dibenzylamine compound 253 (766.5 mg, 2.46 mmol) and triethylamine (0.411 ml, 2.95 mmol, 1.2 mol eq.) were dissolved in chloroform and acryloyl chloride (245 mg, 2.71 mmol, 1.1 mol eq.) dissolved in chloroform was added thereto under ice-cooling. The reaction mixture was stirred at room temperature for 45 minutes. After the completion of the reaction, the reaction mixture was poured into water and extracted with chloroform. The chloroform 153 layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent, the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 254 (749.0 mg, 83.4 MS m/z: 365, H-NMR 8: 3.80 (3H, s, OCH 3 4.48 (2H, d, J=13.4Hz, CH2), 4.60 (2H, d, J=12.4Hz, CH2), 5.76 (1H, dd, J=2.0, 10.2Hz, CH=CH 2 6.49 (1H, dd, 16.8Hz, CH=CH 2 6.65 (1 H, dd, J=10.2, 16.8Hz, CH=CHg), 6.84 (1 H, d, Ar-H), 6.88 (1H, d, J=8.5Hz, Ar-H), 7.07 (1H, d, J=8.3Hz, Ar-H), 7.16 (1H, d, J=8.8Hz, Ar-H), 7.18 (3H, d, J=7.6Hz, Ar-H), 7.27 (1H, d, J=9.5Hz, Ar-

H).

The conjugated ketone compound 254 (612.8 mg, 1.68 mmol) and (+)-1-(1-naphthyl)ethylamine (345 mg, 2.01 mmol, 1.2 mol eq.) were dissolved in chloroform/methanol 1) and allowed to stand at room temperature for 12 days. After the completion of the reaction, the solvent was distilled off under reduced pressure and the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil K-2311 *(668.3 mg, 74.2 MS m/z: 536, 1 H-NMR d: 1.53 (3H, d, J=6.6Hz, CHg), 2.55-2.73 (2H, m, CH_), 2.84-2.96 (2H, m, CHg), 3.79 (3H, d, J=3.2Hz, OCHg), 4.36 (2H, d, J=10.0Hz, CH), 4.54 (2H, d, J=12.9Hz, CHg), 4.70 (1H, q, J=6.6Hz, CH), 6.82 (1H, d, J=8.8Hz, Ar-H), 6.85 (1H, d, J=8.8Hz, Ar-H), 7.02 (1H, d, J=8.5Hz, Ar-H), 7.12 (1H, d, J=8.8Hz, Ar-H), 7.13-7.18 (3H, m, Ar-H), 7.22 (1H, d, J=8.5Hz, Ar-H), 7.45-7.51 (3H, m, Ar-H), 7.70 (1 H, t, J=6.6Hz, Ar-H), 7.74 (1H, d, J=8.3Hz, Ar- 7.86 (1H, d, J=8.1Hz, Ar-H), 8.16 (1H, d, J=8.1Hz, Ar-H).

Example 121: Synthesis of K-2312 4-Hydroxybenzaldehyde (490 mg, 4.01 mmol, 1.1 mol eq.) and 4methoxybenzylamine (0.476 ml, 3.64 mmol) were dissolved in methanol and MgSO 4 (525.8 mg, 4.37 mmol, 1.2 mol eq.) and AcOH (5 drops) were added thereto. Then the obtained mixture was stirred at room temperature for minutes. After the completion of the reaction, sodium boron hydride (172 mg, 4.55 mmol, 1.25 mol eq.) was added to the reaction mixture. Then the obtained -154 mixture was stirred at room temperature for 10 minutes. After the completion of the reaction, the solvent was distilled off under reduced pressure. The obtained residue was extracted with chloroform. The chloroform layer was washed with a saturated aqueous solution of sodium hydrogencarbonate, water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate and the solvent was distilled off under reduced pressure. The oil thus obtained was purified by column chromatography [silica gel, chloroform/methanol] to thereby give a colorless oil 255 (858.9 mg, 97.1 MS m/z: 243, 1 H-NMR 8: 3.69 (2H, s, CH), 3.77 (2H, s, CHg), 3.79 (3H, s, OCH), 6.64 (2H, d, J=8.5Hz, Ar-H), 6.86 (2H, d, J=8.8Hz, Ar-H), 7.09 (2H, d, Ar-H), 7.26 (2H, d, J=8.5Hz, Ar-H).

The dibenzylamine compound 255 (521.4 mg, 2.15 mmol) and triethylamine (0.359 ml, 2.57 mmol, 1.2 mol eq.) were dissolved in chloroform and acryloyl chloride (214 mg, 2.36 mmol, 1.1 mol eq.) dissolved in chloroform was added thereto under ice-cooling. The reaction mixture was stirred at room temperature for 1 hour. After the completion of the reaction, the reaction mixture was poured into water and extracted with chloroform. The chloroform 0 layer was washed with water and a saturated aqueous solution of sodium chloride and dried over sodium sulfate. After distilling off the solvent, the oil thus obtained was purified by column chromatography [silica gel, chloroform] to thereby give a colorless oil 256 (375.5 mg, 58.8 MS m/z: 297, 'H-NMR 8: 3.80 (3H, d, J=6.8Hz, OCH3), 4.44 (2H, d, J=16.1Hz, CH2), 4.56 (2H, d, J=9.0Hz, CHg), 5.76 (1H, dd, J=2.2, 10.2Hz, CH=CHg), 6.48 (1H, ddd, J=2.2, 7.1, 16.6Hz, CH=CH 2 6.64 (1H, ddd, J=3.2, 10.2, 16.6Hz, CH=CH2), 6.79 (1H, d, J=8.5Hz, Ar-H), 6.83 (1H, d, J=8.5Hz, Ar-H), 6.85 (1H, d, J=8.5Hz, Ar-H), 6.89 (1H, d, J=8.5Hz, Ar-H), 6.98 (1H, d, J=8.3Hz, Ar-H), 7.08 (1H, d, J=6.8Hz, Ar-H), 710 (1H, d, J=6.8Hz, Ar-H), 7.19 (1H, d, Ar-H).

The conjugated ketone compound 256 (260.2 mg, 0.88 mmol) and (+)-1-(1-naphthyl)ethylamine (180 mg, 1.05 mmol, 1.2 mol eq.) were dissolved in chloroform/methanol (4 1) and allowed to stand at room temperature for 13 155 days. After the completion of the reaction, the solvent was distilled off under reduced pressure and the oil thus obtained was purified by column chromatography [silica gel, chloroform/methanol] to thereby give a colorless oil K-2312 (177.4 mg, 43.3 MS m/z: 468, 1 H-NMR 6: 1.61 (3H, d, J=6.8Hz, CH 3 2.63-2.71 (1H, m, CH2), 2.81-2.88 (2H, m, CH), 2.95 (1H, d, J=5.4Hz, CH2), 3.78 (3H, d, J=5.4Hz, OCH3), 4.22 (2H, d, J=18.3Hz, CH2), 4.27 (2H, d, J=30.5Hz, CH2), 4.81-4.86 (1H, m, CH), 6.72 (1H, d, J=8.5Hz, Ar-H), 6.74 (1H, d, J=8.5Hz, Ar-H), 6.82 (1H, d, J=8.8Hz, Ar-H), 6.83 (1H, d, J=8.5Hz, Ar-H), 6.85 (1H, d, J=8.5Hz, Ar- 6.98 (1H, d, J=8.8Hz, Ar-H), 7.02 (1H, d, J=8.5Hz, Ar-H), 7.10 (1H, d, Ar-H), 7.45-7.54 (3H, m, Ar-H), 7.77 (2H, d, J=7.6Hz, Ar-H), 7.88 (1H, d, J=8.1Hz, Ar-H), 8.11 (1H, d, J=8.1Hz, Ar-H).

Example 122: Synthesis of K-2280 (N-{5-[(4-methoxyphenyl)thio]pentyl-N- R)-1-(1-naphthyl)ethyl]amine) 4-Methoxythiophenol (753 mg, 5.37 mmol) was dissolved in acetonitrile (10 ml). To the obtained solution were successively added at room temperature potassium carbonate (754 mg, 5.46 mmol) and dibromopentane (0.73 ml, 5.35 mmol) and the reaction mixture was stirred at room temperature for 3 hours. After confirming the completion of the reaction by TLC, potassium carbonate (931 mg, 6.75 mmol) and naphthyl)ethylamine (0.52 ml, 3.22 mmol) were added at the same temperature to the reaction system. Further, the reaction mixture was stirred at °C for 12 hours. After the completion of the reaction, the mixture was cooled by allowing to stand at room temperature and water was added thereto. Next, the reaction mixture was subjected to separatory extraction with chloroform and a saturated aqueous solution of sodium chloride and washed. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 200: 1) to thereby give a pale yellow, syrupy compound K-2280 as a free compound. Subsequently, 5 ml of 10 hydrochloric acid/methanol was poured into the K-2280 obtained above and 156allowed to stand for 3 minutes followed by concentration. The pale yellow crystals thus obtained were subjected to Kiriyama's filtration and the precipitate was washed with diethyl ether. Thus 210 mg (0.55 mmol, yield: 20.6 of K- 2280 hydrochloride was obtained as white crystals.

400MHz-NMR 10.49 (1H, bs), 9.98 (1H, bs), 8.24 (1H, d, J=7.32Hz), 7.98 (1H, d, J=8.56Hz), 7.94 (1H, dd, J=8.04Hz, J=1.48Hz), 7.90 (1H, d, J=8.28Hz), 7.52-7.68 (3H, 7.19-7.23 (2H, 6.73-6.77 (2H, 5.14-5.24 (1H, m), 3.73 (3H, 2.67-2.75 (2H, 2.65 (2H, t, J=7.20Hz), 2.02 (3H, d, J=6.84Hz), 1.91-1.99 (2H, 1.38-1.46 (2H, 1.21-1.35 (2H, m/z=379.

Example 123: Synthesis of K-2281 (N-[(1R)-1-(1-naphthyl)ethyl]-N-{4-[(2,4,5trichlorophenyl)thio]butyl}amine) 2,4,5-Trichlorothiophenol (770 mg, 3.61 mmol) was dissolved in acetonitrile (10 ml). To the obtained solution were successively added at room temperature potassium carbonate (560 mg, 4.05 mmol) and 1,4dibromobutane (0.43 ml, 3.60 mmol) and the reaction mixture was stirred at room temperature for 3 hours. After confirming the completion of the reaction by TLC, potassium carbonate (545 mg, 3.94 mmol) and naphthyl)ethylamine (0.41 ml, 3.94 mmol) were added at the same temperature to the reaction system. Further, the reaction mixture was stirred at 85 °C for 12 hours. After the completion of the reaction, the mixture was cooled by allowing to stand at room temperature and water was added thereto. Next, the reaction mixture was subjected to separatory extraction with chloroform and a saturated aqueous solution of sodium chloride and washed. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated .under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 200: 1) to thereby give a pale yellow, syrupy compound K-2281 as a free compound. Subsequently, 10 ml of 10 hydrochloric acid/methanol was poured into the K-2281 obtained above and allowed to stand for 5 minutes followed by concentration. The pale yellow crystals thus obtained were subjected to Kiriyama's filtration and the precipitate 157 was washed with diethyl ether. Thus 280 mg (0.59 mmol, yield: 15.0 of K- 2281 hydrochloride was obtained as white crystals.

400MHz-NMR 10.64 (1H, bs), 10.07 (1H, bs), 8.26 (1H, dd, J=7.3Hz, J=0.7Hz), 8.01 (1H, d=8.3Hz), 7.90-7.95 (2H, 7.52-7.68 (3H, 7.36 (1H, 7.11 (1H, 5.20-5.26 (1H, 2.76 (2H, t, J=7.0Hz), 2.76-2.82 (2H, 2.87 (3H, d, J=6.8Hz), 1.53-1.63 (2H, m/z=437, 439.

Example 124: Synthesis of K-2282 R)-1-(1-naphthyl)ethyl]-N-{5-[(2,4,5trichlorophenyl)thio]pentyl}amine) 2,4,5-Trichlorothiophenol (1.53 g, 7.15 mmol) was dissolved in acetonitrile (15 ml). To the obtained solution were successively added at room temperature potassium carbonate (1.083 g, 7.84 mmol) and dibromopentane (0.98 ml, 7.19 mmol) and the reaction mixture was stirred at room temperature for 2.5 hours. After confirming the completion of the reaction by TLC, potassium carbonate (1.00 g, 7.25 mmol) and naphthyl)ethylamine (0.69 ml, 4.27 mmol) were added at the same temperature to the reaction system. Further, the reaction mixture was stirred at 85 °C for 12 hours. After the completion of the reaction, the mixture was cooled by allowing to stand at room temperature and water was added thereto. Next, the reaction mixture was subjected to separatory extraction with chloroform and a saturated aqueous solution of sodium chloride and washed. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform: methanol 200: 1) to thereby give a pale yellow, syrupy compound K-2282 as a free compound. Subsequently, 15 ml of 10 hydrochloric acid/methanol was poured into the K-2282 obtained above and allowed to stand for 5 minutes followed by concentration. The pale yellow crystals thus obtained were subjected to Kiriyama's filtration and the precipitate was washed with diethyl ether. Thus 283 mg (0.58 mmol, yield: 13.5 of K- 2282 hydrochloride was obtained as white crystals.

400MHz-NMR 10.55 (1H, bs), 10.03 (1H, bs), 8.25 (1H, d, J=7.3Hz), 8.00 (1H, d, J=8.5Hz), 7.90-7.95 (2H, 7.54-7.68 (3H, 7.37 (1H, 7.16 (1H, s), 158 5.17-5.26 (1H, 2.73-2.82 (4H, 1.97-2.05 (2H, 2.05 (3H, d, J=6.6Hz), 1.52-1.60 (2H, 1.31-1.45 (2H, m/z=451, 453.

Example 125: Synthesis of K-2287 (N-[(1R)-1-(1-naphthyl)ethyl]-N-(4-{[4- (trifluoromethoxy)phenyl)thio]butyl)amine) 4-Trifluoromethoxythiophenol (908 mg, 4.68 mmol) was dissolved in acetonitrile (10 ml). To the obtained solution were successively added at room temperature potassium carbonate (679 mg, 4.91 mmol) and 1,4dibromobutane (0.568 ml, 4.69 mmol) and the reaction mixture was stirred at room temperature for 5 hours. After confirming the completion of the reaction by TLC, potassium carbonate (710 mg, 5.14 mmol) and naphthyl)ethylamine (0.53 ml, 3.28 mmol) were added at the same temperature to the reaction system. Further, the reaction mixture was stirred at °C for 12 hours. After the completion of the reaction, the mixture was cooled by allowing to stand at room temperature and water was added thereto. Next, the reaction mixture was subjected to separatory extraction with chloroform and a saturated aqueous solution of sodium chloride and washed. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform: methanol 200: 1) to thereby give a pale yellow, syrupy compound K-2287 as a free compound. Subsequently, 10 ml of 10 hydrochloric acid/methanol was poured into the K-2287 obtained above and allowed to stand for 5 minutes followed by concentration. The pale yellow crystals thus obtained were subjected to Kiriyama's filtration and the precipitate was washed with hexane. Thus 245 mg (0.54 mmol, yield: 16.5 of K-2287 hydrochloride was obtained as white crystals.

400MHz-NMR 10.58 (1H, bs), 10.07 (1H, bs), 8.25 (1H, d, J=6.8Hz), 8.00 (1H, d, J=8.5Hz), 7.90-7.96 (2H, 7.52-7.67 (3H, 7.15-7.19 (3H, 7.02-7.04 (2H, 5.19-5.24 (1H, 2.73-2.76 (4H, 2.06-2.17 (2H, 2.06 (3H, d, J=6.8Hz), 1.41-1.59 (2H, m/z=419.

Example 126: Synthesis of K-2288 (N-[(1R)-1-(1-naphthyl)ethyl]-N-(5-{[4- (trifluoromethoxy)phenyl)thio]pentyl)amine) 159 4-Trifluoromethoxythiophenol (995 mg, 5.12 mmol) was dissolved in acetonitrile (10 ml). To the obtained solution were successively added at room temperature potassium carbonate (715 mg, 5.17 mmol) and dibromopentane (0.70 ml, 5.14 mmol) and the reaction mixture was stirred at room temperature for 5 hours. After confirming the completion of the reaction by TLC, potassium carbonate (770 mg, 5.57 mmol) and naphthyl)ethylamine (0.58 ml, 3.59 mmol) were added at the same temperature to the reaction system. Further, the reaction mixture was stirred at °C for 12 hours. After the completion of the reaction, the mixture was cooled by allowing to stand at room temperature and water was added thereto. Next, the reaction mixture was subjected to separatory extraction with chloroform and a saturated aqueous solution of sodium chloride and washed. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform: methanol 200 to thereby give a pale yellow, syrupy compound K-2288 as a free compound. Subsequently, 10 ml of 10 hydrochloric acid/methanol was poured into the K-2288 obtained above and allowed to stand for 5 minutes followed by concentration. The pale yellow crystals thus obtained were subjected to Kiriyama's filtration and the precipitate was washed with hexane. Thus 313 mg (0.67 mmol, yield: 18.7 of K-2288 hydrochloride was obtained as white crystals.

400MHz-NMR 10.53 (1H, 10.03 (1H, bs), 8.24-8.26 (1H, 7.99 (1H, d, J=8.3Hz), 7.52-7.67 (3H, 7.19-7.23 (2H, 7.04-7.07 (2H, 5.15-5.25 (1H, 2.76 (2H, t, J=7.2Hz), 2.69-2.78 (2H, 2.03 (3H, d, J=6.8Hz), 1.92- 2.04 (2H, 1.49 (2H, tt, J=7.4Hz, J=7.4Hz), 1.27-1.38 (2H, m/z=433.

Example 127: Synthesis of K-2293 (N-{4-[(4-chlorophenyl)thio]butyl}-N-[(1 R)- 1 -naphthyl)ethyl]amine) 4-Chlorothiophenol (782 mg, 5.41 mmol) was dissolved in acetonitrile ml). To the obtained solution were successively added at room temperature potassium carbonate (850 mg, 6.15 mmol) and 1,4dibromobutane (0.65 ml, 5.44 mmol) and the reaction mixture was stirred at 160 room temperature for 5 hours. After confirming the completion of the reaction by TLC, potassium carbonate (775 mg, 5.61 mmol) and naphthyl)ethylamine (0.62 ml, 3.84 mmol) were added at the same temperature to the reaction system. Further, the reaction mixture was stirred at °C for 24 hours. After the completion of the reaction, the mixture was cooled by allowing to stand at room temperature and water was added thereto. Next, the reaction mixture was subjected to separatory extraction with chloroform and a saturated aqueous solution of sodium chloride and washed. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 200: 1) to thereby give a pale yellow, syrupy compound K-2293 as a free compound. Subsequently, 10 ml of 10 hydrochloric acid/methanol was poured into the K-2293 obtained above and allowed to stand for 5 minutes followed by concentration. The pale yellow crystals thus obtained were subjected to Kiriyama's filtration and the precipitate was washed with diethyl ether. Thus 420 mg (1.03 mmol, yield: 26.9 of K- 2293 hydrochloride was obtained as white crystals.

400MHz-NMR 10.58 (1H, bs), 10.05 (1H, bs), 8.25 (1H, d, J=6.8Hz), 7.99 (1H, d, J=8.3Hz), 7.94 (1H, dd, J=8.0Hz, J=1.2Hz), 7.91 (1H, d, J=8.04Hz), 7.52- 7.67 (3H, 7.12-7.16 (2H, 7.06-7.10 (2H, 5.16-5.25 (1H, 2.70- 2.74 (4H, 2.06-2.15 (2H, 2.05 (3H, d, J=6.6Hz), 1.40-1.57 (2H, m), m/z=369.

Example 128: Synthesis of K-2240 R)-1-(1-naphthyl)ethyl]-N-(3-{[4- (trifluoromethyl) phenyl]thio}propyl)amine) K-2240 hydrochloride was obtained as white crystals by the same method as the one employed for the synthesis of K-2293 but replacing the 4chlorothiophenol and 1,4-dibromobutane respectively by 4trifluoromethylthiophenol and 1,3-dibromopropane. m/z 389.

Example 129: Synthesis of K-2263 (N-{4-[(4-fluorophenyl)thio]butyl}-N-[(1 R)- 1 -naphthyl)ethyl]amine) 161 K-2263 hydrochloride was obtained as white crystals by the same method as the one employed for the synthesis of K-2293 but replacing the 4chlorothiophenol by 4-fluorothiophenol.

400MHz-NMR 10.57 (1H, bs), 10.04 (1H, bs), 8.24 (1H, d, J=7.3Hz), 7.99 (1H, d, J=8.52Hz), 7.90-7.96 (2H, 7.52-7.67 (3H, 7.15-7.20 (2H, 6.86- 6.92 (2H, 5.19-5.22 (1H, 2.67-2.77 (2H, 2.69 (2H, t, J=7.1Hz), 2.05-2.15 (2H, 2.05 (3H, d, J=6.8Hz), 1.36-1.54 (2H, m/z=353.

Example 130: Synthesis of K-2269 (N-{4-[(3-methoxyphenyl)thio]butyl}-N- -naphthyl)ethyl]amine) K-2269 hydrochloride was obtained as white crystals by the same method as the one employed for the synthesis of K-2293 but replacing the 4chlorothiophenol by 3-methoxythiophenol.

400MHz-NMR 10.58 (1H, bs), 10.06 (1H, bs), 8.24-8.26 (1H, 7.99 (1H, d, SJ=8.3Hz), 7.88-7.94 (3H, 7.53-7.67 (3H, 7.08 (1H, dd, J=8.3Hz, J=8.3Hz), 6.71-6.74 (2H, 6.64 (1H, ddd, J=8.3Hz, J=2.4Hz, J=1.OHz), 5.15-5.25 (1H, 2.70-2.79 (2H, 2.75 (2H, t, J=7.2Hz), 2.07-2.16 (2H, m), 2.05 (3H, d, J=6.8Hz), 1.43-1.60 (2H, m/z=365.

Example 131: Synthesis of K-2271 (N-{[4-(5-ethoxy-1,3-benzothiazol-2yl)thio]butyl-N-[(1 R)-1-(1-naphthyl)ethyl]amine) K-2271 hydrochloride was obtained as white crystals by the same method as the one employed for the synthesis of K-2293 but replacing the 4chlorothiophenol by 6-ethoxy-2-mercaptobenzothiazole.

400MHz-NMR 10.56 (1H, bs), 10.04 (1H, bs), 8.29 (1H, d, J=7.0Hz), 8.02 (1H, d, J=8.5Hz), 7.87-7.92 (2H, 7.52-7.70 (4H, 7.13 (1H, d, J=2.2Hz), 6.96 (1H, dd, J=8.8Hz, J=2.2Hz), 5.20-5.28 (1H, 4.02 (2H, dd, J=13.9Hz, J=7.1Hz), 3.27 (2H, dd, J=7.1Hz, J=7.1Hz), 2.20-2.60 (4H, 2.12-2.23 (2H, 2.06 (3H, d, J=6.6Hz), 1.76-1.87 (2H, 1.42 (3H, t, J=6.8Hz), m/z=436.

Example 132: Synthesis of K-2279 (N-{[5-(3-methoxyphenyl)thio]pentyl}-N- R)-1 -naphthyl)ethyl]amine) K-2279 hydrochloride was obtained as white crystals by the same method as the one employed for the synthesis of K-2293 but replacing the 4- 162 ch loroth io phenol and 1 ,4-dibromobutane respectively by 3-methoxythiophenol and 1 400MHz-NMR 10.51 (1 H, bs), 9.99 (1 H, bs), 8.24 (1 H, d, J=7.1lHz), 7.89-7.99 (3H, in), 7.54-7.67 (3H, in), 7.10 (1 H, dd, J=7.9Hz, J=7.9Hz), 6.75-6.79 (2H, in), 6.61 -6.65 (1 H, ddd, J=8.OHz, J=2.4Hz, J=0.7Hz), 5.14-5.24 (1 H, in), 3.72 (3H, 2.68-2.79 in), 2.03 (3H, d, J=6.8Hz), 1.93-1.99 (2H, in), 1.47-1 .54 (2H, in), 1.24-1.38 (2H, in), m/z=379.

Example 133: Synthesis of K-2284 R)-1 -naphthyl) ethyl] f{[2,3,5,6-tetrafluoro-4- (trifluoroinethyl) phenyl]thiolpentyl)amine) K-2284 hydrochloride was obtained as white crystals by the same method as the one employed for the synthesis of K-2293 but replacing the 4chiorothiophenol and 1 ,4-dibromobutane respectively by 2,3,5,6-tetrafluoro-4trifluoromethyithiophenol and 1 ~.:~:400MHz-NMR 10.54 (1 H, bs), 10.43 (1 H, bs), 8.24 (1 H, d, J=6.6Hz), 7.99 (1 H, d, J=8.3Hz), 7.90-7.96 (2H, in), 7.55-7.67 (3H, in), 5.15-5.25 (1 H, Ibs), 2.91 (2H, t, J=7.2Hz), 2.70-2.80 (2H, in), 2.04 (3H, d, J=6.6Hz), 1.93-2.02 (2H, in), 1.48 (2H, tt, J=7.4Hz, J=7.4Hz), 1.26-1.41 (2H, in), m/z=489.

Example 134: Synthesis of K-2286 (N-{6-[(4-chlorophenyl)thio]hexyl}-N-[(1

R)-

1 -naphthyl)ethyl]ainine) K-2286 hydrochloride was obtained as white crystals by the same method as the one employed for the synthesis of K-2293 but replacing the 1 ,4-dibromobutane by 1 ,6-dibromohexane. inlz 397.

Example 135: Synthesis of K-2292 R)-1 -naphthyl)ethyl]-N-(7- [2,3,5,6-tetrafluoro-4-(trifluoromethyl) phenyl]thiolheptyl)ainine) K-2292 hydrochloride was obtained as white crystals by the same method as the one employed for the synthesis of K-2293 but replacing the 4chlorothiophenol and 1 ,4-dibroinobutane respectively by 2,3,5,6-tetrafluoro-4trifluorometylthiophenol and 1 ,7-dibroinopentane.

400MHz-NMR 10.48 (1 H, bs), 9.98 (1 H, bs), 8.26 (1 H, d, J=6.8Hz), 8.00 (1 H, d, J=8.3Hz), 7.94 (1 H, d, J=7.3Hz), 7.91 (1 H, dl, J=8.OHZ), 7.54-7.68 (3H, in), 5.21 163 (1 H, bs), 2.92 (2H, t, J=7.3Hz), 2.74 (2H, bs), 2.05 d, J=5.1 Hz), 1.97 (2H, bs), 1.42-1.50 (2H, in), 1.23-1.38 in), 1. 17 (4H, bs), m/z=517.

Example 136: Synthesis of K-2295 K-2295 hydrochloride was obtained as white crystals by the same method as the one employed for the synthesis of K-2293 but replacing the 4chlorothiophenol and 1 ,4-dibromobutane respectively by 2,4,5trichlorothiophenol and 1 -bromo-2-chloroethane.

400MHz-NMR 10.94 (1 H, bs), 10.31 (1 H, bs), 8.17 (1 H, d, J=6.6Hz), 7.88-7.96 (3H, in), 7.55-7.65 (3H, in), 7.42 (1 H, 7.29 (1 H, 5.20-5.28 (1 H, in), 3.47-3.59 (2H, in), 2.92-3.07 in), 2.03 (3H, d, J=6.6Hz), m/z=409.

Example 137: Synthesis of K-2296 (N-{[5-(2,5-dichlorophenyl)thio] pentyl}-N- R)-1 -naphthyl)ethyl]amine) K-2296 hydrochloride was obtained as white crystals by the same method as the one employed for the synthesis of K-2293 but replacing the 4chlorothiophenol and 1 ,4-dibromobutane respectively by dichlorothiophenol and 1 400MHz-NMR 10.63 (1 H, bs), 10.08 (1 H, bs), 8.26 (1 H, d, J=6.8Hz), 8.01 (1 H, d, =8.5Hz), 7.90-7.94 (2H, in), 7.52-7.68 (3H, in), 7.18 (1 H, d, J=8.3Hz), 6.98- 7.02 (2H, in), 5.18-5.28 (1 H, in), 2.75-2.84 (2H, in), 2.77 (2H, t, J=7.2Hz), 2.12-2.20 (2H, in), 2.07 (3H, d, J=6.6Hz), 1.56-1.67 (4H, mn), m/z=417.

Example 138: Synthesis of K-2297 R)-1 -naphthyl) ethyl] -N {[2,3,5,6-tetraflIuoro-4- (trifl uo roimethyl) p h enyl]th io}b utyl) am in e) K-2297 hydrochloride was obtained as white crystals by the same method as the one employed for the synthesis of K-2293 but replacing the 4- :chlorothiophenol by 2,3,5,6-tetrafluoro-4-trifluoroinethylthiophenol.

400MHz-NMR 10.59 (1 H, bs), 10.08 (1 H, 8.23 (1 H, d, J=6.6Hz), 8.00 (1 H, d, J=8.3Hz), 7.94 (1 H, dd, J=8.OHZ, J=1.2Hz), 7.55-7.67 (3H, in), 5.18-5.23 (1 H, in), 2.89 (2H, t, J=7.3Hz), 2.70-2.82 (2H, in), 2.04-2.13 (2H, in), 2.05 (3H, d, J=6.6Hz), 1.47-1.60 (2H, in), m/z=475.

Example 139: Synthesis of K-2298 (N-{4-[(2,5-dichlorophenyi)thio]butyl}-N- R)-1 -naphthyl)ethyl]amine) 1 64 K-2298 hydrochloride was obtained as white crystals by the same method as the one employed for the synthesis of K-2293 but replacing the 4chlorothiophenol by 400MHz-NMR 10.64 (1 H, bs), 10.09 (1 H, bs), 8.26 (1 H, d, J=6.6Hz), 8.01 (1 H, d, J=8.3Hz), 7.89-7.94 (2H, in), 7.52-7.68 (3H, in), 7.18 (1 H, d, J=8.3Hz), 7.01 (1 H, dd, J=6.6Hz, J=2.4Hz), 5.18-5.28 (1 H, in), 2.73-2.85 (2H, in), 2.76 (2H, t, J=7.2Hz), 2.16 (2H, tt, J=7.2Hz, J=7.2Hz), 2.07 (3H, d, J=6.8Hz), 1.52-1.68 (2H, in), mlz=403.

Example 140: Synthesis of K-2301 (N-II(1 R)-1 -nap hthyl) ethyl] -N (trifluoromethoxy) phenyl]thiolhexyl)amine) K-2301 hydrochloride was obtained as white crystals by the same method as the one employed for the synthesis of K-2293 but replacing the 4chlorothiophenol and 1 ,4-dibromobutane respectively by 4trifluoromethoxythiophenol and 1 ,6-dibromohexane.

::400MHz-NMR 10.53 (1 H, bs), 10.00 (1 H, bs), 8.27 (1 H, d, J=7.3Hz), 8.00 (1 H, d, J=8.3Hz), 7.89-7.95 (2H, in), 7.52-7.68 (3H, in), 7.21 -7.24 (2H, in), 7.05-7.08 (2H, in), 5.21 (1 H, bs), 2.70-2.78 (2H, in), 2.76 (2H, t, J=7.3Hz), 2.06 (3H, d, J=6.6Hz), 1.92-2.02 (2H, in), 1.46-1.54 (2H, in), 1. 17-1.35 (4H, in), m/z=447.

Example 141: Synthesis of K-2302 (N-{4-[(2,4-diiethylphenyl)thio]butyl}-N- [1 R)-1 -naphthyl) ethyl] amine) K-2302 hydrochloride was obtained as white crystals by the same OV, method as the one employed for the synthesis of K-2293 but replacing the 4chlorothiophenol by 2,4-dimethylthiophenol.

400MHz-NMR 10.60 (1 H, bs), 10.05 (1 H, bs), 8.25 (1 H, d, J=7.3Hz), 7.99 (1 H, d, J=8.6Hz), 7.93 (1 H, d, J=7.84Hz), 7.89 (1 H, d, J=8.3Hz), 7.51 -7.66 (3H, in), 7.00 (1 H, d, J=7.8Hz), 6.90 (1 H, 6.83 (1 H, d, J=7.8Hz), 5.15-5.24 (1 H, in), 2.70-2.78 (2H, in), 2.66 (2H, t, J=7.2Hz), 2.22 (6H, 2.07-2.13 (2H, in), 2.05 (3H, d, J=6.8Hz), 1.40-1.55 (2H, in), mlz=363.

Example 142: Synthesis of K-2303 (N-{5-[(2,4-diinethylphenyl)thiolpeltyl}-N- R)-1 -naphthyl)ethyllamine) 165 K-2303 hydrochloride was obtained as white crystals by the same method as the one employed for the synthesis of K-2293 but replacing the 4chiorothiophenol and 1 ,4-dibromobutane respectively by 2,4dimethylthiophenol and 1 400MHz-NMR 10.51 (1 H, bs), 10.00 (1 H, bs), 8.25 (1 H, d, J=7.1 Hz), 7.98 (1 H, d, J=8.3Hz), 7.94 (1 H, dd, J=7.8Hz, J=1 .2Hz), 7.90 (1 H, d, J=8.3Hz), 7.53-7.67 in), 7.05 (1 H, d, J=7.8Hz), 6.90 (1 H, 6.85 (1 H, d, J=7.8Hz), 5.14-5.23 (1 H, in), 2.67-2.78 in), 2.67 t, J=7.3Hz), 2.24 2.21 s), 2.02 d, J=6.6Hz), 1.92-2.01 in), 1.43-1.51 in), 1.27-1.34 in), mlz=3 77.

Example 143: Synthesis of K-2304 (N-{4-[(4-methylphenyl)thio]butyl}-N-[(1 R)- 1 -naphthyl)ethyl]amine) K-2304 hydrochloride was obtained as white crystals by the same method as the one employed for the synthesis of K-2293 but replacing the 4- *::chlorothiophenol by 4-methylthiophenol.

*.400MHz-NMR 10.55 (1 H, bs), 10.03 (1 H, bs), 8.25 (1 H, d, J=7.1lHz), 7.99 (1 H, :4 J=8.5Hz), 7.93-7.95 (1 H, in), 7.89 (1 H, d, J=8.OHz), 7.06-7.86 in), *6.96-6.99 in), 5.18-5.22 (1 H, in), 2.68-2.77 in), 2.69 t, J=7.2Hz), 2.25 2.04-2.14 in), 2.04 d, J=6.6Hz), 1.37-1.55 in), in/z=349.

boo.* Example 144: Synthesis of K-2305 (N-{5-[(4-methylphenyl)thiolpentyl}-N- R)-1 -naphthyl)ethyl]ainine) K-2305 hydrochloride was obtained as white crystals by the same method as the one employed for the synthesis of K-2293 but replacing the 4chlorothiophenol and 1 ,4-dibroinobutane respectively by 4-methylthiophenol and 1 400MHz-NMR 10.50 (1 H, bs), 9.99 (1 H, bs), 8.25 (1 H, d, J=7.1 Hz), 7.98 (1 H, d, J=8.3Hz), 7.94 (1 H, dd, J=7.8Hz, J=1.2Hz), 7.89 (1 H, d, J=8.3Hz), 7.52-7.66 in), 7.11-7.13 in), 6.98-7.00 in), 5.18 (1 H, bs), 2.68-2.73 in), 2.71 t, J=7.2Hz), 2.24 2.02 d, J=6.6Hz), 1.91-1.99 in), 1.42-1.50 (2H, in), 1.26-1.34 in), in/z=363.

166 Example 145: Synthesis of K-2275 K-2305 hydrochloride was obtained as white crystals by the same method as the one employed for the synthesis of K-2293 but replacing the 4chlorothiophenol and 1,4-dibromobutane respectively by 3trifluoromethylthiophenol and 1-bromo-2-chloroethane.

400MHz-NMR 10.88 (1H, bs), 10.25 (1H, bs), 8.16 (1H, d, J=6.6Hz), 7.87-7.95 (3H, 7.52-7.65 (3H, 7.40 (1H, bs), 7.31-7.34 (2H, 7.21-7.26 (1H, m), 5.18-5.28 (1H, 3.53 (2H, t, J=7.7Hz), 2.91-3.06 (2H, 2.01 (3H, d, J=6.84Hz), m/z=375.

Example 146: Synthesis of K-2314 K-2314 hydrochloride was obtained as white crystals by the same method as the one employed for the synthesis of K-2293 but replacing the 4chlorothiophenol by 4-methoxythiophenol.

400MHz-NMR 10.55 (1H, bs), 10.03 (1H, bs), 8.25 (1H, d, J=7.4Hz), 7.99 (1H, d, J=8.5Hz), 7.89-7.95 (2H, 7.52-7.68 (3H, 7.15-7.18 (2H, 6.71-6.75 (2H, 5.18-5.22 (1H, 3.74 (3H, 2.67-2.76 (2H, 2.64 (2H, t, J=7.1Hz), 2.03-2.15 (2H, 2.05 (2H, d, J=6.8Hz), 1.32-1.50 (2H, m), *000 m/z=365.

Example 147: Synthesis of K-2008 °K-2008 hydrochloride was obtained as white crystals by the same method as the one employed for the synthesis of K-2293 but replacing the 4chlorothiophenol, 1,4-dibromobutane and (R)-(+)-1-(1-naphthyl)ethylamine respectively by 3-trifluoromethylthiophenol, 1 -bromo-2-chloroethane and (+)-3-methoxy-a-methylbenzylamine. m/z 355.

Example 148: Synthesis of S-1 (580 mg, 4.20 mmol) was dissolved in acetonitrile (6 ml). To the obtained solution were successively added at room temperature potassium carbonate (785 mg, 5.68 mmol) and 1-bromo-2chloroethane (0.35 ml, 4.21 mmol) and the reaction mixture was stirred at room temperature for 2.5 hours. After confirming the completion of the reaction by TLC, potassium carbonate (730 mg, 5.28 mmol) and (R)-(+)-3-methoxy-a- 167 benzylmethylamine (500 mg, 3.30 mmol) were added at the same temperature to the reaction system. Further, the reaction mixture was stirred at 90 °C for 24 hours. After the completion of the reaction, the mixture was cooled by allowing to stand at room temperature and water was added thereto. Next, the reaction mixture was subjected to separatory extraction with chloroform and a saturated aqueous solution of sodium chloride and washed. The organic layer thus obtained was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The organic residue was purified by silica gel column chromatography (chloroform methanol 200: 1) to thereby give a pale yellow, syrupy compound S-1 (332 mg, 1.05 mmol, yield: 31.8 500MHz- H-NMR 7.30 (1 H, d, J=8.0Hz), 7.21 (1 H, dd, J=8.0Hz, J=8.0Hz), 7.06 (1H, 6.86-6.90 (3H, 6.75-6.78 (1H, 3.80 (3H, 3.74 (1H, q, 2.95-3.03 (2H, 2.68-2.77 (2H, 2.32 (3H, 2.27 (3H, 1.34 (3H, d, J=6.5Hz), m/z=315.

Example 149: Synthesis of S-2 S-2 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 1 -bromo-2-chloroethane by 1,3dibromopropane.

500MHz-'H-NMR 7.22 (1H, dd, J=8.0Hz, J=8.0Hz), 7.06 (1H, 7.02 (1H, d, 6.86-6.88 (3H, 6.76-6.78 (1 H, 3.80 (3H, 3.72 (1H, q, J=6.5Hz), 2.85-2.96 (2H, 2.53-2.66 (2H, 2.29 (3H, 2.28 (3H, s), 1.74-1.82 (2H, 1.33 (3H, d, J=6.5Hz), m/z=329.

Example 150: Synthesis of S-3 S-3 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 1 -bromo-2-chloroethane by 1,4dibromobutane.

500MHz-'H-NMR 7.22 (1H, dd, J=8.3Hz, J=8.3Hz), 7.04 (1H, 7.03 (1H, d, 6.85-6.89 (3H, 6.75-6.78 (1H, 3.80 (3H, 3.71 (1H, q, J=6.8Hz), 2.85 (2H, t, J=7.3Hz), 2.42-2.55 (2H, 2.30 (3H, 2.29 (3H, s), 1.56-1.70 (4H, 1.33 (3H, d, J=6.8Hz), m/z=343.

168 Example 151: Synthesis of S-4 S-4 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 1-bromo-2-chloroethane by dibromopentane.

500MHz-'H-NMR 7.23 (1H, dd, J=8.3Hz, J=8.3Hz), 7.05 (1H, 7.03 (1H, d, 6.87-6.88 (3H, 6.76-6.78 (1H, 3.81 (3H, 3.72 (1H, q, 2.85 (1 H, t, J=7.5Hz), 2.40-2.51 (2H, 2.31 (3H, 2.30 (3H, s), 1.61-1.67 (2H, 1.42-1.51 (4H, 1.34 (3H, d, J=6.5Hz), m/z=357.

Example 152: Synthesis of was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 1 -bromo-2-chloroethane by 1,6dibromohexane.

500MHz- 1 H-NMR 7.23 (1H, dd, J=8.0Hz, J=8.0Hz), 7.05 (1H, 7.03 (1H, d, J=8.0Hz), 6.86-6.89 (3H, 6.76-6.78 (3H, 3.81 (3H, 3.72 (1H, q, J=7.0Hz), 2.85 (2H, t, J=7.3Hz), 2.39-2.52 (2H, 2.31 (3H, 2.30 (3H, s), 1.61-1.67 (2H, 1.39-1.50 1.34 (3H, d, J=7.0Hz), 1.29-1.34 (2H, m), m/z=371.

Example 153: Synthesis of S-6 S-6 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 1-bromo-2-chloroethane by 1,7dibromoheptane.

500MHz-H-NMR 7.22 (1H, dd, J=8.0Hz, J=8.0Hz), 7.05 (1H, 7.03 (1H, d, 6.80-6.86 (3H, 6.75-6.78 (1H, 3.81 (3H, 3.72 (1H, q, J=6.8Hz), 2.85 (2H, t, J=7.5Hz), 2.38-2.51 (2H, 2.31 (3H, 2.29 (3H, s), 1.60-1.66 (2H, 1.37-1.48 (4H, 1.34 (3H, d, J=6.8Hz), 1.27-1.30 (4H, m), m/z=385.

Example 154: Synthesis of S-7 S-7 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 1 -bromo-2-chloroethane by 1,8dibromooctane.

169 500MHz-' H-NMR 7.23 (1 H, dd, J=8.3Hz, J=8.3Hz), 7.06 (1 H, 7.03 (1 H, d, J=8.OHz), 6.87-6.89 in), 6.75-6.78 (1 H, in), 3.81 3.72 (1 H, q, 2.86 t, J=7.5Hz), 2.39-2.51 in), 2.31 2.30 s), 1.61-1.67 in), 1.38-1.47 (4H, in), 1 .34 d, J=6.5Hz), 1.23-1.31 mn), mlz=3 99.

Example 155: Synthesis of S-8 S-8 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the (R)-(+)-3-methoxy-abenzylmethylamine by -naphthyl)ethylamine.

500MHz- 1 H-NMR 8.16 (1 H, d, J=8.8Hz), 7.83-7.87 (1 H, in), 7.74 (1 H, d, J=8.OHz), 7.64 (1 H, d, J=7.1 Hz), 7.42-7.51 in), 7.05 (1 H, 7.03 (1 H, d, J=8.OHz), 6.88 (1 H, d, J=7.8Hz), 4.63 (1 H, q, J=6.6Hz) 3.05 t, J=6.6Hz), 2.77-2.87 in), 2.32 2.24 1.49 d, J=6.6Hz), m/z=335.

Example 156: Synthesis of S-9 S-9 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 1 -bromo-2-chloroethane and 3-methoxy-cx-benzylmethylamine respectively by 1 ,3-dibromopropane and -naphthyl)ethylainine.

500MHz- 1 H-NMR 8.18 (1 H, d, J=8.3Hz), 7.83-7.88 (1 H, in), 7.74 (1 H, d, J=8.3Hz), 7.64 (1 H, d, J=6.8Hz), 7.44-7.52 in), 7.25 (1 H, 7.06 (1 H, s), 7.02 (1 H, d, J=7.7Hz), 6.87 (1 H, d, J=7.7Hz), 4.62 (1 H, q, J=6.6Hz), 2.87-3.00 in), 2.64-2.77 in), 2.28 2.27 1.81-1.88 in), 1.49 d, J=6.6Hz), in/z=349.

:Example 157: Synthesis of S-1 0 3-1 0 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 1 -broino-2-chloroethane and 3-inethoxy-ci-benzylinethylamine respectively by 1 ,4-dibroinobutane and -naphthyl)ethylainine.

500MHz- 1 H-NMR 8.17 (1 H, d, J=8.3Hz), 7.85-7.88 (1 H, in), 7.74 (1 H, d, J=8.OHz), 7.66 (1 H, d, J=6.8Hz), 7.03 (1 H, 7.01 (1 H, d, J=7.8Hz), 6.86-6.89 170 (1 H, in), 4.64 (1 H, q, J=6.2Hz), 2.85 t, J=6.8Hz), 2.55-2.65 in), 2.30 2.28 1.65-1.70 in), 1.50 d, J=6.2Hz), mlz=363.

Example 158: Synthesis of S-il1 S-1 1 was synthesized by almost the same method as the one employed for the synthesis of S-i but replacing the 1 -broino-2-chloroethane and 3-methoxy-c±-benzylinethylamine respectively by 1 ,5-dibroinopentane and -naphthyl)ethylamine.

500MHz-1 H-NMR 8.45 (1 H, d, J=8.0Hz), 8.17 (1 H, d, J=8.3Hz), 7.85-7.88 (1 H, in), 7.74 d, J=8.3Hz), 7.64 (1iH, d, J=7.1 Hz), 7.42-7.52 in), 7.01 -7.04 in), 6.87 (1 H, q, J=7.6Hz), 4.62 (1 H, q, J=6.5Hz), 2.85 t, J=7.3Hz), 2.51 -2.63 in), 3.00 2.29 1.61 -1 .68 in), 1.44-1.57 (4H-, in), 1 .49 d, J=6.5Hz), in/z=377.

Example 159: Synthesis of S-1 2 :S-1 2 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 1 -broino-2-chloroethane and 3-inethoxy-a-benzylmethylainine respectively by 1 ,6-dibromohexane and -naphthyl)ethylainine.

500MHz- 1 H-NMR 8.17 (1 H, d, J=8.3Hz), 7.73 (1 H, d, J=8.OHz), 7.64 (1 H, d, J=7.1 Hz), 7.40-7.52 in), 6.06-6.98 in), 6.87 (1 H, d, J=7.6Hz), 4.62 (1 H, q, J=6.6Hz), 2.84 t, J=7.3Hz), 2.49-2.63 in), 2.30 2.29 1.59-1.67 in), 1.46-1.55 in), 1.49 d, J=6.6Hz), 1.27-1 .46 in), in/z=391.

Example 160: Synthesis of S-13 frS-1 3 was synthesized by almost the same method as the one employed *fo the synthesis of S-1 but replacing the 1 -broino-2-chloroethane and 3-methoxy-a-benzylmethylaine respectively by 1 ,7-dibroinoheptane and -naphthyl)ethylainine.

500MHz-1 H-NMR 8.17 (1 H, d, J=8.3Hz), 7.85-7.88 (1 H, in), 7.74 (1 H, d, J=8.3Hz), 7.68 (1 H, d, J=7.1 Hz), 7.41 -7.53 in), 7.04 (1 H, 7.02 (1 H, d, J=7.6Hz), 6.87 (1 H, d, J=7.6Hz), 4.66 (1 H, q, J=6.5Hz), 2.84 t, J=7.3Hz), 171 2.30 2.29 1.58-1.66 in), 1.53 d, J=6.5Hz), 1.34-1.44 in), 1.26-1.30 in), mlz=405.

Example 161: Synthesis of S-1 4 S-1 4 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 1 -bromo-2-chloroethane and 3-methoxy-ct-benzylmethylamine respectively by 1 ,8-dibromooctane and -naphthyl)ethylamine. m/z 419.

Example 162: Synthesis of S-1 5 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 1 -bromo-2-chloroethane and 3-methoxy-cz-benzylmethylamine respectively by 1, 1 0-dibromodecane and -naphthyl)ethylamine.

**400MHz- 1 H-NMR 8.18 (1 H, d, J=8.6Hz), 7.83-7.88 (1 H, in), 7.73 (1 H, d, J=8.3Hz), 7.65 (1 H, d, J=6.8Hz), 7.40-7.52 mn), 7.06 (1 H, 7.03 (1 H, d, 6.87 (1 H, d, J=7.6Hz), 4.63 (1 H, q, J=6.5Hz), 2.86 (2H, t, J=7.3HZ), 2.50-2.62 in), 2.31 2.30 1.60-1.70 in), 1.49 d, 1.20-1.50 (14H, mn), in/z=447.

Example 163: Synthesis of S-16 S-1 6 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 1 -bromo-2-chloroethane and 3-inethoxy-a-benzylinethylamine respectively by 1, 1 2-dibromododecane and -naphthyl)ethylamine.

400MHz- 1 H-NMR 8.17 (1 H, d, J=8.3Hz), 7.85-7.88 (1 H, in), 7.74 (1 H, d, 7.65 (1 H, d, J=7.1lHz), 7.46-7.53 in), 7.06 (1 H, 7.03 (1 H, d, J=7.8Hz), 6.87 (1 H, d, J=7.8Hz), 4.63 (1 H, q, J=6.6Hz), 2.87.(2H, t, J=7.4Hz), 2.50-2.63 in), 2.31 2.30 1.61 -1 .69 in), 1.15-1.55 (18H, in), 1.50 d, J=6.6Hz), in/z=475.

Example 164: Synthesis of S-1 7 S-1 7 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol by 2,4diinethylthiophenol.

172 400MHz-'H-NMR 7.21 (1 H, dd, J=8.0Hz, J=8.0Hz), 7.14 (1 H, d, J=8.0Hz), 6.98 (1H, 6.90-6.92 (1H, 6.85-6.88 (2H, 6.75-6.81 (1H, 3.80 (3H, s), 3.72 (1H, q, J=6.6Hz), 2.93-2.97 (2H, 2.62-2.74 (2H, 2.34 (3H, 2.27 (3H, 1.33 (3H, d, J=6.6Hz), m/z=315.

Example 165: Synthesis of S-18 S-18 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1bromo-2-chloroethane respectively by 2,4-dimethylthiophenol and 1,3dibromopropane.

400MHz- 1 H-NMR 7.22 (1 H, dd, J=8.1 Hz, J=8.1 Hz), 7.16 (1 H, d, J=7.8Hz), 6.98 (1H, 6.92-6.95 (1H, 6.86-6.88 (2H, 6.75-6.79 (1H, 3.80 (3H, s), 3.71 (1H, q, J=6.6Hz), 2.80-2.93 (2H, 2.51-2.65 (2H, 2.32 (3H, 2.28 (3H, 1.70-1.81 (2H, 1.32 (3H, d, J=6.6Hz), m/z=329.

Example 166: Synthesis of S-19 S-19 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1bromo-2-chloroethane respectively by 2,4-dimethylthiophenol and 1,4dibromobutane.

400MHz-'H-NMR 7.23 (1H, dd, J=8.3Hz, J=8.3Hz), 7.16 (1H, d, J=7.8Hz), 6.98 (1H, slike), 6.93-6.95 (1H, 6.86-6.88 (2H, 6.75-6.79 (1H, 3.80 (3H, 3.71 (1H, q, J=6.6Hz), 2.81 (2H, t, J=6.9Hz), 2.40-2.54 (2H, 2.33 (3H, s), 2.28 (3H, 1.53-1.66 (4H, 1.33 (3H, d, J=6.6Hz), m/z=343.

Example 167: Synthesis of S-20 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1bromo-2-chloroethane respectively by 2,4-dimethylthiophenol and dibromopentane.

400MHz- H-NMR 7.23 (1 H, dd, J=8.0Hz, J=8.0Hz), 7.16 (1H, d, J=7.8Hz), 6.98 (1H, 6.95 (1H, d, J=8.0Hz), 6.66-6.89 (2H, 6.70-6.79 (1H, 3.81 (3H, 3.71 (1 H, q, J=6.6Hz), 2.81 (2H, t, J=7.3Hz), 2.38-2.52 (2H, 2.33 (3H, s), 173- 2.28 (3H, 1.56-1.64 (2H, 1.35-1.50 (4H, 1.34 (3H, d, J=6.6Hz), m/z=357.

Example 168: Synthesis of S-21 S-21 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1bromo-2-chloroethane respectively by 2,4-dimethylthiophenol and 1,6dibromohexane.

400MHz-'H-NMR 7.23 (1H, dd, J=8.0Hz, J=8.0Hz), 7.16 (1H, d, J=7.8Hz), 6.98 (1H, 6.93-6.96 (1H, 6.87-6.90 (2H, 6.75-6.79 (1H, 3.81 (3H, s), 3.72 (1H, q, J=6.6Hz), 2.81 (2H, t, J=7.3Hz), 2.38-2.51 (2H, 2.34 (3H, s), 2.28 (3H, 1.56-1.64 (2H, 1.24-1.50 (6H, 1.34 (2H, d, J=6.6Hz), m/z=371.

Example 169: Synthesis of S-22 S-22 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1bromo-2-chloroethane respectively by 2,4-dimethylthiophenol and 1,7dibromoheptane.

400MHz-'H-NMR 7.23 (1H, dd, J=8.0Hz, J=8.0Hz), 7.16 (1H, d, J=7.8Hz), 6.99 (1H, 6.93-6.96 (1H, 6.87-6.90 (2H, 6.73-6.79 (1H, 3.81 (3H, s), 3.72 (1H, q, J=6.6Hz), 2.81 (2H, t, J=7.4Hz), 2.37-2.51 (2H, 2.34 (3H, s), 2.28 (3H, 1.56-1.64 (2H, 1.24-1.46 (8H, 1.34 (3H, d, J=6.6Hz), m/z=385.

Example 170: Synthesis of S-23 S-23 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1bromo-2-chloroethane respectively by 2,4-dimethylthiophenol and 1,8dibromooctane.

400MHz-'H-NMR 7.23 (1H, dd, J=8.3Hz, J=8.3Hz), 7.17 (1H, d, J=8.0Hz), 6.99 (1H, 6.95 (1H, d, J=8.0Hz), 6.87-6.89 (1H, 6.75-6.79 (1H, 3.81 (3H, 3.72 (1H, q, J=6.6Hz), 2.82 (2H, t, J=7.4Hz), 2.38-2.52 (2H, 2.34 (3H, s), 174 2.28 (3H, 1.55-1.64 (2H, 1.20-1.50 (10H, 1.34 (3H, d, J=6.6Hz), m/z=399.

Example 171: Synthesis of S-24 S-24 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 3-methoxy-a-benzylmethylamine respectively by 2,4-dimethylthiophenol and -naphthyl)ethylamine.

400MHz- 1 H-NMR 8.15 (1H, d, J=8.16Hz), 7.83-7.90 (1H, 7.72 (1H, d, 7.63 (1H, d, J=7.3Hz), 7.42-7.52 (3H, 7.14 (1H, d, J=7.8Hz), 6.98 (1H, 6.87-6.90 (1H, 4.61 (1H, q, J=6.5Hz), 3.02 (2H, t, J=8.7Hz), 2.73- 2.81 (2H, 2.34 (3H, 2.27 (3H, 1.48 (3H, d, J=6.5Hz), m/z=335.

Example 172: Synthesis of was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 -bromo-2chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 2,4-dimethylthiophenol, 1,3-dibromopropane and naphthyl)ethylamine. m/z 349.

Example 173: Synthesis of S-26 S-26 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 -bromo-2chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 2,4-dimethylthiophenol, 1,6-dibromohexane and naphthyl)ethylamine.

*400MHz-'H-NMR 8.15 (1H, d, J=8.31Hz), 7.85-7.87 (1H, 7.23 (1H, d, J=8.3Hz), 7.64 (1H, d, J=7.1Hz), 7.15 (1H, d, J=7.8Hz), 6.98 (1H, 6.93-6.95 (1H, 4.62 (1H, q, J=6.6Hz), 2.80 (2H, t, J=7.3Hz), 2.48-2.62 (2H, 2.35 (3H, 2.27 (3H, 1.57-1.63 (2H, 1.43-1.53 (2H, 1.25-1.44 (4H, m), 1.49 (3H, d, J=6.6Hz), m/z=391.

Example 174: Synthesis of S-27 S-27 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 -bromo-2- 175 chioroethane and (+)-3-methoxy-a-benzylmethylamine respectively by 2,4-dimethylthiophenol, 1 ,7-dibromoheptane and naphthyl)ethylamine.

400MHz- 1 H-NMR 8.15 (1 H, d, J=8.3Hz), 7.87 (1 H, d, J=6.OHz), 7.68-7.78 (2H, in), 7.45-7.55 (3H, in), 7.15 (1 H, d, J=7.8Hz), 6.98 (1 H, 6.94 (1 H, d, J=7.8Hz), 4.69 (1 H, q, J=6.6Hz), 2.79 t, J=7.3Hz), 2.50-2.63 (2H, in), 2.33 (3H, 2.27 (3H, 1.14-1.62 (13H, in), m/z=405.

Example 175: Synthesis of S-28 S-28 was synthesized by almost the same method as the one employed for the synthesis of S-i but replacing the 2,5-diinethylthiophenol, 1 -broino-2chloroethane and (+)-3-methoxy-a-benzylmethylainine respectively by 2,4-dimethylthiophenol, 1 ,8-dibromooctane and naphthyl)ethylainine.

400MHz- H-NMR 8.15 (1H,d, J=8.OHz), 7.86-7.90 (1H,mi), 7.70-7.80 (2H,mi), :7.45-7.56 (3H, in), 7.16 (1 H, dl, J=7.8Hz), 6.98 (1 H, 6.94 (1 H, d, J=7.8Hz), 4.72 (1 H, q, J=6.4Hz), 2.80 (2H, t, J=7.4Hz), 2.50-2.65 (2H, in), 2.33 (3H, s), 2.27 (3H, 1.17-1.63 (15H, in), m/z=419.

Example 176: Synthesis of S-29 S-29 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethyithiophenol by 2,6diinethylthiophenol.

400MHz- 1 H-NMR 7.21 (1 H, dd, J=8.1 Hz, J=8.1lHz), 7.05-7.12 (3H, in), 6.83- 6.86 (2H, in), 6.73-6.78 (1 H, in), 3.80 (3H, 3.69 (1 H, q, J=6.6Hz), 2.72-2.82 (2H, in), 2.57-2.64 (2H, in), 2.51 (6H, 1.32 (3H, d, J=6.6Hz), in/z=315.

Example 177: Synthesis of was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1 bromo-2-chloroethane respectively by 2,6-dimethylthiophenol and 1,3di broinopropane.

400MHz- 1 H-NMR 7.22 (1 H, dd, J=8.1lHz, J=8.1 Hz), 7.05-7.09 (3H, in), 6.84- 6.86 (2H, in), 6.74-6.78 (1 H, in), 3.80 (3H, 3.69 (1 H, q, J=6.6Hz), 2.62-2.70 176 (2H, 2.51-2.60 (2H, 2.50 (6H, 1.61-1.70 (2H, 1.32 (3H, d, J=6.6Hz), m/z=329.

Example 178: Synthesis of S-31 S-31 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1bromo-2-chloroethane respectively by 2,6-dimethylthiophenol and 1,4dibromobutane.

400MHz-'H-NMR 7.22 (1H, dd, J=8.0Hz, J=8.0Hz), 7.04-7.09 (3H, 6.85- 6.88 (2H, 6.77 (1H, ddd, J=8.0Hz, J=2.4Hz, J=1.0Hz), 3.80 (3H, 3.70 (1H, q, J=6.6Hz), 2.61 (2H, t, J=6.7Hz), 2.51 (6H, 2.39-2.48 (2H, 1.48- 1.58 (4H, 1.32 (3H, d, J=6.6Hz), m/z=343.

Example 179: Synthesis of S-32 S-32 was synthesized by almost the same method as the one employed the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1bromo-2-chloroethane respectively by 2,6-dimethylthiophenol and dibromopentane.

400MHz-'H-NMR 7.23 (1H, dd, J=8.0Hz, J=8.0Hz), 7.06-7.11 (1H, 6.86- 6.88 (2H, 6.75-6.79 (1 H, 3.81 (3H, 3.71 (1 H, q, J=6.6Hz), 2.61 (2H, t, J=7.3Hz), 2.52 (6H, 2.38-2.49 (2H, 1.34-1.54 (6H, 1.33 (3H, d, J=6.6Hz), m/z=357.

S" Example 180: Synthesis of S-33 S-33 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1bromo-2-chloroethane respectively by 2,6-dimethylthiophenol and 1,6dibromohexane.

400MHz-'H-NMR 7.23 (1H, dd, J=8.0Hz, J=8.0Hz), 7.07-7.11 (3H, 6.86- 6.88 (2H, 6.75-6.79 (1 H, 3.81 (3H, 3.71 (1 H, q, J=6.6Hz), 2.61 (2H, t, J=7.3Hz), 2.52 (6H, 2.36-2.50 (2H, 1.21-1.54 (8H, 1.33 (3H, d, J=6.6Hz), m/z=371.

Example 181: Synthesis of S-34 177 S-34 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1bromo-2-chloroethane respectively by 2,6-dimethylthiophenol and 1,7dibromoheptane.

400MHz- 1 H-NMR 7.20-7.25 (1H, 7.07-7.09 (3H, 6.86-6.90 (2H, m), 6.75-6.78 (1H, 3.81 (3H, 3.72 (1H, q, J=6.6Hz), 2.61 (2H, t, J=7.32Hz), 2.53 (6H, 2.36-2.50 (2H, 1.20-1.54 (10H, 1.34 (3H, d, J=6.6Hz), m/z=385.

Example 182: Synthesis of was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1bromo-2-chloroethane respectively by 2,6-dimethylthiophenol and 1,8dibromooctane.

t*o* 400MHz-'H-NMR 7.20-7.25 (1H, 7.05-7.10 (3H, 6.88-6.89 (2H, m), 6.76-6.79 (1H, 3.81 (3H, 3.73 (1H, q, J=6.5Hz), 2.61 (2H, t, J=7.3Hz), 2.53 (6H, 2.37-2.49 (2H, 1.20-1.55 (12H, 1.35 (3H, d, m/z=399.

Example 183: Synthesis of S-36 S-36 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and o S 3-methoxy-a-benzylmethylamine respectively by 2,6-dimethylthiophenol and -naphthyl)ethylamine.

400MHz-'H-NMR 8.15 (1H, d, J=8.0Hz), 7.83-7.90 (1H, 7.73 (1H, d, .i J=8.3Hz), 7.63 (1H, d, J=7.1Hz), 7.43-7.52 (3H, 7.04-7.12 (3H, 4.59 (1H, q, J=6.6Hz), 2.77-2.86 (2H, 2.70 (2H, t, J=6.6Hz), 2.50 (6H, 1.47 (3H, d, J=6.6Hz), m/z=335.

Example 184: Synthesis of S-37 S-37 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1-bromo-2chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 178 2,6-dimethylthiophenol, 1 ,3-dibromopropane and naphthyl) ethylamine.

400MHz- 1 H-NMR 8.15 (1 H, d, J=8.OHZ), 7.84-7.87 (1 H, in), 7.73 (1 H, d, J=8.3Hz), 7.62 (1 H, d, J=7.1 Hz), 7.44-7.51 in), 7.04-7.11 in), 4.58 (1 H, q, J=6.5Hz), 2.58-2.73 (4H, in), 2.50 1.68-1.75 in), 1.47 (3H, d, J=6.5Hz), m/z=349.

Example 185: Synthesis of S-38 S-38 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol, 1 -broino-2chloroethane and (R)-(+)-3-methoxy-a-benzylinethylainine respectively by 2,6-dimethylthiophenol, 1 ,4-dibroinobutane and naphthyl) ethyla'inine.

*see 400MHz-'H-NMR 8.16 (1 H, d, J=8.3Hz), 7.85-7.88 (1 H, in), 7.73 (1 H, d, J=8.3Hz), 7.63 (1 H, d, J=7.1 Hz), 7.44-7.52 in), 7.05-7.11 in), 4.61 (1 H, q, J=6.5Hz), 2.61 t, J=7.3Hz), 2.50-2.59 in), 2.50 (6H, 1.50- 1.64 in), 1.48 d, J=6.5Hz), m/z=363.

Example 186: Synthesis of S-39 Cot, S-39 was synthesized by almost the same method as the one employed the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 -broino-2chloroethane and (R)-(+)-3-methoxy-a-benzylmethylainine respectively by ::.so2,6-dimethylthiophenol, 1 ,5-dibroinopentane and naphthyl) ethylainine.

400MHz-1 H-NMR 8.17 (1 H, d, J=8.OHz), 7.85-7.88 (1 H, in), 7.74 (1 H, d, J=8.3Hz), 7.63 (1 H, d, J=7.1 Hz), 7.44-7.52 in), 7.06-7.08 in), 4.61 (1 H, q, J=6.6Hz), 2.61 t, J=7.1 Hz), 2.50-2.58 (2H, in), 2.51 (6H, 1.35- 1.55 in), 1.48 d, J=6.6Hz), in/z=377.

Example 187: Synthesis of was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethyithiophenol, 1 -broino-2chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 179 2,6-dimethylthiophenol, 1 ,6-dibromohexane and nap hthyl) ethylamine.

400M Hz- 1 H-N MR 8.17 (1 H, d, J=8.0Hz), 7.85-7.87 (1 H, in), 7.74 (1 H, d, J=8.OHz), 7.64 (1 H, d, J=5.9Hz), 7.44-7.52 in), 7.05-7.09 in), 4.62 (1 H, q, J=6.5Hz), 2.50-2.62 in), 2.52 1.23-1.53 in), 1.49 (3H-, d, J=6.5Hz), m/z=391.

Example 188: Synthesis of S-41 S-41 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 -broino-2chioroethane and -(+)-3-methoxy-ct-benzylmethylamine respectively by 2,6-dimethylthiophenol, 1 ,7-dibromoheptane and naphthyl)ethylamine.

**400MHz- 1 H-NMR 8.17 (1 H, d, J=8.3Hz), 7.85-7.88 (1 H, in), 7.74 (1 H, d, 7.64 (1 H, d, J=7.1lHz), 7.44-7.53 in), 7.07-7.09 in), 4.62 H, q, J=6.6Hz), 2.50-2.62 (4H, in), 2.52 1.20-1.53 (1 OH, in), 1.49 (3H-, J=6.6Hz), m/z=405.

Example 189: Synthesis of S-42 S-42 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 -bromo-2chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 2,6-dimethylthiophenol, 1 ,8-dibromooctane and naphthyl)ethylamine.

400MHz- 1 H-NMR 8.15 (1 H, d, J=8.6Hz), 7.86-7.89 (1 H, mn), 7.74-7.78 (2H, in), :7.46-7.54 in), 6.99-7.10 (3H, in), 4.70-4.78 (1 H, in), 2.51 -2.62 in), 2.52 1.07-1.84 (12H, mn), 1.59 d, J=6.1 Hz), m/z=419.

Example 190: Synthesis of S-43 S-43 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol by 3,4dimethylthiophenol.

400MHz- 1 H-NMR 7.21 (1 H, dd, J=8.OHz, J=8.OHz), 7.11 (1 H, 7.00-7.07 (2H, in), 6.80-6.87 in), 6.75-6.87 in), 6.75-6.78 (1 H, in), 3.79 3.72 180 (1H, q, J=6.5Hz), 2.95-2.99 (2H, 2.63-2.70 (2H, 2.21 (3H, 2.20 (3H, 1.33 (3H, d, J=6.5Hz), m/z=315.

Example 191: Synthesis of S-44 S-44 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1bromo-2-chloroethane respectively by 3,4-dimethylthiophenol and 1,3dibromopropane.

400MHz- 1 H-NMR 7.20-7.25 (1H, 7.12 (1H, 7.01-7.08 (2H, 6.84-6.88 (2H, 6.75-6.78 (1H, 3.80 (3H, 3.70 (1H, q, J=7.0Hz), 2.83-2.95 (2H, 2.50-2.63 (2H, 2.22 (3H, 2.21 (3H, 1.72-1.77 (2H, 1.32 (3H, d, m/z=329.

Example 192: Synthesis of was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1- S. bromo-2-chloroethane respectively by 3,4-dimethylthiophenol and 1,4dibromobutane.

400MHz-'H-NMR 7.22 (1 H, dd, J=8.0Hz, J=8.0Hz), 7.11 (1H, 7.01-7.07 (2H, 6.85-6.87 (2H, 6.75-6.78 (1H, 3.80 (3H, 3.70 (1H, q, 2.84 (2H, t, J=7.5Hz), 2.40-2.52 (2H, 2.22 (3H, 2.21 (3H, 1.54-1.65 (4H, 1.32 (3H, d, J=7.0Hz), m/z=343.

Example 193: Synthesis of S-46 S-46 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1- S• bromo-2-chloroethane respectively by 3,4-dimethylthiophenol and dibromopentane. m/z 357.

Example 194: Synthesis of S-47 S-47 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1bromo-2-chloroethane respectively by 3,4-dimethylthiophenol and 1,6dibromohexane.

181 400MHz-'H-NMR 7.23 (1 H, dd, J=8.0Hz, J=8.0Hz), 7.12 (1 H, 7.02-7.08 (2H, 6.86-6.89 (2H, 6.75-6.78 (1H, 3.81 (3H, 3.71 (1H, q, 2.84 (2H, t, J=7.3Hz), 2.38-2.50 (2H, 2.23 (3H, 2.22 (3H, 1.56-1.62 (2H, 1.24-1.48 (6H, 1.33 (3H, d, J=7.0Hz), m/z=377.

Example 195: Synthesis of S-48 S-48 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1bromo-2-chloroethane respectively by 3,4-dimethylthiophenol and 1,7dibromoheptane.

400MHz- H-NMR 7.22 (1H, dd, J=8.0Hz, J=8.0Hz), 7.11 (1H, 7.01-7.08 (2H, 6.86-6.88 (2H, 6.75-6.78 (1H, 3.80 (3H, 3.71 (1H, q, 2.80 (2H, t, J=7.5Hz), 2.38-2.50 (2H, 2.22 (3H, 2.21 (3H, 1.56-1.62 (2H, 1.33-1.45 (4H, 1.33 (3H, d, J=6.5Hz), 1.24-1.28 (4H, m/z=385.

Example 196: Synthesis of S-49 S-49 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1- .bromo-2-chloroethane respectively by 3,4-dimethylthiophenol and 1,8dibromooctane.

400MHz- 1 H-NMR 7.21-7.25 (1H, 7.12 (1H, 7.02-7.08 (2H, 6.87-6.89 o (1H, d, J=8.0Hz), 6.87 (1H, 6.76-6.78 (1H, 3.80 (3H, 3.70-3.74 (1H, 2.85 (2H, t, J=7.8Hz), 2.38-2.50 (2H, 2.22 (3H, 2.21 (3H, 1.56- 1.62 (2H, 1.33-1.46 (4H, 1.34 (3H, d, J=7.0Hz), 1.25 (6H, bs), m/z=399.

Example 197: Synthesis of S-50 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 3-methoxy-a-benzylmethylamine respectively by 3,4-dimethylthiophenol and -naphthyl)ethylamine.

Example 198: Synthesis of S-51 S-51 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1-bromo-2chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 182 3,4-dimethylthiophenol, 1 ,3-dibromopropane and naphthyl) ethylamine.

400MHz- 1 H-NMR 8.16 (1 H, d, J=8.5Hz), 8.85 (1 H, d, J=9.0Hz), 7.72 (1 H, d, 7.61 (1 H, d, J=7.5Hz), 7.43-7.49 (3H, in), 7.11 (1 H, 6.97-7.07 (2H, in), 4.58 (1 H, q, J=6.5Hz), 2.85-2.97 (2H, in), 2.61 -2.73 (2H, in), 2.22 (6H, 1.76-1.82 (2H, in), 1.46 (3H, d, J=6.5Hz), m/z=349.

Example 199: Synthesis of S-52 S-52 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 -bromo-2chioroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 3,4-dimethylthiophenol, 1 ,4-dibromobutane and naphthyl)ethylainine.

400MHz- 1 H-NMR 8.86 (1H, d, J=9.OHz), 8.18 (1H, d, J=8.5Hz), 7.73 (1H, d, 7.62 (1 H, d, J=7.OHz), 7.44-7.51 (3H, in), 7.11 (1 H, 7.01-7.07 mn), 4.60 (1 H, q, J=6.5Hz), 2.84 t, J=6.8Hz), 2.50-2.62 (2H, in), 1.60- 1.68 (4H, mn), 1.47 (3H, d, J=6.5Hz), mlz=363.

Example 200: Synthesis of S-53 S-53 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 -bromo-2chloroethane and (-i)-3-iethoxy-a-benzylmethylamine respectively by 3,4-diinethylthiophenol, 1 ,5-dibromopentane and naphthyl)ethylamine.

400MHz- 1 H-NMR 8.17 (1 H, d, J=8.5Hz), 7.86 (1 H, dd, J=8.OHz, J=1 .5Hz), 7.73 H, d, J=8.OHz), 7.62 (1 H, d, J=7.OHz), 7.44-7.51 (3H, in), 7.11 (1 H, 7.01 7.09 (2H, in), 4.60 (1 H, q, J=6.5Hz), 2.84 (2H, t, J=7.3Hz), 2.50-2.61 (2H, in), 2.22 (3H, 2.24 (3H, 1.57-1.63 (2H, in), 1.41 -1 .53 (4H, in), 1.48 (3H, d, m/z=377.

Example 201: Synthesis of S-54 S-54 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 -bromo-2chloroethane and (R)-(+)-3-methoxy-a-benzylmethylainine respectively by 183 3,4-dimethylthiophenol, 1 ,6-dibromohexane and naphthyl)ethylamine. mlz 391.

Example 202: Synthesis of was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 -bromo-2chioroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 3,4-dimethylthiophenol, 1 ,7-dibromoheptane and naphthyl)ethylamine.

400MHz- 1 H-NMR 8.18 (1 H, d, J=8.OHz), 7.86 (1 H, d, J=8.OHz), 7.73 (1 H, d, J=8.OHz), 7.63 (1 H, d, J=7.5Hz), 7.39-7.51 (3H, in), 7.11 (1 H, 7.01 -7.07 (2H, in), 4.60 (1 H, q, J=6.5Hz), 2.83 (2H, t, J=7.3Hz), 2.49-2.59 (2H, in), 2.22 (3H, 2.20 (3H, 1.28-1.62 (10H, in), 1.48 (3H, d, J=6.5Hz), mlz=405.

Example 203: Synthesis of S-56 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol, 1 -broino-2chloroethane and -(+)-3-inethoxy-a-benzylinethylainine respectively by 3,4-dimethylthiophenol, 1,8-dibromooctane and naphthyl)ethylamine.

400MHz- H-NMR 8.18 (1 H, d, J=8.OHz), 7.87 (1 H, d, J=8.OHz), 7.74 (1 H, d, J=8.OHz), 7.65 (1 H, d, J=7.5Hz), 7.45-7.52 (3H, in), 7.12 (1 H, 7.02-7.08 (2H, in), 4.63 (1 H, q, J=7.OHz), 2.84 (2H, t, J=7.3Hz), 2.51 -2.62 (2H, in), 2.22 (3H, 2.21 (3H, 1.56-1.62 (2H, in), 1.50 (3H, d, J=7.OHz), 1.45-1.55 (2H, in), 1.33-1.42 (2H, in), 1.25-1.28 (6H, in), m/z=419.

,Example 204: Synthesis of S-57 S-57 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol by dimethylthiophenol.

400MHz- 1 H-NMR 7.24 (1 H, dd, J=8.OHz, J=8.OHz), 6.96 (2H, 6.88-6.91 (2H, in), 6.82 (1 H, 6.78-6.80 (1 H, in), 3.82 (3H, 3.76 (1 H, q, J=6.5Hz), 3.01 3.06 (2H, in), 2.69-2.78 (2H, in), 2.28 (6H, 1.36 (3H, d, J=6.5Hz), in/z=315.

184 Example 205: Synthesis of S-58 S-58 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1bromo-2-chloroethane respectively by 3,5-dimethylthiophenol and 1,3dibromopropane.

400MHz-'H-NMR 7.22 (1 H, dd, J=8.0Hz, J=8.0Hz), 6.93 (2H, 6.86-6.88 (2H, 6.76-6.78 (2H, 3.80 (3H, 3.71 (1H, q, J=6.5Hz), 2.86-2.98 (2H, m), 2.51-2.65 (2H, 2.27 (6H, 1.74-1.81 (2H, 1.32 (3H, d, m/z=329.

Example 206: Synthesis of S-59 S-59 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1bromo-2-chloroethane respectively by 3,5-dimethylthiophenol and 1,4dibromobutane.

400MHz-'H-NMR 7.22 (1 H, dd, J=7.5Hz, J=7.5Hz), 6.92 (2H, 6.86-6.88 (2H, 6.75-6.78 (2H, 3.80 (3H, 3.71 (1H, q, J=7.0Hz), 2.86 (2H, t, 2.39-2.54 (2H, 2.27 (6H, 1.55-1.68 (4H, 1.33 (3H, d, m/z=343.

Example 207: Synthesis of was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1bromo-2-chloroethane respectively by 3,5-dimethylthiophenol and dibromopentane.

400MHz- 1 H-NMR 7.22 (1 H, dd, J=8.0Hz, J=8.0Hz), 6.92 (2H, 6.86-6.88 (2H, 6.75-6.78 (2H, 3.81 (3H, 3.71 (1H, q, J=7.0Hz), 2.87 (2H, t, J=7.3Hz), 2.39-2.51 (2H, 2.27 (6H, 1.58-1.65 (2H, 1.40-1.49 (4H, 1.33 (3H, d, J=7.0Hz), m/z=357.

Example 208: Synthesis of S-61 S-61 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1- 185 bromo-2-chloroethane respectively by 3,5-dimethylthiophenol and 1,6dibromohexane.

400MHz- 1 H-NMR 7.23 (1 H, dd, J=8.0Hz, J=8.0Hz), 6.93 (2H, 6.86-6.89 (2H, 6.76-6.78 (2H, 3.81 (3H, 3.71 (1H, q, J=6.5Hz), 2.87 (2H, t, J=7.3Hz), 2.39-2.88 (2H, 2.27 (6H, 1.58-1.65 (2H, 1.36-1.49 (4H, 1.33 (3H, d, J=6.5Hz), 1.25-1.31 (2H, m/z=371.

Example 209: Synthesis of S-62 S-62 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1bromo-2-chloroethane respectively by 3,5-dimethylthiophenol and 1,7dibromoheptane.

400MHz- H-NMR 7.23 (1 H, dd, J=8.0Hz, J=8.0Hz), 6.93 (2H, 6.86-6.89 (2H, 6.75-6.78 (2H, 3.81 (3H, 3.72 (1H, q, =7.0Hz), 2.87 (2H, t, 2.38-2.51 (2H, 2.72 (6H, 1.58-1.64 (2H, 1.35-1.47 (4H, 1.33 (3H, d, J=7.0Hz), 1.25-1.30 (4H, m/z=385.

Example 210: Synthesis of S-63 S-63 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1bromo-2-chloroethane respectively by 3,5-dimethylthiophenol and 1,8dibromooctane.

400MHz- 1 H-NMR 7.21 (1 H, dd, J=8.0Hz, J=8.0Hz), 6.91 (2H, 6.85-6.88 (2H, 6.77 (1H, 6.74-6.75 (1H, 3.79 (3H, 3.71 (1H, q, J=6.5Hz), 2.86 (2H, t, J=7.5Hz), 2.37-2.49 (2H, 2.26 (6H, 1.57-1.63 (2H, 1.34-1.43 (4H, 1.32 (3H, d, J=6.5Hz), 1.20-1.30 (6H, m/z=399.

Example 211: Synthesis of S-64 S-64 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 3-methoxy-a-benzylmethylamine respectively by 3,5-dimethylthiophenol and -naphthyl)ethylamine.

400MHz- 1 H-NMR 8.15 (1H, d, J=8.0Hz), 7.85-7.87 (1H, 7.72 (1H, d, 7.63 (1H, d, J=6.5Hz), 7.42-7.52 (3H, 6.93 (2H, 6.79 (1H, s), 186 4.62 (1 H, q, J=6.5Hz), 3.05 t, J=6.5Hz), 2.76-2.84 rn), 2.24 s,) 1.48 d, J=6.5Hz), mlz=335.

Example 212: Synthesis of was synthesized by almost the same method as the one employed for the synthesis of S-i but replacing the 2,5-dimethylthiophenol, 1 -bromo-2chloroethane and (R)-(+)-3-methoxy-ct-benzylmethylamine respectively by 1 ,3-dibromopropane and naphthyl) ethylamine.

400MHz-'H-NMR 8.18 (1 H, d, J=8.5Hz), 7.86 (1 H, d, J=7.OHz), 7.24 (1 H, d, 7.63 (1 H, d, J=6.5Hz), 7.45-7.51 in), 6.93 6.78 (1 H, s), 4.60 (1 H, q, J=6.5Hz), 2.89-3.01 (2H, in), 2.63-2.75 in), 2.26 (6H, s), 1.79-1.85 in), 1.48 d, J=6.5Hz), m/z=349.

Example 213: Synthesis of S-66 S-66 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 -bromo-2chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 3,5-dimethylthiophenol, 1 ,4-dibromobutane and naphthyl)ethylamine.

400MHz- 1 H-NMR 8.86 (1 H, d, J=8.5Hz), 8.18 (1 H, d, J=8.OHz), 7.63 (1 H, d, 7.23 (1 H, d, J=8.OHz), 7.44-7.51 in), 6.92 6.78 (1 H, s), 4.61 (1 H, q, J=7.OHz), 2.86-2.88 (2H, in), 2.53-2.64 in), 2.26 s), 1.60-1.70 in), 1.48 d, J=7.OHz), m/z=363.

a Example 214: Synthesis of S-67 S-67 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 -bromo-2chloroethane and -3-methoxy-cz-benzylmethylamine respectively by 1 ,5-dibromopentane and naphthyl) ethylamine.

400MHz-'H-NMR 8.85 (1 H, d, J=7.5Hz), 8.16 (1 H, d, J=8.5Hz), 7.72 (1 H, d, J=8.OHz), 7.61 (1 H, d, J=7.5Hz), 7.43-7.50 in), 6.91 6.77 (1 H, s), 187 4.60 (1 H, q, J=6.5Hz), 2.85 (2H, t, J=7.5Hz), 2.49-2.60 (2H, in), 2.25 (6H, s), 1.58-1.64 (2H, in), 1.41-1.53 (4H, in), 1.47 d, J=6.5Hz), mlz=377.

Example 215: Synthesis of S-68 S-68 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 -bromo-2chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 1 ,6-dibromohexane and naphthyl)ethylamine.

400MHz-1 H-NMR 8.18 (1 H, d, J=8.5Hz), 7.86 (1 H, d, J=7.5Hz), 7.73 (1 H, d, 7.63 (1 H, d, J=7.5Hz), 7.46-7.50 (3H, in), 6.92 (2H, 6.77 (1 H, s), 4.61 (1 H, q, J=6.5Hz), 2.86 (2H, t, J=7.3Hz), 2.52-2.61 (2H, in), 2.26 (6H, s), 1.57-1.64 (2H, in), 1.45-1.57 (2H, in), 1.48 d, J=6.5Hz), 1.35-1.44 (2H, in), :1.29-1.36 m/z=391.

Example 216: Synthesis of S-69 S-69 was synthesized by almost the same method as the one employed for the synthesis of S-i but replacing the 2,5-dimethylthiophenol, 1 -broino-2chioroethane and -3-inethoxy-a-benzylmethylamine respectively by 1 ,7-dibroinoheptane and naphthyl)ethylainine.

400MHz-'H-NMR 8.18 (1 H, d, J=8.OHz), 7.86 (1 H, d, J=8.OHz), 7.73 (1 H, d, J=8.OHz), 7.64 (1 H, d, J=7.5Hz), 7.45-7.52 (3H, in), 6.92 (2H, 6.78 (1 H, s), 4.62 (1 H, q, J=7.OHz), 2.86 (2H, t, J=7.3Hz), 2.51 -2.60 (2H, in), 2.27 (6H, s), 1.79-1.85 (2H, in), 1.57-1.63 (2H, in), 1.49 d, J=7.OHz), 1.39 (2H, bs), 1 .29 (4H, bs), in/z=405.

Example 217: Synthesis of was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 -bromo-2chloroethane and (R)-(+)-3-inethoxy-a-benzylmethylamine respectively by 1 ,8-dibroinooctane and naphthyl)ethylamine.

188 400MHz- 1 H-NMR 8.18 (1 H, d, J=8.5Hz), 7.86 (1 H, d, J=8.OHz), 7.73 (1 H, d, J=8.OHz), 7.64 (1 H, d, J=7.5Hz), 7.44-7.52 in), 6.93 (2H, 6.78 (1 H, s), 4.62 (1 H, q, J=6.5Hz), 2.87 (2H, t, J=7.5Hz), 2.50-2.61 (2H, in), 2.27 (6H, s), 1.58-1.64 (2H, in), 1.47-1.52 (2H, in), 1.49 d, J=6.5Hz), 1.35-1.42 (2H, in), 1.24-1.30 (6H, mn), mlz=419.

Example 218: Synthesis of S-71 S-71 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethyithiophenol by 4bromothiophenol.

400MHz-'H-NMR 7.33-7.37 (2H, in), 7.22 (1 H, dd, J=8.OHz, J=8.OHz), 7.13- 7.16 (2H, in), 6.83-6.87 (2H, in), 6.76-6.79 (1 H, in), 3.80 (3H, 3.72 (1 H, q, 2.99 t, J=6.5Hz), 2.59-2.75 (2H, in), 1.34 (3H, d, m/z=365, 367.

Example 219: Synthesis of S-72 S-72 was synthesized by almost the same method as the one employed *for the synthesis of S-1 but replacing the 2,5-d imethylthio phenol and 1 bromo-2-chloroethane respectively by 4-bromothiophenol and 1,3dibromopropane.

400MHz-'H-NMR 7.37 (2H, d, J=8.8Hz), 7.23 (1 H, dd, J=8.1 Hz, J=8.1 Hz), 7.15 (2H, d, J=8.8Hz), 6.85-6.88 (2H, in), 6.78 (1 H, ddd, J=8.1 Hz, J=2.4Hz, J=1 .0Hz), 3.80 (3H, 3.71 (11 H, q, J=8.2Hz), 2.85-2.98 (2H, in), 2.50-2.65 (2H, in), 1.71-1.81 (2H, in), 1.33 (3H, d, J=6.6Hz), m/z=379, 381.

Example 220: Synthesis of S-73 S-73 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1 broino-2-chloroethane respectively by 4-bromothiophenol and 1,4dibromobutane.

400MHz-'H-NMR 7.37 (2H, d, J=8.5Hz), 7.23 (1 H, dd, J=8.1 Hz, J=8.1 Hz), 7.15 (2H, d, J=8.5Hz), 6.85-6.88 (2H, in), 6.75-6.79 (1 H, in), 3.80 (3H, 3.71 (1 H, q, J=6.6Hz), 2.85 (2H, t, J=7.1lHz), 2.39-2.54 (2H, in), 1.51-1.69 (4H, in), 1.33 (3H, d, J=6.6Hz), m/z=393, 395.

189 Example 221: Synthesis of S-74 S-74 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1bromo-2-chloroethane respectively by 4-bromothiophenol and dibromopentane.

400MHz- 1 H-NMR 7.37 (2H, d, J=8.8Hz), 7.23 (1H, dd, J=8.2Hz, J=8.2Hz), 7.15 (2H, d, J=8.8Hz), 6.86-6.88 (2H, 6.76-6.79 (1H, 3.81 (3H, 3.72 (1H, q, J=6.6Hz), 2.86 (2H, t, J=7.3Hz), 2.38-2.52 (2H, 1.60 (2H, tt, J=7.3Hz, J=7.3Hz), 1.36-1.51 (4H, 1.34 (3H, d, J=6.6Hz), m/z=407, 409.

Example 222: Synthesis of was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1bromo-2-chloroethane respectively by 4-bromothiophenol and 1,6dibromohexane.

400MHz-H-NMR 7.37 (2H, d, J=8.6Hz), 7.23 (1H, dd, J=8.1Hz, J=8.1Hz), 7.15 (2H, d, J=8.6Hz), 6.87-6.89 (2H, 6.76-6.79 (1H, 3.81 (3H, 3.72 (1H, q, J=6.6Hz), 2.86 (2H, t, J=7.3Hz), 2.38-2.52 (2H, 1.60 (2H, tt, J=7.3Hz, J=7.3Hz), 1.23-1.50 (6H, 1.35 (3H, d, J=6.6Hz), m/z=421, 423.

Example 223: Synthesis of S-76 S-76 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1bromo-2-chloroethane respectively by 4-bromothiophenol and 1,7dibromoheptane.

400MHz- 1 H-NMR 7.38 (2H, d, J=8.5Hz), 7.23 (1H, dd, J=8.1Hz, J=8.1Hz), 6.87-6.89 (2H, 6.78 (1H, ddd, J=8.3Hz, J=2.4Hz, J=1.0Hz), 3.81 (3H, s), 3.73 (1H, q, J=6.6Hz), 2.86 (2H, t, J=7.3Hz), 2.38-2.52 (2H, 1.60 (2H, tt, J=7.3Hz, J=7.3Hz), 1.08-1.50 (8H, 1.36 (3H, d, J=6.6Hz), m/z=435, 437.

Example 224: Synthesis of S-77 S-77 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1- -190 bromo-2-chloroethane respectively by 4-bromothiophenol and 1,8dibromooctane.

400MHz- 1 H-NMR 7.35-7.40 in), 7.23 (11H, d, J=8.0Hz), 7.14-7.18 in), 6.88-6.92 in), 6.74-6.80 (1 H, in), 3.81 3.75 (1 H, q, J=6.7Hz), 2.86 t, J=7.6Hz), 2.39-2.53 in), 1.54-1.64 in), 1.20-1.50 (10H, in), 1.38 d, J=6.7Hz), mlz=449, 451.

Example 225: Synthesis of S-78 S-78 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethyithiophenol and 3-methoxy-a-benzylinethylamine respectively by 4-bromothio phenol and -naphthyl)ethylamine.

Example 226: Synthesis of S-79 ~:S-79 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol, 1 -bromo-2chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 4bromothiophenol, 1 ,3-dibromopropane and -naphthyl)ethylamine.

400MHz- 1 H-NMR 8.16 (1 H, d, J=7.8Hz), 7.85-7.88 (1 H, in), 7.74 (1 H, d, J=8.3Hz), 7.62 (1 H, d, J=6.8Hz), 7.44-7.52 in), 7.32-7.42 in), 7.10- 7.15 in), 4.60 (1 H, q, J=6.6Hz), 2.83-3.05 in), 2.60-2.77 (2H, in), 1.76-1.87 in), 1.49 d, J=6.6Hz), in/z=399, 401.

Example 227: Synthesis of was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 -broino-2chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 4bromothiophenol, 1 ,4-dibroinobutane and -naphthyl)ethylainine.

400MHz- 1 H-NMR 8.17 (1 H, d, J=7.8Hz), 7.84-7.88 (1 H, in), 7.74 (1 H, d, J=8.28Hz), 7.62 (1 H, d, J=6.6Hz), 7.43-7.52 (3H, in), 7.33-7.37 (2H, in), 7.11 7.16 in), 4.61 (1 H, q, J=6.5Hz), 2.85 d, J=7.OHz), 2.50-2.64 (2H, in), 1.58-1.68 in), 1.48 d, J=6.5Hz), in/z=413, 415.

Example 228: Synthesis of S-81 191 S-81 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 -bromo-2chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 4bromothiophenol, 1,5-dibromopentane and -naphthyl)ethylamine.

400MHz- 1 H-NMR 8.17 (1H, d, J=8.3Hz), 7.85-7.88 (1H, 7.74 (1H, d, J=8.2Hz), 7.64 (1H, d, J=7.3Hz), 7.45-7.53 (3H, 7.34-7.37 (2H, 7.11- 7.16 (2H, 4.62 (1H, q, J=6.6Hz), 2.85 (2H, t, J=7.3Hz), 2.49-2.62 (2H, m), 1.40-1.65 (6H, 1.49 (3H, d, J=6.6Hz), m/z=427, 429.

Example 229: Synthesis of S-82 S-82 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 -bromo-2chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 4bromothiophenol, 1,6-dibromohexane and -naphthyl)ethylamine.

Example 230: Synthesis of S-83 S-83 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 -bromo-2chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 4bromothiophenol, 1,7-dibromoheptane and (R)-(+)-1-(1-naphthyl)ethylamine.

400MHz- 1 H-NMR 8.30 (1H, bs), 8.10 (1H, d, J=8.0Hz), 7.90 (1H, d, J=8.1Hz), 7.82 (1H, d, J=8.1 Hz), 7.49-7.59 (3H, 7.33-7.38 (2H, 7.11-7.15 (2H, m), 4.96 (1H, bs), 2.80 (2H, t, J=7.3Hz), 2.54-2.74 (2H, 0.95-1.88 (13H, m), m/z=455, 457.

Example 231: Synthesis of S-84 S-84 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 -bromo-2chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 4bromothiophenol, 1,8-dibromooctane and -naphthyl)ethylamine.

400MHz- H-NMR 8.35 (1H, bs), 8.13 (1H, d, J=8.0Hz), 7.88 (1H, d, J=8.2Hz), 7.79 (1H, d, J=8.3Hz), 7.45-7.56 (3H, 7.33-7.39 (2H, 7.12-7.18 (2H, m), 4.82 (1H, bs), 2.84 (2H, t, J=7.3Hz), 2.58-2.64 (2H, 1.00-1.74 (15H, m), m/z=469, 471.

192- Example 232: Synthesis of was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1bromo-2-chloroethane respectively by 4-iodophenol and 1,3-dibromopropane.

400MHz-'H-NMR 7.50-7.54 (2H, 7.21 (1H, dd, J=8.0Hz, J=8.0Hz), 6.86- 6.88 (2H, 6.76 (1H, dd, J=8.0Hz, J=2.5Hz), 6.61-6.65 (2H, 3.93-4.00 (1H, 3.78 (3H, 3.72-3.76 (1H, 2.58-2.70 (2H, 1.86-1.94 (2H, m), 1.34 (3H, d, J=7.0Hz), m/z=411.

Example 233: Synthesis of S-86 S-86 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1bromo-2-chloroethane respectively by 4-iodophenol and 1,4-dibromobutane.

400MHz- H-NMR 7.50-7.53 (2H, 7.22 (1H, dd, J=3.0Hz, J=3.0Hz), 6.87- 6.89 (2H, 6.76-6.78 (1H, 6.61-6.64 (2H, 3.88 (1H, t, J=6.8Hz), 3.80 3.73 (1 H, q, J=6.8Hz), 2.46-2.58 (2H, 1.72-1.82 (2H, 1.55-1.67 (2H, 1.34 (3H, d, J=6.8Hz), m/z=425.

Example 234: Synthesis of S-87 S-87 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1bromo-2-chloroethane respectively by 4-iodophenol and 400MHz- 1 H-NMR 7.52 (2H, d, J=8.5Hz), 7.20-7.25 (1H, 6.87 (2H, s), 0 6.74-6.80 (1H, 6.64 (2H, d, J=8.0Hz), 3.88 (2H, t, J=6.5Hz), 3.80 (3H, s), 3.72 (1 H, q, J=6.3Hz), 2.40-2.55 (2H, 1.71-1.77 (2H, 1.40-1.45 (4H, m), 1.34 (3H, d, J=6.3Hz), m/z=439.

Example 235: Synthesis of S-88 S-88 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1bromo-2-chloroethane respectively by 4-iodophenol and 1,6-dibromohexane.

400MHz-'H-NMR 7.52 (2H, d, J=9.0Hz), 7.23 (1H, dd, J=8.0Hz, 6.87-6.89 (2H, 6.77 (1H, dd, J=8.0Hz, J=2.0Hz), 6.64 (2H, d, 3.88 (3H, t, J=6.5Hz), 3.81 (3H, 3.72 (1H, q, J=7.0Hz), 2.41-2.53 (2H, m), 193 1.71-1.76 (2H, 1.46-4.50 (2H, 1.39-1.45 (2H, 1.31-1.38 (2H, m), 1.34 (3H, d, J=6.5Hz), m/z=453.

Example 236: Synthesis of S-89 S-89 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1bromo-2-chloroethane respectively by 4-iodophenol and 1,7-dibromoheptane.

400MHz-'H-NMR 7.52 (2H, d, J=9.0Hz), 7.22 (1H, dd, J=8.0Hz, 6.87-6.89 (2H, 6.76-6.78 (1H, 6.65 (2H, d, J=8.5Hz), 3.88 (2H, t, 3.81 (3H, 3.72 (1 H, q, J=6.5Hz), 2.39-2.51 (2H, 1.70-1.76 (2H, 1.37-1.49 (4H, 1.34 (3H, d, J=6.5Hz), 1.25-1.35 (6H, m/z=467.

Example 237: Synthesis of was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1bromo-2-chloroethane respectively by 4-iodophenol and 1,8-dibromooctane.

400MHz-'H-NMR 7.53 (2H, d, J=8.5Hz), 7.23 (1 H, dd, J=8.0Hz, 6.87-6.89 (2H, 6.75-6.78 (1H, 6.65 (2H, d, J=8.5Hz), 3.89 (2H, t, J=6.8Hz), 3.81 (3H, 3.72 (1 H, q, J=6.5Hz), 2.39-2.51 (2H, 1.71-1.76 (2H, 1.38-1.47 (4H, 1.34 (3H, d, J=6.5Hz), 1.25-1.35 (6H, m/z=481.

Example 238: Synthesis of S-91 S-91 was synthesized by almost the same method as the one employed S" for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1-bromo-2chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 4iodophenol, 1,3-dibromopropane and -naphthyl)ethylamine.

400MHz-'H-NMR 8.17-8.19 (1H, 7.84-7.87 (1H, 7.73 (1H, d, 7.61 (1H, d, J=7.0Hz), 7.50-7.53 (2H, 7.34-7.49 (3H, 6.61 (2H, d, 4.63 (1H, q, J=6.5Hz), 3.95-4.01 (2H, 2.69-2.80 (2H, 1.91- 1.97 (2H, 1.49 (3H, d, J=6.5Hz), m/z=431.

Example 239: Synthesis of S-92 S-92 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1-bromo-2- -194 chioroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 4iodophenol, 1 ,4-dibromobutane and -naphthyl)ethylamine.

400MHz- 1 H-NMR 8.19 (1 H, d, J=7.5Hz), 7.86 (1 H, d, J=8.OHZ), 7.73 (1 H, d, J=8.OHz), 7.64 (1 H, d, J=8.0Hz), 7.45-7.52 (5H, in), 6.61 (2H, d, J=7.5Hz), 4.63 (1 H, q, J=6.5Hz), 3.88 (2H, t, J=6.5Hz), 2.56-2.69 (2H, in), 1.74-1.84 (2H, in), 1.62-1.68 (2H, in), 1.49 (3H, d, J=6.5Hz), mlz=445.

Example 240: Synthesis of S-93 S-93 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol, 1 -bromo-2chloroethane and (R)-(+)-3-methoxy-a-benzylinethylamine respectively by 4iodophenol, 1 ,5-dibromopentane and -naphthyl) ethylamine.

400MHz- H-NMR 8.18 (1 H, d, J=8.OHz), 7.86 (1 H, d, J=8.5Hz), 7.73 (1 H, d, J=8.OHz), 7.64 (1 H, d, J=7.OHz), 7.45-7.53 (5H, in), 6.63 (2H, d, 4.58-4.64 (1 H, in), 3.85-3.88 (2H, in), 2.50-2.65 (2H, in), 1.70-1.76 (2H, mn), 1.40-1.55 (4H, in), 1.49 (3H, d, J=6.5Hz), m/z=459.

Example 241: Synthesis of S-94 S-94 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 -bromo-2chioroethane and (R)-(+)-3-methoxy-ct-benzylmethylainine respectively by 4iodophenol, 1 ,6-dibromohexane and -naphthyl)ethylamine.

400MHz-'H-NMR 8.18 (1 H, d, J=8.5Hz), 7.83 (1 H, d, J=7.OHz), 7.72 (1 H, d, 7.64 (1 H, d, J=7.5Hz), 7.40-7.53 (5H, in), 6.63 (2H, d, J=9.5Hz), 4.62 (1 H, q, J=6.5Hz), 3.87 (2H, t, J=6.5Hz), 2.50-2.62 (2H, in), 1.70-1.75 (2H, in), 1.35-1.60 (6H, in), 1.49 (3H, d, J=6.5Hz), m/z=473.

Example 242: Synthesis of was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol, 1 -bromo-2chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 4iodophenol, 1 ,7-dibromoheptane and -nap hthyl) ethylami ne.

400MHz- 1 H-NMR 8.17 (1 H, d, J=8.5Hz), 7.87 (1 H, d, J=8.OHz), 7.74 (1 H, d, 7.67 (1 H, d, J=7.OHz), 7.45-7.53 (5H, in), 6.64 (2H, d, J=8.5Hz), 4.65 195 (1H, q, J=7.0Hz), 3.87 (2H, t, J=6.8Hz), 2.51-2.63 (2H, 1.78-1.84 (2H, m), 1.69-1.75 (2H, 1.52 (3H, d, J=7.0Hz), 1.25-1.45 (6H, m/z=487.

Example 243: Synthesis of S-96 S-96 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1-bromo-2chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 4iodophenol, 1,8-dibromooctane and (R)-(+)-1-(1-naphthyl)ethylamine.

400MHz-'H-NMR 8.86 (1H, d, J=7.5Hz), 8.18 (1H, d, J=8.5Hz), 7.74 (1H, d, 7.66 (1H, d, J=7.5Hz), 7.45-7.54 (5H, 6.65 (2H, d, J=8.5Hz), 4.64 (1H, q, J=6.5Hz), 3.88 (2H, t, J=6.8Hz), 2.51-2.63 (2H, 1.79-1.85 (2H, m), 1.70-1.75 (2H, 1.51 (3H, d, J=6.5Hz), 1.24-1.43 (8H, m/z=501.

Example 244: Synthesis of S-97 !i S-97 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol by 2napthalenethiol. m/z 337.

Example 245: Synthesis of S-98 S-98 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1bromo-2-chloroethane respectively by 2-naphthalenethiol and 1,3dibromopropane.

400MHz- 1 H-NMR 7.75-7.77 (1H, 7.69-7.73 (3H, 7.37-7.48 (3H, m), 7.21 (1H, dd, J=8.2Hz, J=8.2Hz), 6.85-6.88 (2H, 6.75-6.79 (1H, 3.79 (3H, 3.71 (1H, q, J=6.6Hz), 2.98-3.11 (2H, 2.54-2.68 (2H, 1.78-1.87 (2H, 1.32 (3H, d, J=6.6Hz), m/z=351.

Example 246: Synthesis of S-99 S-99 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1bromo-2-chloroethane respectively by 2-naphthalenethiol and 1,4dibromobutane.

400MHz-'H-NMR 7.69-7.78 (4H, 7.38-7.51 (3H, 7.21 (1 H, dd, 6.85-6.88 (2H, 6.76 (1H, ddd, J=8.3Hz, J=2.4Hz, J=1.0Hz), 3.79 196 3.71 (1 H, q, J=6.6Hz), 2.99 t, J=7.1lHz), 2.41-2.55 in), 1.56- 1.74 (4H, in), 1.33 d, J=6.6Hz), m/z=365.

Example 247: Synthesis of S-1 00 S-1 00 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethyithiophenol and 1 -bromo-2-chloroethane respectively by 2-naphthalenethiol and dibromopentane.

400MHz-'H-NMR 7.69-7.78 in), 7.37-7.51 in), 7.22 (1 H, dd, J=8.OHz, 6.86-6.88 in), 6.77 (1 H, ddd, J=8.0Hz, J=2.4Hz, J=1 .0Hz), 3.80 3.71 (1 H, q, J=6.6Hz), 2.99 (2H, t, J=7.3Hz), 2.39-2.52 in), 1.67 ft, J=7.3Hz, J=7.3Hz), 1.41-1.53 in), 1.33 d, J=6.6Hz), m/z=379.

Example 248: Synthesis of S-1 01 S-i 01 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethyithiophenol and 1 -bromo-2-chloroethane respectively by 2-naphthalenethiol and 1,6dibromohexane.

400MHz-'H-NMR 7.70-7.78 in), 7.38-7.47 in), 7.23 (1 H, dd, J=8.3Hz, J=8.3Hz), 6.86-6.88 in), 6.77 (1 H, ddd, J=8.3Hz, J=2.4Hz, J=1 .0Hz), 3.80 3.71 (1 H, q, J=6.6Hz), 2.99 t, J=7.3Hz), 2.37-2.51 in), 1.67 Ut, J=7.3Hz, J=7.3Hz), 1.39-1.50 in), 1.25-1.35 in), 1.33 d, m/z=393.

Example 249: Synthesis of S-1 02 S-1 02 was synthesized by almost the same method as the one *employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1 -bromo-2-chloroethane respectively by 2-naphthalenethiol and 1,7dibroinoheptane.

400MHz-1 H-NMR 7.70-7.78 in), 7.38-7.47 (3H, in), 7.24 (1 H, dd, J=8.1 Hz, J=8.1 Hz), 6.90-6.95 in), 6.78-6.81 (1 H, in), 3.81 3.79-3.82 (1 H, in), 2.99 t, J=7.4Hz), 2.41-2.54 in), 1.66 tt, J=7.4Hz, J=7.4Hz), 1.15-1.55 in), 1.43 d, J=6.6Hz), in/z=407.

197 Example 250: Synthesis of S-1 03 3-1 03 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethyithiophenol and 1 -bromo-2-chloroethane respectively by 2-naphthalenethiol and 1,8dibromooctane.

400MHz-1 H-NMR 7.70-7.78 in), 7.38-7.47 in), 7.23 (1 H, d, J=7.8Hz), 6.88-6.92 (2H, in), 6.78 (1 H, ddd, J=8.3Hz, J=2.7Hz, J=1.OHz), 3.81 s), 3.76 (1 H, q, J=6.4Hz), 2.99 (2H, t, J=7.3Hz), 2.39-2.52 in), 1.66 (2H, tt, J=7.3Hz, J=7.3Hz), 1. 15-1.55 (10OH, mn), in/z=421.

Example 251: Synthesis of S-1 04 S-1 04 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and **(R)-(+)-3-inethoxy-a-benzylmethylainne respectively by 2- *.naphthalenethiophenol and -naphthyl)ethylamine. mlz 357.

Example 252: Synthesis of S-1 S-1 05 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 broino-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylainine respectively by 2-naphthalenethiol, 1 ,3-dibromopropane and '*:*.naphthyl)ethylainine.

400MHz-'H-NMR 8.14-8.16 (1 H, in), 7.84-7.88 (1 H, in), 7.75-7.77 in), 7.68-7.76 in), 7.64 (1 H, d, J=6.6Hz), 7.36-7.48 in), 4.61 (1 H, q, :J=6.6Hz), 3.00-3.14 in), 2.66-2.79 in), 1.88 in), 1.49 d, J=6.6Hz), m/z=371.

Example 253: Synthesis of S-1 06 S-1 06 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 broino-2-chloroethane and (R)-(+)-3-methoxy-ct-benzylinethylainine respectively by 2-naphthalenethiol, 1 ,4-dlibromobutane and naphthyl)ethylainine.

198 400MHz-'H-NMR 8.16 (1 H, d, J=8.1lHz), 7.84-7.87 (1 H, in), 7.74'-7.77 (2H, in), 7.68-7.72 (3H, in), 7.63 (1 H, dl, J=7.1lHz), 7.36-7.51 (6H, in), 4.62 (1 H, q, J=6.6Hz), 2.98 (2H, t, J=7.OHZ), 2.52-2.65 1.63-1.76 (4H, in), 1.48 (3H, d, J=6.6Hz), mlz=385.

Example 254: Synthesis of S-1 07 .S-1 07 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-inethoxy-cx-benzylinethylainine respectively by 2-naphthalenethiol, 1 ,5-dibromopentane and naphthyl) ethylamine.

Example 255: Synthesis of S-1 08 S-1 08 was synthesized by almost the same method as the one so employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-inethoxy-a-benzylmethylamifle ~.respectively by 2-naphthalenethiol, 1 ,6-dibromohexane and @se naphthyl)ethylamine.

400MHz-'H-NMR 8.16 (1 H, d, J=8.3Hz), 7.85-7.88 (1 H, in), 7.74-7.77 (2H, in), 00007.69-7.73 (3H, in), 7.64 (1 H, dl, J=7.1lHz), 7.38-7.52 (6H, in), 4.62 (1 H, q, 2.98 (2H, t, J=7.4Hz), 2.49-2.62 (2H, in), 1.66 (2H, Ut, J=7.4Hz, 1.27-1.54 (6H, in), 1.49 (3H, dl, J=6.5Hz), in/z=413.

see* Example 256: Synthesis of S-1 09 S-1 09 was synthesized by almost the same method as the one :.*;employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 cc bromo-2-chloroethane and (R)-(+)-3-inethoxy-a-benzylinethylamine respectively by 2-naphthalenethiol, 1 ,7-dibroinoheptane and nap hthyl) ethylamine.

400MHz- 1 H-NMR 8.16 (1H, in), 7.84-7.87 (1 H, in), 7.69-7.77 (5H, in), 7.64 (1 H, dl, J=6.8Hz), 7.37-7.53 (6H, in), 4.62 (1 H, q, J=6.6Hz), 2.98 (2H, t, J=7.4Hz), 2.48-2.62 (2H, in), 1.65 (2H, Ut, J=7.4Hz, J=7.4Hz), 1.25-1.52 (8H, in), 1.49 (3H, d, J=6.6Hz), m/z=427.

199 Example 257: Synthesis of S-110 S-110 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 2-naphthalenethiol, 1,8-dibromooctane and naphthyl)ethylamine.

400MHz-'H-NMR 8.14 (1H, d, J=8.3Hz), 7.85-7.88 (1H, 7.67-7.79 (6H, m), 7.37-7.53 (6H, 4.70 (1H, q, J=6.6Hz), 2.98 (2H, t, J=7.3Hz), 2.50-2.65 (2H, 1.65 (2H, tt, J=7.3Hz, J=7.3Hz), 1.05-1.60 (1 OH, 1.57 (3H, d, J=6.6Hz), m/z=441.

Example 258: Synthesis of S-11 S-111 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol by 2-methoxythiophenol.

400MHz-'H-NMR 7.14-7.22 (3H, 6.81-6.89 (4H, 6.73-6.76 (1H, m), 3.85 (3H, 3.78 (3H, 3.71 (1H, q, J=6.6Hz), 2.98 (2H, t, J=6.5Hz), 2.61- 2.73 (2H, 1.32 (3H, d, J=6.6Hz), m/z=317.

Example 259: Synthesis of S-112 S-112 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1 -bromo-2-chloroethane respectively by 2-methoxythiophenol and 1,3dibromopropane.

400MHz-'H-NMR 7.21-7.25 (2H, 7.14-7.19 (1H, 6.82-6.92 (4H, m), 6.77 (1H, ddd, J=8.3Hz, J=2.4Hz, J=1.OHz), 3.87 (3H, 3.80 (3H, 3.73 (1 H, q, J=6.6Hz), 2.85-2.98 (2H, 2.52-2.67 (2H, 1.73-1.86 (2H, 1.33 (3H, d, J=6.6Hz), m/z=331.

Example 260: Synthesis of S-113 S-113 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1 -bromo-2-chloroethane respectively by 2-methoxythiophenol and 1,4dibromobutane.

200 400MHz-'H-NMR 7.21-7.25 in), 7.14-7.19 (1 H, in), 6.82-6.93 in), 6.75-6.79 (1 H, ddd, J=8.OHz, J=2.4Hz, J=1.0Hz), 3.88 3.80 s), 3.72 (1 H, q, J=6.6Hz), 2.86 t, J=7.OHz), 2.41 -2.55 in), 1.58-1.71 (4H-, in), 1.34 d, J=6.6Hz), mlz=345.

Example 261: Synthesis of S-i 14 S-1 14 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol and 1 -broino-2-chloroethane respectively by 2-methoxythiophenol and dibromopentane.

400MHz-1 H-NMR 7.21 -7.26 (2H, mn), 7.13-7.18 (1 H, in), 6.82-6.93 (4H, in), 6.76-6.79 (1 H, in), 3.88 3.81 (3H, 3.72 (1 H, q, J=6.6Hz), 2.86 (2H, t, J=7.4Hz), 2.38-2.52 in), 1.56-1.67 in), 1.38-1.53 in), 1.34 d, :J=6.6Hz), m/z=359.

Example 262: Synthesis of S-1 1 S-1 1 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethyithiophenol and 1 -bromo-2-chloroethane respectively by 2-inethoxythiophenol and 1,6dibromohexane.

400MHz-1 H-NMR 7.19-7.24 in), 7.12-7.16 (1 H, in), 6.81-6.91 in), 6.74-6.77 (1 H, in), 3.86 3.79 3.70 (1 H, q, J=6.6Hz), 2.84 (2H, t, 2.36-2.50 in), 1.57-1.65 (2H, in), 1.23-1.48 (6H, in), 1.32 d, J=6.6Hz), in/z=373.

Example 263: Synthesis of S-1 16 S-1 16 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol and 1 -broino-2-chloroethane respectively by 2-inethoxythiophenol and 1,7dibroinoheptane.

400MHz-1 H-NMR 7.21 -7.27 (2H, in), 7.13-7.18 (1 H, in), 6.89-6.97 in), 6.80-6.85 (1 H, mn), 3.88 3.83 3.80-3.83 (2H, t, J=7.3Hz), 2.85 (1 H, in), 2.43-2.56 (2H, in), 1.36-1.66 in), 1.47 d, J=6.2Hz), 1. 18-1.30 in), in/z=387.

201 Example 264: Synthesis of S-1 17 S-1 17 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1 -bromo-2-chloroethane respectively by 2-meth oxyth io phenol and 1 ,8dibromooctane.

400MHz-1 H-NMR 7.21-7.25 (2H, in), 7.13-7.18 (1H, in), 6.82-6.94 in), 6.76-6.79 (1 H, in), 3.88 (3H, 3.81 (3H, 3.73 (2H, t, J=7.3Hz), 2.86 (1 H, q, 2.38-2.52 in), 1.60-1.70 (2H, in), 1.20-1.60 (10H, in), 1.35 (3H, d, J=6.5Hz), m/z=401.

Example 265: Synthesis of 3-1 18 S-1 18 was synthesized by almost the same method as the one employed for the synthesis of S-i but replacing the 2,5-dimethyithiophenol and (R)-(+)-3-methoxy-a-benzylmethylainine respectively by 2-methoxythiophenol 7 and -naphthyl)ethylamine.

*:400MHz-' H-NMR 8.15 (1 H, d, J=7.6Hz), 7.84-7.87 (1 H, in), 7.73 (1 H, d, J=8.OHz), 7.64 (1 H, d, J=6.4Hz), 7.40-7.51 (3H, in), 7.24 (1 H, dd, J=7.6Hz, J=1.7Hz), 7.18 (1 H, ddd, J=7.8Hz, J=7.8Hz, J=1 .7Hz), 6.81-6.88 (2H, in), 4.62 (1 H, q, J=6.6Hz), 3.84 (3H, 3.05 (2H, t, J=6.4Hz), 2.73-2.82 (2H, in), 1.48 (3H, d, J=6.6Hz), m/z=337.

Example 266: Synthesis of S-1 19 S-1 19 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 broino-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 2-methoxythiophenol, 1 ,3-dibromopropane and naphthyl)ethylamine.

400MHz-'H-NMR 8.15 (1H, d, J=7.6Hz), 7.82-7.86 (1H, in), 7.72 (1H, d, J=8.3Hz), 7.63 (1 H, d, J=6.8Hz), 7.43-7.50 in), 7.21 (1 H, dd, J=7.6Hz, 7.14 (1 H, ddd, J=8.OHZ, J=8.OHz, J=1 .5Hz), 6.87 (1 H, dd, J=7.6Hz, J=1 .2Hz), 6.81 (1 H, dd, J=8.OHz, J=1. .1Hz), 4.61 (1 H, q, J=6.6Hz), 3.84 (3H, s), 2.85-2.99 (2H, in), 2.61-2.77 (2H, in), 1.78-1.86 (2H, in), 1.47 (3H, d, J=6.6Hz), m/z=351.

202 Example 267: Synthesis of S-1 S-i 20 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-methoxy-cebenzylmethylamine respectively by 2-methoxythiophenol, 1 ,4-dibromobutane and naphthyl)ethylamine.

400MHz-l H-NMR 8.17 (1 H, d, J=8.OHz), 7.85-7.88 (1 H, in), 7.73 (1 H, d, J=8.3Hz), 7.64 (1 H, d, J=7.1 Hz), 7.44-7.52 in), 7.21 (1 H, dd, J=7.8Hz, J=1 .6Hz), 7.13-7.18 (1 H, in), 6.89 (ddd, J=7.6Hz, J=7.6Hz, J=1 .2Hz), 6.82 (1 H, dd, J=8.3Hz, J=1 .2Hz), 4.62 (1 H, q, J=6.5Hz), 3.86 2.83-2.88 in), 2.52-2.65 in), 1.64-1.70 in), 1.49 d, J=6.5Hz), m/z=365.

Example 268: Synthesis of S-1 21 S-1 21 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 2-inethoxythiophenol, 1 ,5-dibromopentane and naphthyl)ethylamine.

400MHz- 1 H-NMR 8.17 (1 H, d, J=8.OHz), 7.83-7.88 (1 H, in), 7.71-7.75 (1 H, in), 7.63 (1 H, d, J=7.OHz), 7.41 -7.52 in), 7.21 (1 H, dd, J=7.6Hz, J=1.7Hz), 7.15 (1 H, ddd, J=7.6Hz, J=7.6Hz, J=1.7Hz), 6.90 (1 H, ddd, J=7.6Hz, J=7.6Hz, J=1.2Hz), 6.82 (1 H, dd, J=8.2Hz, J=1.1lHz), 4.61 (1 H, q, J=6.6Hz), 3.87 s), *2.85 t, J=7.3Hz), 2.50-2.62 in), 1.40-1.48 in), 1.49 d, J=6.6Hz), m/z=379.

Example 269: Synthesis of S-1 22 S-1 22 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 broino-2-chloroethane and (R)-(+)-3-methoxy-ct-benzylmethylamine respectively by 2-methoxythiophenol, 1 ,6-dibromohexane and naphthyl)ethylamine. m/z 393.

Example 270: Synthesis of S-1 23 203 S-1 23 was synthesized by almost the same method as the one employed for the synthesis of S-i but replacing the 2,5-dimethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 2-methoxythiophenol, 1 ,7-dibromoheptane and naphthyl) ethylamine.

400MHz- 1 H-NMR 8.15 (1 H, d, J=8.3Hz), 7.87 (1 H, dl, J=7.1 Hz), 7.70-7.78 (2H, in), 7.41-7.51 (3H, in), 7.21 (1 H, dd, J=7.6Hz, J=1.5Hz), 7.12-7.17 (1 H, in), 6.90 (1 H, ddd, J=7.6Hz, J=7.6Hz, J=1.2Hz), 6.80-6.83 (1 H, mn), 4.67-4.75 (1 H, in), 3.87 (3H, 2.84 (2H, t, J=7.3Hz), 2.51 -2.64 (2H, in), 1.05-1.64 (13H, in), in/z=407.

Example 271: Synthesis of S-1 24 S-1 24 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol, 1 ***broino-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine ~:respectively by 2-methoxythiophenol, 1 ,8-dibromooctane and naphthyl)ethylamine.

400MHz- 1 H-NMR 8.16 (1 H, d, J=8.3Hz), 7.86-7.89 (1 H, in), 7.70-7.78 (2H, in), 7.46-7.55 (3H, in), 7.22 (1 H, dd, J=7.6Hz, J=1.7Hz), 7.13-7.17 (1 H, in), 6.87- 6.92 (1 H, in), 4.70 (1 H, bs), 3.88 (3H, 2.85 (2H, t, J=7.4Hz), 2.52-2.64 (2H, in), 1.05-1.65 (15H, in), m/z=421.

Example 272: Synthesis of S-1 S-1 25 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethyithiol by 3- *methoxythiophenol.

400MHz-'H-NMR 7.22 (1H, d, J=8.OHz), 7.16 (1H, dd, J=8.OHz, J=8.OHz), 6.83-6.89 (4H, in), 6.77 (1 H, ddd, J=8.OHz, J=2.6Hz, J=1.OHz), 6.71 (1 H, ddd, J=2.6Hz, J=1.OHz), 3.80 (3H, 3.78 (3H, 3.74 (1 H, q, 3.02-3.06 (2H, in), 2.67-2.78 (2H, in), 1.35 (3H, dl, J=6.5Hz), m/z=317.

Example 273: Synthesis of S-1 26 S-1 26 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol and 204 1 -bromo-2-chloroethane respectively by 3-methoxythiophenol and 1,3di bromopropane.

400MHz- 1 H-NMR 7.23 (1 H, dd, J=8.OHz, J=8.OHz), 7.18 (1 H, dd, J=8.OHz, J=8.OHz), 6.86-6.89 (3H, in), 6.85 (1 H, dd, J=2.1lHz, J=2.1lHz), 6.78 (1 H, ddd, J=8.OHz, J=2.4Hz, J=1 .2Hz), 6.70 (1 H, ddd, J=8.4Hz, J=2.7Hz, J=1 .0Hz), 3.81 (3H, 3.78 (3H, 3.72 (1 H, q, J=6.6Hz), 2.88-3.02 (2H, in), 2.51-2.66 (2H, in), 1.74-1.87 (2H, in), 1.33 (3H, d, J=6.6Hz), mlz=331.

Example 274: Synthesis of 3-1 27 S-1 27 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthio phenol and 1 -broino-2-chloroethane respectively by 3-methoxythiophenol and 1,4dibromobutane.

400MHz- 1 H-NMR 7.23 (1 H, dd, J=8.OHz, J=8.OHz), 7.18 (1 H, dd, J=8.OHz, J=8.OHz), 6.86-6.89 (3H, in), 6.83-6.84 (1 H, in), 6.76-6.79 (1 H, in), 6.69 (1 H, ddd, J=8.OHz, J=2.4Hz, J=1 .0Hz), 3.81 (3H, 3.79 3.72 (1 H, q, J=6.6Hz), 2.89 (2H, t, J=7.1 Hz), 2.40-2.55 in), 1.53-1.72 (4H, in), 1.34 (4H, in), m/z=345.

Example 275: Synthesis of S-1 28 S-1 28 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1 -bromo-2-chloroethane respectively by 3-methoxythiophenol and dibromopentane.

400MHz- 1 H-NMR 7.23 (1 H, dd, J=8.OHz, J=8.OHz), 7.18 (1 H, dd, J=8.OHz, J=8.OHz), 6.86-6.89 (3H, in), 6.84 (1 H, dd, J=4.1lHz, J=4.1lHz), 6.76-6.79 (1 H, in), 6.70 (1 H, ddd, J=8.OHz, Jx2.4Hz, J=1 .0Hz), 3.81 (3H, 3.79 (3H, 3.72 (1 H, q, J=6.5Hz), 2.89 (2H, t, J=7.3Hz), 2.38-2.52 (2H, in), 1.59-1.67 (2H, in), 1.37-1.52 (4H, in), 1.34 (3H, d, J=6.5Hz), m/z=359.

Example 276: Synthesis of S-1 29 S-i 29 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethyithiophenol and 205 1 -bromo-2-chloroethane respectively by 3-methoxythiophenol and 1,6dibromohexane.

400MHz- 1 H-NMR 7.24 (1 H, dd, J=8.0Hz, J=8.OHz), 7.18 (1 H, dd, 6.86-6.90 in), 6.83-6.85 (1 H, in), 6.76-6.79 (1 H, in), 6.69 (1 H, ddd, J=8.3Hz, J=2.6Hz, J=1.OHz), 3.81 (3H, 3.79 3.72 (1 H, q, J=6.6Hz), 2.89 (2H, t, J=7.3Hz), 2.37-2.51 (2H, in), 1 .59-1.67 (2H, in), 1.24- 1.52 (6H, in), 1.35 (3H, d, J=6.6Hz), m/z=373.

Example 277: Synthesis of S-i S-1 30 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1 -bromo-2-chloroethane respectively by 3-methoxythiophenol and 1,7dibromoheptane.

**400MHz- 1 H-NMR 7.24 (1 H, dd, J=8.OHz, J=8.OHz), 7.18 (1 H, dd, J=8.OHz, -8.0Hz), 6.86-6.90 (3H, in), 6.76-6.80 (1 H, in), 6.69 (1 H, ddd, J=8.OHz, J=2.4Hz, J=1 .0Hz), 3.81 (3H, 3.79 (3H, 3.74 (1 H, q, J=6.6Hz), 2.89 (2H, t, J=7.3Hz), 2.38-2.52 (2H, in), 1.58-1.66 (2H, in), 1. 19-1.49 (8H, in), 1.37 (3H, d, J=6.6Hz), m/z=387.

Example 278: Synthesis of S-1 31 S-1 31 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol and 1 -bromo-2-chloroethane respectively by 3-methoxythiophenol and 1,8dibromooctane.

400MHz-'H-NMR 7.23 (1H, dd, J=8.OHz, =8.0Hz), 7.18 (1H, dd, J=8.OHz, J=8.OHz), 6.87-6.91 (3H, in), 6.84-6.85 (1 H, mn), 6.78 (1 H, ddd, J=8.OHz, J=2.4Hz, J=0.8Hz), 6.69 (1 H, ddd, J=8.OHz, J=2.4Hz, J=0.8Hz), 3.81 (3H, s), 3.79 (3H, 3.73 (1 H, q, J=6.5Hz), 2.89 (2H, t, J=7.4Hz), 2.38-2.52 (2H, in), 1.59-1.70 (2H, in), 1.20-1.50 (1 OH, in), 1.35 (3H, d, J=6.5Hz), m/z=401.

Example 279: Synthesis of S-i 32 S-1 32 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethyithiophenol and 206 -(+)-3-methoxy-a-benzylmethylamine respectively by 3-methoxythiophenol and -naphthyl)ethylamine.

400MHz-'H-NMR 8.15 (1 H, d, J=7.8Hz), 7.85-7.87 (1 H, in), 7.73 (1 H, d, J=8.3Hz), 7.63 (1 H, d, J=6.6Hz), 7.42-7.55 (3H, in), 7.12-7.16 (1 H, in), 6.85- 6.89 (2H, in), 6.69-6.72 (1 H, in), 4.63 (1 H, q, J=6.5Hz), 3.76 (1 H, 3.08 (2H, t, J=6.4Hz), 2.76-2.87 (2H, in), 1.49 (3H, d, J=6.5Hz), mlz=337.

Example 280: Synthesis of S-133 S-1 33 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol, 1 broino-2-chloroethane and (R)-(+)-3-inethoxy-ax-benzylmethylamine respectively by 3-methoxythiophenol, 1 ,3-dibromopropane and naphthyl) ethylamine.

400MHz-'H-NMR 8.18 (1 H, d, J=9.4Hz), 7.85-7.88 (1 H, in), 7.74 (1 H, d, *J=8.OHz), 7.63 (1H, d, J=6.6Hz), 7.44-7.52 (3H, in), 7.16 (1 H, dd, J=7.8Hz, J=7.8Hz), 6.84-6.89 (2H, in), 6.68-6.71 (1 H, mn), 4.61 (1 H, q, J=6.6Hz), 3.77 (3H, 2.91-3.04 (2H, in), 2.62-2.76 (2H, in), 1.80-1.90 (2H, in), 1.48 (3H, d, J=6.6Hz), in/z=351.

Example 281: Synthesis of S-134 34 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-inethoxy-at-benzylinethylamine respectively by 3-inethoxythiophenol, 1 ,4-dibromobutane and naphthyl)ethylamine.

**400MHz- 1 H-NMR 8.17 (1 H, d, J=8.OHz), 7.85-7.88 (1H, in), 7.73 (1 H, d, J=8.OHz), 7.63 (1 H, d, J=6.84Hz), 7.44-7.52 (3H, in), 7.16 (1 H, dd, J=7.8Hz, J=7.8Hz), 6.83-6.88 (2H, in), 6.67-6.70 (1 H, in), 4.62 (1 H, q, J=6.6Hz), 3.77 (3H, 2.89 (2H, t, J=7.1lHz), 2.51-2.65 (2H, in), 1.59-1.73 (4H, in), 1.49 (3H, d, J=6.6Hz), m/z=365.

Example 282: Synthesis of S-1 S-1 35 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 207 bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzyimethylamine respectively by 3-methoxyth io phenol, 1 ,5-dibromopentane and naphthyl) ethylamine.

400MHz- 1 H-NMR 8.17 (1 H, d, J=8.OHz), 7.85-7.88 (1 H, in), 7.74 (1 H, d, J=8.1lHz), 7.63 (1 H, d, J=6.6Hz), 7.43-7.52 in), 7.17 (1 H, dd, J=8.OHz, 6.85-6.88 (1 H, in), 6.84 (1 H, dd, J=2.1 Hz, J=2.1lHz), 6.69 (1 H, ddd, J=6.7Hz, J=2.4Hz, J=0.7Hz), 4.62 (1 H, q, J=6.6Hz), 3.78 2.88 t, J=7.3Hz), 2.50-2.63 in), 1.59-1.67 (2H, in), 1 .40-1.55 in), 1.49 d, J=6.6Hz), mlz=379.

Example 283: Synthesis of S-136 S-1 36 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-inethoxy-a-benzylinethylainine respectively by 3-methoxythiophenol, 1 ,6-dibromohexane and naphthyl)ethylamine.

:400MHz-'H-NMR 8.16 (1 H, d, J=8.3Hz), 7.80-7.88 in), 7.73-7.76 (1 H, in), 7.41 -7.53 in), 6.85-6.88 (1 H, in), 6.83 (1 H, dd, J=2.1lHz, J=2.1 Hz), 6.68 (1 H, ddd, J=8.4Hz, J=2.4Hz, J=0.9Hz), 4.67 (1 H, q, J=6.6Hz), 2.87 t, J=7.3Hz), 2.51 -2.63 in), 1.25-1.66 (11 H, mn), m/z=393.

Example 284: Synthesis of S-137 S-1 37 was synthesized by almost the same method as the one employed for the synthesis of S-i but replacing the 2,5-dimethylthiophenol, 1 broino-2-chloroethane and (R)-(+)-3-methoxy-a-benzylinethylamine respectively by 3-methoxythiophenol, 1 ,7-dibromoheptane and naphthyl)ethylamine.

400MHz- 1 H-NMR 8.15 (1 H, d, J=8.3Hz), 7.86-7.89 (1 H, in), 7.75-7.80 (2H, in), 7.45-7.55 in), 7.16 (1 H, dd, J=8.1 Hz, J=8.1 Hz), 6.82-6.88 (2H, in), 6.68 (1 H, ddd, J=8.3Hz, J=2.4Hz, J=0.7Hz), 4.70-4.78 (1 H, in), 3.78 (3H, 2.86 t, J=7.3Hz), 2.52-2.65 in), 1.05-1.65 (13H, in), in/z=407.

Example 285: Synthesis of S-138 208 S-138 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 3-methoxythiophenol, 1,8-dibromooctane and naphthyl)ethylamine.

400MHz- 1 H-NMR 8.14 (1H, d, J=8.0Hz), 7.87-7.89 (1H, 7.77 (1H, d, 7.47-7.55 (3H, 7.17 (1H, dd, J=8.1Hz, J=8.1Hz), 6.83-6.89 (2H, 6.68 (1H, ddd, J=8.3Hz, J=2.4Hz, J=1.OHz), 4.75 (1H, bs), 3.78 (3H, s), 2.88 (2H, t, J=7.3Hz), 2.53-2.66 (2H, 1.00-1.75 (15H, mlz=421.

Example 286: Synthesis of S-139 S-139 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiol by 4methoxythiophenol.

S. 400MHz-'H-NMR 7.28 (2H, d, J=8.0Hz), 7.21 (1H, dd, J=8.0Hz, 6.75-6.88 (5H, 3.80 (3H, 3.78 (3H, 3.70 (1H, q, J=6.6Hz), 2.88-2.93 (2H, 2.57-2.70 (2H, 1.34 (3H, d, J=6.6Hz), m/z=317.

Example 287: Synthesis of S-140 S-140 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1 -bromo-2-chloroethane respectively by 4-methoxythiophenol and 1,3dibromopropane.

****400MHz-'H-NMR 7.31 (2H, d, J=8.8Hz), 7.23 (1H, dd, J=8.1Hz, J=8.1Hz), 6.85-6.88 (2H, 6.82 (2H, d, J=8.8Hz), 6.77 (1H, ddd, J=8.2Hz, J=2.7Hz, J=1.OHz), 3.80 (3H, 3.79 (3H, 3.70 (1H, q, J=6.6Hz), 2.77-2.89 (2H, m), 2.49-2.64 (2H, 1.64-1.80 (2H, 1.32 (3H, d, J=6.6Hz), m/z=331.

Example 288: Synthesis of S-141 S-141 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1 -bromo-2-chloroethane respectively by 4-methoxythiophenol and 1,4dibromobutane.

209 400MHz- 1 H-NMR 7.31 d, J=8.8Hz), 7.23 (1 H, dd, J=8.OHz, J=8.OHz), 6.85-6.89 (2H, in), 6.82 (2H, d, J=8.8Hz), 6.76-6.79 (1 H, in), 3.81 (3H, 3.79 3.71 (1 H, q, J=6.6Hz), 2.75-2.80 in), 2.33-2.53 in), 1.53-1.62 (4H, in), 1.33 (3H, d, J=6.6Hz), mlz=345.

Example 289: Synthesis of S-142 3-1 42 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethyithiophenol and 1 -bromo-2-chloroethane respectively by 4-methoxythiophenol and 1 dibroinopentane.

400MHz- 1 H-NMR 7.31 d, J=8.8Hz), 7.23 (1 H, dd, J=8.OHz, J=8.OHz), 6.86-6.89 in), 6.83 d, J=8.8Hz), 6.76-6.80 (1 H, in), 3.81 3.79 3.71 (1 H, q, J=6.6Hz), 2.78 t, J=7.3Hz), 2.38-2.52 in), 1.50- 1.60 in), 1.36-1.50 in), 1.34 d, J=6.6Hz), in/z=359.

Example 290: Synthesis of S-143 :S-1 43 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol and 1 -bromo-2-chloroethane respectively by 4-methoxythiophenol and 1,6dibromohexane.

*400MHz- 1 H-NMR 7.31 (2H, d, J=8.8Hz), 7.23 (1 H, dd, J=8.OHz, J=8.OHz), 6.87-6.90 in), 6.81-6.85 (2H, in), 6.76-6.80 (1 H, in), 3.81 (3H, 3.79 (3H, 3.73 (1 H, q, J=6.6Hz), 2.78 t, J=7.3Hz), 2.38-2.51 in), 1.21-1.59 in), 1.35 d, J=6.6Hz), m/z=373.

Example 291: Synthesis of S-144 :S-1 44 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1 -bromo-2-chloroethane respectively by 4-methoxythiophenol and 1,7dlibroinoheptane.

400MHz-1 H-NMR 7.32 d, J=8.8Hz), 7.24 (1 H, dd, J=8.OHz, J=8.OHz), 6.88-6.91 in), 6.83 (2H, d, J=8.8Hz), 6.76-6.80 (1 H, in), 3.81 (3H, 3.79 3.75 (1 H, q, J=6.6Hz), 2.78 (2H, t, J=7.4Hz), 2.38-2.52 in), 1 210 1.60 in), 1.20-1.30 (4H, in), 1.32-1.40 (2H, in), 1.37 (3H, d, J=6.6Hz), mlz=387.

Example 292: Synthesis of S-1 S-1 45 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethyithiophenol and 1 -bromo-2-chloroethane respectively by 4-inethoxythiophenol and 1,8dibromooctane.

400MHz-1 H-NMR 7.29-7.33 (2H, in), 7.25 (1 H, dd, J=8.OHz, J=8.OHz), 6.92- 6.99 (2H, rn), 6.79-6.85 (2H, in), 3.83 (3H, 3.79 (3H, 3.81-3.84 (1 H, mn), 2.78 (2H, t, J=7.4Hz), 2.43-2.56 (2H, in), 1.43-1.60 (4H, in), 1.19-1.40 (8H, in), 1.48 (3H, d, J=5.9Hz), m/z=401.

Example 293: Synthesis of S-146 S-1 46 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethyithiophenol and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 4-methoxythiophenol and -naphthyl)ethylamine.

400MHz- 1 H-NMR 8.15 (1 H, d, J=7.6Hz), 7.85-7.89 (1lH, in), 7.73 (1 H, d, J=8.2Hz), 7.62 (1 H, d, J=6.6Hz), 7.42-7.52 (3H, in), 7.27-7.30 (2H, in), 6.75- 6.80 (2H, in), 4.61 (1 H, q, J=6.5Hz), 3.78 (3H, 2.97 (2H, t, J=6.2Hz), 2.68- 2.78 (2H, in), 1.48 (3H, d, J=6.5Hz), m/z=337.

Example 294: Synthesis of S-147 S-1 47 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 broino-2-chloroethane and (R)-(+)-3-methoxy-ca-benzylmethylamine respectively by 4-methoxythiophenol, 1 ,3-dibromopropane and naphthyl)ethylamine.

400MHz-'H-NMR 8.15 (1H, d, J=7.8Hz), 7.85-7.88 (1 H, in), 7.74 (1 H, d, J=8.3Hz), 7.64 (1 H, d, J=7.1 Hz), 7.46-7.52 (3H, in), 7.27-7.31 (2H, in), 6.77- 6.82 (2H, in), 4.61 (1 H, q, J=6.5Hz), 3.78 (3H, 2.79-2.92 (2H, in), 2.61 -2.75 (2H, in), 1.73-1.81 (2H, mn), 1.49 (3H, d, J=6.5Hz), m/z=351.

211 Example 295: Synthesis of S-148 S-1 48 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 4-methoxythiophenol, 1 ,4-dibromobutane and naphthyl)ethylamine.

400MHz- 1 H-NMR 8.16 (1 H, d, J=8.OHz), 7.85-7.88 (1 H, in), 7.74 (1 H, d, J=8.3Hz), 7.64 (1 H, d, J=6.4Hz), 7.45-7.53 in), 7.28-7.31 in), 6.78- 6.82 in), 4.62 (1 H, q, J=6.4Hz), 3.78 2.78 t, J=6.7Hz), 2.49- 2.63 in), 1.46-1.68 in), 1.49 d, J=6.4Hz), mlz=365.

Example 296: Synthesis of S-1 49 3-1 49 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylainine respectively by 4-methoxythiophenol, 1 ,5-dibromopentane and naphthyl)ethylamine.

400MHz-'H-NMR 8.17 (1 H, d, J=8.3Hz), 7.83-7.88 (1 H, in), 7.74 (1 H, d, J=8.OHz), 7.63 (1 H, d, J=7.1 Hz), 7.46-7.53 in), 7.28-7.32 (2H, in), 6.79- 6.83 in), 4.62 (1 H, q, J=6.6Hz), 3.78 2.78 t, J=7.3Hz), 2.48- 2.61 in), 1.46-1.60 in), 1.49 d, J=6.6Hz), 1.36-1.44 in), m/z=379.

Example 297: Synthesis of S-1 S-1 50 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-inethoxy-a-benzylmethylainine respectively by 4-inethoxythiophenol, 1 ,6-dibromohexane and naphthyl)ethylainine.

400MHz- 1 H-NMR 8.17 (1 H, d, J=8.OHz), 7.82-7.88 (1 H, in), 7.74 (1 H, d, J=8.3Hz), 7.65 (1 H, d, J=7.1 Hz), 7.41 -7.54 in), 7.28-7.33 (2H, in), 6.80- 6.84 in), 4.63 (1 H, q, J=6.4Hz), 3.78 2.75-2.79 (2H, in), 2.49-2.61 in), 1.24-1.58 (8H, in), m/z=393.

212 Example 298: Synthesis of S-151 S-151 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 4-methoxythiophenol, 1,7-dibromoheptane and naphthyl)ethylamine.

400MHz- 1 H-NMR 8.15 (1H, d, J=8.0Hz), 7.86-7.88 (1H, 7.71-7.77 (2H, m), 7.46-7.54 (3H, 7.29-7.32 (2H, 6.80-6.84 (2H, 4.69 (1H, bs), 3.80 (3H, 2.77 (2H, t, J=7.5Hz), 2.51-2.64 (2H, 1.00-1.64 (13H, m/z=407.

Example 299: Synthesis of S-152 S-152 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 4-methoxythiophenol, 1,8-dibromooctane and naphthyl)ethylamine.

400MHz- 1 H-NMR 8.15 (1H, d, J=8.0Hz), 7.86-7.89 (1H, 7.71-7.77 (2H, m), 7.45-7.54 (3H, 7.29-7.33 (2H, 6.80-6.85 (2H, 4.66-4.76 (1H, m), 3.78 (3H, 2.78 (2H, t, J=7.3Hz), 2.51-2.64 (2H, 1.05-1.56 (15H, m), m/z=421.

Example 300: Synthesis of S-153 S-153 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiol by 2,3,5,6-tetrafluorothiophenol.

400MHz-'H-NMR 7.21 (1H, dd, J=8.0Hz, J=8.0Hz), 6.96-7.06 (1H, 6.82- 6.86 (2H, 6.74-6.77 (1 H, 3.80 (3H, 3.70 (1 H, q, J=6.6Hz), 3.03 (2H, t, 2.55-2.67 (2H, 1.34 (3H, d, J=6.6Hz), m/z=359.

Example 301: Synthesis of S-154 S-154 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1-bromo-2-chloroethane respectively by 2,3,5,6-tetrafluorothiophenol and 1,3dibromopropane.

213 400MHz- 1 H-NMR 7.23 (1H, dd, J=8.3Hz, J=8.3Hz), 6.97-7.06 (1H, 6.84- 6.87 (2H, 6.74-6.79 (1H, 3.81 (3H, 3.70 (1H, q, J=6.6Hz), 2.90-3.03 (2H, 2.49-2.65 (2H, 1.66-1.75 (2H, 1.33 (3H, d, J=6.6Hz), m/z=373.

Example 302: Synthesis of S-155 S-155 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1 -bromo-2-chloroethane respectively by 2,3,5,6-tetrafluorothiophenol and 1,4dibromobutane.

400MHz- 1 H-NMR 7.23 (1H, dd, J=8.1Hz.J=8.1Hz), 6.97-7.06 (1H, 6.84- 6.88 (2H, 6.76-6.78 (1H, 3.81 (3H, 3.70 (1 H, q, J=6.6Hz), 2.91 (2H, t, J=6.6Hz), 2.37-2.53 (2H, 1.53-1.63 (4H, 1.32 (3H, d, J=6.6Hz), m/z=387.

:Example 303: Synthesis of S-156 S-156 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and S1 -bromo-2-chloroethane respectively by 2,3,5,6-tetrafluorothiophenol and dibromopentane.

400MHz- H-NMR 7.23 (1H, dd, J=8.0Hz, J=8.0Hz), 6.96-7,.05 (1H, 6.85- 6.89 (2H, 6.75-6.79 (1H, 3.81 (3H, 3.71 (1 H, q, J=6.5Hz), 2.91 (2H, t, J=7.3Hz), 2.37-2.51 (2H, 1.50-1.59 (2H, 1.36-1.46 (4H, 1.33 (3H, d, "J=6.6Hz), m/z=401.

Example 304: Synthesis of S-157 S-157 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1-bromo-2-chloroethane respectively by 2,3,5,6-tetrafluorothiophenol and 1,6dibromohexane.

400MHz- H-NMR 7.23 (1H, dd, J=8.1Hz, J=8.1Hz), 6.97-7.06 (1H, 6.86- 6.89 (2H, 6.78-6.79 (1H, 3.81 (3H, 3.72 (1 H, q, J=6.6Hz), 2.91 (2H, t, J=7.3Hz), 2.37-2.51 (2H, 1.51-1.58 (2H, 1.23-1.49 (6H, 1.34 (3H, d, J=6.6Hz), m/z=415.

214 Example 305: Synthesis of S-158 S-158 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1-bromo-2-chloroethane respectively by 2,3,5,6-tetrafluorothiophenol and 1,7dibromoheptane.

400MHz-'H-NMR 7.24 (1H, dd, J=8.0Hz, J=8.0Hz), 6.97-7.05 (1H, 6.88- 6.90 (2H, 6.78 (1H, 3.81 (3H, 3.74 (1H, q, J=6.7Hz), 2.91 (2H, t, J=7.3Hz), 2.38-2.51 (2H, 1.20-1.58 (8H, 1.36 (3H, d, J=6.7Hz), m/z=429.

Example 306: Synthesis of S-159 S-159 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and -bromo-2-chloroethane respectively by 2,3,5,6-tetrafluorothiophenol and 1,8dibromooctane.

400MHz-'H-NMR 7.22-7.26 (1H, 6.97-7.05 (1H, 6.89-6.92 (2H, m), 6.78-6.81 (1H, 3.81 (3H, 3.77 (1H, q, J=6.6Hz), 2.91 (2H, t, J=7.4Hz), 2.40-2.54 (2H, 1.17-1.57 (12H, 1.40 (3H, d, J=6.6Hz), m/z=443.

Example 307: Synthesis of S-160 S-160 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 2,3,5,6tetrafluorothiophenol and (R)-(+)-1-(1-naphthyl)ethylamine.

400MHz- 1 H-NMR 8.15 (1H, d, J=8.3Hz), 7.84-7.89 (1H, 7.72 (1H, d, J=8.3Hz), 7.61 (1H, d, J=7.1Hz), 7.48 (1H, d, J=7.1Hz), 7.43-7.52 (3H, m), 6.95-7.03 (1H, 4.61 (1H, q, J=6.6Hz), 3.06 (2H, t, J=6.1Hz), 2.65-2.75 (2H, 1.48 (3H, d, J=6.6Hz), m/z=379.

Example 308: Synthesis of S-161 S-161 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine 215 respectively by 2,3,5,6-tetrafluorothiophenol, 1 ,3-dibromopropane and 1 -naphthyl)ethylamine.

400MHz-1 H-NM R 8.16 (1 H, d, J=8.OHz), 7.85-7.88 (1 H, in), 7.74 (1 H, d, J=8.3Hz), 7.61 (1 H, d, J=6.6Hz), 7.44-7.52 in), 6.95-7.04 (1 H, in), 4.60 (1 H, q, J=6.5Hz), 2.93-3.05 in), 2.61-2.75 in), 1.68-1.78 in), 1 .48 (3H, d, J=6.5Hz), mlz=393.

Example 309: Synthesis of 3-162 S-1 62 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol, 1 bromo-2-chloroethane and -3-methoxy-a-benzylinethylainine respectively by 2,3,5,6-tetrafluorothiophenol, 1 ,4-dibromobutane and 1 -naphthyl)ethylamine.

400MHz-1 H-NMR 8.17 (1 H, d, J=8.3Hz), 7.85-7.87 (1 H, in), 7.73 (1 H, d, J=8.3Hz), 7.62 (1 H, d, J=7.1 Hz), 7.44-7.52 (3H, in), 6.95-7.04 (1 H, in), 4.61 (1 H, q, J=6.6Hz), 2.90 t, J=6.7Hz), 2.48-2.62 in), 1.57-1.63 in), 1.48 d, J=6.6Hz), m/z=407.

Example 310: Synthesis of 3-1 63 3-1 63 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 :.bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 2,3,5,6-tetrafluorothiophenol, 1 ,5-dibroinopentane and 1 -naphthyl)ethylamine.

400MHz-1 H-NMR 8.17 (1 H, d, J=8.3Hz), 7.85-7.88 (1 H, in), 7.74 (1 H, d, J=8.3Hz), 7.63 (1 H, d, J=6.8Hz), 7.44-7.52 (3H, in), 6.95-7.04 (1 H, in), 4.61 (1 H, q, J=6.6Hz), 2.90 t, J=7.2Hz), 2.48-2.62 in), 1.38-1.58 in), 1.49 d, J=6.6Hz), in/z=421.

Example 311: Synthesis of S-1 64 S-1 64 was synthesized by almost the same method as'the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol, 1 bromo-2-chloroethane and -(+)-3-inethoxy-ct-benzylinethylamine 216 respectively by 2,3,5,6-tetrafluorothiophenol, 1 ,6-dibromohexane and 1 -naphthyl)ethylamine.

400MHz- 1 H-NMR 8.17 (1 H, d, J=8.3Hz), 7.85-7.88 (1 H, in), 7.74 (1 H, d, J=8.1lHz), 7.65 (1 H, d, J=7.1lHz), 7.45-7.53 (3H, in), 6.98-7.02 (1 H, in), 4.63 (1 H, q, J=6.6Hz), 2.89 t, J=7.3Hz), 2.47-2.62 (2H, in), 1.23-1.57 (8H, in), 1.50 d, J=6.6Hz), mlz=435.

Example 312: Synthesis of S-1 S-1 65 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 broino-2-chloroethane and (R)-(+)-3-methoxy-a-benzylinethylamine respectively by 2,3,5,6-tetrafluorothiophenol, 1 ,7-dibroinoheptane and 1 -naphthyl)ethylamine.

:400MHz-' H-NMR 8.13 (1 H, d, J=8.3Hz), 7.87-7.89 (1 H, in), 7.78 (1 H, d, 0 go J=8.OHz), 7.47-7.56 (3H, in), 6.95-7.04 (1 H, in), 4.79 (1 H, q, J=6.4Hz), 2.87 (2H, t, J=7.3Hz), 2.52-2.68 (2H, in), 1.02-1.70 (1iOH, in), 1.65 (3H, d, J=6.4Hz), m/z=449.

0go Example 313: Synthesis of S-1 66 S-1 66 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol, 1 ego*,broino-2-chloroethane and (R)-(+)-3-inethoxy-a-benzylinethylamine 5555.respectively by 2,3,5,6-tetrafluorothiophenol, 1 ,8-dibroinooctane and 1 -naphthyl)ethylamine.

400MHz-'H-NMR 8.11 (1H, d, J=8.5Hz), 7.88-7.91 (1H, in), 7.80 (1H, d, J=8.3Hz), 7.44-7.57 (3H, in), 6.95-7.03 (1 H, in), 4.89 (1 H, bs), 2.88 (2H, t, J=7.3Hz), 2.54-2.72 (2H, in), 1.00-1.80 (15H, in), m/z=463.

Example 314: Synthesis of S-1 67 S-1 67 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethyithiol by chloro-2-mercaptobenzothiazole.

400MHz- 1 H-NMR 7.80 (1iH, d, J=1.7Hz), 7.63 (1 H, dd, J=8.6Hz, J=1.2Hz), 7.18-7.28 (2H, in), 6.86-6.90 (2H, in), 6.74-6.78 (1 H, in), 3.80 (3H, 3.77- 217 3.82 (1 H, in), 3.43-3.47 (2H, in), 2.85-3.00 in), 1.35 (3H, d, J=6.6Hz), mlz=378.

Example 315: Synthesis of S-i 68 3-1 68 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethyithiophenol and 1 -bromo-2-chloroethane respectively by 5-oh loro-2-mercaptobenzothiazole and 1 ,3-dibromopropane.

400MHz-'H-NMR 7.79 (1 H, d, J=2.OHz), 7.63 (1 H, d, J=8.2Hz), 7.19-7.27 (2H, in), 6.87-6.89 (2H, in), 6.77-6.79 (1 H, in), 3.80 (3H, 3.74 (1 H, q, J=6.6Hz), 3.33-3.47 (2H, in), 2.55-2.72 (2H, in), 1 .93-2.00 (2H, in), 1.35 (3H, dl, J=6.6Hz), m/z=392.

Example 316: Synthesis of S-1 69 :S-1 69 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1 -bromo-2-chloroethane respectively by 5-chloro-2-mercaptobenzothiazole and 1 ,4-dibromobutane.

400MHz- 1 H-NMR 7.82 (1 H, d, J=2.OHZ), 7.63 (1 H, d, J=8.5Hz), 7.21 -7.27 (2H, mn), 6.87-6.90 (2H, in), 6.76-6.79 (1 H, in), 3.80 (3H, 3.73 (1 H, q, J=6.6Hz), 3.32 (2H, t, J=7.3Hz), 2.45-2.60 (2H, in), 1.78-1.90 (2H, in), 1.59-1.65 (2H, in), 1.34 (3H, d, J=6.6Hz), m/z=406.

Example 317: Synthesis of S-170 S-1 70 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1 -broino-2-chloroethane respectively by 5-chloro-2-mercaptobenzothiazole and 1 400MHz- 1 H-NMR 7.83 (1 H, d, J=2.OHz), 7.63 (1 H, d, J=7.6Hz), 7.20-7.27 (2H, in), 6.86-6.87 (2H, in), 6.75-6.78 (1 H, in), 3.81 (3H, 3.72 (3H, 3.72 (1 H, q, J=6.6Hz), 3.31 (2H, t, J=7.3Hz), 2.41 -2.55 (2H, in), 1.80 (2H, tt, J=7.3Hz, J=7.3Hz), 1.43-1.57 (4H, in), 1.34 (3H, d, J=6.6Hz), m/z=420.

Example 318: Synthesis of S-1 71 218 S-i 71 was synthesized by almost the same method as the one employed for the synthesis of S-i but replacing the 2,5-dimethylth io phenol and 1 -bromo-2-chloroethane respectively by 5-chloro-2-mercaptobenzothiazole and 1 ,6-dibromohexane.

400MHz- 1 H-NMR 7.82-7.83 (1 H, in), 7.63 (1 H, dd, J=8.6Hz, J=1.7Hz), 7.19- 7.26 in), 6.88-6.93 in), 6.75-6.81 (1 H, in), 3.82 3.75-3.83 (1 H, in), 3.30 t, J=7.3Hz), 2.42-2.56 in), 1.79 tt, J=7.3Hz, J=7.3Hz), 1.30-1.56 in), 1.40 d, J=6.4Hz), inlz=434.

Example 319: Synthesis of S-1 72 S-1 72 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethyithio phenol and 1 -broino-2-chloroethane respectively by 5-chloro-2-inercaptobenzothiazole and 1 ,7-dibromoheptane.

400MHz-1 H-NMR 7.83 (1 H, d, J=2.2Hz), 7.63 (1 H, d, J=8.3Hz), 7.24-7.27 (2H-, in), 6.89-6.92 in), 6.77-6.80 (1 H, in), 3.81 3.77 (1 H, q, J=6.6Hz), 3.31 t, J=7.3Hz), 2.41 -2.45 (2H, in), 1.79 tt, J=7.3Hz, =7.3Hz), 1.21 1.55 in), 1.40 d, J=6.6Hz), in/z=448.

Example 320: Synthesis of S-1 73 S-1 73 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol and 1 -broino-2-chloroethane respectively by 5-chloro-2-mercaptobenzothiazole and 1 ,8-dibroinooctane.

:400MHz- 1 H-NMR 8.83 (1 H, d, J=1.6Hz), 7.63 (1 H, d, J=8.5Hz), 7.22-7.27 (2H, in), 6.91 -6.94 in), 6.80 (1 H, dd, J=8.3Hz, J=2.7Hz), 3.82 (3H, 3.78-3.85 (1 H, in), 3.31 t, J=8.8Hz), 2.42-2.53 in), 1.79 (2H, tt, J=8.8Hz, J=8.8Hz), 1.20-1.57 (1 OH, in), 1.43 d, J=6.3Hz), in/z=462.

Example 321: Synthesis of S-1 74 S-1 74 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 5-chloro-2mercaptobenzothiazole and -naphthyl) ethyl ami ne m/z 398.

219 Example 322: Synthesis of S-i S-1 75 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-methoxy-ct-benzylmethylamine respectively by 5-chloro-2-mercaptobenzothiazole, 1 ,3-dibromopropane and -nap hthyl) ethylamine.

400MHz- 1 H-NMR 8.18 (1H, d, J=7.3Hz), 7.84-7.88 (1H, in), 7.73-7.76 (2H, in), 7.64 (1 H, d, J=7.8Hz), 7.62 (1 H, d, J=8.3Hz), 7.43-7.48 (3H, in), 7.23-7.26 (1 H, in), 4.63 (1 H, q, J=6.6Hz), 3.35-3.50 (2H, in), 2.67-2.82 (2H, in), 2.01 (2H, tt, J=6.9Hz, J=6.9Hz), 1.50 (3H, d, J=6.6Hz), mlz=412.

Example 323: Synthesis of S-1 76 S-i 76 was synthesized by almost the same method as the one **employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 5-chloro-2-mercaptobenzothiazole, 1 ,4-dibromobutane and -naphthyl)ethylamine.

400MHz- 1 H-NMR 8.18 (1 H, d, J=8.1lHz), 7.84-7.87 (1 H, in), 8.80 (1 H, d, J=1.9Hz), 7.73 (1 H, d, J=8.3Hz), 7.65 (1 H, d, J=6.8Hz), 7.62 (1 H, d, J=8.3Hz), 7.43-7.52 (3H, in), 7.23-7.26 (1 H, mn), 4.63 (1 H, q, J=6.6Hz), 3.31 (2H, t, J=7.2Hz), 2.56-2.70 (2H, in), 1.82-1.90 (2H, in), 1 .68 (2H, if, J=7.2Hz, J=7.2Hz), 1.49 (3H, d, J=6.6Hz), in/z=426.

Example 324: Synthesis of S-1 77 :S-1 77 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylainine respectively by 5-chloro-2-inercaptobenzothiazole, 1 ,5-dibromopentane and -naphthyl)ethylainine.

400MHz- 1 H-NMR 8.17 (1 H, d, J=8.3Hz), 7.82-7.87 (2H, in), 7.71 -7.42 (1 H, in), 7.58-7.64 (2H, in), 7.41-7.52 (3H, in), 7.23-7.26 (1 H, in), 4.62 (1 H, q, J=6.6Hz), 3.30 (2H, t, J=7.3Hz), 2.51 -2.65 (2H, in), 1.79 (2H, if, J=7.3Hz, J=7.3Hz), 1.58-1.60 (4H, in), 1.49 (3H, d, J=6.6Hz), m/z=440.

220 Example 325: Synthesis of 3-1 78 S-1 78 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 bromo-2-chloroethane and -(+)-3-methoxy-ct-benzylmethylamine respectively by 5-chloro-2-mercaptobenzothiazole, 1, 6-dibromohexane and -naphthyl)ethylamine.

400MHz- 1 H-NMR 8.17 (1 H, d, J=8.5Hz), 7.82-7.88 in), 7.71-7.75 (1 H, in), 7.65 (1 H, d, J=7.1 Hz), 7.62 (1 H, d, J=8.5Hz), 7.42-7.52 (3H, mn), 7.23-7.26 (1 H, in), 4.63 (1 H, q, J=6.6Hz), 3.29 t, J=7.3Hz), 2.51-2.64 in), 1.78 tt, J=7.3Hz, J=7.3Hz), 1.32-1.56 in), 1 .50 (3H, d, J=6.6Hz), in/z=454.

Example 326: Synthesis of S-1 79 S-1 79 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 bromo-2-chloroethane and -(+)-3-methoxy-a-benzylmethylamine respectively by 5-chloro-2-mercaptobenzothiazole, 1 ,7-dibromoheptane and -naphthyl) ethylamine.

400MHz- 1 H-NMR 8.15 (1 H, d, J=8.3Hz), 7.86-7.88 (1 H, in), 7.82-7.83 (1 H, mn), 7.72-7.78 in), 7.62 (1 H, dd, J=8.6Hz, J=0.5Hz), 7.45-7.55 in), 7.23- 7.26 (1 H, in), 4.71 (1 H, q, J=6.6Hz), 3.29 (1 H, t, J=7.3Hz), 2.50-2.66 in), 1.71-1.80 (2H, in), 1.58 (3H, d, J=6.6Hz), 1.06-1.64 (8H, mn), m/z=468.

Example 327: Synthesis of S-180 S-1 80 was synthesized by almost the same method as the one :employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 5-chloro-2-mercaptobenzothiazole, 1 ,8-dibromooctane and -naphthyl)ethylamine.

400MHz- 1 H-NMR 8.15 (1 H, d, J=8.3Hz), 7.85-7.88 (1 H, in), 7.83 (1 H, d, J=2.4Hz), 7.45 (1 H, d, J=8.OHz), 7.71 (1 H.d.J=6.8Hz), 7.62 (1 H, d, J=8.6Hz), 7.45-7.54 (1 H, in), 7.23-7.24 (1 H, in), 4.70 (1 H, q, J=6.6Hz), 3.30 (2H, t, J=7.3Hz), 2.52-2.65 in), 1.68-1.84 in), 1 .56 (3H, d, J=6.6Hz), 1.06- 1.59 (1 OH, in), m/z=482.

221 Example 328: Synthesis of S-181 S-181 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiol by 2,3,5,6-tetrachloro-4-mercaptopyridine.

400MHz- 1 H-NMR 7.23 (1H, d, J=8.0Hz), 6.84-6.87 (2H, 6.76-6.79 (1H, m), 3.81 (3H, 3.69 (1H, q, J=6.6Hz), 3.06-3.19 (2H, 2.50-2.66 (2H, 1.69 (2H, tt, J=7.0Hz, J=7.0Hz), 1.33 (3H, d, J=6.6Hz), m/z=424, 426.

Example 329: Synthesis of S-182 S-182 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1-bromo-2-chloroethane respectively by 2,3,5,6-tetrachloro-4mercaptopyridine and 1,3-dibromopropane. m/z 438, 440.

Example 330: Synthesis of S-183 S-183 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1 -bromo-2-chloroethane respectively by 2,3,5,6-tetrachloro-4mercaptopyridine and 1,4-dibromobutane. m/z 452, 454.

Example 331: Synthesis of S-184 S-184 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1 -bromo-2-chloroethane respectively by 2,3,5,6-tetrachloro-4mercaptopyridine and 400MHz- 1 H-NMR 7.24 (1H, dd, J=8.0Hz, J=8.0Hz), 6.86-6.88 (2H, 6.76- 6.79 (1H, 3.05 (2H, t, J=7.3Hz), 3.81 (3H, 3.71 (1H, q, J=6.5Hz), 2.38- 2.52 (2H, 1.55 (2H, tt, J=7.1Hz, J=7.1Hz), 1.36-1.50 (4H, 1.34 (3H, d, m/z=466, 468.

Example 332: Synthesis of S-185 S-185 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1-bromo-2-chloroethane respectively by 2,3,5,6-tetrachloro-4mercaptopyridine and 1,6-dibromohexane.

222 400MHz-'H-NMR 7.23 (1H, dd, J=8.0Hz, J=8.0Hz), 6.86-6.89 (2H, 6.76- 6.81 (1H, 3.81 (3H, 3.72 (1H, q, J=6.6Hz), 3.05 (2H, t, J=7.3Hz), 2.37- 2.52 (2H, 1.55 (2H, tt, J=7.2Hz, J=7.2Hz), 1.23-1.49 (6H, 1.34 (3H, d, J=6.6Hz), m/z=480, 482.

Example 333: Synthesis of S-186 S-186 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1-bromo-2-chloroethane respectively by 2,3,5,6-tetrachloro-4mercaptopyridine and 1,7-dibromoheptane.

400MHz-'H-NMR 7.24 (1H, dd, J=8.2Hz, J=8.2Hz), 6.87-6.90 (2H, 6.76- 6.81 (1H, 3.81 (3H, 3.72 (1H, q, J=6.6Hz), 3.05 (2H, t, J=7.3Hz), 2.38- 2.51 (2H, 1.55 (2H, tt, J=7.3Hz, J=7.3Hz), 1.20-1.49 (8H, 1.35 (3H, d, J=6.6Hz), m/z=494, 496.

Example 334: Synthesis of S-187 S-187 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1 -bromo-2-chloroethane respectively by 2,3,5,6-tetrachloro-4mercaptopyridine and 1,8-dibromooctane.

400MHz-'H-NMR 7.24 (1H, dd, J=8.0Hz, J=8.0Hz), 6.88-6.90 (2H, 6.76- 6.79 (1H, 3.81 (3H, 3.73 (1H, q, J=6.6Hz), 3.06 (2H, t, J=7.3Hz), 2.39- 2.53 (2H, 1.55 (2H, tt, J=7.3Hz, J=7.3Hz), 1.20-1.50 (10H, 1.35 (3H, d, J=6.6Hz), m/z=508, 510.

*Example 335: Synthesis of S-188 S-188 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 2,3,5,6-tetrachloro-4mercaptopyridine and (R)-(+)-1-(1-naphthyl)ethylamine. m/z 444, 446.

Example 336: Synthesis of S-189 S-189 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine 223 respectively by 2,3,5, 6-tetrachloro-4-mercaptopyrid ine, 1 ,3-d ibromo propane and -naphthyl)ethylamine.

400MHz- 1 H-NMR 8.17 (1 H, d, J=7.8Hz), 7.85-7.88 (1 H, in), 7.74 (1 H, d, J=8.OHz), 7.60 (1 H, d, J=6.8Hz), 7.44-7.52 (3H, in), 4.60 (1 H, q, 3.08-3.21 (2H, in), 2.61-2.75 (2H, mn), 1.69-1.76 (2H, in), 1.49 (3H, d, mlz=458, 460.

Example 337: Synthesis of S-i S-1 90 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol, 1 bromo-2-chloroethane and -3-methoxy-a-benzylmethylamine respectively by 2,3,5,6-tetrachloro-4-mercaptopyridine, 1 ,4-dibroinobutane and -naphthyl)ethylainine.

400MHz-1 H-NMR 8.40 (1 H, d, J=8.OHz), 7.82-7.88 (1 H, in), 7.69-7.75 (2H, in), 7.43-7.51 (3H, in), 4.04 (1 H, q, J=6.6Hz), 2.47-2.70 (4H, in), 1.78-1.82 (4H, in), 1.53 (3H, dl, J=6.6Hz), m/z=472, 474.

Example 338: Synthesis of S-1 91 S-1 91 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 2,3,5,6-tetrachloro-4-mercaptopyridine, 1 and -naphthyl)ethylamine.

400MHz- 1 H-NMR 8.17 (1 H, d, J=8.3Hz), 7.85-7.88 (1 H, in), 7.75 (1 H, d, :J=8.OHz), 7.66 (1 H, dl, J=6.8Hz), 7.45-7.53 (3H, in), 4.64 (1 H, q, J=6.6Hz), 3.03 (2H, t, J=7.2Hz), 2.49-2.63 (2H, in), 1.35-1.60 (9H, in), m/z=486, 488.

Example 339: Synthesis of S-1 92 S-1 92 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-methoxy-ct-benzylmethylamine respectively by 2,3,5,6-tetrachloro-4-niercaptopyridine, 1 ,6-dibromohexane and -naphthyl)ethylamine.

224 400MHz- 1 H-NMR 8.16 (1 H, d, J=8.OHz), 7.86-7.89 (1 H, in), 7.76 (1 H, dl, J=8.3Hz), 7.70 (1 H, bs), 7.46-7.54 (3H, in), 4.69 (1 H, bs), 3.02 (2H, t, J=7.2Hz), 2.51 -2.64 (2H, in), 1.25-1.60 (11 H, in), mlz=500, 502.

Example 340: Synthesis of S-1 93 S-1 93 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol, 1 bromo-2-chloroethane and -(+)-3-methoxy-a-benzylmethylainine respectively by 2,3,5 ,6-tetrachloro-4-inercaptopyridine, 1 ,7-dibromoheptane and -naphthyl)ethylainine.

400MHz- 1 H-NMR 8.15 (1 H, d, J=8.3Hz), 7.86-7.89 (1 H, in), 7.70-7.78 (1 H, in), 7.46-7.55 (3H, in), 4.74 (1 H, bs), 3.03 (2H, t, J=7.2Hz), 2.50-2.66 (2H, mn), 1.05-1.65 (13H, in), m/z=514, 516.

Example 341: Synthesis of S-1 94 S-1 94 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-methoxy-ct-benzylimethYlainine respectively by 2,3,5,6-tetrachloro-4-inercaptopyridine, 1 ,8-dibroinooctane and -naphthyl)ethylamine.

400MHz- 1 H-NMR 8.15 (1 H, d, J=8.3Hz), 7.86-7.89 (1 H, in), 7.72-7.78 (2H, in), 7.46-7.54 (3H, in), 4.72 (1 H, q, J=7.2Hz), 3.04 (2H, t, J=7.2Hz), 2.52-2.57 (2H, in), 1.00-1.56 (12H, in), 1.58 (3H, d, J=6.2Hz), m/z=528, 530.

Example 342: Synthesis of S-1 *S-1 95 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol and (R-+--ehx--ezlehlmn respectively by 2,3,5,6-tetrafluoro-4trifluoromethylthiophenol and -1 -naphthyl)ethylamine. m/z 447.

Example 343: Synthesis of S-1 96 S-1 96 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3methoxy-a-benzylinethylainine 225 respectively by 2,3,5,6-tetrafluoro-4-trifluoromethylthiophenol, 1,3dibromopropane and -naphthyl)ethylamine.

400MHz- 1 H-NMR 8.16 (1 H, d, J=8.OHz), 7.84-7.86 (1 H, in), 7.73 (1 H, d, J=8.OHz), 7.60 (1 H, d, J=6.8Hz), 7.43-7.51 (3H, in), 4.59 (1 H, q, J=6.2Hz), 3.02-3.15 in), 2.60-2.74 in), 1.67-1 .77 in), 1.48 d, J=6.2Hz), m/z=461.

Example 344: Synthesis of S-1 97 3-1 97 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 broino-2-chloroethane and -(+)-3-methoxy-a-benzylinethylamine respectively by 2,3,5,6-tetrafluoro-4-trifluoromethylthiophenol, 1,6dibroinohexane and -naphthyl)ethylainine.

400MHz- 1 H-NMR 8.17 (1 H, d, J=8.2Hz), 7.85-7.88 (1 H, in), 7.75 (1 H, d, J=8.3Hz), 7.66 (1 H, d, J=6.8Hz), 7.45-7.53 (3H, in), 4.64 (1 H, q, J=6.4Hz), 2.99 t, J=7.3Hz), 2.50-2.63 in), 1.48-1.60 in), 1.52 d, J=6.4Hz), 1.26-1.42 in), mlz=503.

Example 345: Synthesis of S-1 98 S-1 98 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol, 1 broino-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 2,3 ,5,6-tetrafluoro-4-trifluoro methylthiophenol, 1,7dibromoheptane and -naphthyl) ethylamine.

:400MHz-l H-NMR 8.17 (1 H, d, J=8.3Hz), 7.85-7.88 (1 H, in), 7.74 (1 H, d, J=8.3Hz), 7.66 (1 H, d, J=6.8Hz), 7.45-7.52 (3H, in), 4.65 (1 H, q, J=6.4Hz), 3.00 t, J=7.4Hz), 2.50-2.63 in), 1 .47-1.60 in), 1.52 (3H, d, J=6.4Hz), 1.23-1.41 (6H, mn), m/z=517.

Example 346: Synthesis of S-1 99 S-1 99 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol, 1 bromo-2-chloroethane and -(+)-3-methoxy-ct-benzylinethylainine 226 respectively by 2,3,5,6-tetrafluoro-4-trifluoromethylthiophelol, 1,8dibromooctane and -naphthyl)ethylamine.

400MHz- 1 H-NMR 8.16 (1 H, d, J=8.3Hz), 7.86-7.88 (1 H, in), 7.75 (1 H, d, J=8.3Hz), 7.69 (1 H, d, J=6.1 Hz), 7.45-7.53 (3H, in), 4.67 (1 H, q, J=6.4Hz), 3.01 (2H, t, J=7.3Hz), 2.51-2.64 (2H, in), 1.20-1.70 (15H, mn), m/z=531.

Example 347: Synthesis of S-200 S-200 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 bromo-2-chloroethane and -3-inethoxy-a-benzylinethylainine respectively by 2,3,5,6-tetrafluoro-4-trifluoromethylthiophenol, 1,10dibromodecane and -naphthyl)ethylamine.

400MHz- 1 H-NMR 8.17 (1 H, d, J=8.3Hz), 7.51 -7.88 (1 H, in), 7.74 (1 H, d, 7.64 (1 H, d, J=7.1 Hz), 7.44-7.52 (3H, in), 4.62 (1 H, q, J=6.6Hz), 3.02 (2H, t, J=7.4Hz), 2.50-2.62 (2H, in), 1.54-1.62 (2H, in), 1.49 (3H, d, J=6.6Hz), 1.00-1.54 (14H, in), m/z=559.

Example 348: Synthesis of S-201 S-201 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol, 1 broino-2-chloroethane and (R)-(+)-3-inethoxy-a-benzyrlethylanmine respectively by 2,3,5,6-tetrafluoro-4-trifluoromethylthiophenol, 1, 12dibromododecane and -naphthyl)ethylamine.

400MHz- 1 H-NMR 8.17 (1 H, d, J=8.3Hz), 7.85-7.88 (1 H, in), 7.74 (1 H, d, :J=8.OHz), 7.66 (1 H, d, J=7.1 Hz), 7.45-7.53 (3H, in), 4.64 (1H, q, J=6.6Hz), 3.03 (2H, t, J=7.4Hz), 2.50-2.63 (2H, in), 1.20-1.63 (18H, in), 1.51 (3H, d, J=6.6Hz), in/z=587.

Example 349: Synthesis of S-202 S-202 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethyithiophenol and (+)-3-methoxy-a-benzylmethylamine respectively by 2-isopropylthiophenol and -naphthyl)ethylainine.

227 400MHz- 1 H-NMR 8.16 (1 H, d, J=7.8Hz), 7.84-7.87 (1 H, in), 7.72 (1 H, d, J=8.OHz), 7.63 (1 H, d, J=7.1 Hz), 7.41-7.54 in), 7.23-7.27 in), 7.13- 7.16 (1 H, in), 7.03-7.07 (1 H, in), 4.63 (1 H, q, J=6.5Hz), 3.45-3.54 (1 H, in), 3.04 t, J=6.2Hz), 2.81 t, J=6.8Hz), 1.48 d, J=6.5Hz), 1. 19-1.22 (6H-, in), mlz=349.

Example 350: Synthesis of S-203 S-203 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-inethoxy-a-benzylinethylamine respectively by 2-isopropylthiophenol, 1 ,3-dibromopropane and naphthyl) ethylamine.

**400MHz- 1 H-NMR 8.17 (1 H, d, J=7.8Hz), 7.86 (1 H, d, J=7.8Hz), 7.73 (1 H, d, J=8.OHz), 7.63 (1 H, d, J=7.3Hz), 7.43-7.51 (3H, in), 7.22-7.29 (2H, in), 7.08- ~.7.17 in), 4.60 (1 H, q, J=6.4Hz), 3.42-3.50 (1 H, in), 2.87-3.00 in), 2.62-2.76 in), 1.79-1.86 in), 1.48 (3H, d, J=6.4Hz), 1.18-1.22 (6H, in), m/z=363.

Example 351: Synthesis of S-204 S-204 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-d imethylth io phenol, 1 broino-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 2-isopropylthiophenol, 1 ,4-dibroinobutane and naphthyl) ethylamine.

400MHz-1 H-NMR 8.17 (1 H, d, J=8.OHz), 7.85-7.87 (1 H, in), 7.73 (1 H, d, J=8.3Hz), 7.63 (1 H, d, J=6.8Hz), 7.44-7.51 in), 7.22-7.27 (2H, in), 7.07- 7.18 in), 4.61 (1 H, q, J=6.5Hz), 3.44-3.53 (1 H, in), 2.85 (2H, t, J=6.8Hz), 2.51-2.65 mn), 1.63-1.70 in), 1.48 d, J=6.5Hz), 1.21 d, J=6.8Hz), in/z=377.

Example 352: Synthesis of S-205 S-205 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-methoxy-cz-benzylmethylamine 228 respectively by 2-isopropylthiophenol, 1 ,5-dibromopentane and naphthyl) ethylamine.

400MHz- 1 H-NMR 8.17 (1 H, d, J=8.OHz), 7.85-7.88 (1 H, in), 7.73 (1 H, d, J=8.3Hz), 7.63 (1 H, d, J=7.1lHz), 7.44-7.52 in), 7.22-7.28 in), 7.08- 7.18 in), 4.61 (1 H, q, J=6.5Hz), 3.42-3.53 (1 H, in), 2.85 (2H, t, J=7.3Hz), 2.49-2.62 in), 1.59-1.67 in), 1.40-1.56 in), 1.48 d, 1.21 d, J=6.8Hz), mlz=391.

Example 353: Synthesis of 3-206 3-206 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 broino-2-chloroethane and (+)-3-methoxy-ct-benzylmethylainine respectively by 2-isopropylthiophenol, 1 ,6-dibromohexane and **.naphthyl)ethylamine.

~.400MHz- 1 H-NMR 8.17 (1 H, d, J=8.OHz), 7.85-7.88 (1 H, in), 7.73 (1 H, d, J=8.3Hz), 7.64 (1 H, d, J=6.8Hz), 7.41 -7.52 in), 7.21-7.29 (2H, in), 7.09- 7.17 in), 4.62 (1 H, q, J=6.5Hz), 3.43-3.53 (1 H, in), 2.84 t, J=7.3Hz), 2.49-2.62 in), 1.58-1.66 in), 1.45-1.55 in), 1.25-1.45 (4H, in), 1.49 (3H, in), 1.21 -1 .23 (6H, in), in/z=405.

Example 354: Synthesis of S-207 S-207 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 bromo-2-chloroethane and (+)-3-inethoxy-cx-benzylmethylainine respectively by 2-isopropylthiophenol, 1 ,7-dibromoheptane and naphthyl)ethylamine.

400MHz- 1 H-NMR 8.17 (1 H, d, J=8.3H 7.85-7.88 (1 H, in), 7.74 (1lH, d, J=8.OHz), 7.65 (1 H, d, J=7.1lHz), 7.44-7.52 (3H, in), 7.22-7.29 in), 7.09- 7.17 in), 4.63 (1 H, q, J=6.6Hz), 3.43-3.54 (1 H, in), 2.85 (2H, t, J=7.4Hz), 2.49-2.62 in), 1.57-1.65 (2H, in), 1.36-1.55 in), 1.49 d, J=6.6Hz), 1.25-1.30 in), 1.20-1.25 in), in/z=419.

Example 355: Synthesis of S-208 229 S-208 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 2-isopropylthiophenol, 1,8-dibromooctane and naphthyl)ethylamine.

400MHz- H-NMR 8.18 (1H, d, J=8.5Hz), 7.85-7.88 (1H, 7.74 (1H, d, 7.65 (1H, d, J=7.1Hz), 7.44-7.53 (3H, 7.23-7.29 (2H, 7.09- 7.17 (2H, 4.63 (1H, q, J=6.6Hz), 3.43-3.54 (1H, 2.85 (2H, t, J=7.4Hz), 2.50-2.62 (2H, 1.58-1.67 (2H, 1.24-1.52 (10H, 1.50 (3H, d, J=6.6Hz), 1.22 (6H, d, J=6.8Hz), m/z=433.

Example 356: Synthesis of S-209 S-209 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiol by 2,4,5trichlorothiophenol.

400MHz- H-NMR 7.44 (1H, 7.29 (1H, 7.23 (1H, dd, J=8.3Hz, J=8.3Hz), 6.87-6.89 (2H, 6.76-6.79 (1H, 3.80 (3H, 3.76 (1H, q, J=6.6Hz), 3.03 (2H, t, J=6.5Hz), 2.70-2.85 (2H, 1.36 (3H, d, J=6.6Hz), m/z=389, 391.

Example 357: Synthesis of S-210 S-210 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1 -bromo-2-chloroethane respectively by 2,4,5-trichlorothiophenol and 1,3dibromopropane.

400MHz-H-NMR 7.44 (1H, 7.30 (1H, 7.22-7.25 (1H, 6.87-6.90 (2H, 6.77-6.80 (1H, 3.81 (3H, 3.74 (1H, q, J=6.5Hz), 2.89-3.03 (2H, m), 2.54-2.70 (2H, 1.77-1.85 (2H, 1.36 (3H, d, J=6.5Hz), m/z=403, 405.

Example 358: Synthesis of S-211 S-211 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1-bromo-2-chloroethane respectively by 2,4,5-trichlorothiophenol and 1,4dibromobutane.

230 400MHz- 1 H-NMR 7.44 (1H, 7.21-7.27 (2H, 6.86-6.90 (2H, 6.76-6.79 (1H, 3.81 (3H, 3.72 (1H, q, J=6.6Hz), 2.86-2.91 (2H, 2.43-2.58 (2H, 1.58-1.76 (4H, 1.34 (3H, d, J=6.6Hz), m/z=419, 421.

Example 359: Synthesis of S-212 S-212 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1-bromo-2-chloroethane respectively by 2,4,5-trichlorothiophenol and dibromopentane.

400MHz- 1 H-NMR 7.44 (1H, 7.21-7.26 (2H, 6.87-6.90 (2H, 6.76-6.79 (1H, 3.81 (3H, 3.72 (1H, q, J=6.6Hz), 2.89 (2H, t, J=7.3Hz), 2.41-2.55 (2H, 1.64-1.71 (2H, 1.43-1.56 (4H, 1.35 (3H, d, J=6.6Hz), m/z=431, 433.

Example 360: Synthesis of S-213 S-213 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1-bromo-2-chloroethane respectively by 2,4,5-trichlorothiophenol and 1,6dibromohexane.

400MHz-'H-NMR 7.44 (1H, 7.21-7.26 (2H, 6.87-6.90 (2H, 6.76-6.79 (1H, 3.81 (3H, 3.72 (1H, q, J=6.6Hz), 2.88 (2H, t, J=7.3Hz), 2.39-2.53 (2H, 1.63-1.71 (2H, 1.28-1.52 (6H, 1.34 (3H, d, J=6.6Hz), m/z=445, 447.

Example 361: Synthesis of S-214 S-214 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1 -bromo-2-chloroethane respectively by 2,4,5-trichlorothiophenol and 1,7dibromoheptane.

400MHz-'H-NMR 7.44 (1H, 7.21-7.26 (2H, 6.87-6.91 (2H, 6.76-6.80 (2H, 3.81 (3H, 3.73 (1H, q, J=6.6Hz), 2.89 (2H, t, J=7.3Hz), 2.39-2.53 (2H, 1.64-1.71 (2H, 1.39-1.48 (4H, 1.25-1.37 (6H, 1.35 (3H, d, J=6.6Hz), m/z=459, 461.

231 Example 362: Synthesis of S-215 S-215 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1 -bromo-2-chloroethane respectively by 2,4,5-trichlorothiophenol and 1 ,8dibromooctane.

400MHz-'H-NMR 7.44 (1 H, 7.25 (1 H, 7.24 (1 H, dd, J=8.0Hz, J=8.OHz), 6.87-6.90 in), 6.76-6.79 (1 H, in), 3.81 3.73 (1 H, q, J=6.6Hz), 2.89 (1 H, t, J=7.3Hz), 2.38-2.52 in), 1.64-1.71 in), 1.40-1.50 in), 1.35 d, J=6.6Hz), 1.25-1.35 in), mlz=473, 735.

Example 363: Synthesis of S-216 S-216 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 0 broino-2-chloroethane and (R)-(+)-3-inethoxy-ct-benzylmethylamine respectively by 2,4,5-trichlorothiophenol, 1 ,3-dibromopropane and (1 -naphthyl)ethylamine.

400MHz-1 H-NMR 8.20 (1 H, d, J=8.OHz), 7.85-7.88 (1 H, in), 7.75 (1 H, d, J=8.OHz), 7.64 (1 H, d, J=7.1lHz), 7.45-7.52 mn), 7.43 (1 H, 7.29 (1 H, s), 4.63 (1 H, q, J=6.5Hz), 2.90-3.05 in), 2.64-2.80 in), 1.81 -1 .89 in), 1.52 d, J=6.5Hz), m/z=423, 425.

Example 364: Synthesis of S-217 S-217 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol, 1 bromo-2-chloroethane and -(+)-3-inethoxy-a-benzylmethylamine respectively by 2,4,5-trichlorothiophenol, 1 ,6-dibroinohexane and naphthyl)ethylainine.

400MHz- 1 H-NMR 8.17 (1 H, d, J=8.3Hz), 7.86-7.88 (1 H, in), 7.75 (1 H, d, J=8.3Hz), 7.66 (1 H, d, J=6.8Hz), 7.45-7.53 in), 7.44 (1 H, 7.23 (1 H, s), 4.65 (1 H, q, J=6.6Hz), 2.86 (2H, t, J=7.3Hz), 2.51 -2.66 in), 1.30-1.73 (8H-, in), 1.52 (3H, d, J=6.6Hz), in/z=465, 467.

Example 365: Synthesis of S-218 232 S-21 8 was synthesized by almost the same method as the one employed for the synthesis of S-i but replacing the 2,5-dimethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-methoxy-ct-benzylmethylamine respectively by 2,4,5-trich loroth io phenol, 1 ,7-dibromoheptane and (1 -naphthyl)ethylamine.

400MHz- 1 H-NMR 8.17 (1 H, d, J=8.3Hz), 7.86-7.88 (1 H, in), 7.75 (1 H, d, J=8.3Hz), 7.68 (1 H, d, J=6.6Hz), 7.45-7.53 mn), 7.43 (1 H, 7.24 (1 H, s), 4.66 (1 H, q, J=6.4Hz), 2.87 t, J=7.3Hz), 2.51-2.64 in), 1.25-1.70 in), 1.53 d, J=6.4Hz), mlz=423, 425.

Example 366: Synthesis of S-219 S-219 was synthesized by almost the same method as the one 00 employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 bromo-2-chloroethane and -3-methoxy-oa-benzylinethylamine **:respectively by 2,4,5-trichlorothiophenol, 1 ,8-dibromooctane and naphthyl)ethylamine.

400MHz- H-NMR 8.17 (1 H, d, J=8.3Hz), 7.86-7.89 (1 H, in), 7.75 (1 H, d, J=8.3Hz), 7.68 (1 H, bs), 7.45-7.53 (3H, in), 7.44 (1 H, 7.24 (1 H, 4.67 (1 H, bs), 2.88 (2H, t, J=7.3Hz), 2.51-2.64 (2H, in), 1.23-1.71 (15H, in), in/z=493, 495.

Example 367: Synthesis of S-220 S-220 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-d im ethyith iophenol and :1 -bromo-2-chloroethane respectively by 6-ethoxy-2-mercaptobenzothiazole and 1 ,3-dibromopropane. in/z 402.

Example 368: Synthesis of S-221 S-221 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1 -broino-2-chloroethane respectively by 6-ethoxy-2-mercaptobenzothiazole and 1 ,4-dibromobutane.

400MHz- 1 H-NMR 7.71 (1 H, d, J=8.8Hz), 7.20-7.24 in), 6.98 (1 H, dd, J=9.OHz, J=2.4Hz), 6.87-6.89 in), 6.77 (1 H, ddd, J=8.OHz, J=2.4Hz, 233 J=1 .0Hz), 4.06 (2H, q, J=6.9Hz), 3.80 (3H, 3.28 (2H, t, J=7.SHz), 2.45-2.61 (2H, in), 1.75-1.88 (2H, in), 1.58-1.70 (2H, in), 1.44 t, J=7.5Hz), 1.35 (3H-, d, J=6.9Hz), m/z=416.

Example 369: Synthesis of S-222 S-222 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthio phenol and 1 -bromo-2-chloroethane respectively by 6-ethoxy-2-mercaptobenzothiazole and 1 400MHz- 1 H-NMR 7.23 (1 H, d, J=8.8Hz), 7.20-7.25 (2H, in), 6.99 (1 H, dd, J=8.8Hz, J=2.4Hz), 6.87-6.90 (2H, in), 6.76-6.77 (1 H, in), 4.03-4.11 (2H, in), 3.81 (3H, 3.72 (1 H, q, J=6.6Hz), 3.27 (2H, t, J=7.6Hz), 2.41 -2.54 (2H, in), 1.74-1.82 (2H, in), 1.41-1.56 (4H, in), 1.44 (3H, t, J=6.8Hz), 1.34 (3H, d, J=6.6Hz), m/z=430.

Example 370: Synthesis of S-223 3-223 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethyithiophenol and 1 -bromo-2-chloroethane respectively by 6-ethoxy-2-mercaptobenzothiazole and 1 ,6-dibromohexane.

400MHz-'H-NMR 7.73 (1 H, d, J=9.OHz), 7.20-7.25 (2H, in), 6.99 (1H, dd, J=8.8Hz, J=2.4Hz), 6.88-6.90 (2H, in), 6.77 (1 H, ddd, J=8.3Hz, J=2.4Hz, J=1.OHz), 4.06 (2H, q, J=7.OHz), 3.81 (3H, 3.73 (1 H, q, J=6.OHz), 3.27 (2H, t, J=7.3Hz), 2.40-2.53 in), 1.74-1.81 (2H, in), 1.25-1.53 (6H, in), 1.44 (3H, t, J=7.OHz), 1.35 (3H, d, J=6.OHz), in/z=444.

Example 371: Synthesis of S-224 S-224 was synthesized by almost the same method as the one employed for the synthesis of S-i but replacing the 2,5-diinethyithiophenol and 1 -broino-2-chloroethane respectively by 6-ethoxy-2-inercaptobenzothiazole and 1 ,7-dibroinoheptane.

400MHz- 1 H-NMR 7.72 (1 H, d, J=9.OHz), 7.25 (1 H, dd, J=6.9Hz, J=6.9Hz), 7.21 (1 H, d, J=2.4Hz), 6.98 (1 H, dd, J=9.OHz, J=2.4Hz), 6.78-6.82 (1 H, in), 4.06 234 (3H, q, J=7.0Hz), 3.82 (3H, 3.79-3.85 (1H, 3.27 (2H, t, J=7.3Hz), 2.43- 2.56 (2H, 1.73-1.80 (2H, 1.18-1.57 (11H, 1.44 (3H, t, m/z=458.

Example 372: Synthesis of S-225 S-225 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1 -bromo-2-chloroethane respectively by 6-ethoxy-2-mercaptobenzothiazole and 1,8-dibromooctane.

400MHz- 1 H-NMR 7.23 (1H, d, J=8.8Hz), 7.21-7.24 (2H, 6.99 (1H, dd, J=8.8Hz, J=2.7Hz), 6.87-6.91 (2H, 6.76-6.80 (1H, 4.06 (2H, q, 3.81 (3H, 3.75 (1H, q, J=6.6Hz), 3.28 (2H, t, J=7.3Hz), 1.99-2.53 (2H, 1.74-1.81 (2H, 1.24-1.48 (10H, 1.44 (3H, t, J=7.0Hz), 1.37 (3H, d, J=6.6Hz), m/z=472.

Example 373: Synthesis of S-226 S-226 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 6-ethoxy-2mercaptobenzothiazole and -naphthyl)ethylamine. m/z 408: :Example 374: Synthesis of S-227 S-227 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 6-ethoxy-2-mercaptobenzothiazole, 1,3-dibromopropane and -naphthyl)ethylamine. m/z 422.

Example 375: Synthesis of S-228 S-228 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 6-ethoxy-2-mercaptobenzothiazole, 1,4-dibromobutane and -naphthyl)ethylamine.

235 400MHz- 1 H-NMR 8.18 (1 H, d, J=8.3Hz), 7.84-7.88 (1 H, in), 7.73 01H, d, J=8.3Hz), 7.70 (1 H, d, J=9.OHz), 7.65 (1 H, d, J=7.1lHz), 7.44-7.52 in), 7.20 (1 H, d, J=2.4Hz), 6.97 (1 H, dd, J=9.OHz, J=2.4Hz), 4.63 (1 H, q, J=6.6Hz), 4.05 q, J=7.OHz), 3.28 dt, J=9.2Hz, J=1 .2Hz), 2.55-2.69 in), 1.81-1.90 in), 1 .63-1.72 in), 1.50 d, J=6.6Hz), 1.43 t, J=7.OHz), mlz=436.

Example 376: Synthesis of S-229 S-229 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 bromo-2-chloroethane and -3-methoxy-a-benzylmethylamine respectively by 6-ethoxy-2-inercaptobenzothiazole, 1 ,5-dibromopentane and -naphthyl)ethylamine.

400MHz- 1 H-NMR 8.17 (1 H, d, J=8.3Hz), 7.83-7.88 (1 H, in), 7.73 (1 H, d, J=8.OHz), 7.72 (1 H, d, J=8.8Hz), 7.64 (1 H, d, J=7.3Hz), 7.44-7.52 (3H, in), 7.20 H, d, J=2.4Hz), 6.98 (1 H, dd, J=9.OHz, J=2.7Hz), 4.62 (1 H, q, J=6.5Hz), 4.06 q, J=7.OHz), 3.27 t, J=7.3Hz), 2.52-2.65 in), 1.70-1.82 (2H, in), 1.49 (3H, d, J=6.5Hz), 1.44 t, J=7.OHz), 1.41 -1 .60 in), in/z=450.

Example 377: Synthesis of S-230 .0.00:S-230 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 '0.00bromo-2-chloroethane and -3-methoxy-ct-benzylmethylamine respectively by 6-ethoxy-2-mercaptobenzothiazole, 1 ,6-dibromohexane and -naphthyl) ethylainine.

0 400MHz- H-NMR 8.17 (1 H, d, J=8.5Hz), 7.82-7.88 (1 H, in), 7.71-7.75 (2H, in), 7.66 (1 H, d, J=7.OHz), 7.41 -7.53 (3H, in), 7.20 (1 H, d, J=2.7Hz), 6.98 (1 H, dd, J=8.8Hz, J=2.7HZ), 4.64 (1 H, q, J=6.4Hz), 4.05 (2H, q, J=7.OHz), 3.26 (2H, t, J=7.3Hz), 2.50-2.64 in), 1.73-1.81 (2H, in), 1.30-1.55 in), 1.51 (3H, d, J=6.4Hz), 1.43 (3H, t, J=7.OHz), m/z=464.

Example 378: Synthesis of S-231 3-23 1 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 236 bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 6-ethoxy-2-mercaptobenzothiazole, 1, 7-dibromoheptane and -naphthyl)ethylamine.

400MHz- 1 H-NMR 8.15 (1 H, d, J=8.3Hz), 7.86-7.88 (1 H, in), 7.72-7.78 (2H, in), 7.72 (1 H, d, J=9.1lHz), 7.45-7.55 (3H, in), 6.98 (1 H, dd, J=8.8Hz, J=2.4Hz), 4.72 (1 H, q, J=6.4Hz), 4.05 (2H, q, J=7.OHz), 3.25 (2H, t, J=7.3Hz), 2.52-2.66 (2H, in), 1.64-1.82 (2H, in), 1.59 (3H, d, J=6.4Hz), 1.43 (3H, t, J=7.OHz), 1.03- 1.68 (8H, mn), mlz=478.

Example 379: Synthesis of S-232 S-232 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-inethoxy-a-benzylmethylamine respectively by 6-ethoxy-2-inercaptobenzothiazole, 1 ,8-dibroinooctane and -naphthyl)ethylainine.

400MHz-1 H-NMR 8.16 (1 H, d, J=8.5Hz), 7.86-7.88 (1 H, in), 7.68-7.76 (3H, in), 7.45-7.53 (3H, in), 7.21 (1 H, d, J=2.4Hz), 6.98 (1 H, dd, J=8.8Hz, J=2.4Hz), 4.67 (1 H, q, J=6.4Hz), 4.06 (2H, q, J=7.OHz), 3.27 (2H, t, J=7.4Hz), 2.51 -2.64 (2H, in), 1.69-1.80 (2H, in), 1.54 (3H, d, J=6.4Hz), 1.43 (3H, t, J=7.OHz), 1.20- 1.60 (10OH, mn), m/z=492.

Example 380: Synthesis of S-233 S-233 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethyithiophenol and (R)-(+)-3-inethoxy-a-benzylinethylainine respectively by 2,4- :dichlorothiophenol and -naphthyl)ethylamine. m/z 375.

Example 381: Synthesis of S-234 S-234 was synthesized by almost the same method as the one em ployed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-inethoxy-a-benzylinethylamine respectively by 2,4-dichlorothiophenol, 1 ,3-dibromopropane and naphthyl)ethylamine.

237 400MHz- 1 H-NMR 8.18 (1 H, d, J=7.6Hz), 7.84-7.89 (1 H, in), 7.74 (1 H, d, J=8.3Hz), 7.63 (1 H, d, J=7.1lHz), 7.45-7.56 (3H, in), 7.34-7.56 (1 H, in), 7.33- 7.34 in), 4.62 (1 H, q, J=6.6Hz), 2.88-3.04 in), 2.63-2.78 in), 1.79-1.87 in), 1.50 d, J=6.6Hz), m/z=389.

Example 382: Synthesis of S-235 S-235 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 broino-2-chloroethane and -3-methoxy-ax-benzylinethylainine respectively by 2,4-dichlorothiophenol, 1 ,4-di bromo butane and naphthyl)ethylamind.

400MHz- 1 H-NMR 8.18 (1 H, d, J=8.OHz), 7.86-7.88 (1 H, in), 7.75 (1 H, bs), 7.67 (1 H.bs), 7.45-7.53 in), 7.35-7.36 (1 H, in), 7.13-7.14 in), 4.61-4.69 (1 H, in), 2.84-2.89 in), 2.52-2.68 in), 1.48-1.73 in), m/z=403.

Example 383: Synthesis of S-236 S-236 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 broino-2-chloroethane and (R)-(+)-3-methoxy-ct-benzylinethylamine respectively by 2,4-dichlorothiophenol, 1 ,5-dibromopentane and naphthyl)ethylamine.

400MHz-' H-NMR 8.18 (1 H, dl, J=8.OHz), 7.86-7.88 (1 H, in), 7.75 (1 H, dl, J=8.3Hz), 7.65 (1 H, d, J=7.1 Hz), 7.45-7.53 (3H, in), 7.35-7.37 (1 H, in), 7.14- 7.16 in), 4.64 (1 H, q, J=6.4Hz), 2.87 (2H, t, J=7.3Hz), 2.51 -2.64 in), 1.60-1.68 in), 1.42-1.58 in), 1.51 d, J=6.4Hz), in/z=417.

:Example 384: Synthesis of S-237 55 S-237 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-inethoxy-a-benzylinethylamine respectively by 2,5-dichlorothiophenol, 1 ,3-dibroinopropane and naphthyl) ethylainine.

400MHz- 1 H-NMR 8.20 (1 H, d, J=8.OHz), 7.84-7.87 (1 H, in), 7.74 (1 H, d, J=8.OHz), 7.66 (1 H, d, J=7.1lHz), 7.44-7.52 in), 7.19-7.25 in), 7.03 238 (1 H, dd, J=8.SHz, J=2.4Hz), 4.62 (1 H, q, J=6.6Hz), 2.90-3.06 (2H, in), 2.62- 2.80 (2H, in), 1.86 (2H, tt, J=7.0Hz, J=7.OHz), 1.50 (3H, d, J=6.6Hz), mlz=389.

Example 385: Synthesis of 3-238 S-238 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-methoxy-ct-benzylmethylamine respectively by 2,5-dichlorothiophenol, 1 ,6-dibromohexane and naphthyl) ethylamine.

400MHz- 1 H-NMR 8.18 (1 H, d, J=8.3Hz), 7.85-7.88 (1 H, in), 7.73 (1 H, d, J=8.OHz), 7.64 (1 H, d, J=6.8Hz), 7.44-7.53 (3H, in), 7.23-7.26 (1 H, mn), 7.14 (1 H, d, J=2.4Hz), 7.03 (1 H, dd, J=8.6Hz, J=2.4Hz), 4.63 (1 H, q, J=6.5Hz), 2.87 (2H, t, J=7.3Hz), 2.51-2.64 (2H, in), 1.68 (1 H, ft, J=7.3Hz, J=7.3Hz), 1.30-1.56 (6H, in), 1.50 (3H, d, J=6.5Hz), m/z=431.

Example 386: Synthesis of S-239 **:S-239 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-inethoxy-a-benzylmethylamine respectively by 2,5-dichlorothiophenol, 1 ,7-dibromoheptane and naphthyl) ethylamine.

400MHz-1 H-NMR 8.16 (1 H, d, J=8.3Hz), 7.86-7.88 (1 H, in), 7.75 (1 H, d, J=8.OHz), 7.70 (1 H, d, J=7.1 Hz), 7.45-7.53 (3H, in), 7.23 (1 H, 7.14 (1 H, d, J=2.4Hz), 7.03 (1 H, d, J=2.4Hz, J=6.3Hz), 4.68 (1 H, q, J=6.4Hz), 2.87 (2H, t, J=7.3Hz), 2.50-2.65 (2H, in), 1.66 (2H, ift, J=7.3Hz, 7.3Hz), 1.55 (3H, d, J=6.4Hz), 1.05-1.60 (8H, mn), m/z=445.

Example 387: Synthesis of S-240 S-240 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 broino-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylainine respectively by 2,5-dichlorothiophenol, 1 ,8-dlibromooctane and naphthyl) ethylamine.

239 400MHz- 1 H-NMR 8.16 (1 H, dl, J=8.3Hz), 8.85-8.88 (2H, in), 7.75 (1 H, dl, J=8.3Hz), 7.70 (1 H, d, J=7.1lHz), 7.45-7.54 (3H, in), 7.24 (1 H, 7.14 (1 H, dl, J=2.4Hz), 7.02 (1 H, dd, J=8.5Hz, J=2.4Hz), 4.69 (1 H, q, J=6.5Hz), 2.86 t, J=6.8Hz), 2.51-2.65 (2H, in), 1.66 (2H, tt, J=6.8Hz, J=6.8Hz), 1.55 (3H, d, 1.03-1.55 (1 OH, in), mlz=459.

Example 388: Synthesis of S-241 S-24 1 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethyithiophenol and (R)-(+)-3-methoxy-cebenzylmethylamine respectively by 4trifluoromethoxythiophenol and -naphthyl)ethylainine. m/z 391.

Example 389: Synthesis of 3-242 S-242 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 0* bromo-2-chloroethane and -(+)-3-inethoxy-a-benzylmethylainine respectively by 4-trifluoroinethoxythiophenol, 1 ,3-dibromopropane and -1 nptyetyai.

400MHz-1 H-NMR 8.16-8.20 (1 H, in), 7.82-7.89 (1 H, in), 7.74 (1 H, dl, J=8.OHz), 7.62 (1 H, dl, J=6.6Hz), 7.44-7.52 (3H, in), 7.27-2.30 (2H, in), 7.08-7.11 (2H, in), 4.61 (1 H, q, J=6.6Hz), 2.88-3.05 (2H, mn), 2.61-2.76 (2H, in), 1.77-1.85 (2H, in), 1.49 (3H, dl, J=6.6Hz), in/z=405.

Example 390: Synthesis of S-243 ~.SS-243 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylainine respectively by 4-trifluoromethoxythiophenol, 1 ,7-dibroinoheptane and -naphthyl) ethylamine.

400MHz-'H-NMR 8.10 (1H, d, J=8.3Hz), 7.78-7.81 (1 H, in), 7.66 (1 H, dl, J=8.3Hz), 7.57 (1 H, dl, J=6.8Hz), 7.37-7.45 (3H, in), 7.21 -7.24 (2H, in), 7.03- 7.05 (2H, in), 4.55 (1 H, q, J=6.6Hz), 2.80 (2H, t, J=7.3Hz), 2.41 -2.55 (2H, in), 1.49-1.57 (2H, in), 1. 18-1.45 (8H, in), 1.42 (3H, dl, J=6.6Hz), m/z=461.

240 Example 391: Synthesis of S-244 S-244 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 4-trifluoromethoxythiophenol, 1,8-dibromooctane and 1 -naphthyl)ethylamine.

400MHz- H-NMR 8.17 (1H, d, J=8.3Hz), 7.85-7.88 (1H, 7.74 (1H, d, 7.65 (1H, d, J=7.1Hz), 7.44-7.53 (3H, 7.28-7.33 (2H, 7.10- 7.13 (2H, 4.64 (1H, q, J=6.6Hz), 2.87 (2H, t, J=7.4Hz), 2.49-2.62 (2H, m), 1.56-1.65 (2H, 1.46-1.55 (2H, 1.50 (3H, d, J=6.6Hz), 1.33-1.42 (2H, m), 1.23-1.30 (6H, m/z=475.

Example 392: Synthesis of S-245 S-245 was synthesized by almost the same method as the one i employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol by 2-chlorobenzylmercaptan.

400MHz-'H-NMR 7.33-7.38 (1H, 7.28-7.31 (1H, 7.47-7.26 (3H, m), 6.87-6.88 (2H, 6.78 (1H, ddd, J=8.1Hz, J=2.4Hz, J=1.OHz), 3.81 (3H, s), 3.77 (2H, 3.70 (1H, q, J=6.5Hz), 2.57-2.73 (4H, 1.33 (3H, d, m/z=335.

Example 393: Synthesis of S-246 S-246 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1-bromo-2-chloroethane respectively by 2-chlorobenzylmercaptan and 1,3dibromopropane.

400MHz-'H-NMR 7.32-7.37 (2H, 7.14-7.25 (3H, 6.86-6.88 (2H, m), 6.77 (1H, ddd, J=8.3Hz, J=2.7Hz, J=1.0Hz), 3.80 (5H, 3.71 (1H, q, J=6.6Hz), 2.44-2.61 (4H, 1.70-1.78 (2H, 1.32 (3H, d, J=6.6Hz), m/z=349.

Example 394: Synthesis of S-247 S-247 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 241 1 -bromo-2-chloroethane respectively by 2-chlorobenzylmercaptan and dibromopentane.

400MHz- 1 H-NMR 7.32-7.36 (2H, in), 7.14-7.27 (3H, in), 6.88-6.89 (2H, in), 6.76-6.79 (1 H, in), 3.81 (3H, 3.80 (2H, 3.73 (1 H, q, J=6.6Hz), 2.38-2.51 (4H, in), 1.30-1.60 (6H, in), 1.35 (3H, d, J=6.6Hz), mlz=377.

Example 395: Synthesis of S-248 S-248 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethyithio phenol and 1 -broino-2-chloroethane respectively by 2-chlorobenzylmercaptan and 1,6dibromohexane.

400MHz-'H-NMR 7.33-7.36 (2H, in), 7.14-7.27 (3H, in), 6.87-6.90 (2H, in), 6.74-6.79 (1 H, in), 3.81 (5H, 3.72 (1 H, q, J=6.6Hz), 2.37-2.51 (4H, in), 1.56 (2H, ft, J=7.3Hz, J=7.3Hz), 1.40-1.49 (2H, in), 1.20-1.38 (4H, in), 1.34 (3H, d, J=6.6Hz), m/z=391.

Example 396: Synthesis of S-249 S-249 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and (R)-(+)-3-methoxy-a-benzylmethylainine respectively by 2chlorobenzylmercaptan and -nap hthyl) ethylamine.

400MHz- 1 H-NMR 8.16 (1 H, d, J=8.OHz), 7.85-7.87 (1 H, in), 7.74 (1 H, d, J=8.3Hz), 7.65 (1 H, d, J=6.8Hz), 7.44-7.53 (3H, in), 7.24-7.34 (2H, in), 7.13- 7.18 (2H, in), 4.60 (1 H, q, J=6.6Hz), 3.77 (2H, 2.63-2.78 (4H, in), 1.48 (3H, d, J=6.6Hz), in/z=355.

Example 397: Synthesis of S-250 S-250 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylinethylainine respectively by 2-chlorobenzylmercaptan, 1 ,3-dibromopropane and (1 -naphthyl)ethylainine.

400MHz- 1 H-NMR 8.16 (1 H, d, J=8.3Hz), 7.84-7.88 (1 H, in), 7.74 (1 H, d, J=8.3Hz), 7.63 (1 H, d, J=6.8Hz), 7.44-7.52 (3H, in), 7.28-7.34 (2H, mn), 7.12- 242 7.18 (2H, in), 4.62 (1 H, q, J=6.6Hz), 3.79 (2H, 2.45-2.72 (4H, in), 1.75-1.81 (2H, in), 1.49 (3H, d, J=6.6Hz), mlz=369.

Example 398: Synthesis of S-251 3-251 was synthesized by almost the same method as the one employed for the synthesis of S-i but replacing the 2,5-dimethyithiophenol by 4-chlorobenzylmercaptan.

400MHz- 1 H-NMR 7.21 -7.26 (3H, in), 7.15-7.19 in), 6.85-6.87 (2H, in), 6.76-6.80 (1 H, in), 3.81 (3H, 3.68 (1 H, q, J=6.6Hz), 3.58 (2H, dl, J=2.OHz), 2.49-2.67 (4H, in), 1.33 dl, J=6.6Hz), m/z=335.

Example 399: Synthesis of S-252 S-252 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1 -bromo-2-chloroethane respectively by 4-chlorobenzylmercaptan and 1,3dlibromopro pane.

400MHz- 1 H-NMR 7.19-7.27 (5H, in), 6.85-6.87 (2H, in), 6.76-6.79 (1 H, in), 3.80 (3H, 3.69 (1 H, q, J=6.6Hz), 3.63 (2H, 2.35-2.59 (4H, in), 1.63-1.73 (2H, in), 1.32 (3H, dl, J=6.6Hz), m/z=349.

Example 400: Synthesis of S-253 3-253 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and (R)-(+)-3methoxy-c-benzylinethylainine respectively by 4chlorobenzylmercaptan and -naphthyl)ethylainine. in/z 355.

Example 401: Synthesis of 3-254 S-254 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-d imethylth io phenol, 1 broino-2-chloroethane and -3-methoxy-a-benzylmethylamine respectively by 4-chlorobenzylmercaptan, 1 ,3-dibromopropane and (1 -naphthyl)ethylanfe.

400MHz-'H-NMR 8.17 (1 H, d, J=2.1lHz), 7.85-7.88 (1 H, in), 7.73-7.75 (1 H, d, J=8.1lHz), 7.62 (1 H, dl, J=7.4Hz), 7.45-7.53 (3H, in), 7.17-7.25 (4H, in), 4.60 243 (1H, q, J=6.6Hz), 3.61 (2H, 2.55-2.71 (2H, 2.37-2.48 (2H, 1.70-1.78 (2H, 1.48 (3H, d, J=6.6Hz), m/z=369.

Example 402: Synthesis of S-255 S-255 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1-bromo-2-chloroethane respectively by 2-quinolinethiol and 1,4dibromobutane.

400MHz- H-NMR 7.83-7.88 (2H, 7.69 (1H, d, J=8.0Hz), 7.59-7.63 (1H, m), 7.37-7.41 (1H, 7.15-7.24 (2H, 6.86-6.90 (2H, 6.73-6.78 (1H, m), 3.78 (3H, 3.73 (1H, q, J=6.8Hz), 3.30 (2H, t, J=6.8Hz), 2.47-2.61 (2H, m), 1.58-1.84 (4H, 1.33 (3H, d, J=6.8Hz), m/z=366.

Example 403: Synthesis of S-256 S-256 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1 -bromo-2-chloroethane respectively by 2-quinolinethiol and dibromopentane.

400MHz-'H-NMR 7.90 (1H, d, J=8.4Hz), 7.85 (1H, d, J=8.4Hz), 7.67-6.70 (1H, 7.60-7.64 (1H, 7.38-7.42 (1H, 7.22 (1H, dd, J=6.2Hz, J=6.2Hz), 7.18 (1H, d, J=8.4Hz), 6.86-6.90 (2H, 6.75-6.78 (1H, 3.80 (3H, 3.74 (1H, q, J=6.4Hz), 3.32 (2H, t, J=7.4Hz), 2.40-2.55 (2H, 1.76 (2H, tt, J=7.4Hz, J=7.4Hz), 1.44-1.59 (4H, 1.34 (3H, d, J=6.4Hz), m/z=380.

Example 404: Synthesis of S-257 S-257 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and 1 -bromo-2-chloroethane respectively by 2-quinolinethiol and 1,6dibromohexane.

400MHz-'H-NMR 7.91 (1H, d, J=8.2Hz), 7.85 (1H, d, J=8.8Hz), 7.70 (1H, dd, J=1.2Hz), 7.61-7.64 (1H, 7.38-7.43 (1H, 7.23 (1H, dd, J=8.0Hz), 7.18 (1H, d, J=8.4Hz), 6.88-6.90 (2H, 6.76-6.79 (1H, 3.80 (3H, 3.74 (1H, q, J=6.4Hz), 3.34 (2H, t, J=7.2Hz), 2.41-2.54 (2H, 244 in), 1.78 (2H, tt, J=7.2Hz, J=7.2Hz), 1.41-1.54 (4H, in), 1.35 (3H, d, J=6.4Hz), mlz=3 94.

Example 405: Synthesis of S-258 S-258 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylainine respectively by 2-quinolinethiol, 1 ,4-dibromobutane and naphthyl)ethylamine.

400MHz-'H-NMR 8.18 (1 H, d, J=8.OHz), 7.83-7.87 (3H, in), 7.73 (1 H, d, 7.65-7.70 in), 7.56-7.60 (1H, mn), 7.43-7.52 (3H, in), 7.37-7.42 (1 H, in), 7.17 (1 H, d, J=8.8Hz), 4.65 (1 H, q, J=6.4Hz), 3.32 (2H, t, J=7.2Hz), 2.59-2.75 (2H, in), 1.67-1.87 in), 1.49 (3H, d, J=6.4Hz), in/z=386.

Example 406: Synthesis of S-259 S-259 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol, 1 bromo-2-chloroethane and -3-inethoxy-a-benzylmethylainine respectively by 2-quinolinethiol, 1,5-dibromopentane and naphthyl)ethylamine.

400MHz- 1 H-NMR 8.16 (1 H, d, J=8.OHz), 7.83-7.92 (3H, in), 7.58-7.74 (4H, in), 7.37-7.52 (4H, in), 7.18 (1 H, d, J=8.4Hz), 4.63 (1 H, q, J=6.4Hz), 3.32 (2H, t, J=7.4Hz), 2.54-2.66 (2H, in), 1.40-1.82 (6H, in), 1.49 (3H, d, J=6.4Hz), m/z=400.

Example 407: Synthesis of S-260 S-260 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-diinethylthiophenol, 1 broino-2-chloroethane and -3-inethoxy-a-benzylinethylainine respectively by 2-quinolinethiol, 1 ,6-dibromohexane and naphthyl)ethylamine.

400MHz- 1 H-NMR 8.17 (1 H, d, J=8.4Hz), 7.37-7.82 (11 H, in), 7.18 (1 H, d, J=8.8Hz), 4.60-4.70 (1 H, in), 3.30 (2H, t, J=7.4Hz), 2.46-2.83 (4H, in), 1.20- 1.77 in), m/z=414.

245 Example 408: Synthesis of S-261 S-261 was synthesized by almost the same method as the one employed for the synthesis of S-i but replacing the 2,5-dimethyithiophenol and -3-methoxy-ca-benzylmethylamine respectively by 4-methyithiophenol and -naphthyl)ethylamine.

400MHz- 1 H-NMR 8.13-8.16 (1 H, in), 7.83-7.89 (1 H, in), 7.72 (1 H, d, J=8.4Hz), 7.62 (1 H, d, J=6.8Hz), 7.41-7.52 in), 7.21 d, J=8.OHz), 7.02-7.05 (2H-, in), 4.61 (1 H, q, J=6.8Hz), 3.02 t, J=6.2Hz), 2.71 -2.82 in), 2.29 (3H, 1.48 d, J=6.8Hz), mlz=321.

Example 409: Synthesis of S-262 S-262 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 4-methyithiopheol, 1,3-dibromopropane and naphthyl)ethylamine.

400MHz- 1 H-NMR 8.16 (1 H, d, J=7.6Hz), 7.83-7.88 (1 H, in), 7.73 (1 H, d, J=8.4Hz), 7.63 (1 H, d, J=7.2Hz), 7.44-7.51 (3H, in), 7.21 d, J=8.OHz), 7.04-7.07 in), 4.59 (1 H, q, J=6.8Hz), 2.85-2.96 in), 2.61 -2.74 in), 2.30 1.79 ft, J=7.1 Hz, J=7.1lHz), 1.47 (3H, d, J=6.8Hz), m/z=335.

Example 410: Synthesis of S-263 3-263 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-methoxy-c-benzylmethylamine respectively by 5-fluoro-2-mercaptobenzothiazole, 1 ,5-dibromopentane and (R)-(+)-1-(1-naphthyl)ethylamine. m/z =424.

Example 411: Synthesis of S-264 S-264 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1 bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylainine respectively by 5-fluoro-2-mercaptobenzothiazole, 1 ,6-dibromohexane and -naphthyl)ethylamine. m/z 438.

-246- Example 412: Synthesis of S-265 K-2117 (hydrochloride) (110 mg, 0.267 mmol) was dissolved in 2.2 ml of toluene (reagent grade). Next, m-chloroperbenzoic acid (56.0 mg, 0.325 mmol) was added thereto at room temperature and the obtained mixture was stirred at the same temperature for 1 hour.

After confirming the completion of the reaction by TLC, a saturated aqueous solution of sodium hydrogencarbonate and a saturated aqueous solution of sodium thiosulfate were added thereto at room temperature and the reaction mixture was subjected to separatory extraction with chloroform and a saturated aqueous solution of sodium chloride and washed. The organic layer thus obtained was dried over anhydrous sodium sulfate. The obtained organic layer was further concentrated under reduced pressure and the residue was purified by column chromatography [silica gel, 5 g, chloroform/methanol 150/1] to thereby give a pale yellow, syrupy compound S-265 (82 mg, 0.214 mmol, yield: 78.3 m/z 391.

Example 413: Synthesis of S-266 K-2117 (hydrochloride) (500 mg, 0.121 mmol) was dissolved in 20 ml of toluene (reagent grade). Next, m-chloroperbenzoic acid (58.0 mg, 0.336 mmol) was added thereto at room temperature and the obtained mixture was stirred at the same temperature for 8 hours. After confirming the completion of the reaction by TLC, a saturated aqueous solution of sodium hydrogencarbonate and a saturated aqueous solution of sodium thiosulfate were added thereto at room temperature and the reaction mixture was subjected to separatory extraction with chloroform and a saturated aqueous Ssolution of sodium chloride and washed. The organic layer thus obtained was dried over anhydrous sodium sulfate. The obtained organic layer was further concentrated under reduced pressure and the residue was purified by column chromatography [silica gel, 5 g, chloroform/methanol 150/1] to thereby give a pale yellow, syrupy compound S-266 (28 mg, 0.0686 mmol, yield: 56.7 m/z 408.

247 Example 414: Synthesis of F-8 (5 g) was dissolved in acetonitrile (100 ml). Then N-(2-bromoethylphthalimide) (7.8 g) was added thereto while stirring at 0 OC.

Further, potassium carbonate (4.04 g) was added thereto. After 1 hour, water was added and the resulting mixture was extracted with ethyl acetate. The organic layer was washed with a saturated aqueous solution of sodium chloride, dried over sodium sulfate, filtered and concentrated. The crystals thus obtained were washed with chloroform to thereby give dichlorophenylthio)ethyl)phthalimide (8.28 MS m/z: 351 Example 415: Synthesis of F-37 N-(2-(2',5'-Dichlorophenylthio)ethyl)phthalimide (7.06 g) was added to ethanol (120 ml). After further adding hydrazine monohydrate (6.9 ml), the obtained mixture was heated under reflux for 1.5 hours. Then it was brought to room temperature and water was added thereto followed by extraction with chloroform. The organic layer was washed with a saturated aqueous solution of sodium chloride, dried over sodium sulfate, filtered and concentrated. The crude product thus obtained was purified by column chromatography (silica gel, chloroform/methanol 20 1) to thereby give 2- (2',5'-dichlorophenylthio)ethylamine (F-37) (4.29 MS m/z: 221 Example 416: Synthesis of F-12 2-(2',5'-Dichlorophenylthio)ethylamine (F-37) (250 mg) was mixed with 3'-methoxyacetophenone (0.15 ml). After adding titanium tetraisopropoxide (0.4 ml), the mixture was stirred for 3 hours. After adding ethanol (3 ml), sodium boron hydride (43 mg) was further added to the reaction mixture under ice-cooling. Then the mixture was brought to room temperature and stirred for hours. The reaction mixture was concentrated and ethyl acetate and water were added thereto. The insoluble matters were filtered off and the organic layer was washed with a saturated aqueous solution of sodium chloride, dried over sodium sulfate, filtered and concentrated. The crude product thus obtained was purified by column chromatography (silica gel, chloroform/methanol 50 1) to thereby give 248 methoxyphenyl) ethyl) (2',5'-dichlorophenylthio) ethylamine (F-i12) (146 mg).

MS mlz: 355 Example 417: Synthesis of F-13 The procedure employed for the synthesis of F-i 2 was repeated but replacing the 3'-m ethoxyacetophe none by 3',4'-dimehtoxyacetophenone to thereby give (3,4-dim ethoxyphenyl) ethyl) (2',51dichlorophenylthio)ethylamine (F-1 MS ml/z :385 Example 418: Synthesis of F-14 The procedure employed for the synthesis of F-i 2 was repeated but replacing the 3'-methoxyacetophenone by 3'-methylacetophenone to thereby give -(3-methylphenyl) ethyl) (2',5'-dichlorophenylthio)ethylamine (F- 14). MS m/z: 339 Example 419: Synthesis of The procedure employed for the synthesis of F-i 2 was repeated but replacing the 3'-methoxyacetophenone by 4'-methylacetophenone to thereby *6give (1 (4-methyl phenyl) ethyl) 5'-dichlorophenylthio) ethylamine (F- 13). MS m/z: 339 Example 420: Synthesis of F-i 6 The procedure employed for the synthesis of F-i 2 was repeated but replacing the 3'-m ethoxyacetophe none by 3' ,4',5'-trimethoxyacetophenone to thereby give (3,4,5-trimethoxyp henyl) ethyl) dichlorophenylthio)ethylamine (F-1 MS mlz: 415 Example 421: Synthesis of F-i 7 The procedure employed for the synthesis of F-i 2 was repeated but replacing the 3'-methoxyacetophenone by 4'-hydroxyacetophenone to thereby give (1 -(4-hyd roxyphe nyl) ethyl) 5'-d ich loro phenylth io) ethylanhin e (F-1 MS m/z: 341 Example 422: Synthesis of F-i 8 The procedure employed for the synthesis of F-i 2 was repeated but replacing the 3'-methoxyacetophenone by 3'-(trifluoromethyl)acetophenone to -249thereby give -(3-trifluo romethylphe nyl) ethyl) dichlorophenylthio)ethylamine MS mlz: 393 Example 423: Synthesis of F-21 The procedure employed for the synthesis of F-i 2 was repeated but replacing the 3'-methoxyacetophenone by 4'-hydroxy-3'methoxyacetophenone to thereby give -(4-hydroxy-3methoxyphenyl) ethyl) 5'-dich lorophenylthio) ethylam ine MS m/z: 371 Example 424: Synthesis of F-22 The procedure employed for the synthesis of F-i 2 was repeated but replacing the 3'-methoxyacetophenone by 4'-bromoacetophenone to thereby give -(4-bromophenyl)ethyl)-2-(2',5'-dichlorophenylthio)ethylamine (F- 22). MS mlz 405 Example 425: Synthesis of F-23 ::The procedure employed for the synthesis of F-i 2 was repeated but replacing the 3'-methoxyacetophenone by 3'-bromoacetophenone to thereby give -(3-bromophenyl) ethyl) ich lorophenylthio) ethylam ine (F- 23). MS m/z: 405 Example 426: Synthesis of F-24 The procedure employed for the synthesis of F-i 2 was repeated but replacing the 3'-methoxyacetophenone by 2'-bromoacetophenone to thereby give -(2-bromophenyl) ethyl) -2-(2',5'-dichlorophenylthio) ethylamine (F- 24). MS m/z: 405 Example 427: Synthesis of F-29 *.:The procedure employed for the synthesis of F-i 2 was repeated but replacing the 3'-methoxyacetophenone by 3',4'-dihydroxyacetophenone to thereby give (3,4-dihydroxyphenyl) ethyl) dichlorophenylthio)ethylamine MS m/z: 357 Example 428: Synthesis of The procedure employed for the synthesis of F-i 2 was repeated but replacing the 3'-methoxyacetophenone by 2',5'-dichloroacetophenone to 250 thereby give -(2,5-chlorophenyl) ethyl) dichlorophenylthio)ethylamine MS mlz 395 Example 429: Synthesis of F-31 The procedure employed for the synthesis of F-1 2 was repeated but replacing the 3'-methoxyacetophenone by 3'-f luoro-4'-methoxyacetophenone to thereby give (1 (3-fluoro-4-methoxyp henyl) ethyl) dichlorophenylthio)ethylamine MS m/z 373 Example 430: Synthesis of The procedure employed for the synthesis of F-i 2 was repeated but replacing the 3'-methoxyacetophenone by 3'-(trifluoromethoxy)acetophenone to thereby give (3-trifl uoromethoxyp henyl) ethyl) dichlorophenylthio)ethylamine MS mlz 409 (Mi).

Example 431: Synthesis of F-48 :::The procedure employed for the synthesisof F-1i2was repeated but 00 replacing the 3'-methoxyacetophenone by 3',4'-dimethylacetophenone to thereby give (3,4-dimethylphenyl) ethyl) 0dichlorophenylthio)ethylamine MS mlz 353 Example 432: Synthesis of F-49 0 0 0 0The procedure employed for the synthesis of F-i 2 was repeated but *0000 replacing the 3'-methoxyacetophenone by 2'-chloroacetophenone to thereby give (1 (2-ch lorophenyl) ethyl) ichlo roph enylth io) ethylam ine (F- 0000% 49). MS m/z: 359 0000 Example 433: Synthesis of 06400:The procedure employed for the synthesis of F-i 2 was repeated but replacing the 3'-methoxyacetophenone by 3'-chloroacetophenone to thereby give -(3-chlorophenyl) ethyl) 5'-d ichlorophenylthio) ethylamifle (F- MS mlz: 359 (M I.

Example 434: Synthesis of F-51 The procedure employed for the synthesis of F-12 was repeated but replacing the 3'-methoxyacetophenone by 4'-chloroacetophenone to thereby 251 give -(4-chlorophenyl)ethyl)-2-(2',5'-dichlorophenylthio)ethylamine (F- 51). MS m/z:359 Example 435: Synthesis of F-52 The procedure employed for the synthesis of F-12 was repeated but replacing the 3'-methoxyacetophenone by 3'-fluoroacetophenone to thereby give -(3-fluorophenyl)ethyl)-2-(2',5'-dichlorophenylthio)ethylamine (F- 52). MS m/z: 343 Example 436: Synthesis of F-53 The procedure employed for the synthesis of F-12 was repeated but replacing the 3'-methoxyacetophenone by 4'-fluoroacetophenone to thereby give (4-fluorophenyl)ethyl)-2-(2',5'-dichlorophenylthio)ethylamine (F- 53). MS m/z: 343 Example 437: Synthesis of F-54 The procedure employed for the synthesis of F-12 was repeated but replacing the 3'-methoxyacetophenone by 2',5'-dimethylacetophenone to thereby give -(2,5-dimethylphenyl)ethyl)-2-(2',5'dichlorophenylthio)ethylamine MS m/z: 353 Example 438: Synthesis of The procedure employed for the synthesis of F-12 was repeated but replacing the 3'-methoxyacetophenone by 2',4'-dimethylacetophenone to thereby give -(2,4-dimethylphenyl)ethyl)-2-(2',5'dichlorophenylthio)ethylamine MS m/z: 353 Example 439: Synthesis of F-57 The procedure employed for the synthesis of F-12 was repeated but replacing the 3'-methoxyacetophenone by 2',4'-dichloroacetophenone to thereby give -(2,4-dichlorophenyl)ethyl)-2-(2',5'dichlorophenylthio)ethylamine MS m/z: 395 Example 440: Synthesis of F-58 The procedure employed for the synthesis of F-12 was repeated but replacing the 3'-methoxyacetophenone by 3',4'-dichloroacetophenone to 252 thereby give (±)-N-(1-(3,4-dichlorophenyl)ethyl)-2-(2',5'dichlorophenylthio)ethylamine MS m/z: 395 Example 441: Synthesis of F-63 3'-Hydroxyacetophenone (200 mg) was dissolved in acetonitrile (4 ml).

After adding ethyl iodide (0.2 ml) and potassium carbonate (347 mg), the mixture was stirred at 70 °C for 9 hours. After 9 hours, water and ethyl acetate were added to the reaction mixture followed by separation. The organic layer was washed with a saturated aqueous solution of sodium chloride, dried over sodium sulfate, filtered and concentrated. The crude product thus obtained was purified by silica gel chromatography (n-hexane: ethyl acetate 8 1) to thereby give 204 mg of 3'-ethoxyacetophenone. The procedure employed for the synthesis of F-12 was repeated but replacing the 3'-methoxyacetophenone by 3'-ethoxyacetophenone to thereby give (±)-N-(1-(3-ethoxyphenyl)ethyl)-2- MS m/z: 369 Example 442: Synthesis of F-64 The procedure employed for the synthesis of 3'-ethoxyacetophenone was repeated but replacing the ethyl iodide by n-propyl iodide to thereby give 3'-n-propoxyacetophenone. The procedure employed for the synthesis of F-12 was repeated but replacing the 3'-methoxyacetophenone by 3'-npropoxyacetophenone to thereby give (±)-N-(1-(3-n-propoxyphenyl)ethyl)-2- (2',5'-dichlorophenylthio)ethylamine MS m/z: 383 Example 443: Synthesis of The procedure employed for the synthesis of 3'-ethoxyacetophenone was repeated but replacing the ethyl iodide by n-butyl iodide to thereby give 3'-n-butoxyacetophenone. The procedure employed for the synthesis of F-12 was repeated but replacing the 3'-methoxyacetophenone by 3'-nbutoxyacetophenone to thereby give (±)-N-(1-(3-n-butoxyphenyl)ethyl)-2- MS m/z: 397 (M Example 444: Synthesis of K-2255 The procedure employed for the synthesis of 3'-ethoxyacetophenone was repeated but replacing the ethyl iodide by n-hexyl bromide to thereby give 253 3'-n-hexyloxyacetophenone. The procedure employed for the synthesis of F- 12 was repeated but replacing the 3'-methoxyacetophenone by 3'-nhexyloxyacetophenone to thereby give (±)-N-(1-(3-n-hexyloxyphenyl)ethyl)-2- (K-2255). MS m/z 425 Example 445: Synthesis of F-67 The procedure employed for the synthesis of 3'-ethoxyacetophenone was repeated but replacing the ethyl iodide by isopropyl iodide to thereby give 3'-isopropoxyacetophenone. The procedure employed for the synthesis of F- 12 was repeated but replacing the 3'-methoxyacetophenone by 3'isopropoxyacetophenone to thereby give (±)-N-(1-(3-isopropoxyphenyl)ethyl)- 2-(2',5'-dichlorophenylthio)ethylamine MS m/z: 383 Example 446: Synthesis of F-68 ~The procedure employed for the synthesis of 3'-ethoxyacetophenone was repeated but replacing the ethyl iodide by dodecane iodide to thereby give 3'-dodecylxyacetophenone. The procedure employed for the synthesis of F-12 was repeated but replacing the 3'-methoxyacetophenone by 3'-ndodecyloxyacetophenone to thereby give dodecyloxyphenyl)ethyl)-2-(2',5'-dichlorophenylthio)ethylamine MS m/z 509 Example 447: Synthesis of F-69 The procedure employed for the synthesis of 3'-ethoxyacetophenone was repeated but replacing the ethyl iodide by isobutyl iodide to thereby give 3'-isobutoxyacetophenone. The procedure employed for the synthesis of F-12 was repeated but replacing the 3'-methoxyacetophenone by 3'isobutoxyacetophenone to thereby give (±)-N-(1-(3-isobutoxyphenyl)ethyl)-2- MS m/z: 397 Example 448: Synthesis of K-2258 The procedure employed for the synthesis of 3'-ethoxyacetophenone was repeated but replacing the ethyl iodide by 4-chrolobenzyl bromide to thereby give 3'-(4-chlorobenzyloxy)acetophenone. The procedure employed for the synthesis of F-12 was repeated but replacing the 3'- 254 methoxyacetophenone by 3'-(4-chlorobenzyloxy)acetophenone to thereby give -(3-(4-chlorobenzyloxy)phenyl)ethyl)-2-(2',5'dichlorophenylthio)ethylamine (K-2258). MS m/z: 465 Example 449: Synthesis of F-71 The procedure employed for the synthesis of 3'-ethoxyacetophenone was repeated but replacing the ethyl iodide by 2-chlorobenzyl bromide to thereby give 3'-(2-chlorobenzyloxy)acetophenone. The procedure employed for the synthesis of F-12 was repeated but replacing the 3'methoxyacetophenone by 3'-(2-chlorobenzyloxy)acetophenone to thereby give -(3-(2-chlorobenzyloxy)phenyl)ethyl)-2-(2',5'dichlorophenylthio)ethylamine MS m/z 465 Example 450: Synthesis of F-72 The procedure employed for the synthesis of 3'-ethoxyacetophenone was repeated but replacing the ethyl iodide by benzyl bromide to thereby give :3'-benzyloxyacetophenone. The procedure employed for the synthesis of F-1 2 was repeated but replacing the 3'-methoxyacetophenone by 3'benzyloxyacetophenone to thereby give -(3-benzyloxyphenyl) ethyl)-2- (2',5'-dichlorophenylthio)ethylamine MS m/z 431 Example 451: Synthesis of F-73 The procedure employed for the synthesis of 3'-ethoxyacetophenone was repeated but replacing the ethyl iodide by 2,6-dichlorobenzyl bromide to thereby give 3'-(2,6-dichlorobenzyloxy) acetophenone. The procedure employed for the synthesis of F-1 2 was repeated but replacing the 3'methoxyacetophenone by 3'-(2,6-dichlorobenzyloxy)acetophenone to thereby give -(3-(2,6-dichlorobenzyloxy) phenyl)ethyl) dichlorophenylthio)ethylamine MS m/z: 501 Example 452: Synthesis of K-2260 The procedure employed for the synthesis of 3'-ethoxyacetophenone was repeated but replacing the ethyl iodide by 1 -bromo-6-chlorohexane to thereby give 3'-(6-chlorohexyloxy)acetophenone. The procedure employed for the synthesis of F-12 was repeated but replacing the 3'-methoxyacetophenone -255 by 3'-(6-chlorohexyloxy)acetophenone to thereby give chlorohexyloxy) phenyl) ethyl)-2- (2',5'-dichlorophenylthio) ethylamine (K-2260).

MS m/z: 459 Example 453: Synthesis of The procedure employed for the synthesis of 3'-ethoxyacetophenone was repeated but replacing the ethyl iodide by 1 -bromo-6-chlorohexane to thereby give 3'-(2-chloroethoxy)acetophenone. The procedure employed for the synthesis of F-12 was repeated but replacing the 3'-methoxyacetophenone by 3'-(2-chloroethoxy)acetophenone to thereby give chloroethoxy)phenyl)ethyl)-2-(2',5'-dichlorophenylthio)ethylamine MS m/z: 403 Example 454: Synthesis of F-76 The procedure employed for the synthesis of 3'-ethoxyacetophenone was repeated but replacing the ethyl iodide by 2-methylbenzyl bromide to thereby give 3'-(2-methylbenzyl)acetophenone. The procedure employed for the synthesis of F-12 was repeated but replacing the 3'-methoxyacetophenone by 3'-(2-methylbenzyl)acetophenone to thereby give methylbenzyl)phenyl)ethyl)-2-(2',5'-dichlorophenylthio)ethylamine MS m/z: 445 Example 455: Synthesis of K-2268 The procedure employed for the synthesis of 3'-ethoxyacetophenone was repeated but replacing the ethyl iodide by 4-methylbenzyl bromide to thereby give 3'-(4-methylbenzyloxy)acetophenone. The procedure employed *for the synthesis of F-1 2 was repeated but replacing the 3'methoxyacetophenone by 3'-(4-methylbenzyloxy)acetophenone to thereby give (4-methylbenzyloxy) phenyl)ethyl)-2-(2',5'dichlorophenylthio)ethylamine (K-2268). MS m/z: 445 Example 456: Synthesis of F-78 The procedure employed for the synthesis of F-12 was repeated but replacing the 3'-methoxyacetophenone by 2-acetyl-5-methylfuran to thereby -256 give (5-methyl)furanyl)ethyl)-2-(2' ,5'-dichlorophenylthio) ethylamine MS m/z 329 Example 457: Synthesis of F-79 The procedure employed for the synthesis of F-12 was repeated but replacing the 3'-methoxyacetophenone by 2-acetylfuran to thereby give (1-(2-furanyl)ethyl)-2-(2',5'-dichlorophenylthio)ethylamine MS m/z 315 Example 458: Synthesis of The procedure employed for the synthesis of F-12 was repeated but replacing the 3'-methoxyacetophenone by 2-acetyl-1 -methylpyrrole to thereby give pyrrolyl)ethyl)-2-(2',5'-dichlorophenylthio)ethylamine MS m/z 328 Example 459: Synthesis of F-81 The procedure employed for the synthesis of F-12 was repeated but replacing the 3'-methoxyacetophenone by 2-acetylthiophene to thereby give -(2-thienyl)ethyl)-2-(2',5'-dichlorophenylthio)ethylamine MS m/z: 331 Example 460: Synthesis of F-82 The procedure employed for the synthesis of F-12 was repeated but replacing the 3'-methoxyacetophenone by 3-acetyl-2,5-dimethylfuran to *thereby give (±)-N-(1-(3-(2,5-dimethyl)furanyl)ethyl)-2-(2',5'dichlorophenylthio)ethylamine MS m/z: 343 Example 461: Synthesis of F-83 *The procedure employed for the synthesis of F-12 was repeated but replacing the 3'-methoxyacetophenone by 3-acetylthiophene to thereby give -(3-thienyl) ethyl)-2-(2',5'-dichlorophenylthio)ethylamine MS m/z 331 Example 462: Synthesis of F-84 The procedure employed for the synthesis of F-12 was repeated but replacing the 3'-methoxyacetophenone by 2-acetyl-5-methylthiophene to 257 thereby give (5-methyl)thienyl) ethyl) dichlorophenylthio)ethylamine MS mn/z 345 Example 463: Synthesis of The procedure employed for the synthesis of F-i 2 was repeated but replacing the 3'-methoxyacetophenone by 3-acetyl-1 -methylpyrrole to thereby give -methyl) pyrrolyl) ethyl) 5'-dich lorophenylthio) ethylami ne MS mlz 329 Example 464: Synthesis of F-86 The procedure employed for the synthesis of F-i 2 was repeated but replacing the 3'-methoxyacetophenone by 5-acetyl-2,4-dimethylthiazle to thereby give (2,4-d imethyl)th iazolyl) ethyl) dichlorophenylthio)ethylamine MS ml/z 360 ~:Example 465: Synthesis of The procedure employed for the synthesis of 3'-ethoxyacetophenone :was repeated but replacing the ethyl iodide by cyclohexylmethyl bromide to thereby give (cyclo hexyl meth oxybe nzyloxy) aceto phe none. The procedure employed for the synthesis of F-i 2 was repeated but replacing the 3'methoxyacetophenone by 3'-(cyclohexylmethoxybenzyloxy)-acetophenone to thereby give -(3-(cyclohexylmethoxybenzyoxy) phenyl) ethyl) dichlorophenylthio)ethylamine MS m/z 437 Example 466: Synthesis of F-91 The procedure employed for the synthesis of F-i 2 was repeated but replacing the 3'-methoxyacetophenone by 2-acetylpyridine to thereby give N* N(1 -(2-pyridyl) ethyl) 5'-dich lorophenylth io)ethylami ne MS mlz: 327 Example 467: Synthesis of F-92 The procedure employed for the synthesis of F-i 2 was repeated but replacing the 3'-methoxyacetophenone by 3-acetylpyridine to thereby give N- (i -(3-pyridyl) ethyl) 5'-dich loroph enylth io)ethylami ne MS mlz: 326 258 Example 468: Synthesis of F-93 The procedure employed for the synthesis of F-12 was repeated but replacing the 3'-methoxyacetophenone by 4-acetylpyridine to thereby give N-(1-(4-pyridyl)ethyl)-2-(2',5'-dichlorophenylthio)ethylamine MS m/z 326 Example 469: Synthesis of F-94 The procedure employed for the synthesis of F-12 was repeated but replacing the 3'-methoxyacetophenone by 2-acetylpyrazine to thereby give (±)-N-(1-(2-pyrazyl)ethyl)-2-(2',5'-dichlorophenylthio)ethylamine MS m/z: 327 Example 470: Synthesis of The procedure employed for the synthesis of F-12 was repeated but replacing the 3'-methoxyacetophenone by 3-acetyl-2- (methylaminesulfonyl)thiophene to thereby give methylaminosulfonyl)thienyl)ethyl)-2-(2',5'-dichlorophenylthio)ethylamine (F- MS m/z 425 Example 471: Synthesis of F-96 The procedure employed for the synthesis of F-12 was repeated but .replacing the 3'-methoxyacetophenone by 3-acetylindole to thereby give N-(1-(3-indolyl)ethyl)-2-(2',5'-dichlorophenylthio)ethylamine MS m/z 364 Example 472: Synthesis of F-97 Di(4-trifluoromethyl)benzylamine (450 mg) was dissolved in methylene chloride (10 ml) and bromoacetic acid (186 mg) was added thereto. After further adding WSC. HCI (390 mg), the reaction mixture was heated under reflux for 30 minutes. Then it was brought back to room temperature and separated into aqueous and ethyl acetate layers. The organic layer was washed with a saturated aqueous solution of sodium chloride, dried over sodium sulfate, filtered and concentrated. The crude product thus obtained was purified by silica gel chromatography (n-hexane ethyl acetate 3 1) to thereby give 510 mg of a bromo compound. This bromo compound (500 mg) 259 was dissolved in acetonitrile (10 ml) and potassium carbonate (763 mg) and (R)-(+)-1-(1-naphthyl)ethylamine (0.18 ml) was added thereto. After further adding tetrabutylammonium iodide (41 mg), the mixture was heated under reflux. After 2 hours, it was brought back to room temperature and separated into aqueous and chloroform layers. The organic layer washed with a saturated aqueous solution of sodium chloride, dried over sodium sulfate, filtered and concentrated. The crude product thus obtained was purified by silica gel chromatography (n-hexane ethyl acetate 2 1) to thereby give 280 mg of a F-97. MS m/z: 544 Example 473: Synthesis of F-98 The procedure employed for the synthesis of F-97 was repeated but replacing the di(4-trifluoromethyl)benzylamine by (4trifluoromethoxy)benzylamine to thereby give F-98. MS m/z 576 Example 474: Synthesis of F-99 The procedure employed for the synthesis of F-97 was repeated but replacing the bromoacetic acid by 5-bromopentanoic acid to thereby give F-99.

:00..0 MS m/z: 586 Example 475: Synthesis of F-100 The procedure employed for the synthesis of F-97 was repeated but replacing the di(4-trifluoromethyl)benzylamine by (4-chloro)benzylamine to °thereby give F-100. MS m/z: 476 Example 476: Synthesis of F-101 The procedure employed for the synthesis of F-99 was repeated but replacing the di(4-trifluoromethyl)benzylamine by di(4trifluoromethoxy)benzylamine to thereby give F-101. MS m/z: 618 Example 477: Synthesis of F-102 The procedure employed for the synthesis of F-98 was repeated but replacing the bromoacetic acid by 4-bromobutyric acid to thereby give F-102.

MS m/z 604 (M Example 478: Synthesis of F-103 260 The procedure employed for the synthesis of F-98 was repeated but replacing the bromoacetic acid by 6-bromohexanoic acid to thereby give F-103.

MS m/z: 632 Example 479: Synthesis of F-104 The procedure employed for the synthesis of F-103 was repeated but replacing the di(4-trifluoromethoxy)benzylamine by di(4trifluoromethyl)benzylamine to thereby give F-104. MS m/z: 600 Example 480: Synthesis of F-105 The procedure employed for the synthesis of F-101 was repeated but replacing the di(4-trifluoromethyl)benzylamine by di(4-chloro)benzylamine to thereby give F-105. MS m/z: 533 (M+1 Example 481: Synthesis of F-106 The procedure employed for the synthesis of F-102 was repeated but replacing the di(4-trifluoromethoxy)benzylamine by di(4-chloro)benzylamine to thereby give F-106. MS m/z 505 (M+1 Example 482: Synthesis of F-107 The procedure employed for the synthesis of F-99 was repeated but replacing the di(4-trifluoromethyl)benzylamine by di(4-chloro)benzylamine to thereby give F-107. MS m/z: 519 (M+1 Example 483: Synthesis of F-108 The procedure employed for the synthesis of F-98 was repeated but replacing the bromoacetic acid by 8-bromooctanoic acid to thereby give F-108.

MS m/z: 660 Example 484: Synthesis of F-109 The procedure employed for the synthesis of F-108 was repeated but replacing the di(4-trifluoromethoxy)benzylamine by di(4trifluoromethyl)benzylamine to thereby give F-109. MS m/z: 628 Example 485: Synthesis of F-110 The procedure employed for the synthesis of F-108 was repeated but replacing the di(4-trifluoromethyl)benzylamine by di(4-chloro)benzylamine to thereby give F-110. MS m/z 561 (M+1 261 Example 486: Synthesis of F- 11 The procedure employed for the synthesis of F-99 was repeated but replacing the di(4-trifluoromethyl)benzylamine by N-(4-trifluoromethylbenzyl)- N-(3,4-dichlorobenzyl)amine to thereby give F-111. MS m/z: 587 (M+1 Example 487: Synthesis of F-112 The procedure employed for the synthesis of F-103 was repeated but replacing the di(4-trifluoromethoxy)benzylamine by N-(4trifluoromethylbenzyl)-N-(3,4-dichlorobenzyl)amine to thereby give F-112. MS m/z 601 Example 488: Synthesis of F-113 The procedure employed for the synthesis of F-97 was repeated but replacing the di(4-trifluoromethyl)benzylamine by N-(4-trifluoromethylbenzyl)- N-(3,4-dichlorobenzyl)amine to thereby give F-113. MS m/z: 544 (M Example 489: Synthesis of F-1 14 The procedure employed for the synthesis of F-108 was repeated but replacing the di(4-trifluoromethoxy)benzylamine by N-(4trifluoromethylbenzyl)-N-(3,4-dichlorobenzyl)amine to thereby give F-114. MS m/z 628 Example 490: Synthesis of F-115 The procedure employed for the synthesis of F-102 was repeated but o**e replacing the di(4-trifluoromethoxy)benzylamine by N-(4trifluoromethylbenzyl)-N-(3,4-dichlorobenzyl)amine to thereby give F-115. MS m/z 572 Example 491: Synthesis of F-116 The procedure employed for the synthesis of F-115 was repeated but replacing the 4-bromobutyric acid by 12-bromododecanoic acid to thereby give F-116. MS m/z: 684 Example 492: Synthesis of F-117 The procedure employed for the synthesis of F-102 was repeated but replacing the di(4-trifluoromethoxy)benzylamine by dibenzylamine to thereby give F-117. MS m/z: 450 262 Example 493: Synthesis of F-118 The procedure employed for the synthesis of F-103 was repeated but replacing the di(4-trifluoromethoxy)benzylamine by dibenzylamine to thereby give F-118. MS m/z: 464 (M Example 494: Synthesis of F-119 The procedure employed for the synthesis of F-108 was repeated but replacing the di(4-trifluoromethoxy)benzylamine by dibenzylamine to thereby give F-119. MS m/z: 492 (M Example 495: Synthesis of F-120 The procedure employed for the synthesis of F-97 was repeated but replacing the di(4-trifluoromethoxy)benzylamine by dibenzylamine to thereby give F-120. MS m/z 408 (M Example 496: Synthesis of S-267 S-267 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol and S* (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 4-tert-butylthiophenol and (R)-(+)-l-(1-naphthyl)ethylamine. m/z 363.

Example 497: Synthesis of S-268 S-268 was synthesized by almost the same method as the one employed for the.synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1- °"bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 4-tert-butylthiophenol, 1,3-dibromopropane and naphthyl)ethylamine. m/z 377.

Example 498: Synthesis of S-269 S-269 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 4-tert-butylthiophenol, 1,4-dibromobutane and naphthyl)ethylamine. m/z 391.

Example 499: Synthesis of S-270 263 S-270 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 4-tert-butylthiophenol, 1,5-dibromopentane and naphthyl)ethylamine. m/z 405.

Example 500: Synthesis of S-271 S-271 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 4-tert-butylthiophenol, 1,6-dibromohexane and naphthyl)ethylamine. m/z 419.

Example 501: Synthesis of S-272 S-272 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine respectively by 4-tert-butylthiophenol, 1,7-dibromoheptane and naphthyl)ethylamine. m/z 433.

Example 502: Synthesis of S-273 S-273 was synthesized by almost the same method as the one employed for the synthesis of S-1 but replacing the 2,5-dimethylthiophenol, 1- *o bromo-2-chloroethane and (R)-(+)-3-methoxy-a-benzylmethylamine 9 respectively by 4-tert-butylthiophenol, 1,8-dibromooctane and naphthyl)ethylamine. m/z 447.

Example 503: Synthesis of S-274 S-274 was synthesized by almost the same method as the one employed for the synthesis of S-265 but replacing the K-2117 by K-2027. m/z 399.

Example 504: Synthesis of S-275 S-275 was synthesized by almost the same method as the one employed for the synthesis of S-265 but replacing the K-2117 by K-2076. m/z 433.

264 Example 505: Synthesis of S-276 S-276 was synthesized by almost the same method as the one employed for the synthesis of K-2310 but replacing the 4- (trifluoromethoxy)benzaldehyde by 4-dimethylaminobenzaldehyde.

Example 506: Synthesis of S-277 S-277 can be synthesized by almost the same method as the one employed for the synthesis of K-2310 but replacing the 4-methylbenzylamine and 4-(trifluoromethoxy)benzaldehyde respectively by 4-tert-butylbenzylamine and 3,4-dichlorobenzaldehyde.

Example 507: Synthesis of S-278 S-278 can be synthesized by almost the same method as the one employed for the synthesis of K-2310 but replacing the 4-methylbenzylamine and 4-(trifluoromethoxy)benzaldehyde respectively by 4-nitrobenzylamine and 3,4-dichlorobenzaldehyde.

Example 508: Synthesis of S-279 S-279 can be synthesized by almost the same method as the one employed for the synthesis of K-2310 but replacing the 4-methylbenzylamine and 4-(trifluoromethoxy)benzaldehyde respectively by 3,4dichlorobenzylamine and 4-dimethylaminobenzaldehyde.

Example 509: Synthesis of S-280 S-280 was synthesized by almost the same method as the one employed for the synthesis of K-2310 but replacing the 4- (trifluoromethoxy)benzaldehyde by 3,4-dimethoxybenzaldehyde.

Example 510: Synthesis of S-281 S-281 was synthesized by almost the same method as the one employed for the synthesis of K-2310 but replacing the 4-methylbenzylamine and 4-(trifluoromethoxy)benzaldehyde respectively by 4- (trifluoromethyl)benzylamine and 3,4-dimethoxybenzaldehyde.

Example 511: Synthesis of S-282 265 S-282 was synthesized by almost the same method as the one employed for the synthesis of K-2310 but replacing the 4- (trifluoromethoxy)benzaldehyde by 3,4-dimethylbenzaldehyde.

Example 512: Synthesis of S-283 S-283 was synthesized by almost the same method as the one employed for the synthesis of K-2310 but replacing the 4-methylbenzylamine and 4-(trifluoromethoxy)benzaldehyde respectively by 4- (trifluoromethyl)benzylamine and 3,4-dimethylbenzaldehyde.

Example 513: Synthesis of S-284 S-284 was synthesized by almost the same method as the one employed for the synthesis of K-2310 but replacing the 4i* (trifluoromethoxy)benzaldehyde by 3,4-methylenedioxybenzaldehyde.

Example 514: Synthesis of S-285 S-285 was synthesized by almost the same method as the one employed for the synthesis of K-2310 but replacing the 4-methylbenzylamine and 4-(trifluoromethoxy)benzaldehyde respectively by 4-tert-butylbenzylamine and 4-tert-butylbenzaldehyde.

Example 515: Synthesis of S-286 S-286 was synthesized by almost the same method as the one employed for the synthesis of K-2310 but replacing the 4- (trifluoromethoxy)benzaldehyde by 4-chlorobenzaldehyde.

Example 516: Synthesis of S-287 0* S-287 was synthesized by almost the same method as the one employed for the synthesis of K-2310 but replacing the 4-methylbenzylamine and 4-(trifluoromethoxy)benzaldehyde respectively by 4-chlorobenzylamine and 4-pyridinecarboxyaldehyde.

Example 517: Synthesis of S-288 S-288 was synthesized by almost the same method as the one employed for the synthesis of K-2310 but replacing the 4-methylbenzylamine and 4-(trifluoromethoxy)benzaldehyde respectively by 4- (trifluoromethyl)benzylamine and 4-pyridinecarboxyaldehyde.

-266- Example 518: Synthesis of S-289 S-289 can be synthesized by almost the same method as the one employed for the synthesis of K-2310 but replacing the 4-methylbenzylamine and 4-(trifluoromethoxy)benzaldehyde respectively by 3,4dichlorobenzylamine and 4-phenylbenzaldehyde.

Example 519: Synthesis of S-290 S-290 can be synthesized by almost the same method as the one employed for the synthesis of K-2310 but replacing the 4-methylbenzylamine and 4-(trifluoromethoxy)benzaldehyde respectively by 3,4dimethylbenzylamine and 4-phenylbenzaldehyde.

Example 520: Synthesis of S-291 S-291 can be synthesized by almost the same method as the one .\employed for the synthesis of K-2310 but replacing the 4-methylbenzylamine and 4-(trifluoromethoxy)benzaldehyde respectively by 3,4dimethoxybenzylamine and 4-phenylbenzaldehyde.

Example 521: Synthesis of S-292 S-292 can be synthesized by almost the same method as the one employed for the synthesis of K-2310 but replacing the 4-methylbenzylamine and 4-(trifluoromethoxy)benzaldehyde respectively by 3,4dichlorobenzylamine and 4-methylthiobenzaldehyde.

Example 522: Synthesis of S-293 S-293 can be synthesized by almost the same method as the one employed for the synthesis of K-2310 but replacing the 4-methylbenzylamine and 4-(trifluoromethoxy)benzaldehyde respectively by 3,4dimethylbenzylamine and 4-methylthiobenzaldehyde.

Example 523: Synthesis of S-294 S-294 can be synthesized by almost the same method as the one employed for the synthesis of K-2310 but replacing the 4-methylbenzylamine and 4-(trifluoromethoxy)benzaldehyde respectively by 3,4dimethoxybenzylamine and 4-methylthiobenzaldehyde.

267 Example 524: Synthesis of S-295 S-295 can be synthesized by almost the same method as the one employed for the synthesis of K-2310 but replacing the 4-methylbenzylamine and 4-(trifluoromethoxy)benzaldehyde respectively by 4- (trifluoromethyl)benzylamine and 3-chloro-4-fluorobenzaldehyde.

Example 525: Synthesis of S-296 S-296 can be synthesized by almost the same method as the one employed for the synthesis of K-2310 but replacing the 4- (trifluoromethoxy)benzaldehyde by 3-chloro-4-fluorobenzaldehyde.

Example 526: Synthesis of S-297 S-297 can be synthesized by almost the same method as the one employed for the synthesis of K-2310 but replacing the 4-methylbenzylamine and 4-(trifluoromethoxy)benzaldehyde respectively by 4- (trifluoromethyl)benzylamine and 4-chloro-3-nitrobenzaldehyde.

Example 527: Synthesis of S-298 S-298 can be synthesized by almost the same method as the one i employed for the synthesis of K-2310 but replacing the 4o* (trifluoromethoxy)benzaldehyde by 4-chloro-3-nitrobenzaldehyde.

Example 528: Synthesis of S-299 S-299 was synthesized by almost the same method as the one employed for the synthesis of K-2310 but replacing the 4-methylbenzylamine and 4-(trifluoromethoxy)benzaldehyde respectively by 4-chlorobenzylamine and 5-methyl-2-thiophenecarboxyaldehyde.

Example 529: Synthesis of S-300 S-300 was synthesized by almost the same method as the one employed for the synthesis of K-2310 but replacing the 4-methylbenzylamine and 4-(trifluoromethoxy)benzaldehyde respectively by 4- (trifluoromethyl)benzylamine and 5-methyl-2-thiophenecarboxyaldehyde.

Example 530: The activities of the compounds of the present invention on calcium receptors were measured. The measurement was performed in accordance 268 with the method described in Example 4 of Nemeth et al., PCT/US95/13704 (International Publication No. W096/12697). In brief, HEK293 cells were transfected with a plasmid pHuPCaR4.0 containing a human calcium receptor gene and loaded with fluo-3. The loading was carried out by incubating the cells at 37 °C for 1 hour in Dulbecco's modified Eagle's medium which contained about 5 [PM of fluo-3/AM and had been buffered with 20 mM HEPES.

Next, the cells were rinsed with Hank's balanced salt solution which contained 1 mM CaCl 2 and 1 mM MgCl 2 and had been buffered with 20 mM HEPES.

Then each test compound was added to the cells and the fluorescence was measured with the use of an excitation wavelength of 485 nm and an emission wavelength of 540 nm. The results are shown in Table 1.

269 Page(s)293-1 2 2 bare claims pages They appear after the table listings Table 1

S

S

Compound 2 6 8 12 14 16 18 20 22 24 26 28 30 32 34 36 38 42 44

EC

5 0(piLM) 13 7.6 1.9 1.0 1.2 2.9 0.55 0.75 3.2 0.31 0.44 1.8 1.6 0.071 0.051 0.71 0.21 0.98 5.1 0.14 0.15 Compound 46 52 53 56 59 62 65 68 71 74 77 80 83 88 93 103 106 109 112 117 123

EC

5 o( 1

IM)

0.93 0.48 1.6 0.28 1.02 0.509 0.524 0.65 0.27 7.2 0.464 3.2 0.11 0.3 0.064 0.27 0.078 0.2 0.1 270 Table 1 (cont.) Compound K-2003 K-2004 K-2005 K-2006 K-2007 K-2008 K-201 0 K-201 1 K-2012 K-201 5 K-201 6 K-2017 K-2018 K-2027 K-2030 K-2033 K-2034 K-2035 K-2040 K-2041 K-2045 K-2046 K-2047

EC

5 0(4tM) 0.29 0.42 0.43 0.77 0.47 0.86 0.14 0.21 0.87 0.49 0.36 0.36 0.33 0.39 0.049 0.35 0.061 0.22 0.08 0.1 0.87 0.14 0.13 Compound K-2048 K-2049 K-2050 K-2051 K-2052 K-2055 K-2056 K-2057 K-2058 K-2059 K-2061 K-2066 K-2075 K-2076 K-2078 K-2079 K-2080 K-2082 K-2084 K-2085 K-2087 K-2117 K-2177

EC

5 o( 1 iM) 0.73 0.83 0.55 0.34 5.7 0.057 0.039 0.41 0.39 0.27 0.15 0.26 0.14 6.2 0.17 0.2 0.77 2.81 0.12 0.13 0.087 0.043 0.075 271 Table 1 (cont.) Compound EC 5 o( 1 iM) Compound EC 5 0(tM)

C.

CC...

C

C

*CCC..

C

C.

C

C.

K-2240 K-2243 K-2246 K-2247 K-2248 K-2249 K-2250 K-225 1 K-2252 K-2253 K-2254 K-2255 K-2256 K-2257 K-2258 K-2259 K-2260 K-2261 K-2262 K-2263 K-2264 K-2265 K-2266 0.36 0.092 0.12 0.13 0.078 0.082 0.076 0.051 0.018 0.19 0.088 9.6 0.18 0.039 0.38 0.0024 0.096 0.026 0.084 0.11 0.016 0.061 0.036 K-2267 K-2268 K-2269 K-2270 K-2271 K-2272 K-2273 K-2274 K-2275 K-2276 K-2277 K-2278 K-2279.

K-2280 K-2281 K-2282 K-2283 K-2284 K-2285 K-2 28 6 K-2287 K-2288 K-2289 0.014 0.089 0.071 0.14 0.14 0.052 0.16 1.2 0.27 0.064 0.93 2.50 0.63 0.27 0.43 0.34 0.093 0.36 0.32 0.62 0.062 0.14 0.074 272 Table 1 (cont.) Compound K-2290 K-2291 K-2292 K-2293 K-2294 K-2295 K-2296 K-2297 K-2298 K-2299 K-2300 K-2301 K-2302 K-2303 K-2304 K-2305 ECso(,M) 0.1 0.081 0.074 0.28 0.062 1.36 0.22 0.23 0.34 0.15 0.14 0.8 0.5 0.35 0.098 0.11 Compound K-2306 K-2309 K-2310 K-2311 K-2312 K-2314 S-16 S-52 S-64 S-69 S-80 S-165 S-193 S-201 S-202 S-265

EC

5 o(M) 1.85 0.066 0.059 0.053 0.08 0.29 0.11 0.16 0.098 0.31 0.1 0.15 0.066 0.18 0.15 0.91 .*0 0 .000 a 006..

::0.0 0.a Example 531: The compound of the present invention was administered to rats so as to examine the effects of the compound on the plasma calcium ion level and serum PTH level. The test was performed by orally administering single dose of the compound of the invention or a control compound to normal male SD rats with six animals in each group.

To the group 1 was administered as a control a 10 cyclodextrin aqueous solution in a dose of 2.5 ml/kg. To the group 2 was administered as a reference (R)-N-(3-(2-chlorophenyl)propyl)-1-(3-methoxyphenyl)ethylamine (KRN568) dissolved in a 10 cyclodextrin aqueous solution in a dose of pmol/kg. To the group 3 was administered the compound of the present

I

273 invention dissolved in a 10 cyclodextrin aqueous solution in a dose of pmol/kg, provided that 1 sodium-CMC aqueous solution was used in place of cyclodextrin aqueous solution for the compounds marked with in Table 2.

Blood of each rat was collected from the tail tip before the administration and 30 minutes and 1, 2, 4, 8 and 24 hours thereafter (or at the time indicated in Table and the plasma Ca 2 level and serum PTH level were measured. The data of the serum PTH level were statistically processed by the multiple comparison analysis in accordance with Steel's calibration by using the group 1 as the control. The results are shown in Table 2 and Figs. 46-96.

S0

*S

274 Table 2 Compoun Plasma Ca 2 (mmol/) 0Ohr 1lhr 2 hr 4 hr 8 hr 24 hr 48 hr K-2027 mea 1.427 1.197 1.102 0.995 1.048 1.363 K-2052 n S. E.

mea n S. E.

mea n S. E.

0.010 1.425 0.015 1.470 p p p.

pp p p p p p p p p p p.

K-2087 K-2240 K-2247 0.008 mea 1.415 n S. E.

mea n S. E.

0.009 1.400 0.053 1.283 0.012 1.325 0.015 1.302 0.038 1.378 0.014 1.327 0.030 1.328 0.013 1.317 0.015 1.390 0.027 1.187 0.007 1.243 0.009 1.272 0.022 1.298 0.018 1.225 0.022 1.212 0.019 1.227 0.026 1.260 0.027 1.087 0.016 1.197 0.012 1.175 0.027 1.175 0.018 1.122 0.010 1.177 0.009 1.133 0.031 1.138 0.024 0.013 1.185 0.006 1.255 0.008 1.230 0.003 1.217 0.016 1.203 0.016 mea 1.457 K-2250 K-2255 K-2258 K-2262 n

S.E.

mea n

S.E.

0.014 1.413 0.020 mea 1.452 0.019 1.232 0.012 1.207 0.014 1.142 n

S.E.

mea 0.009 1.413 275 n

S.E.

K-2263 mea n

S.E.

K-2264** mea n

S.E.

0.020 1.423 0.011 1.403 0.015 0.009 1.273 0.028 1.335 0.019 0.021 1.237 0.024 1.203 0.019 0.017 1.212 0.016 1.013 0.019 0.020 1.308 0.011 0.998 1.182 0.021 0.027 1.240 a 0.017 276 Table 2 (cont.) Compoun Plasma Ca 2

(MMOIII)

0Ohr 1lhr 2 hr mea 1.425 1.430 1.363 K-2265 K-2266 n

S.E.

mea 0.019 1.417 K-2267 K-2269 n S.E. 0.020 mea 1.417 n S. E. 0.015 mea 1.450 n

S.E.

K-2270** mea n

S.E.

0.016 1.430 0.012 1.368 0.021 1.347 0.018 1.152 0.057 1.355 0.014 1.278 0.017 1.382 0.014 1.200 0.064 1.233 0.010 1.222 0.036 1.212 0.019 1.140 0.029 1.238 0.019 1.227 0.017 1.237 0.011 1.155 0.034 1.167 4 hr 1.260 0.023 1.065 0.023 1.027 0.016 1.097 8 hr 1.218 0.008 1.045 0.017 1.022 0.018 1.173 0.017 1.175 0.020 1.197 1.370 0.009 1.312 0.023 24 hr 48 hr 0.012 mea 1.428 K-2271 n S. E.

K'2272** mea n

S.E.

0.012 1.442 0.017 1.088 0.016 1.128 0.023 1.075 0.011 1.130 0.022 1.077 0.015 K-2279 K-2280 mea 1.443 n S.E. 0.014 mea 1.443 0.022 1.022 0.015 1.210 0.010 1.142 1.240 0.012 1.445 0.015 1.405 277 n S. E. 0.010 0.017 0.013 0.011 0.017 0.008 K-2281 mea 1.437 1.380 1.245 1.103 0.993 1 2 3 0 *b n S.E. 0.015 0.017 0.031 0.011 0.011 0.014 K-2282** mea 1.435 1.425 1.298 1.168 1.078 1 2 3 0 -b n S.E. 0.016 0.019 0.015 0.017 0.010 0.014 K-2283** mea 1.433 1.395 1.305 1.210 1.253 n S. E. 0.016 0.015 0.014 0.013 0.014 278 Table 2 (cont.) Compoun Plasma Ca 2 (MMOl/) 0 hr mea 1.428 1 hr 1.377 2 hr 4 hr 1.267 1.152 K-2284 K- 228 6 9. 9 .9 9 9

S.

9* 9 9 9 9.

9 9 999 0 09 .9.9 9**900 9 999 9 *99* *99.

9.

9. 9 99..

4 999999 9 90 9 99 99 n

S.E.

mea n

S.E.

mea n

S.E.

mea n 0.018 1.405 0.017 1.403 0.013 1.405 K-2287 K-2288 S. E. 0.012 K-289 mea n

S.E.

K-2290** mea n

S.E.

1 .407 0.011 1.318 0.015 1.180 0.019 1.190 0.018 1.270 0.018 1.428 0.014 1.298 0.041 1.375 0.007 1.245 0.025 1.218 0.018 1.042 0.017 1.057 0.020 1.173 0.022 1.248 0.028 1.247 0.022 1.252 0.012 1.152 0.025 1.088 0.021 0.955 0.019 0.955 0.018 1.003 0.017 1.063 0.019 1.130 0.021 1.152 0.015 1.068 8 hr 1.102 0.020 1.098 0.018 0.950 0.006 0.905 0.009 1.093 0.025 1.055 0.033 1.132 0.019 1.108 0.015 1.088 24 hr 48 hr 1.390 0.008 1.200 0.041 1.162 0.020 1.412 0.014 1.392 0.012 1.387 0.015 0.013 1.380 0.007 K-2291 K-2292 K-2293 mea 1.410 n

S.E.

mea n S. E.

mea 0.017 1.412 0.014 1.408 279 n S. E. 0.012 0.039 0.022 0.020 0.014 K-2294** mea 1.410 1.357 1.255 1.117 1.022 n S.E. 0.018 0.014 0.022 0.026 0.015 K-2296** mea 1.410 1.340 1.195 1.113 1.083 n S.E. 0.013 0.009 0.013 0.014 0.016 K-2297 mea 1.405 1.393 1.305 1.172 1.082 n S.E. 0.016 0.010 0.022 0.016 0.022 0 0 280 Table 2 (cont.) Compoun Plasma Ca 2 1 (MMOl/1) 0Ohr 1lhr 2 hr 4 hr 8 hr 24 hr 48 hr K-2298 K-2299 mea 1.405 1.348 1.265 1.187 1.100 n S. E.

mea n 0.015 1.395 S. E. 0.015 K-2300** mea 1.395 n

S.E.

mea K-2301 n S. E.

K-2302** mea n

S.E.

K-2303 mea n

S.E.

0.014 1.397 0.009 1.412 0.014 1.415 0.018 1.382 0.014 1.415 0.015 1.428 0.015 1.287 0.013 1.293 0.015 1.237 0.030 1.238 0.019 1.255 0.021 1.262 0.029 1.242 0.018 1.320 0.030 1.192 0.021 1.158 0.019 1.165 0.017 1.130 0.013 1.165 0.018 1.157 0.023 1.170 0.013 1.207 0.024 0.998 0.019 0.958 0.022 1.077 0.024 0.978 0.016 1.020 0.010 1.053 0.006 1.098 0.025 1.018 0.017 0.983 0.014 1.022 0.014 1.075 0.019 1.010 0.016 1.032 0.023 1.065 0.012 1.202 0.022 0.963 1 .382*c 0.013 1.397*C 0.020 1 .350&c 0.010 K-2304 K-2305 K-2309 mea n

S.E.

mea n

S.E.

mea 281 n S. E. 0.016 0.012 0.024 0.029 0.008 0.003 K-231 0 mea 1.428 1.342 1.188 1.008 0.943 1 3 3 0 d" n S. E. 0.014 0.014 0.025 0.026 0.013 0.014 K-231 1 ~Iea 1.447 1.375 1.232 1.075 1.110 n S. E. 0.014 0.011 0.012 0.016 0.034 KRN568 mea 1.378 1.305 1.237 1.290 1.340 n S.E. 0.018 0.014 0.008 0.012 0.015 NOTE: 31 hr, 27hr, 23hr, 28hr As these tables and figures clearly show, the compound of the present invention was able to lower the plasma Ca 2 level and serum PTH level in vivo.

282

Claims (2)

1. A compound having the formula: Arl-[CR' R2]p-X-[CR3 Rl-[CR5R]-NR7_[CR'R)-Ar2 wherein: Ar 1 is selected from the group consisting of aryl, heteroaril, bis(arylmethyl)amino, bis(heteroarylmethyl)amino and arylmethyl (heteroarylmethyl)amino; X is selected from the group consisting of oxygen/sulfur, sulfinyl, sulfonyl, carbonyl and amino; R1, R2, R R4 R R 6, R and R9 are indeperptently selected from the group consisting of hydrogen, alkyl, cycloalkyl, altenyl, alkynyl, trihalomethyl, aryl, heteroaryl, heteroalicyclic, halogen, hydroxy, alkoxy, thioalkoxy, aryloxy, thioaryloxy, carbonyl, thiocarbonyl, C-9rboxyl, O-carboxyl, C-amido, N-amido, O-carbamyl, N-carbamyl, O-thiocartlamyl, N-thiocarbamyl, cyano, nitro, amino and NRo 10 wherein, R' 0 and R" are independently %elected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, cyclo 1, aryl, carbonyl, trihaloacetyl, sulfonyl, trihalomethanesulfonyl any, combined, a five- or six-member heteroalicyclic ring containing at least obe nitrogen; any two adjacent groups may be combined to form five- or six-member fused cycloalkyl grotlps; R 7 is selected from the group consisting of hydrogen, alkyl, cycloalkyl, alkenyl, alkynyl, aryl, h$dogen, cyano, hydroxy, alkoxy, O-carboxyl, trihaloacetyl and trihalometharesulfonyl; Ar 2 is selected from the group consisting of aryl and heteroaryl; p is an jhteger of from 0 to 6, inclusive; and, q is ah integer of from 0 to 14, inclusive; or/a pharmaceutically acceptable salt or hydrate of said compound.

283- 2. The compound, salt or hydrate of claim 1 wherein: R 5 is selected from the group consisting of hydrogen, unsubstitutedfower alkyl and lower alkyl substituted with one or more halogens; and R 6 and R 7 are hydrogen. 3. The compound, salt or hydrate of claim 2 whereipTR 5 is hydrogen. 4. The compound, salt or hydrate of claim 3 wl'erein R 1 R 2 R 3 and R 4 are hydrogen. The compound, salt or hydrate of claim 4 wherein R 8 and R 9 are independently selected from the group consisting of hydrogen, unsubstituted alkyl, lower alkyl substituted with one qr more halogens, unsubstituted alkenyl, lower alkenyl substituted with one or/more halogens, unsubstituted alkynyl, alkynyl substituted with one or mo/e halogens and, combined, unsubstituted cycloalkyl and cycloalkeny. 6. The compound, salt 6r hydrate of claim 5 wherein Arl is selected from the group consisting of phenyl, naphthyl, indolyl, fluorenyl, dibenzofuranyl, carbazolyl, benzoxazo6-2-yl, benzthiazole-2-yl, pyridin-4-yl, quinolin-2-yl and dibenzylamino. 7. The corround, salt or hydrate of claim 6 wherein Arl is optionally substituted with one or more groups independently selected from the group consisting at halogen, unsubstituted lower alkyl, lower alkyl substituted with one or more halogens, hydroxy, unsubstituted lower alkoxy, lower alkoxy substitited with one or more halogens, nitro, unsubstituted phenyl and phenyl substuted with one or more groups selected from unsubstituted lower alkyl, ha4ogen, trihalomethyl and trihalomethoxy; d is hydrogen; and -284 R 9 is unsubstituted lower alkyl. 8. The compound, salt or hydrate of claim 7 wherein Ar 2 is selected from the group consisting of phenyl, naphthyl, quinolin-4-yl, pyridin-2hl, pyridin-3-yl, pyridin-4-yl, pyrimidinyl, furan-2-yl, furan-3-yl, thiophen-2-yl, ~iophen-3-yl, pyrrol-2-yl and pyrrol-3-yl. 9. The compound, salt or hydrate of claim 8 wherein: Ar 2 is optionally substituted with one or more group6 independently selected from the group consisting of unsubstituted mediytn alkyl, medium alkyl substituted with one or more halogens, hydroxf, unsubstituted medium alkoxy, medium alkoxy substituted with one or mor9'nalogens, halogen, unsubstituted benzyloxy, benzyloxy substituted with one or more groups independently selected from halogen and methyl. 10. The compound, salt or hydrAte of claim 6 or 7 wherein Ar 2 is selected from the group consisting of optibnally substituted phenyl and optionally substituted naphthyl. 11. The compound, soft or hydrate of claim 9 or 10 wherein Arl is phenyl substituted with one or/more groups selected from the group consisting of unsubstituted loweraKyl, halogen, trihalomethyl, unsubstituted lower alkoxy, trihalomethoxy, trjaloacetyl and nitro. 12. The compound, salt or hydrate of claim 11 wherein p is 1 and Ar 2 is selected frm the group consisting of 3-methoxyphenyl and unsubstituted naphthy' 13. The compound, salt or hydrate of claim 12 wherein q is an integer of fyom 1 to 8, inclusive. 285 14. The compound, salt or hydrate of claim 11 wherein 0 is 0, Ar 2 is 3- methoxyphenyl or unsubstituted naphthyl, and q is an integer of from 1 to 8, inclusive. The compound, salt or hydrate of claim 14vherein R 8 is hydrogen and R 9 is methyl. 16. The compound, salt or hydrate of claim 15 wherein X is selected from the group consisting of oxygen and sulfur. 17. The compound, salt or hydrate of claim 16 wherein said compound is the R enantiomer. 18. A prodrug of any of said compounds of claims 1 through 17, inclusive. 19. A compound of theformula: Ar3-(C 12)r-Q-(CH 2 )s-CHR13-NH-CR1 4 R 5 -Ar4 Swherein: Ar 3 is selected frorm the group consisting of aryl and heteroaryl optionally substituted with one or more groups independently selected from the group consisting of upsubstituted lower alkyl, lower alkyl substituted with one or more halogens, upsubstituted lower alkenyl, lower alkenyl substituted with one or more halogens, halogen, hydroxy, unsubstituted lower alkoxy, lower alkoxy substitLted with one or more halogens, unsubstituted lower thioalkoxy, nitro, formyl, acetoxy, acetyl, -CH 2 0H, CH 3 CH(OH)-, -C(=O)NH 2 cyano, -N(lower alkll) 2 phenyl, phenoxy, benzyl, benzyloxy, methylenedioxy, ethylenedioxy, a, p(-dimethylbenzyl, and -OCH 2 COOH; Ar 4 is selected from the group consisting of aryl and heteroaryl optionally substituted with one or more groups independently selected from the group consisting of unsubstituted lower alkyl, lower alkyl substituted with one or more 286 halogens, unsubstituted lower alkenyl, lower alkenyl substituted with one qr more halogens, unsubstituted lower alkoxy, lower alkoxy substituted with one or more halogens, hydroxy, lower thioalkoxy, halogen, methylenedioxy, ethylenedioxy, acetoxy, -OCH 2 COOH, -C(=O)NH 2 cyano, and -CHOH; r is an integer of from 0 to 6, inclusive; s is an integer of from 0 to 14, inclusive; Q is selected from the group consisting of oxygen, sulfur, carbonyl and -NH-; R 1 3 is hydrogen or lower alkyl; and R 1 4 and R 1 5 are independently selected from the group cpnsisting of hydrogen, alkyl and, combined, cycloalkyl and cycloalkenyl; or a pharmaceutically acceptable salt or hydrate of said compound. The compound, salt, hydrate or prodrug.Of claim 19 wherein: Ar 3 is selected from the groups consisting of unsubstituted phenyl, phenyl substituted with one or more groups selected from the group consisting of unsubstituted lower alkyl, lower alkyl substituted with one or more halogens, halogen, unsubstituted lower alkoxy, lower alkoxy substituted with one or more halogens, nitro, dimethylamino and unsubstituted phenyl, and optionally substituted naphthyl; Ar 4 is selected from the groups consisting of unsubstituted phenyl, phenyl substituted with one or more groups selected from the group consisting of unsubstituted lower alkyl,,iower alkyl substituted with one or more halogens, unsubstituted lower alkoxy, lower alkoxy substituted with one or more halogens, and halogen, and optionally substituted naphthyl; R 1 4 is selected from the group consisting of unsubstituted lower alkyl and lower alkyl substituted with one or more halogens; and R' 1 is hydrogen. 21. The compound, salt, hydrate or prodrug of claim 20 wherein: Ar 3 is selected from the groups consisting of unsubstituted phenyl, phenyl substituted with one or more groups selected from the group consisting of 287 unsubstituted lower alkyl, lower alkyl substituted with one or more halogens, halogen, unsubstituted lower alkoxy, lower alkoxy substituted with one or more halogens, nitro, dimethylamino and unsubstituted phenyl, and unstbstituted naphthyl; Ar 4 is selected from the groups consisting of unsubstituted phenyl, phenyl substituted with one or more groups selected from the group consisting of unsubstituted lower alkyl, lower alkyl substituted with one or more halogens, unsubstituted lower alkoxy, lower alkoxy substituted with one or more halogens, and halogen, and unsubstituted naphthyl; r is 0 or 1, wherein when r is 1, R 12 is hydrogen. 22. The compound, salt or hydrate of ofaim 21 wherein s is and integer of from 1 to 8, inclusive. 23. The compound, salt or hydrate of claim 21 wherein s is and integer of from 1 to 5, inclusive. 24. The compound, saft or hydrate of claim 23 wherein Q is selected from the group consisting of.oxygen and sulfur. 25. The compound, salt or hydrate of claim 24 wherein R 13 is selected from the group consisting of hydrogen and methyl. 26. The/compound, salt or hydrate of claim 25 wherein R 13 is hydrogen and R 14 is m9thyl. 27. The compound, salt or hydrate of claim 26 wherein said compound is the R enantiomer. 28. A prodrug of any of said compounds of claims 19 through 27, inclusive. 288 29. A compound of the formula: Ar 5 -(CHR 1 6 )t-W-(CH 2 )u-CHR 7 -NH-CH(R' 18 )-Ar wherein: Ar 5 is aryl, dicyclic or tricyclic heteroaryl, arylmethyl(arylmethy)amino, heteroarylmethyl (heteroarylmethyl)amino or arylmethyl (heteroarylmethyl)amino optionally substituted with one or more groups independently selected from the group consistng of unsubstituted lower alkyl, unsubstituted lower alkenyl, halogen, hydroxy, unsubstituted lower alkoxy, unsubstituted lower thioalkoxy, lower alkyl substituted with one or more halogens, lower alkenyl substituted with one orjnore halogens, lower alkoxy substituted with one or more halogens, nitro, formyl, acetoxy, acetyl, -CH 2 0H, CH 3 CH(OH)-, -C(=O)NH 2 cyano, -N(unsubstituted lower alkyl) 2 phenyl, phenoxy, benzyl, benzyloxy, a, a -dimethylbenzyl, methylenedioxy, ethylenedioxy and -OCH 2 COOH; Ar 6 is aryl or dicyclic or tricyclic heteroaryl optionally substituted with one or more groups independently selected from the group consisting of unsubstituted lower alkyl, lower alkyl substituted with one or more halogens, unsubstituted lower alkenyl, lower alkeyl substituted with one or more halogens, unsubstituted lower allloxy, lower alkoxy substituted with one or more halogens, halogen, lydroxy, unsubstituted lower thioalkoxy, lower thioalkoxy Ssubstituted with one or more halogens, benzyloxy, methylenedioxy, ethylenedioxy,.acetoxy, -OCH 2 COOH, -C(=O)NH 2 cyano, and -CH 2 0H; t is O or 1; u is an integer of from 0 to 11, inclusive; W is solected from the group consisting of oxygen, sulfur, sulfinyl, sulfonyl, cartonyl and amino; RP and R17 are H or unsubstituted lower alkyl; and R 1 8 is unsubstituted lower alkyl; or a pharmaceutically acceptable salt or hydrate of said compound. 289 The compound, salt or hydrate of claim 29 wherein: Ar 5 is phenyl, indole, benzothiazole, benzoxazole, dibenzofuran, capbazole, pyridine, fluorene, quinoline, naphthalene, chromenone, tetrahydrobenzothiazepine, dibenzylamino, benzyl(naphthylmethyl)amino, benzyl (pyridylmethyl)amino, thienylmethyl (benzyl)amino, furylmethyl(benzyl)amino or N-alkyl-pyrrolylmethyl(benzyj'amino optionally substituted with one or more groups independently selected from the group consisting of unsubstituted lower alkyl, halogen, unsuDstituted lower alkoxy, lower alkyl substituted with one or more halogens/lower alkoxy substituted with one or more halogens, nitro, dimethylamino ard unsubstituted phenyl; and Ar 6 is thiophene, furan, pyrrole, phenyl, naphthalene, pyridine, pyrazine or thiazole optionally substituted with one or4tnore groups independently selected from the group consisting of unsubstittted lower alkyl, halogen, unsubstituted lower alkoxy, lower alkyl substituted with one or more halogens, lower alkoxy substituted with one or more halogens, hydroxy and benzyloxy optionally substituted with halogen or methyl; R 16 and R 17 are H or methyl; and R' 8 is methyl. 31. The compound, salt or hydrate of claim 30 wherein: Ars is phenyl, benzothiazole, benzoxazole, dibenzofuran, carbazole, pyridine, quinoline or naphthalene optionally substituted with one or more groups independently selected from the group consisting of unsubstituted lower alkyl, halogen, upsubstituted lower alkoxy, lower alkyl substituted with one or more halogen sand lower alkoxy substituted with one or more halogens; Ar 6 is henyl or naphthalene, wherein said phenyl is optionally substituted with one.or more groups independently selected from the group consisting of ursubstituted lower alkoxy, lower alkoxy substituted with one or more halogens And benzyloxy optionally substituted with halogen or methyl: 290 t is O; u is an integer of from 1 to 8, inclusive; W is sulfur; and R 17 is H. 32. The compound, salt or hydrate of claim 31 wherein: Ar 5 is selected from the group consisting of phenyl optionafly substituted with one or more groups independently selected from the group consisting of unsubstituted lower alkyl, halogen, unsubstituted lower alkoxy, lower alkyl substituted with one or more halogens and lower aloxy substituted with one or more halogens; Ar 6 is 3-methoxyphenyl or a-naphthyl; and u is an integer of from 2 to 6, inclusive. 33. The compound, salt or hydrate of claim 30 wherein: Ar 5 is dibenzylamino, benzyl(napltthylmethyl)amino or benzyl(pyridylmethyl)amino optionally substituted with one or more groups independently selected from (he group consisting of unsubstituted lower alkyl, halogen, unsubstituted lower alkoxy, lower alkyl substituted with one or more halogens and lower alkoxy substituted with one or more halogens; Ar 6 is naphthyl or metfoxyphenyl; t is zero; u is an integer offrom 0 to 8, inclusive; W is carbony) and R 17 is H. 34. The compound, salt or hydrate of claim 33 wherein: Ars/s dibenzylamino optionally substituted with one or more groups independently selected from the group consisting of unsubstituted lower alkyl, halogen, unsubstituted lower alkoxy, lower alkyl substituted with one or more halogens and lower alkoxy substituted with one or more halogens; 291 Ar 6 is 3-methoxyphenyl or a-naphthyl; and u is 1. The compound, salt or hydrate claimed in any one of Qlaims 29-34 wherein said compound is the R enantiomer. 36. '-naphthyl) ethyl] (2',5'-dichoropher)ylthio) ethylamine, N- R) -1 -nap hthyl) ethyl] -N (trifl u oro methoxvYPhenyl]thio}PentyI) am in e, R)-1 -naphthyl) ethyl] -N-(4-114- (trifluoromethoxy) phenyllthiolbutyl)amine, N-{4,zt(2,4- dimethylphenyl)thio]butyl}-N-[(1 R)-1 -naplflhyl) ethyl] ami ne, R)-1 naphthyl) ethyl] (5-f{[4-(trifl uoro methyl) plnyl]thio}Pe ntyI) ami ne, R)-1 (1 -nap hthy) ethyl] -N -f4-[(2,4,5-trichlo ro ph eny) thio] butyIlam ine, chlorophenyl)thio]pentyl-N-[(l R) -1 (I'-nap hthyl) ethyl] am ine, dimethylphenyl)thiolpentyl-N-[(1 1-(1 -naphthyl) ethyl] amin e, R)-1 naphthyl) ethyl]-N- (trifluoroi'ethyl) phenyllthio}butyl)amine, N-{4-II(4- methylphenyl)thio]butyl}-N-[(1 i)-1 -naphthyl)ethyl]amine, chlorophenyI)thio]butyl-N-W R)-1 -naphthyl)ethyl]amine, R)-1 nap hthyl) ethyl] (6-f flI uoro methoxy) ph enyl]th io}hexyl) am ine, methoxyphenyl)thio]pentyl}-N-[(1 R)-1 -naphthyl)ethyllamine, R)-1 naphthyl) ethyl]- N-{5-f(2,4,5-trich lo roph enyl)th iol) pe ntyllami ne, R)-1 naphthyl) ethyl]-N-(4-{ [2,3,5 ,6-tetrafluoro-4- (trifluoromethyl),pnenyl]thiobutyI) amine, N-{5-[(2,5-dichlorophenyl)thiO]peltYl}- R)-1 -paphthyl) ethyl] amine, N-{5-[(4fuorophenyl)thio~pentyl}-N-[(l R)- 1 -nap hthyl) ethyl]lam ine, N-{6-[(4-chlorophenyl)thio]hexyl}-N-[(1 R)-1 naphthylydthyllamine, N-{4-[(3-methoxyphenyl)thiobutyl}-N-I(1R)-1 naphtbyl) ethyl]lamifnle, N-{5-[(4-methylphenyl)thio]pentyl-N-[(1 R)-1 napbthyl) ethyl]lami ne, N-{4-I(2,5-dichlorophenyl)thiobuty}-N-[(1 R)-1 nap hthyl) ethyl] am ine, R)-1 -naphthyl) ethyl] -N-(5-{[2,3,5,6-tetrafluoro-4 .ItrifluoromethyI) phenyl]thiolpentyl) amine, R)-1 -nap hthyl) ethyl]l-N- (7- {[2,3,5,6-tetrafluoro-4-(trifluoromethyl) phenyl]thiolheptyl)amine, 292 ethoxy-1 ,3-benzothiazol-2-y)thio]buty}-N-[(1 R)-1 -naphthyl) ethyl] arine, N- {[5-(3-methoxyphenyl)thio] pentyl}-N-[(1 R)-1 -nap hthyl) ethyl] amin. R)- 1 (1 -naphthyl) ethyl] (trifl uoromlethyl) phenyl]thiolpropyl) amnine, N- R)-i -naphthyl) ethyl] (trifluoromethyl) phenyi]thiolbutyI) amine, N- {4-[(4-fluorophenyl)thio]butyl}-N-[(1 R)-1 -naphthyl)ethyl]aniine, Ni methylbenzyl)-N 1 -[4-(trifluoromethoxy)benzyl]-3-I[(1 R)-1 ti naphthyl) ethyl] ami nolpropanamide, Ni ,i -di (4-methybenzyl)-3-{[(1 R)-1 naphthyl) ethyl]aminolpropanamide, Ni- (3,4-dichlorefbenzyl)-N 1-(4- methoxybenzyl)-3-{[(1 R)-1 -naphthyl) ethyl] am i Volpropanam ide, Ni methylbenzyl)-N 1 (trifl uo ro methyl) be nzyl]-3{( R)-i naphthyl)ethyllaminolpropaflamide, Ni -(3,4,.dichlorobenzy)-Nl1-[4- (trifluoromethyl) benzyl]-3-{[(i R)-i -napthyl) ethyllaminolpropanamide, Ni (4-chlorobenzyl)-Nl1 (4-methoxybenzy R)-i naphthyl)ethyl]amino}propanamide, r'cli-(4-chlorobenzyl)-N 1 dichlorobenzyl) R)-1 (1 -naph~yl) ethyl] aminolpropanamide, Ni .dich lo rob enzyl) -N 1 (trifl uoro rpethoxy) be nzyl) R)-i1 (1 ::naphthyl) ethyl] ami nolpro pan; rnid e, Ni1-(3,4-dichlorobenzyl)-N 1-(4- :methylbenzyl)-3-I[X1 R)-1 (1 .naphthyI) ethyl] aminolpropaflamide, Ni, Ni -di[4- (trifluoromethoxy) benzyljjo-{[(1 R)-1 -naphthyl) ethyl]laminolp ro palam ide, Ni1 (4-chlIo ro b enzyl) -N (trif u oro methyl) b en zyll R)-i1 (1 naphthy)ethy~aminl0propaflamlide, Ni -(4-methoxybenzyl)-Nl1-[4- *(trifl uorom ethyl) bgfhzyl]-3-{[(l R)-1 -nap hthyl) ethyl] ami no}p ropaflarnid e, Ni ,Ni A-di[4- (trifl~to rom ethyl) be nzyl] R)-i naphthyt)ethyllaminolpropaflamide, Ni, Ni -di(4-chlorobenzyl)-3-{[(i R)-i naphthyl)athiylanlpropaflamide, Ni ,Ni -di(4-methoxybenzyl)-3-{[(i R)-i naphthyl~ethyllaminolpropaflamfide, Ni -benzyl-Nl1-(3,4-dichlorobenzyl)-3- [(0RY1i -naphthyl) ethyl]lami nolp ropan am id e, Ni -(4-chlorobenzyl) -Ni naphithyl methyl) R)-i1 (1 -n aphthyl) ethyl] am inolpropaflamnide, Ni phlorobenzy)-Nl1-(4-chlorobenzyl)-3-{[ (1 R) -1 naphthyl)ethyllamilpropaflamide, Ni -benzyl-N 1 (4-ch lo robe nzyl) R)-1 (1 -nap hthyl) ethyl] ami nolp ropanlamlhide, Ni -(4-chlorobenzyl)-N 1-[4- 293 (trifluoromethoxy)benzyl]-3-{[(1 R)-1-(1-naphthyl)ethyl]amino}propanamide, op N1 ,N1-di(3,4-dichlorobenzyl)-3-{[(1 naphthyl)ethyl]amino}propanamide, or a salt or hydrate thereof. 37. A pharmaceutical composition comprising said compound, salt or hydrate of any of claims 1 through 36, inclusive. 38. A method of treating a patient comprising administring to said patient a therapeutically effective amount of one or more of said compounds of said claims 1 through 37. 39. The method of claim 38 wherein said patient is suffering from a disease or disorder characterized by either or both,of abnormal calcium homeostasis and, an abnormal amoAnt of an intracellular or extracellular messenger whose production can be affected by calcium receptor activity. S 40. A method for modulating the PTH level in a patient comprising administering to said patient an effective amount of said compound of claims 1 through 37. 41. The method ofclaim 40 wherein said effective amount of said compound of claims 1 through 37 reduces said PTH level in a patient. 42. The method of claim 41 wherein said patient has an abnormally high PTH level and effective amount of a compound of claims 1 through 37 reduces said PTH Jevel in said patient to a degree sufficient to cause a decrease in •plasma Ca2. 43. A method for reducing the PTH level in a patient to a level present in a normal individual comprising administering to said patient an effective amount of said compound of claims 1 through 37. 294 44. A method for modulating parathyroid hormone secretion in a patient comprising administering to said patient an effective amount of said compound of claims 1 through 37. The method of claim 44 wherein said effective amount/of said compound of claims 1 through 37 reduces said parathyroid/hormone secretion in said patient. 46. The method of claim 45 wherein said patient has an abnormally high parathyroid secretion and said therapeutically effective amount of said compound of claims 1 through 37 reduces said parathyroid hormone secretion in said patient to a degree sufficient to cause a decrease on plasma Ca 47. A method for modulating one or more Ca 2 receptors activities in a cell comprising administration of one orrnore of said compounds, salts, or hydrates of said claims 1 through 37 to said cell. 48. The method of claim 47 wherein said cell is a parathyroid cell, a juxtaglomerular kidney ceH, a proximal tubule kidney cell, a parafollicular thyroid cell, a bone osteoclast, a keratinocyte or a placental trophoblast. S 49. A method fW(r treating or preventing a disorder selected from the group consisting of hyperparathyroidism, renal osteodystrophy, hypercalcemia malignancy, osteoporosis, Paget's disease and hypertension comprising administering to a patient suffering from said disorder a therapeutically effective amount of said compound of claims 1 through 37. The method of claim 49 wherein said hyperparathyroidism is primary byperparathyroidism. 295 51. The method of claim 49 wherein said hyperparathyroidisrris secondary hyperparathyroidism. 52. A pharmaceutical composition for treatment of primary and secondary hyperparathyroidism comprising the compound, salt or hydrate claimed in any one of claims 29-36. 53. A pharmaceutical composition for treatphent of renalosteodystrophy comprising the compound, salt or hydrate c1aimed in any one of claims 29-36. 54. A pharmaceutical composition f'r treatment of hypercalcemia comprising the compound, salt or hydrate claimed in any one of claims 29-36. A pharmaceutical composition for treatment of hypercalcemia malignancy comprising the cofnpound, salt or hydrate claimed in any one of claims 29-36. 56. A pharmaceutioal composition for treatment of osteoporosis comprising the compound, salt Or hydrate claimed in any one of claims 29-36. 296 296a 57. Use of a compound according to any one of claims 1 to 36 in the preparation of a medicament for the treatment of a disease or disorder characterized by either or both of abnormal calcium horneostasis and, an abnormal amount of an intracellular or extracellular messenger whose production can be affected by calcium receptor activity. 58. Use of a compound according to any one of claims 1 to 36 in the preparation of a medicament for the treatment of b condition in which modulation of the PTH level in a patient would be beneficial 59. A use according to claim 58 whereir)'said medicament contains an amount to of compound according to any one of claims 1 to 36 effective to reduce said PTH level in said patient. A use according to claim 59' wherein said patient has an abnormally high PTH level and the amount of compound according to any one of claims 1 through 36 reduces said PTH level h said patient to a degree sufficient o cause a 15 decrease in plasma Ca 2 61. Use of a compgond according to any one of claims 1 to 36 in the preparation of a medicament for the treatment of a condition in which modulating parathyroid hormone secretion would be beneficial. 62. A use according to claim 61 wherein said medicament contains an amount 20 of compound according to any one of claims 1 to 36 effective to reduce said parathyroid hormone secretion in said patient. 5 63. A use according to claim 62 wherein said patient has an abnormally high parathyroid secretion and said amount of said compound according to any one of claims 1 through 36 reduces said parathyroid hormone secretion in said patient to a/degree sufficient to cause a decrease on plasma Ca 2 FT A.3597SPrCDOC -296b 64. Use of a compound according to any one of claims 1 and 36 in the preparation of a medicament for the treatment for prevehtion of a disorder selected from the group consisting of hyperparathyroidism, renal osteodystrophy, hypercalcemia malignancy, osteoporosis, Paget's disease and hypertension. 65. A use according to claim 64 wherein said hyperparathyroidism is primary hyperparathyroidism. 66. A use according to claim 64 wherein said hyperparathyroidism is secondary hyperparathyroidism. 67. A compound according to cJaim 1, 19, 29 or 36 substantially as hereinbefore described with reference to any of the examples. DATED: 21 September, 2001 SPHILLIPS ORMONDE FITZPATRICK Attorneys for: to 0 KIRIN BEER KABUSHIKI KAISHA and NPS PHARMACEUTICALS, INC 2530 FT AA3397SPDOC